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ABSTRACT
Chapter 1 describes the development of two organocatalytic processes. The first is a 13-
alkylation reaction of Michael acceptors, and represents a novel umpolung process catalyzed by
N-heterocyclic carbenes. The second section discusses the first successful phosphine-catalyzed,
y-alkylation reaction of isomerizable allenoates. A highly enantioselective variant of this reaction
is described.
Chapter 2 discusses nickel-catalyzed cross-coupling reactions of secondary propargylic
halides with a variety of organozinc nucleophiles. Section 2.2 describes progress toward an
asymmetric alkylation reaction. In Section 2.3, the development of the first alkyl-alkyl
secondary-secondary cross-coupling is described; Section 2.4 describes the application of this
coupling reaction to the formal synthesis of a-cembra-2,7,1 1-triene-4,6-diol. The last section of
this thesis (Section 2.5) discusses the development of the first asymmetric Negishi reaction of
arylzinc reagents with secondary electrophiles.
Thesis Supervisor: Gregory C. Fu
Title: Professor of Chemistry
Preface
Parts of this thesis have been adapted from the following articles written and co-written
by the author. The following articles were reproduced in part with permission from the American
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"Umpolung of Michael Acceptors Catalyzed by N-Heterocyclic Carbenes"
Fischer, C.; Smith, S. W.; Powell, D. A.; Fu, G. C. J. Am. Chem. Soc. 2006, 128, 1472-1473.
"Nickel-Catalyzed Asymmetric Cross-Couplings of Racemic Propargylic Halides with Arylzinc
Reagents"
Smith, S. W.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 12645-12647.
"Nickel-Catalyzed Negishi Cross-Couplings of Secondary Nucleophiles with Secondary
Propargylic Electrophiles at Room Temperature"
Smith, S. W.; Fu, G. C. Angew. Chem., Int. Ed. 2008, 47, 9334-9336.
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CHAPTER 1
Progress in Nucleophilic Catalysis
Section 1.1
Umpolung of Michael Acceptors Catalyzed by
N-Heterocyclic Carbenes
A. Introduction
Carbenes are amongst the most heavily investigated reactive species known to organic
chemists.' Carbenes are neutral compounds that possess a divalent carbon atom with an electron
sextet. 2 A unique subset of carbenes is known as N-heterocyclic carbenes, or NHCs. Scheme 1.1
illustrates the most common structural families of NHCs: thiazolylidene, imidazolinylidene,
imidazolylidene and triazolylidene.
Scheme 1.1. Most Common Types of N-heterocyclic Carbenes.
3 4 R3 4 3 4 3
SVN-R1  R2-NVN-R1 R2-NN-R1 'R2NN.0NR1
thiazolylidene imidazolinylidene imidazolylidene triazolylidene
One of the ever expanding applications of NHCs is their use as nucleophilic catalysts. 3
The earliest report of an N-heterocyclic carbene acting as a nucleophilic catalyst was by Ugai in
1943. He showed that naturally occurring thiamin (NHC1-HC1) catalyzes the self-condensation
of benzaldehyde to generate benzoin.4 A mechanistic proposal from Breslows5 (Scheme 1.2) in
1958 suggested that the free base of thiamin adds in a 1,2-fashion to the aldehyde, generating
tetrahedral intermediate I, which, following deprotonation, renders the nucleophilic intermediate
II. Upon condensation and proton transfer, the adduct III releases the thiamin catalyst and the
1 (a) de Fr6mont, P.; Marion, N.; Nolan, S. P. Coord. Chem. Rev. 2009, 253, 862-892. (b) Bourissou, D.; Guerret,
O.; Gabbal, F. P.; Bertrand, G. Chem. Rev. 2000, 100, 39-92.
2 For the first isolated carbenes, see: (a) Igau, A.; Grutzmacher, H.; Baceiredo, H.; Bertrand, G. J. Am. Chem. Soc.
1988, 110, 6463-6466. (b) Arduengo, A. J., III; Harlow, R. L.; Kline, M. J. Am. Chem. Soc. 1991, 113, 361-363.For recent reviews, see: (a) Enders, D.; Niemeier, O.; Henseler, A. Chem. Rev. 2007, 107, 5606-5655. (b) Marion,
N.; Diez-Gonzilez, S.; Nolan, S. P. Angew. Chem., Int. Ed. 2007, 46, 2988-3000. (c) Nair, V.; Bindu, S.; Sreekumar,
V. Angew. Chem., Int. Ed. 2004, 43, 5130-5135.
4 Ugai, T.; Tanaka, S.; Dokawa, S. J. Pharm. Soc. Jpn. 1943, 63, 269-300.
5 Breslow, R. J. Am. Chem. Soc. 1958, 80, 3719-3726.
product, benzoin. Although there was some debate6 about this mechanism, it is now widely
accepted.7
Scheme 1.2. Breslow Mechanism for the Thiamin-Catalyzed Benzoin Condensation.
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The study of NHCs as nucleophilic catalysts was a field that laid largely dormant for a
considerable number of years. This is possibly a result of the difficulties associated with the
synthesis and isolation of free carbenes. In the 1960's Wanzlick studied the chemistry of NHCs,
but never actually isolated them, often handling them in dimeric form.8 The first reports of
6 (a) Lemal, D. M.; Lovald, R. A.; Kawano, K. I. J. Am. Chem. Soc. 1964, 86, 2518-2519. (b) Castells, J.; L6pez
Calahorra, F.; Domingo, L. J. Org. Chem. 1988, 53, 4433-4436. (c) Castells, J.; Domingo, L.; L6pez Calahorra, F.;
Marti, J. Tetrahedron Lett. 1993, 34, 517-520.
7 (a) Yano, Y.; Tamura, Y.; Tagaki, W. Bull. Chem. Soc. Jpn. 1980, 53, 740-744. (b) Breslow, R.; Kool, E.
Tetrahedron Lett. 1988, 29, 1635-1638. (c) van der Berg, H. J.; Challa, G.; Pandit, U. K. J. Mol. Catal. 1989, 51, 1-
12. (d) Diederich, F.; Lutter, H. D. J. Am. Chem. Soc. 1989, 111, 8438-8446. (e) Breslow, R.; Kim, R. Tetrahedron
Lett. 1994, 35, 699-702. (f) Chen, Y.-T.; Barletta, G. L.; Haghjoo, K.; Cheng, J. T.; Jordan, F. J. Org. Chem. 1994,
59, 7714-7722. (g) L6pez Calahorra, F.; Rubires, R. Tetrahedron 1995, 51, 9713-9728. (h) L6pez Calahorra, F.;
Castro, E.; Ochoa, A.; Marti, J. Tetrahedron Lett. 1996, 37, 5019-5022. (i) L6pez Calahorra, F.; Castells, J.;
Domingo, L.; Marti, J.; Bofill, J. M. Heterocycles 1994, 37, 1579-1597. (j) Breslow, R.; Schmuck, C. Tetrahedron
Lett. 1996, 37, 8241-8242. (k) White, M. J.; Leeper, F. J. J. Org. Chem. 2001, 66, 5124-5131.
8 (a) Wanzlick, H.-W. Angew. Chem., Int. Ed. Engl. 1962, 1, 75-80. (b) Wanzlick, H.-W.; Kleiner, H.-J. Angew.
Chem., Int. Ed. Engl. 1964, 2, 65.
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stable, isolable carbenes by Bertrand 9 and Arduengo2b in the late 1980's and early 1990's
sparked a reinvigoration of interest in these unique organocatalysts.
The most extensive applications of NHCs in organocatalysis have been to variants of the
benzoin condensation (Scheme 1.3),1o the Stetter reaction (Scheme 1.4)," and the umpolung of
a,13-unsaturated aldehydes to generate homoenolates (Schemes 1.5 and 1.6).12 In addition to
inter- and intramolecular variants, the enantioselective benzoin reaction witnessed extraordinary
developments as well. 13'14 The Stetter reaction involves the same acyl anion intermediate (II) as
in the benzoin condensation, but here the electrophilic partner is a Michael acceptor, rather than
another aldehyde. The Stetter reaction has received at least as much attention' 5 as the benzoin
condensation, and it too has seen a large number of enantioselective variants.
Scheme 1.3. The Benzoin Condensation.
via: O
R2,
O cat. NHC OO R
O OH R1
R
Scheme 1.4. The Stetter Reaction.
via: 0
O 
3 R3 R 4
R1 R2  R4  cat. NHC R4 R2
R2 O
9 See reference 2a, and: Igau, A.; Baceiredo, A.; Trinquier, G.; Betrand, G. Angew. Chem., Int. Ed. Engl. 1989, 28,621-622.
10 (a) Enders, D.; Balensiefer, T. Acc. Chem. Res. 2004, 37, 534-541. (b) Johnson, J. S. Angew. Chem., Int. Ed. 2004,
43, 1326-1328. (c) Hassner, A.; Rai, K. M. L. Comp. Org. Syn. 1991, 1, 541-577.
11 Stetter, H.; Schreckenberg, M. Angew. Chem., Int. Ed. Engl. 1973, 12, 81.12 Zeitler, K. Angew. Chem., Int. Ed. 2005, 44, 7506-7510.
13 For the first asymmetric benzoin condensation, see: Sheehan, J.; Hunneman, D. H. J. Am. Chem. Soc. 1966, 88,3666.
14 (a) Enders, D.; Kallfass, U. Angew. Chem., Int. Ed. 2002, 41, 1743-1745. (b) Dvorak, C. A.; Rawal, V. H.
Tetrahedron Lett. 1998, 39, 2925-2928. (c) Gerald, A. U.; Lepper, F. J. Tetrahedron Lett. 1997, 38, 3615-3618.15 (a) Kerr, M. S.; Rovis, T. J. Am. Chem. Soc. 2004, 126, 8876-8877. (b) Kerr, M. S.; Rovis, T. Synlett 2003, 1934-
1936. (c) Kerr, M. S.; Read de Alaniz, J.; Rovis, T. J. Am. Chem. Soc. 2002, 124, 10298-10299.
Scheme 1.5. NHC-Promoted Generation of a Homoenolate.
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Perhaps the most diverse chemistry of NHC catalysis is the umpolung of a,p-unsaturated
aldehydes to generate homoenolates (Scheme 1.6). An astounding number of reactions have been
developed based on the addition of NHC-generated homoenolates to assorted electrophiles.
These reactions include, though are by no means limited to, the addition to: aldehydes, 16
imines, 17 1 ,2-cyclohexanedione, 18 a,P-unsaturated aldehydes' 9 and a,p-unsaturated ketones. 20
Also, homoenolate adducts have been shown to participate in Diels-Alder cycloaddition
reactions with electron-deficient olefins. 21
Other processes have also been examined with NHCs as nucleophilic catalysts, including
transesterification reactions, 22 ring-opening reactions 23 and polymerization reactions, 24 among
others.
16 (a) Burstein, C.; Glorius, F. Angew. Chem., Int. Ed. 2004, 43, 6205- 6208. (b) Sohn, S. S.; Rosen, E. L.; Bode, J.
W. J. Am. Chem. Soc. 2004, 126, 14370-14371. (c) Burstein, C.; Tschan, S.; Xie, X.; Glorius, F. Synthesis 2006,
2418-2439.
17 He, M.; Bode, J.W. Org. Lett. 2005, 7, 3131-3134.
18 Nair, V.; Vellalath, S.; Poonoth, M.; Mohan, R.; Suresh, E. Org. Lett. 2006, 8, 507-509.
19 Sohn, S. S.; Bode, J. W. Org. Lett. 2005, 7, 3873-3876.20 Nair, V.; Vellalath, S.; Poonoth, M.; Suresh, E. J. Am. Chem. Soc. 2006, 128, 8736-8737.
21 He, M.; Strubble, J. R.; Bode, J. W. J. Am. Chem. Soc. 2006, 128, 8418-8420.
22 (a) Grasa, G. A.; Kissling, R. M.; Nolan, S. P. Org. Lett. 2002, 4, 3583-3586. (b) Nyce, G.W.; Lamboy, J. A.;
Connor, E. F.; Waymouth, R. M.; Hedrick, J. L. Org. Lett. 2002, 4, 3587-3590. (c) Movassaghi, M.; Schmidt, M. A.
Org. Lett. 2005, 7, 2453-2456.
23 For the opening of meso-epoxides, see: Zhou, H.; Campbell, E. J.; Nguyen, S. T. Org. Lett. 2001, 3, 2229-2231.
For the opening of aziridines, see: Wu, J.; Sun, X.; Ye, S.; Sun, W. Tetrahedron Lett. 2006, 47, 4813-4816.
24 For reviews on the topic, see: (a) Dove, A. P.; Pratt, R. C.; Lohmeijer, B. G. G.; Culkin, D. A.; Hagberg, E. C.;
Nyce, G. W.; Waymouth, R. M.; Hedrick, J. L. Polymer 2006, 47, 4018-4025. (b) Coulembier, O.; Geg6e, P.;
Hedrick, J. L.; Dubois, P. Prog. Polym. Sci. 2006, 31, 723-747.
Scheme 1.6. The Diverse Chemistry of NHC-generated Homoenolates.
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In addition to being interesting nucleophilic catalysts, carbenes have also attracted a great
deal of attention in the context of ligands for metals.25 In 2003, Dr. Matthias Eckhardt in the Fu
group demonstrated, for the first time, that a carbene could serve as an excellent ligand in the
palladium-catalyzed Sonogashira reaction between terminal alkynes and alkyl bromides and
iodides (eq 1.1).26
2.5% [(7r-allyl)PdCl] 2
5.0% NHC2-HCI
Ralkyl-X ---- R 1  ,0
7.5% Cul
X = Br, I 1.4 equiv Cs 2CO 3
DMF/Et 20, 45 "C
Ralkyl R 1
14 examples
50-79% yield
/-\ Cl O
R2-N ,~NR2
R2 = 1-adamantyl
NHC2-HCI
25 For comprehensive reviews, see: (a) Diez-Gonzilez, S.; Marion, N.; Nolan, S. P. Chem. Rev. 2009, 109, in press.
(b) Herrmann, W. A. Angew. Chem., Int. Ed. 2002, 41, 1290-1309.26 Eckhardt, M.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 13642-13643.
0
cross-condensation
enal-1,2-dione
O
R
R
(1.1)
That carbenes could be used as ligands in coupling reactions of P-hydrogen containing
electrophiles was surely in the mind of Dr. Dave Powell of the Fu group in 2004. During his
studies toward the development of a Heck reaction 27 between alkyl halides and electron-deficient
olefins,28 he included them as ligands in his broad screen of reaction conditions. It was the
incorporation of the NHC IMes as a ligand that led to the observation of product formation for
the first time, in 1.2% yield by GC (eq 1.2). In short order, Dr. Powell conducted control
experiments that revealed that product was generated more efficiently in the absence of
palladium (24%, eq 1.2)!
0 2.5% Pd2dba 3  CC
/ Et 10% IMes-HCI OEt Mes-N NMes
10% KOt-Bu IMes.HCI
OTs 2.0 equiv K3PO 4
THF, 60 OC 1.2% yield by GC
without Pd2 dba3: 24% yield by GC
The fact that this transformation was occurring in the absence of palladium was quite
unexpected. It seemed necessary that the NHC itself was catalyzing this reaction. Our
mechanistic hypothesis for this remarkable carbene-catalyzed cyclization is presented in Scheme
1.7. The catalyst (Nu:) adds to the electrophilic P carbon of the a,3-unsaturated ester, generating
an enolate (A). Tautomerization then affords B, in which the P carbon is now nucleophilic. This
represents an umpolung,2 9 as the P carbon of an a,3-unsaturated ester is generally electrophilic.30
Intramolecular displacement of the pendant leaving group results in ring formation (C); base
mediated elimination releases the product and regenerates the active catalyst.
Dr. Powell moved quickly on this result and screened a variety of related, commercially
available, NHC ligands (the free carbenes were generated in situ from the azolium salts via
deprotonation with KOt-Bu). Table 1.1 illustrates the activity Dr. Powell observed for a selection
of common NHCs in this transformation.
27 For a review of the Heck reaction, see: (a) Beletskaya, I. P.; Cheprakov, A. V. Chem. Rev. 2000, 100, 3009-3066.
(b) Brase, S.; de Meijere, A. In Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., Eds.;
Wiley-VCH: New York, 2004; Chapter 5.
28 For the development of an alkyl Heck reaction of unactivated alkenes, see: Firmansjah, L.; Fu, G. C. J. Am. Chem.
Soc. 2007, 129, 11340-11341.
29 (a) Seebach, D. Angew. Chem., Int. Ed. Engl. 1979, 18, 239-258. (b) Umpoled Synthons; Hase, T. A., Ed.; Wiley:
New York, 1987.
30 For processes in which a nucleophilic catalyst promotes a-nucleophilicity (the Morita-Baylis-Hillman reaction),
see: Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811-892.
Scheme 1.7. Possible Mechanism for Carbene-catalyzed P-Alkylations of Michael Acceptors.
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Table 1.1. Initial NHC-HX Examined in the Cyclization Reaction.
0
OU
/ OEt
OTs
10% NHC'HX
10% KOt-Bu
2.0 equiv K2C0 3
THF
OEt
entry NHC-HX temperature (°C) GC yield (%)
1 IMes.HCI 25 10
2 IMes-HCI 60 24
3 IPr.HCI 60 2
4 SIMes.HBF4  60 11
5 SIPr-HBF4 60 0
CI
Mes- NN Mes
IMes.HCI
SBF4
Mes- NN;NMes
SIMes-HBF 4
CIl
ArN ,N-Ar
Ar = 2,6-(i-Pr)-C6H3
IPr-HCI
BF4
Ar-N N'Ar
Ar = 2,6-(i-Pr)-C 6 H3
SIPr-HBF4
Dr. Powell continued to optimize this reaction, examining the impact of various reaction
parameters on product formation. Inorganic bases such as K3PO4, Cs 2CO3 and Rb2CO 3
consistently outperformed amine and guanidine bases. Upon inspection of other potential
NHC.HX precatalysts, both commercially available and easily synthesized ones, Ender's
triazolium carbene precursor 31 NHC7-HC10 4 proved to be best (Table 1.2, entry 6).
Table 1.2. Additional NHC.HX Examined in the Cyclization Reaction.
0
/ OEt
OTs
10% NHC-HX
10% KOt-Bu
2.0 equiv K3PO 4
THF, 60 °C
o
I Et
entry NHC-HX
1 NHC1-HCI
2 NHC3-HCI
3 NHC4-HCI
4 NHC5-HCI
5 NHC6.HCI
6 NHC7-HCIO 4
C\ N CIE)
NHC3"HCI
C G
NHC5.HCI
Me
HO H (CI
.S, NH2
NHC1-HCI /
N
Me
GC yield (%)
0
<5
0
0
0
34
cle
NHC4.HCI
Me E
HO Ph
NHC6-HCI
Ph e
I=N C10 4
Ph~ NN -ph
NHC7-HCO 4
Additional optimization of the reaction conditions with NHC7-HC10 4 proved fruitful. In
fact, simply changing the reaction solvent from THF to dioxane, and increasing the reaction
31 See reference 10, also: (a) Enders, D.; Breuer, K.; Raabe, G.; Runsink, J.; Teles, J. H.; Melder, J.-P.; Ebel, K.;
Brode, S. Angew. Chem., Int. Ed. Engl. 1995, 34, 1021-1023. See also: (b) Walentowski, R.; Wanzlick, H.-W. Z.
Naturforsch., B: Chem. Sci. 1970, 25, 1421-1423.
temperature from 60 C to 80 OC resulted in a dramatic improvement in yield. It was also
observed that when using NHC7-HC10 4, KOt-Bu was no longer necessary to generate the free
carbene. Under these new conditions, the reaction then gave 82% of the desired product (eq 1.3).
o 0
SOEt 10% NHC7-HCIO 4  ,OEt (1.3)
2.5 equiv K3PO4
OTs ioxane80C 82% isolated yield
B. Results and Discussion
It was with this very promising starting point by Dr. Powell that I began my work in the
Fu group in January of 2005. I was given the task of determining the scope of this reaction and
finalizing the reaction conditions. Joining me in this endeavor was Dr. Christian Fischer, who
had just recently completed the first catalytic, asymmetric cross-coupling reaction (see Chapter
2, introduction).
In his final report, Dr. Powell made reference to the sensitivity of this reaction, to both
oxygen and water. For although NHC-HX, are stable to air, the free NHCs are not. Immediately
after we began this project it was clear this was no case of understatement. The reproducibility
observed during optimization of this reaction, as well as with our final conditions (vide infra),
depended greatly on the quality of the anhydrous solvents used, and the expulsion of all moisture
from the solid components. Upon depletion of the supply of K3P0 4 used by Dr. Powell, we
immediately encountered serious reproducibility problems. After extensive investigation of the
proper preparation and quality of various reagents, we began productive study of the scope of
this transformation. It should be noted that, for best results, the K3P0 4 used in these
transformations must be finely ground, dried in a vacuum oven at 150 oC for 24 hours and stored
in a N2-filled glovebox.
Of immediate interest to us was the expansion of the scope of this reaction beyond a,3-
unsaturated ethyl esters. We envisioned that a number of traditional Michael acceptors should
participate in this intriguing cyclization reaction. Gratifyingly, an array of newly prepared
Michael acceptors readily participated in the umpolung process. An exception to this general
observation was that under Dr. Powell's reaction conditions, the cyclization to form a six-
membered ring was not efficient (12% yield, eq 1.4).
o 0
/ OEt 10% NHC7-HCIO 4  I Et (1.4)
OTs 2.5 equiv K3PO 4dioxane, 80 *C
12% GC yield
Thus, in parallel to our preparation of an array of possible substrates, we also devoted
time to surveying alternative reaction conditions to ensure we were working with ideal
conditions. We hypothesized that perhaps a related NHC catalyst might be able to overcome the
shortcomings of NHC7-HC10 4. Effort was focused on the preparation of new NHC-HX
compounds in the hope that we could find a catalyst capable of facilitating the six-membered
ring closure. Early into these efforts we were rewarded with a promising catalyst, NHC8. The
synthesis of NHC8-HC10 4 is presented in Scheme 1.8. The addition of 4-methoxyaniline to
benzoyl chloride cleanly generates N-(4-methoxyphenyl)benzamide, which can be converted into
an imidoyl chloride through use of PC15 at 80 oC. The crude imidoyl chloride is then condensed
with the hydrochloride salt of (4-methoxyphenyl)hydrazine to access the immediate
NHC8*HCIO 4 precursor. The triazolium synthesis is completed upon treatment of this material
with acetic anhydride and formic acid; exchange of the counter-ion provides NHC8-HC10 4 in
analogous fashion to the method reported by Enders.
Scheme 1.8. Synthesis of NHC8*HC10 4.
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Preparation of trianisyl-substituted variant NHC9-HC10 4 was carried out following this
same route. Attempts to prepare the dimethylamino-variant (NHC10-HC10 4) of this catalyst
were unsuccessful, as the final triazolium-forming step failed. This failure was attributed to the
basic dimethyl amines.
MeO
e EC104 C104
N-N 
N-MeO -r I NO - OMe Me2N OP NO1 NMe 2
NHC9-HCIO 4  NHC10.HCIO 4
In any event, with NHC8-HCIO4 in hand, we were able to finalize a single set of reaction
conditions capable of facilitating the cyclization of an array of substrates. Table 1.3 illustrates
our conditions, as well as the effect of various parameters on the efficiency of this
transformation. Upon examination of Table 1.3, it is clear that the reactivity of the five- and six-
membered ring substrates is markedly different. As previously discussed NHC7-HC10 4 works
quite well for the five-membered ring closure (91%), but not for the six-membered ring closure
(37%). Other NHC catalysts are also ineffective at catalyzing this process (entries 4 and 5). A
range of alternative classes of nucleophilic catalysts were also found incapable of promoting this
transformation (entries 6-10). Once we had sorted out our base preparation and drying procedure,
we found that other inorganic bases could also be used under these reaction conditions (entry
11), but stronger bases such as KOt-Bu were completely ineffective. As held true for a wide
range of reaction parameters, the dependence on solvent for the five-membered ring cyclization
differed from that for the six-membered ring (entries 13 and 14). Neither ring closure was
possible at room temperature, and control reactions showed no reaction in the absence of catalyst
or base (entries 16-18).
Table 1.3. The Effect of Various Reaction Parameters on the NHC-Catalyzed P-Alkylation of a
Michael Acceptor.
j C O 2E t  10% NHC8-HCIO 4  CO 2E t
Br 2.5 equiv K3PO 4
n glyme, 80 *C n
yield (%)a
entry change from standard conditions n = 1 n = 2
1 no change 92 85
2 10% NHC9.HCIO 4 instead of 10% NHC8.HCIO 4  88 85
3 10% NHC7.HC1O 4 instead of 10% NHC8.HCIO 4  91 37
4 10% IMes.HCI instead of 10% NHC8.HCIO 4  5 5
5 10% NHC5.HCI instead of 10% NHC8.HCIO 4  < 1 < 1
6 10% DABCO instead of 10% NHC8-HCIO 4  < 1 < 1
7 10% DMAP instead of 10% NHC8.HCIO 4  < 1 < 1
8 10% quinidine instead of 10% NHC8*HCIO 4  < 1 < 1
9 10% PBU3 instead of 10% NHC8-HC1O 4  < 1 < 1
10 10% PPh 3 instead of 10% NHC8-HCIO 4  < 1 < 1
11 2.5 Cs 2 CO 3 instead of 2.5 K3PO 4  87 65
12 2.5 KOt-Bu instead of 2.5 K3PO4  < 1 < 1
13 dioxane instead of glyme 91 70
14 EtOAc instead of glyme 89 60
15 DMA instead of glyme 5 4
16 rt instead of 80 OC 16 2
17 no NHC8-HC1O 4  <1 <1
18 no K3PO4  <1 <1
a Determined by calibrated GC analysis, average of two experiments.
With our final conditions in hand we completed our determination of the scope of this
reaction (Table 1.4). With respect to the leaving group, not only bromides (entry 1), but tosylates
(entry 2) and even chlorides (entry 3) perform well. In addition to the a,p-unsaturated ethyl ester,
a,0-unsaturated allyl esters (entry 4), Weinreb amides (entry 5), and nitriles (entries 6 and 7)
cyclize with good efficiency. We are also able to prepare an oxygen heterocycle via this
procedure (entry 8). As previously mentioned, six-membered rings are accessible (entry 9).
Interestingly, even four-membered rings can be generated, although the yield is somewhat lower
(entry 10).
Table 1.4. Scope of the NHC-Catalyzed P-Alkylation of Michael Acceptors.
EWG
jX
n
10% NHC8-HCIO 4
2.5 equiv K3P04
glyme, 80 °C
EWG
n
entry starting material reaction time (h) yield (%)a
1 (X = Br)
2 (X = OTs)
3 (X = Cl)
4
O
OEt
0
B~r__ 
_
0
5 N Oe 16 68
Me
CN
6 (X = Br) 8 71
O -Br
9 / OEt 16 81
Br
0
10 33 48b/ Et
Br
a Isolated yield (average of two experiments).
was used, with dioxane as the solvent.
b 20% NHC8-HCIO
4
According to our proposed mechanism (Scheme 1.7), a tautomerization should take place
between the initial addition adduct A and the f-nucleophilic intermediate B. To lend some
support to this proposal, we examined the deuterium-exchange process illustrated in eq 1.5.
Under our final reaction conditions, NHC8-HC10 4 promotes a significant amount of scrambling
between the a and p position. This is in sharp contrast to the result with a common nucleophilic
catalyst, PBu3, in which essentially no exchange is observed.
90% D 48% D
o0 0
D/H OMe  10% NHC8-HCIO4 D/H OMe (1.5)
Pentyl 2.5 equiv K3PO 4  Pentyl D/H
glyme, 80 °C
42% D
with 10% PBu3: < 3% D in the 0 position
As one might expect, there are a number of limitations to the cyclization reaction. Even
with the more active NHC8-HC10 4, and our best efforts, there were a variety of substrates which
did not undergo cyclization. Some of these are illustrated in Scheme 1.9. Alkyl ketones not only
did not cyclize, but under the final reaction conditions led to a number of unidentified
decomposition products. Although we had success with formation of an oxygen heterocycle,
nitrogen-containing substrates often decomposed under the reaction conditions. Attempts to
perform a Claisen-type reaction were unsuccessful as well. Interestingly, the six-membered ring
precursor bearing an alkyl chloride, rather than bromide, was completely unreactive. Seven- and
eight-membered rings are not accessible via this route either. Extensive attempts were made to
accomplish an intermolecular variant of this new reaction. In no instance was any desired
product observed, no matter the type of alkyl halide used.
Scheme 1.9. Inefficient Substrates for the Umpolung Cyclization Reaction.
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C. Conclusion
In conclusion, we have demonstrated that, for a range of Michael acceptors, a
nucleophilic NHC is capable of catalyzing a unique intramolecular cyclization reaction which
most likely proceeds via an umpolung process. Our proposed mechanism includes an
unprecedented tautomerization which renders the normally electrophilic P-carbon of the a,p-
unsaturated Michael acceptor nucleophilic and allows for an intramolecular P-alkylation to take
place. This process was found to be amenable to a,f-unsaturated esters, amides, and nitriles; also
a variety of ring sizes may be constructed this way.
D. Experimental
I. General
Unless otherwise noted, all reactions were carried out in oven-dried glassware under an
atmosphere of argon. THF and CH2C1 2 were purified by passage through an alumina column as
described by Grubbs. 32 All chemicals were used without further purification, unless otherwise
noted. Melting points were measured on a Hoover melting apparatus and are uncorrected.
The NHC-catalyzed 13-alkylations are moisture sensitive. Therefore, before use, the
K3PO4 must be dried in a vacuum oven at 150 oC for 24 hours (course K3PO4 , e.g.; from Strem
or Alfa-Aesar, must be ground into a fine powder prior to drying). The dry K3PO4 is stored in a
glovebox
II. Preparation of Substrates and Catalysts
These procedures have not been optimized.
Preparation of cyclization precursors (representative procedure): A 100-mL flask
was charged with pyridinium chlorochromate (2.6 g, 12 mmol), evacuated, and back-filled with
argon. To the orange solid were added CH2C 2 (50 mL) and the bromoalcohol (10 mmol). The
resultant dark-brown mixture was stirred for 3 hours at r.t., and then Et20 (50 mL) was added,
leading to the precipitation of a brown solid. After standing at r.t. for 2 h the crude aldehyde was
filtered through a plug of silica gel under vacuum (washed with Et20). The green solution was
concentrated and placed in a 100-mL flask under argon. After the addition of THF (50 mL) the
Wittig reagent (14 mmol) was added in one portion at r.t.33 The reaction mixture was then
adsorbed onto silica gel and purified by flash chromatography (hexanes/ethyl acetate or
pentane/diethyl ether) to give the cyclization precursors as oils.
32 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518-
1520.
33 Generally, the pre-formed phosphonium ylid was used. If the Wittig or Wittig-Horner reagent was generated in
situ, the crude aldehyde was added to this mixture at -78 C and then allowed to warm to r.t.
0
OEt
Br
(E)-Ethyl-7-bromohept-2-enoate [CAS# 111710-77-1]. Prepared from 5-bromopentan-
1-ol (TCI) and (carbethoxymethylene)triphenylphosphorane (Alfa-Aesar) by the representative
procedure.
'H NMR (CDCl 3, 500 MHz) 6 6.98-6.91 (m, 1H), 5.86-5.82 (m, 1H), 4.22-4.17 (m, 2H),
3.44-3.40 (m, 2H), 2.27-2.22 (m, 2H), 1.92-1.86 (m, 2H), 1.67-1.60 (m, 2H), 1.31-1.28 (m, 3H).
O
OEt
OH
(E)-Ethyl-7-hydroxyhept-2-enoate [CAS# 96251-91-1]. Prepared from
tetrahydropyran-2-ol according to a literature procedure. 34 Into a dried round bottom flask
equipped with a magnetic stirbar and under an argon atmosphere was added tetrahydropyran-2-ol
(2.40 g, 23.5 mmol), carboethoxymethylene triphenylphosphorane (11.2 g, 32.1 mmol; Alfa-
Aesar) and CH2CI 2 (60 mL). The light yellow solution was stirred at room temperature for 48
hours and then concentrated. The resulting solid was taken up in 7:3 hexanes:Et 20 (60 mL), and
the suspension was stirred at room temperature for 30 minutes, and then was filtered through
filter paper on a Hirsch funnel, and was washed with hexanes. The clear filtrate was concentrated
to an oil and purified by column chromatography through silica gel, eluting with 70:30
hexanes:EtOAc to give 3.33 g (82%) of the title compound as a light yellow oil. Analysis by 1H
NMR revealed the product was obtained as an 8:1 mixture of E:Z stereoisomers.
'H NMR (CDCl 3, 500 MHz, major isomer) 6 6.93 (dt, J= 15.5, 7.0 Hz, 1H), 5.80 (dt, J=
15.5, 1.5 Hz, 1H), 4.15 (q, J= 7.0 Hz, 2H), 3.62 (t, J= 6.0 Hz, 2H), 2.25-2.18 (m, 2H), 1.93 (br
s, 1H), 1.60-1.50 (m, 4H), 1.26 (t, J= 7.0 Hz, 3H).
34 Pandey, G.; Hajra, S.; Ghorai, M. K.; Kumar, K. R. J. Org. Chem. 1997, 62, 5966-5973.
0OEt
OTs
(E)-Ethyl-7-(tosyloxy)hept-2-enoate [CAS# 173043-75-9]. A solution of 7-
hydroxyhept-2-enoic acid (3.00 g, 17.4 mmol) and pyridine (2.80 mL, 34.8 mmol) in CH2C12 (30
mL) was cooled to 0 oC in an ice bath, and tosyl chloride (5.0 g, 26 mmol) was added over a 10
minute period. The suspension was stirred at 0 'C for 1 hour, warmed to r.t., and stirred at this
temperature for 16 hours. The reaction mixture was then poured into a 250-mL separatory funnel
that contained aqueous HCI (1.0 M; 150 mL) and extracted with Et20 (3 x 50 mL). The
combined organic layers were washed with brine (50 mL), dried over MgSO 4, filtered, and
concentrated. Purification by column chromatography (90:10 hexanes:EtOAc) gave 3.58 g (63%)
of the desired product as a colorless oil.
'H NMR (CDC13, 500 MHz) 6 7.80 (d, J= 8.2 Hz, 2H), 7.37 (d, J = 8.2 Hz, 2H), 6.91-
6.85 (m, 1H), 5.79-5.70 (m, 1H), 4.22-4.17 (m, 2H), 4.06-4.03 (m, 2H), 2.47 (s, 3H), 2.19-2.06
(m, 2H), 1.71-1.66 (m, 2H), 1.53-1.47 (m, 2H), 1.32-1.28 (m, 3H).
O
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(E)-Ethyl-7-chlorohept-2-enoate [CAS# 107408-35-5]. Prepared from 5-chloropentan-
1-ol (Lancaster) and (carbethoxymethylene)triphenylphosphorane (Alfa-Aesar) by the
representative procedure.
'H NMR (CDC13, 500 MHz) 6 6.96-6.90 (m, 1H), 5.85-5.81 (m, 1H), 4.20-4.16 (m, 2H),
3.55-3.52 (m, 2H), 2.23 (q, J= 7.3 Hz, 2H), 1.82-1.76 (m, 2H), 1.65-1.59 (m, 2H), 1.30-1.26 (m,
3H).
0Br
(E)-Allyl-7-bromohept-2-enoate. Prepared from 5-bromopentan-l-ol (TCI) and allyl
P,P-diethylphosphonoacetate (Aldrich) by the representative procedure.
'H NMR (CDC13, 500 MHz) 6 7.00-6.94 (m, 1H), 6.12-6.09 (m, 1H), 5.98-5.90 (m, 1H),
5.88-5.84 (m, 1H), 5.25-5.23 (m, 1H), 4.64-4.61 (m, 2H), 3.42-3.39 (m, 2H), 2.27-2.22 (m, 2H),
1.91-1.85 (m, 2H), 1.66-1.60 (m, 2H).
13C NMR (CDCl 3, 125 MHz) 6 166.1, 148.7, 132.2, 121.5, 118.1, 64.9, 33.2, 32.0, 31.2,
26.4.
IR (film) 2940, 2864, 1718, 1654, 1438, 1362, 1252, 1175, 1134, 1026, 988, 932 cm' .
HRMS (EI) calcd for C10H 15BrO 2 (M+) 246.0250, found 246.0230.
O
N,OMe
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(E)-7-Bromo-N-methoxy-N-methylhept-2-enamide. Prepared from 5-bromopentan-1-
ol (TCI) and N-methoxy-N-methyl-2-(triphenyl-phosphoranylidene)acetamide (Fluka) by the
representative procedure.
'H NMR (CDC13, 500 MHz) 6 6.98-6.94 (m, 1H), 6.43 (d, J= 6.6 Hz, 1H), 3.71 (s, 3H),
3.44-3.41 (m, 2H), 3.25 (s, 3H), 2.29 (q, J= 7.0 Hz, 2H), 1.93-1.88 (m, 2H), 1.66-1.63 (m, 2H);
13C NMR (CDCl 3, 125 MHz) 6 167.0, 146.9, 119.4, 61.9, 33.6, 32.5, 32.3, 31.7, 26.9.
IR (film) 3054, 2986, 2969, 2940, 2863, 2360, 2306, 1662, 1629, 1460, 1421, 1384,
1265, 1180, 996 cm- .
HRMS (EI) calcd for C9H 6BrNO 2 (M+) 249.0359, found 249.0491.
CN
Br
(E)-7-Bromohept-2-enenitrile [CAS# 99765-31-8]. Prepared from 5-bromopentan-l-ol
(TCI) and (cyanomethyl)triphenylphosphonium chloride (Alfa-Aesar) by the representative
procedure. 35
1H NMR (CDC13, 300 MHz) 6 6.75-6.69 (m, 1H major), 6.53-6.44 (m, 1H minor), 5.36-
5.30 (m, 1H major+minor), 3.42 (q, J = 6.3 Hz, 2H major+minor), 2.47 (q, J = 6.3 Hz. 2H
minor), 2.26 (q, J = 7.2 Hz, 2H) major), 1.91-1.86 (m, 2H major+minor), 1.68-1.60 (m, 2H
major+minor).
13C NMR (CDC13, 125 MHz) 6 155.6, 154.8, 118.0, 101.0, 100.9, 33.8, 33.6, 33.0, 32.5,
32.5, 31.6, 27.3, 26.8.
CN
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(E)-6-Cyanohex-5-enyl 4-methylbenzenesulfonate. Prepared from the monotosylate of
1,5-dihydroxypentane 36 and (cyanomethyl)triphenyl-phosphonium chloride (Alfa-Aesar) by the
representative procedure. 37
'H NMR (CDC13, 500 MHz) 6 7.79 (d, J= 8.2 Hz, 2H major+minor), 7.37 (d, J= 8.2 Hz,
2H major+minor), 6.67-6.61 (m, 1H major), 6.46-6.40 (m, 1H minor), 5.33-5.28 (m, 1H
major+minor), 4.06-4.03 (m, 2H major+minor), 2.47 (s, 3H major+minor), 2.40 (q, J = 8.2 Hz,
2H minor), 2.23-2.18 (m, 2H major), 1.71-1.65 (m, 2H major+minor), 1.56-1.49 (m, 2H
major+minor).
13C NMR (CDCl 3, 125 MHz) 6 155.4, 154.6, 145.6, 133.6, 130.6, 130.5, 128.6, 128.5,
117.9, 101.1, 101.0, 70.5, 70.4, 33.2, 33.1, 31.7, 28.8, 24.8, 24.2, 22.3.
IR (film) 3055, 2987, 2305, 1722, 1712, 1598, 1422, 1358, 1265, 1177 cm-1.
LRMS (ESI) calcd for C14H17NNaO3S (M+Na ) 302.1, found 302.1.
35 Compound was isolated and used in a 2:1, (E):(Z), isomeric mixture.
36 Prepared according to: Bouzide, A.; Sauv6, G. Org. Lett. 2002, 4, 2329-2332.
37 Compound was isolated and used in a 1.7:1, (E):(Z), isomeric mixture.
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(E)-Ethyl 4-(2-bromoethoxy)but-2-enoate [CAS# 439665-65-3].38
1H NMR (CDC13, 500 MHz) 6 6.96-6.92 (m, 1H), 6.12-6.09 (m, 1H), 4.23-4.19 (m, 4H),
3.80 (t, J= 6.1 Hz, 2H), 3.49 (t, J= 6.1 Hz, 2H), 1.31-1.27 (m, 3H).
O
(E)-Ethyl-8-bromooct-2-enoate. Prepared from 6-bromohexan- -ol (TCI) and
(carbethyoxymethylene)triphenyl-phosphorane (Alfa-Aesar) by the representative procedure.
IH NMR (CDCl 3, 500 MHz) 5 6.94 (dt, J= 15.6, 7.0 Hz, 1H), 5.82 (ddd, J= 15.6, 1.5,
0.9 Hz, 1H), 4.20-4.16 (m, 2H), 3.42-3.39 (m, 2H), 2.24-2.20 (m, 2H), 1.90-1.84 (m, 2H), 1.51-
1.45 (m, 4H), 1.30-1.27 (m, 3H).
13C NMR (CDC13, 125 MHz) 6 166.6, 148.7, 121.6, 60.2, 33.6, 32.5, 31.9, 27.6, 27.1,
14.2.
IR (film) 2981, 2936, 2860, 1717, 1655, 1463, 1445, 1367, 1308, 1268, 1241, 1221,
1187, 1134, 1096, 1043, 981 cm -1.
HRMS (EI) calcd for C10H 17BrO2 (M+) 248.0406, found 248.0411.
38 Prepared according to: Lautens, M.; Paquin, J.-F.; Piguel, S. J. Org. Chem. 2002, 67, 3972-3974.
0OEt
Br
(E)-Ethyl-6-bromohex-2-enoate [CAS# 71032-10-5]. Prepared from 4-bromobutan- 1-ol
(TCI) and (carbethoxymethyl-ene)triphenylphosphorane (Alfa-Aesar) by the representative
procedure.
1H NMR (CDC13, 300 MHz) 6 6.98-6.91 (m, 1H), 5.91-5.85 (m, 1H), 4.20 (q, J= 7.1 Hz,
2H), 3.42 (t, J= 6.3 Hz, 2H), 2.40-2.36 (m, 2H), 2.06-2.00 (m, 2H), 1.29 (t, J = 7.1 Hz, 3H).
Ph C10OE
MeO N N'OMZe
NHC8-HC10 4. A 500-mL flask was charged with N-(4-methoxyphenyl)benzamide (24.9
g, 0.109 mol; TCI) and PC15 (22.9 g, 0.110 mol), evacuated, and back-filled with argon. The
flask was fitted with a nitrogen-filled balloon and the mixture heated to 80 oC. Gas evolution
was observed and the yellow-green solution was stirred for 90 minutes. The reaction mixture
was cooled to r.t., and the volatiles were removed under reduced pressure. Solidification
occurred and a green solid was obtained which was used directly in the next step without
purification (1H NMR analysis indicated complete conversion to the imidoyl chloride).
To the green solid was added THF (150 mL) and NEt3 (42 mL, 0.30 mol) which led to
discoloration. To the suspension was added 1-(4-methoxyphenyl)hydrazine hydrochloride (19.3
g, 0.110 mol; TCI) as a slurry in THF (100 mL) via a solid addition funnel slowly over the
course of 30 minutes. The yellow suspension was stirred at r.t. for 18 h, then the volatiles were
completely removed on a rotary evaporator. Acetic acid (2% aqueous solution, 200 mL) was
added and the mixture stirred vigorously. The mixture was extracted with CH 2C12 (5 x 100 mL),
and the combined extracts washed with brine and dried over Na2SO 4. Solvent evaporation gave
a red oil/foam. The material (A) was used without purification in the subsequent step.
In a separate 500-mL 2-necked flask was mixed acetic anhydride (150 mL) and formic
acid (75 mL) under argon. The mixture was heated to 60 oC for 20 minutes, then cooled to r.t.
and transferred to A via cannula under argon. The red solution was stirred for 36 h at r.t. The
volatiles were subsequently removed on a rotary evaporator and high vacuum. To the crude
material was added perchloric acid (35% aqueous solution, 150 mL) and CH 2C12 (150 mL). The
mixture was stirred vigorously and after 30 minutes the layers were separated. The aqueous
layer was extracted with CH 2C 2 (3 x 100 mL) and the combined organic layers washed with
brine, then dried over Na2SO 4 . Solvent evaporation gave a red oil which was dried on high
vacuum for two days. Purification of the triazolium salt was achieved by repeated slow
crystallization from acetone/diethyl ether at -20 oC. 39 The obtained crude triazolium perchlorate
was further purified by recrystallization 40 from CH 2C12 to give the title compound (4.81 g, 10%
over all steps) as a colorless fluffy solid.
mp: 220 'C (methylene chloride);
1H NMR (DMSO-d6, 500 MHz) 6 11.16 (s, 1H), 8.00 (d, J= 8.8 Hz, 2H), 7.64-7.54 (m,
7H), 7.31 (d, J= 8.9 Hz, 2H), 7.20 (d, J= 8.8 Hz, 2H), 3.89 (s, 3H), 3.84 (s, 3H).
13C NMR (DMSO-d 6, 125 MHz) 6 162.2, 161.9, 154.3, 133.4, 130.4, 130.4, 129.2, 129.1,
125.7, 123.7, 123.5, 116.5, 116.3, 57.0, 56.9.
IR (film) 3062, 2840, 1608, 1564, 1508, 1488, 1451, 1307, 1261, 1175, 1025, 834, 733,
694, 623 cm-.
HRMS (ESI) calcd for C22H20N30 2 (M+) 358.1550, found 358.1557; HRMS (ESI) calcd
for C10 4 (M-) 98.9480, found 98.9483.
MeO
-N c04
MeO N N OMe
NHC9-HC10 4. A 500-mL, 2-necked, flask fitted with a reflux condenser was charged
with p-methoxybenzoyl chloride (13.8 mL, 0.100 mol; TCI), evacuated, and back-filled with
argon. Toluene (120 mL) was then added, followed by p-anisidine (12.3 g, 0.100 mol; Alfa-
Aesar), while keeping the flask under a stream of argon. The amine slowly dissolved and
precipitation occurred. The reaction mixture was heated to 120 oC overnight. The suspension
was cooled to r.t. and filtered through a glass frit. The solid was washed with hexanes and dried
39 Initial crystallization can be difficult; it requires diluted conditions and may take up to 5 days.40 CH2C12 was added at reflux until almost all solid had dissolved. After cooling to r.t. the mixture was cooled to
-20 oC for 12 h and the crystallized solid collected with a filter frit. The solid was washed with a little cold CH2C12
and diethyl ether.
under high vacuum overnight. The amide (25.5 g) was obtained as a colorless, slightly violet
solid which was used without further purification.
A 100-mL flask was charged with 4-methoxy-N-(4-methoxyphenyl)benzamide (5.15 g,
20.0 mmol) and PC15 (4.16 g, 20.0 mol), evacuated, and back-filled with argon. The flask was
fitted with a nitrogen-filled balloon and the mixture was heated to 80 oC. Gas evolution was
observed and the yellow-green solution was stirred for 2 h. The reaction mixture was cooled to
r.t. and the volatiles removed at reduced pressure, leading to a green solid that was used in the
next step without further purification ('H NMR analysis indicated complete conversion to the
imidoyl chloride).
To the green solid was added THF (60 mL), 1-(4-methoxyphenyl)hydrazine
hydrochloride (3.50 g, 20.0 mmol; TCI), and NEt 3 (6.3 mL, 45 mmol). [CAUTION: While we
have not observed an exotherm when conducting the reaction on this scale, the hydrazine
addition on larger scale has led to significant warming of the reaction mixture. For large-scale
reactions, we advise that the hydrazine be added as a slurry in THF (see preparation of 1).] The
yellow suspension was stirred at r.t. for 20 h, and then the volatiles were removed on a rotary
evaporator. Acetic acid (2% aqueous solution; 50 mL) was added and the mixture was stirred
vigorously for 15 minutes. The mixture was extracted with CH 2C12 (3 x 100 mL), and the
combined extracts were washed with brine and dried over Na2 SO 4. Solvent evaporation gave a
red oil/foam. The material was used without purification in the subsequent step.
In a separate 250-mL, 2-necked, flask was mixed acetic anhydride (50 mL) and formic
acid (25 mL) under argon. The mixture was heated to 60 'C for 20 minutes, then cooled to r.t.
and transferred to the amidine via cannula under argon. The red solution was stirred for 20 h at
r.t. The volatiles were subsequently removed on a rotary evaporator and high vacuum. To the
crude material was added perchloric acid (35% aqueous solution, 50 mL) and CH2CI 2 (50 mL).
The mixture was stirred vigorously and after 30 minutes the layers were separated. The aqueous
layer was extracted with CH2C12 (3 x 50 mL) and the combined organic layers washed with brine
and dried over Na2 SO 4. Solvent evaporation gave a red oil which was dried on high vacuum for
two days. Crystallization of the triazolium salt was achieved using CH2Cl2/hexanes at -20 oC.
The obtained crude triazolium perchlorate was purified by recrystallization from CH 2C12 to give
the title compound (1.07 g, 11% over all steps) as a beige fluffy solid.
mp: 112 'C
1H NMR (DMSO-d6, 500 MHz) 6 11.08 (s, 1H), 7.98 (d, J= 9.2 Hz, 2H), 7.61 (d, J= 8.9
Hz, 2H), 7.46 (d, J= 8.8 Hz, 2H), 7.29 (d, J= 9.2 Hz, 2H), 7.21 (d, J= 8.9 Hz, 2H), 7.08 (d, J=
8.8 Hz, 2H), 3.88 (s, 3H), 3.85 (s, 3H), 3.81 (s, 3H).
13C NMR (DMSO-d6, 125 MHz) 6 162.0, 161.0, 160.7, 153.1, 130.8, 128.1, 128.0, 124.7,
122.3, 115.3, 115.2, 114.7, 114.4, 55.8, 55.8, 55.6.
IR (film) 3073, 2940, 2841, 1611, 1508, 1498, 1307, 1259, 1176, 1027, 835, 623 cm- .
HRMS (ESI) calcd for C23H22N30 3 (M+) 388.1656, found 388.1653; HRMS (ESI) calcd
for C10 4 (M-) 98.9480, found 98.9484.
Part III: NHC-Catalyzed p-Alkylations
Note: The NHC-catalyzed P-alkylations are moisture sensitive. Please see refer to the
General section of this experimental for details.
General Procedure for Table 1.3. In a glove box, a 4-mL vial was charged with catalyst
NHC8-HC10 4 (4.6 mg, 0.010 mmol), K3PO 4 (53 mg, 0.25 mmol), glyme (0.8 mL), and (E)-ethyl
8-bromooct-2-enoate (24.9 mg, 0.100 mmol). The vial was closed with a teflon cap, sealed with
electrical tape, removed from the glove box, and immerged in a pre-heated oil bath at 800 C.
After 16 h the vial was removed from the oil bath and 19 jl n-decane (0.10 mmol) was added. A
couple of drops from the reaction mixture were passed through a plug of silica gel with diethyl
ether. The filtrate was analyzed by GC to determine the conversion.
General Procedure for Table 1.4. In a glove box, a 20-mL vial was charged with
catalyst NHC8-HC10 4 (46 mg, 0.10 mmol), K3P0 4 (0.53 g, 2.5 mmol; run 1: Strem; run 2:
Lancaster), glyme (8 mL; Fluka, anhydrous), and the substrate (1.00 mmol). The vial was closed
with a teflon cap, sealed with electrical tape, removed from the glove box, and immerged in a
pre-heated oil bath at 80 oC. After the indicated time, the vial was removed from the oil bath and
the reaction mixture directly purified by flash chromatography (pentane/Et 20).
For entries 2, 6, 7, and 8 of Table 1.4, a small amount of isomerization to the P,y-
unsaturated product was observed if a long reaction time was employed.
C0 2 Et
Ethyl-2-cyclopentylideneacetate (Table 1.4, Entry 1) [CAS# 1903-22-6]. The
compound was prepared according to the General Procedure. Reaction time: 8 hours. After
chromatography on silica gel (pentane/Et20 20:1), the desired compound was isolated as a
colorless oil: run 1: 146 mg (95%); run 2: 143 mg (93%).
1H NMR (CDC13, 500 MHz) 6 5.80-5.79 (m, 1H), 4.17-4.12 (m, 2H), 2.78-2.75 (m, 2H), 2.45-
2.42 (m, 2H), 1.77-1.72 (m, 2H), 1.69-1.63 (m, 2H), 1.29-1.26 (m, 3H).
Ethyl-2-cyclopentylideneacetate (Table 1.4, Entry 2) [CAS# 1903-22-6]. The
compound was prepared according to the General Procedure. Reaction time: 16 hours. After
chromatography on silica gel (pentane/Et20 20:1), the desired compound was isolated as a
colorless oil: run 1: 144 mg (94%); run 2: 143 mg (93%).
1H NMR (CDCl 3, 500 MHz) 6 5.80-5.79 (m, 1H), 4.17-4.12 (m, 2H), 2.78-2.75 (m, 2H), 2.45-
2.42 (m, 2H), 1.77-1.72 (m, 2H), 1.69-1.63 (m, 2H), 1.29-1.26 (m, 3H).
CO2Et
Ethyl-2-cyclopentylideneacetate (Table 1.4, Entry 3) [CAS# 1903-22-6]. The
compound was prepared according to the General Procedure. Reaction time: 8 hours. After
chromatography on silica gel (pentane/Et2O 20:1), the desired compound was isolated as a
colorless oil: run 1: 136 mg (88%); run 2: 139 mg (90%).
'H NMR (CDC13 , 500 MHz) 6 5.80-5.79 (m, 1H), 4.17-4.12 (m, 2H), 2.78-2.75 (m, 2H), 2.45-
2.42 (m, 2H), 1.77-1.72 (m, 2H), 1.69-1.63 (m, 2H), 1.29-1.26 (m, 3H).
0
Allyl-2-cyclopentylideneacetate (Table 1.4, entry 4). The compound was prepared
according to the General Procedure. Reaction time: 16 hours. After chromatography on silica gel
(pentane/Et2O 20:1), the desired compound was isolated as a colorless oil: run 1: 148 mg (89%);
run 2: 144 mg (87%).
IH NMR (CDC13, 500 MHz) 6 5.97-5.90 (m, 1H), 5.83 (d, J= 1.8 Hz, 1H), 5.32 (dd, J=
18.6, 17.1 Hz, 1H), 5.21 (d, J= 10.4 Hz, 1H), 4.60-4.59 (m, 2H), 2.79-2.76 (m, 2H), 2.54-2.43
(m, 2H), 1.77-1.61 (m, 4H).
13C NMR (CDC13, 75 MHz) 6 169.9, 166.5, 132.7, 117.7, 111.3, 64.3, 36.0, 32.7, 26.4,
25.5.
IR (film) 2960, 1872, 1717, 1653, 1455, 1419, 1371, 1352, 1303, 1272, 1231, 1194,
1153, 1119, 1027, 993, 929, 857 cml.
HRMS (EI) calcd for C10H130 2 (M-H+) 165.0916, found 165.0909.
O
,NOMe
Me
2-Cyclopentylidene-N-methoxy-N-methylacetamide (Table 1.4, entry 5). The
compound was prepared according to the General Procedure. Reaction time: 8 hours. After
chromatography on silica gel (pentane/Et20 1:1), the desired compound was isolated as a
colorless oil: run 1: 115 mg (68%); run 2: 114 mg (67%).
1H NMR (CDCl 3, 500 MHz) 6 6.33-6.31 (m, 1H), 3.70 (s, 3H), 3.20 (s, 3H), 2.84-2.81
(m, 2H), 2.49-2.46 (m, 2H), 1.76-1.73 (m, 2H), 1.67-1.64 (m, 2H).
13C NMR (CDC13, 125 MHz) 6 168.9, 167.9, 109.6, 62.1, 37.0, 33.1, 33.0, 27.3, 26.1.
IR (film) 3583, 3503, 3257, 3063, 2958, 2870, 2823, 1659, 1631, 1462, 1407, 1381,
1324, 1178, 1091 cm .
HRMS (EI) calcd for C9H15NO2 (M+) 169.1097, found 169.1100.
CN
2-Cyclopentylideneacetonitrile (Table 1.4, entry 6) [CAS# 5732-88-7]. The compound
was prepared according to the General Procedure. Reaction time: 8 hours. Upon cooling, the
reaction mixture was diluted with CH2C12 (30 ml), transferred to a 150-mL separatory funnel and
washed with distilled water (3 x 20 mL) and once with brine (50 mL). The organic layer was
dried over Na2 SO 4 . After filtration through a fritted funnel, the organic layer was concentrated
via a rotary evaporator. The resultant dark-red oil was purified via kugelrohr distillation at 120
'C (10 torr; if the product was purified by flash chromatography, -20% of the P,y-unsaturated
isomer was observed). The desired compound (20:1 mixture of the a,p: p,'-unsaturated isomers)
was isolated as a colorless oil: run 1: 78 mg (72%); run 2: 75 mg (70%).
1H NMR (CDC13, 300 MHz) 8 5.25-5.23 (m, 1H), 2.62-2.58 (m, 2H), 2.48-2.43 (m, 2H),
1.82-1.77 (m, 4H).
CN
2-Cyclopentylideneacetonitrile (Table 1.4, entry 7) [CAS# 5732-88-7]. The compound
was prepared according to the General Procedure. Reaction time: 8 hours. Upon cooling, the
reaction mixture was diluted with CH2C12 (30 ml), transferred to a 150-mL separatory funnel and
washed with distilled water (3 x 20 mL) and once with brine (50 mL). The organic layer was
dried over Na2 SO4 . After filtration through a fritted funnel, the organic layer was concentrated
via a rotary evaporator. The resultant dark-red oil was purified via kugelrohr distillation at 120
'C (10 torr; if the product was purified by flash chromatography, -20% of the P,y-unsaturated
isomer was observed). The desired compound (20:1 mixture of the a,3: p,y-unsaturated isomers)
was isolated as a colorless oil: run 1: 92 mg (86%); run 2: 88 mg (82%).
'H NMR (CDC13, 300 MHz) 6 5.25-5.23 (m, 1H), 2.62-2.58 (m, 2H), 2.48-2.43 (m, 2H),
1.82-1.77 (m, 4H).
C0 2Et
Ethyl-2-(dihydrofuran-3(2H)-ylidene)acetate (Table 1.4, entry 8). The compound was
prepared according to the General Procedure. Reaction time: 6 hours. After chromatography on
silica gel (pentane/Et20 6:1 --+ 3:1), the desired compound (2:1 mixture of the illustrated olefin
isomers, along with -5% of an unidentified isomer) was isolated as a colorless oil: run 1: 117 mg
(75%); run 2: 124 mg (79%).
'H NMR (CDC13, 500 MHz) 6 5.86-5.85 (m, 1H major), 5.80-5.79 (m, 1H minor), 4.72
(m, 2H major), 4.39 (m, 2H minor), 4.20-4.14 (m, 2H major+minor), 3.98 (d, J = 7.0 Hz, 2H
minor), 3.90-3.87 (m, 2H major), 3.05-3.02 (m, 2H minor), 2.74-2.71 (m, 2H major), 1.31-1.24
(m, 3H major+minor).
13C NMR (CDC13, 125 MHz) 6 166.3, 166.1, 162.7, 161.7, 111.4, 110.2, 72.0, 71.5, 68.9,
67.0, 60.0, 59.9, 34.4, 32.6, 17.9, 14.3.
IR (film) 2981, 2860, 1710, 1667, 1373, 1351, 1215, 1124, 1076, 1035, 921, 851 cm -1.
HRMS (EI) calcd for C8H120 3 (M+) 156.0781, found 156.0784.
CO2Et
Ethyl-2-cyclohexylideneacetate (Table 1.4, entry 9) [CAS# 1552-92-7]. The compound
was prepared according to the General Procedure. Reaction time: 16 hours. After
chromatography on silica gel (pentane/Et20 20:1), the desired compound was isolated as a
colorless oil: run 1: 135 mg (80%); run 2: 136 mg (81%).
'H NMR (CDC13, 500 MHz) 6 5.60 (s, 1H), 4.16-4.11 (m, 2H), 2.83-2.81 (m, 2H), 2.20-
2.18 (m, 2H), 1.67-1.57 (m, 4H), 1.29-1.26 (m, 3H).
C 0 2 Et
Ethyl-2-cyclobutylideneacetate (Table 1.4, entry 10) [CAS# 27741-65-7]. The
compound was prepared according the othe General Procedure, except that 20% of catalyst
NHC8-HC10 4 was used, and dioxane was employed as the solvent (a slightly lower yield was
obtained when glyme was used). Reaction time: 33 hours. After chromatography on silica gel
(pentane/Et20O 20:1), the desired compound was isolated as a colorless oil: run 1: 66 mg (47%);
run 2: 70 mg (49%).
'H NMR (CDC13, 300 MHz) 6 5.59-5.57 (m, 1H), 4.14 (q, J= 7.2 Hz, 2H), 3.15-3.12 (m,
2H), 2.85-2.83 (m, 2H), 2.09 (quintet, J= 7.9 Hz, 2H), 1.27 (t, J= 7.2 Hz, 3H).
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SAMPLE
date Nov 3 2005
solvent CDC13
file /data/gfu/Tsm-
/Tsm-02-086dry.fid
ACQUISITION
sfrq 300.100
tn H1
at 1.995
np 17984
sw 4506.5
fb not used
bs 2
tpwr 54
pw 7.0
dl 1.000
tof 0
nt 64
ct 64
alock n
gain not used
FLAGS
il
in
dp
sp
wp
vs
sc
wc
hzmm
is
L rfl
k.) rfp
th
ins
nm
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn not
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
used
y
DISPLAY
-0.0
2397.9
162
0
250
9.59
97.78
2898.3
2181.7
20
1.000
ph
0.32
PPM
1 ppm0.54
1.00 1.53 2.29 3.871.18 3.48
CN
Br
SI I I
3.43
-- .rl-
I I ' " '
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Sep 6 2005
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw
inkle/Tsm-01-033-c-
hecksept05.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -5.6
wp 4007.1
vs 123
sc 0
tl WC 250
W hzmm 16.03
Is 33.57
rfl 4637.5
rfp 3633.1
th 7
Ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14!
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6!
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
CN
OTs
It -- I
SI I I I I I I I I I ' ' 'I ' ' I I I
7 6
3.19 0.41 0.63
3.51 1.00 1.45
5 4
4.70
3
1.57
6.45 2.98
1
4.87
4.58
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STANDARD PROTON PARANETERS
expl s2pul
SAMPLE
date Sep 30 2005
solvent CDC13
file /data/export/-
home/gfu/Tcf/bullw-
Inkle/CF6-098fr28- ~
40.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -4.1
wp 4007.1
vs 112
sc 0
wec 250
hzmm 16.03
is 477.08
rfl 1002;6
rfp 0
th 7
ins 2.000
run cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm
dmf 1I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6!
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
0
OEt
Br
0f
I I
I I . -- - -'
2 1 Ppm
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4
4.09
2.00
7
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STANDARD PROTON PARAMETERS
expi s2pul
SAMPLE
date Jun 30 2005
solvent CDC13
file /data/export/-
home/gfu/Tcf/bullw-
inkle/CF6-011fr37--
50.fld
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -4.1
wp 4007.1
vs 112
sc 0
wc 250
hzmm 16.03
Is 1284.19
rfl 1002.6
rfp 0
th
Ins
nm cdc
7
3.000
DEC. & VT
dfrq 125
dn
dpwr
dof 149
dm
dam
dmf 10
dseq
dres
homo
PROCESSING
wtfile
proc
fn 65
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
1000
1.0
n
ft
536
f
1.970.89
0.88
L . I J LA.--.J
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STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Oct 19 2005
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat
/Tsm-02-086-pure.f-~
id
ACQUISITION
sfrq 300.100
tn H1
at 1.995
np 17984
sw 4506.5
fb not used
bs 16
tpwr 54
pw 7.0
dl 1.000
tof 0
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp -0.3
wp 2398.2
vs 162
sc 0
l wc 250
S hzmm 9.59
is 303.43
rfl 2898.6
rfp 2181.7
th 20
ins 1.000
nm cdc ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfi le
proc
fn not
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
used
0
1 Et
Br
i ~i-F
S' I I I I I
4 3
2.17
2.23
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7
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STANDARD PROTON PARAMETERS
exp2 s2pul
SANPLE
date Jul 10 2005
solvent ONSO
file /data/export/-
home/gfu/Tcf/bul lw-
Inkle/PMPx2carbene
H.fld
ACQUISITION
sfrq 499.751
tn IHl
at. 3.277
np 65536
sw 9998.8
fb not used
bs 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp . -4.1
wp 6004.2
vs 112
sc 0
wc - 250
hzm 24.02
Is 515.44
rfl 1002.5
rfp 0
th 7
Ins 4.000
nm cdc ph
DEC. & VT
dfrq 125.
dn
dpwr
dof 149
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 65
math
werr
wexp
wbs
wnt
.675
C13
34
98.1
nnn
w
000
1.0
n
ft
5536
f
Ph C104
MeO-- OMe
NHC8-HCIO4
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6.93
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STANDARD PROTON PARAMETERS
exp2 s2pul
SANPLE
date Jul 7 2005
solvent DMSO
file /data/export/-
home/gfu/Tcf/bullw-
inkle/CF6-015crop2-
.fid
ACQUISITION
sfrq 499.751
tn H1
at 3.277
np 65536
sw 3998.8
fb not used
bs 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
ii . n
in n
dp y
hs nn
DISPLAY
. p . ... . 994.3
Wp 5005.8
vs 112
rsc 0
Oo wc 250
hzmm 20.02
is 2315.43
rfl 1002.5
rfp 0
th 7
Ins 9.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6
math
werr
wexp
wbs
wnt
.675
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
MeO
eCIO4
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exp4 s2pul
SAMPLE
date Aug 22 2005
solvent CDCIS
file /data/gfu/Tsm-
/Tsm-02-046.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
il n
In n
dp y
hs nn
DISPLAY
sp -6.6
wp 4007.2
vs 224
sc 0
we 250
hzmm 16.03
is 68.08
i rfl 4638.2
rfp 3633.1
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14!
dm
dmm
dmf 1
dseq
dres
homo
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf2
dseq2
dres2
homo2
DEC3
dfrq3
dn3
dpwr3
dof3
dm3
dmm3
dmf3
dseq3
dres3
homo3
PROCESSING
wtfIle
proc
fn 6
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0000
1.0
n
0
1
0
n
c
200
1.0
n
0
1
0
n
c
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1.0
n
ft
5536
f
CO 2Et
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I II
6 5
1.00
I 11111111 I I
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L0.24
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STANDARD 1H OBSERVE
exp3 stdlh
SAMPLE
date Oct 24 2005
solvent CDC13
file /data/gfu/Tsm-
/Tsm-02-096.fid
ACQUISITION
sfrq 300.100
tn H1
at 1.995
np 17984
sw 4506.5
fb not used
bs 16
tpwr 54
pw 7.0
dl 1.000
tof 0
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp -1.1
wp 2400.1
vs 153
sc 0
wc 250
hzmm 9.60
is 438.43
rfl 2898.6
rfp 2181.7
th 20
ins 2.000
nm cdc ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn not
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
C
200
ft
used
Table 1.4, entry 2
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Sep 16 2005
solvent CDCS1
file /data/export/-
home/gfu/Tcf/bullw-
inkle/CF6-088-2fr2-
5-34.fld
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
be 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 8
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -11.8
wp 4001.6
vs 224
sc 0
wc 250
hZmah 16.01
is :906.76
rfl 4637.5
rfp 3628.1
th 7
Ins 4.000
nm cdc ph
I II
DEC. & VT
dfrq 125.674
dn C13
dpwr 34
dof 1498.1
dm nnn
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
wtfl le
proc ft
fn 65536
math f
werr
wexp
wbs
wnt
7
CO2Et
Table 1.4, entry 3
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STANDARD PROTON PARANETERS
expl s2pul
SAMPLE
date Aug 11 2005
solvent CDC13
file /data/export/-
home/gfu/Tcf/bullw-
inkle/CF6-074fr16--
32.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 8
tpwr 56
pw 8.2
dl 3.000
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
In
dp
hs
sp
wp
vs
sc
wc
hzmm
Is
rfl
rfp
th
ins
nm
n
y
nn
DISPLAY
488.0
3507.9
69
0
250
14.03
710.64
4637.8
3628.1
7
2.000
cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm.
dmf 1
dseq
dres
homo
PROCESSING
wtfl le
proc
fn 6!
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
0
Table 1.4, entry 4
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Sep 9 2005
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-02-054.f~
id
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -5.9
wp 4007.4
vs 147
sc 0
wc 250
L hzmm 16.03
is 33.57
rfl 4637.5
rfp 3633.1
th 7
ins 3.000
nm cdc ph
DEC. & VT
dfrq 125.
dn
dpwr
dof 141
dm
dmm
dmf 1(
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6'
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
3000
1.0
n
ft
5536
f
0
OMe
Table 1.4, entry 5
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STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Sep 24 2005
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-02-073-dry.fi~
d
ACQUISITION
sfrq 300.100
tn H1
at 1.995
np 17984
Sw 4506.5
fb not used
bs 16
tpwr 54
pw 7.0
dl 1.000
tof 0
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp 265.9
wp 2037.1
vs 162
sc 0
wc 250
hzmm 8.15
is 198.03
rfl 2898.6
rfp 2181.7
th 20
ins 1.000
nm cdc ph
dfrc
DEC. & VT
300.100
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn not
werr
wexp
wbs
wnt
H1
30
0
nnn
c
200
ft
used
- J LA
CN
Table 1.4, entry 6
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STANDARD 1H OBSERVE
expi stdlh
SAMPLE
date Oct 7 2005
solvent CDC13
file /data/export/~
home/gfu/Tsm/mrhat-
/Tsm-02-076nitrlle
.fid
ACQUISITION
sfrq 300.100
tn H1
at 1.995
np 17984
sw 4506.5
fb not used
bs 16
tpwr 54
pw 7.0
dl 1.000
tof 0
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp -0.0
wp 2398.2
vs 162
sc 0
wec 250
hzmm 9.59
is 243.70
rfl 2898.3
rfp 2181.7
th 20
ins 1.000
nm cdc ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn not
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
C
200
ft
ised
CN
Table 1.4, entry 7
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE DE(
date Oct 2 2005 dfrq
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tcf/bul lw- dof
Inkle/CF6-099fr38-- dm
49.flid dam
ACQUISITION dmf
sfrq 499.749 dseq
tn Hi dres
at 3.277 homo
np 65536 PRO
sw 9998.8 wtfile
fb not used proc
bs 8 fn
tpwr 56 math
pw 8.2
dl 3.000 werr
tof 1498.1 wexp
nt 16 wbs
ct 16 wnt
alock n
gain not used
FLAGS
ii n
In n
dp y
hs nn
DISPLA)
sp -4.1
wp 4007.1
vs 112
sc 0
wc 250
hzmm 16.03
Is 520.36
rfl 1002.6
rfp 0
th 7
Ins 2.000
nm cdc ph
&.  VT
125
14
1
CESSING
6!
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34
98.1
nnn
w
0000
1.0
n
ft
5536
f
CO 2Et6
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STANDARD PROTON PARAMETERS
expl s2pul
SANPLE
date Aug 1 2005
solvent CDC13
file /data/export/-
home/gfu/Tcf/bullw-
inkle/CF6-064-2fr8-
-15.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 8
tpwr 56
pw
dl
tof
nt
ct
alock
gain
FI
iI
in
dp
hs
DI,
sp
wp
vs
sc
wc
0\ hzmm
-1 is
rfl 1
rfp
th
ins
-nm cdc
8.2
3.000
1498.1
16
16
n
not used
LAGS
SPLAY
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm
dmf 1I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6'
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0400
1.0
n
ft
5536
f
Table 1.4, entry 9
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Jun 27 2005
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-01-111-2-
.fid
ACQUISITION
sfrq 499.749
tn H1
at 3.277
np 65536
sw 9998.8
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp 6.3
wp 3993.9
vs 224
sc 0
wc 250
hzmm 15.98
is 33.57
rfl 4638.4
rfp 3633.1
th 7
ins 2.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 61
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
CO2 Et
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Section 1.2
Asymmetric, Phosphine-Catalyzed y-Alkylation of
Allenoates with Nitromethane
A. Introduction
Similar to N-heterocyclic carbenes, it has only been relatively recent that the area of
nucleophilic phosphine catalysis has seen a significant increase in development.4 1 Phosphines,
long used as ligands for transition metal-catalyzed transformations, 42 display a unique reactivity
of their own in processes involving electron-deficient unsaturated carbon-carbon bonds,4 3,44 and
as catalysts for the acylation of alcohols. 45 Tricoordinate phosphorus compounds are fairly
configurationally stable and bear a lone pair of electrons. This lone pair is responsible for much
of the reactivity associated with phosphines, which tend to be less basic and more nucleophilic
than amines. These properties taken together not only make phosphines interesting nucleophilic
catalysts, but allow for the synthesis of P-chiral compounds for asymmetric catalysis.
The study of nucleophilic phosphine-catalyzed activation of alkynoates and allenoates
found its roots in the discovery by Trost, in 1992, that phosphines were capable of catalyzing the
isomerization of conjugated alkynoates and allenoates to dieneoates. This communication46 laid
the groundwork for a wealth of new developments. The reaction displayed a broad scope:
conjugated ketones, esters and amides participated in this process. It was also noted that
unconjugated alkynes were unreactive and that ketones reacted much more rapidly than amides
(Scheme 1.10).
41 For reviews of phosphine-catalyzed reactions, see: (a) Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346,
1035-1050. (b) Ye, L.-W.; Zhou, J.; Tang, Y. Chem. Soc. Rev. 2008, 37, 1140-1152.
42 (a) Quin, L. D., A Guide to Organophosporus Chemistry, Wiley, New York, 2000. (b) Valentine, D. H.;
Hillhouse, J. H. Synthesis 2003, 317-334.
43 For a review of the Morita-Baylis-Hillman reaction, see: (a) Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem.
Rev. 2003, 103, 811-892. For key asymmetric studies, see: (b) Hayase, T.; Shibata, T.; Soai, K.; Wakatsuki, Y.
Chem. Commun. 1998, 1271-1272. (c) Shi, M.; Chen, L.-H.; Li, C.-Q. J. Am. Chem. Soc. 2005, 127, 3790-3800.
44 For recent asymmetric examples of couplings of allenes with an unsaturated partner, see: (a) Zhu, G.; Chen, Z.;
Jiang, Q.; Xiao, D.; Cao, P.; Zhang, X. J. Am. Chem. Soc. 1997, 119, 3836-3837. (b) Wurz, R. P.; Fu, G. C. J. Am.
Chem. Soc. 2005, 127, 12234-12235. (c) Wilson, J. E.; Fu, G. C. Angew. Chem., Int. Ed. 2006, 45, 1426-1429. (d)
Cowen, B. J.; Miller, S. J. J. Am. Chem. Soc. 2007, 129, 10988-10989. (e) Fang, Y.-Q.; Jacobsen, E. N. J. Am.
Chem. Soc. 2008, 130, 5660-5661. (f) Voituriez, A.; Panossian, A.; Fleury-Bregeot, N.; Retailleau, P.; Marinetti, A.
J. Am. Chem. Soc. 2008, 130, 14030-14031.
45 (a) Vedejs, E.; Daugulis, O.; Diver, S. T. J. Org. Chem. 1996, 61, 430-431. (b) Vedejs, E.; Daugulis, O. J. Am.
Chem. Soc. 1999, 121, 5813-5814.
46 Trost, B. M.; Kazmaier, U. J. Am. Chem. Soc. 1992, 114, 7933-7935.
Scheme 1.10. Phosphine-Catalyzed Isomerization Reaction Developed by Trost.
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It was soon found that, through use of alkynoates incapable of isomerization to the diene,
reaction intermediates could be intercepted by various strategies to carry out other
transformations. In 1994, Trost published a PPh3-catalyzed y-addition of a wide variety of acidic
carbon pronucleophiles (pKa < 16) to alkynoates incapable of isomerizing to the diene.47 This
method displayed a broad scope with respect to the incoming pronucelophile (Scheme 1.11). A
buffer was required for high efficiency; it was believed this assisted proton transfers.
Scheme 1.11. Trost's Umpolung y-Alkylation of a Non-Isomerizable Alkynoates.
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47 Trost, B. M.; Li, C.-J. J. Am. Chem. Soc. 1994, 116, 3167-3168.
The work of Trost, and coworkers, set the groundwork for an asymmetric variant of this
reaction developed by Zhang in 1998,48 in which the new chiral center is generated on the
incoming pronucleophile (Scheme 1.12). Zhang made use of their newly developed phospha-
bicyclo[2.2.1 ]heptane catalyst, and found that modest to good levels of enantioselectivity could
be obtained with cyclic pronucleophiles. Under the buffered conditions, only substrates that
would lead to the formation of quaternary stereocenters were presented. It is worth noting that,
unlike the process described by Trost, this report made use of allenoates, and could be carried out
at room temperature.
Scheme 1.12. Zhang's Asymmetric y-Alkylation of Non-Isomerizable Alkynoates.
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Alvarez-Ibarra reported the addition of a-nitroesters to ethyl but-2-ynoate to generate
y,6-didehydrohomoglutamates derivatives (Scheme 1.13).49 This racemic methodology is an
extension of the alkylation work by Trost, with a pronucleophile not examined in the original
report. For reasons that are unclear, this method makes use of an alkynoate again, and elevated
temperatures. The scope presented in this report is general with respect to the a-nitroesters, but
as before, the alkynoate is limited to one incapable of isomerization.
48 Chen, Z.; Zhu, G.; Jiang, Q.; Xiao, D.; Cao, P.; Zhang, X. J. Org. Chem. 1998, 63, 5631-5635.
49Alvarez-Ibarra, C.; Csiky, A. G.; G6mez de la Oliva, C. J. Org. Chem. 2000, 65, 3544-3547.
Scheme 1.13. Addition of a-Nitroesters to Ethyl But-2-ynoate Reported by Alvarez-Ibarra.
O O 5% PPh3  0 R NO2
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Despite these achievements, to the best of our knowledge, there have been no reports of
successful y-addition to isomerizable alkynoates or allenoates with carbon pronucleophiles. 50 In
fact the only two efficient y-addition processes reported to date consist of intramolecular
additions of oxygen pronucleophiles. The first of which was developed in racemic fashion by
Trost in 1994. This methodology allows for the synthesis of an interesting selection of oxygen
heterocycles (Scheme 1.14). During this study it was found that the use of a bidentate phosphine,
an acetic acid additive and nonpolar solvents were crucial in favoring the addition product over
isomerization. The second example of this transformation was completed by Dr. Ying Kit "Jack"
Chung in the Fu lab this year (Scheme 1.15). 51 Building off of the group's previous success44b'c
with monodentate phosphepine catalysts, Dr. Chung developed an asymmetric variant of Trost's
heterocycle synthesis making use of the spirocyclic phosphepine P3. This reaction displayed a
broad scope and allowed access to the product in good to excellent levels of enantioselectivity.
The methodology is capable of the construction of tetrahydrofurans, tetrahydropyrans and
dihydrobenzopyrans.
50 The only examples of intermolecular y-addition have been with nitrogen-based nucleophiles. For addition to ethyl
pent-2-ynoate, see: Liu, B.; Davis, R.; Joshi, B.; Reynolds, D. W. J. Org. Chem. 2002, 67, 4595-4598 (17% yield for
y-addition of a thioamide); For addition to ethyl oct-2-ynoate, see: Trost, B. M.; Dake, G. R. JAm. Chem. Soc. 1997,
119, 7595-7596 (8% yield for y-addition of tetrahydrophthalimide).
51 Chung, Y.-K.; Fu, G. C. Angew. Chem., Int. Ed. 2009, 48, 2225-2227.
Scheme 1.14. Trost's Racemic Synthesis of Oxygen Heterocycles from Hydroxyl-2-alkynoates.
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Scheme 1.15. Phosphine-Catalyzed Enantioselective Synthesis of Oxygen Heterocycles by
Chung and Fu.
R
OH CO2EtC02Et
10% (S)-P3 RCt
50% ArCO2H 0 H CO 2Et
solvent
50-55 "C
a CO 2 Et
78% yield
87% ee
Me
Me >'0 - CO 2Et
90% yield
94% ee
S0 CO2EtH
80% yield
91% ee
0 CO 2Et
86% yield
88% ee
0 0 H CO2 Et
79% yield
84% ee
P-Ph
(S)-P3
It was in this context that we began to think about developing an intermolecular
y-addition: the field was wide open. In the 17 years that has passed since the publication of
Trost's phosphine-catalyzed isomerization reaction, there have been no reports of a successful
y-alkylation reaction of isomerizable alkynoates or allenoates. We had great interest in
attempting to realize this goal, thus we began to study the addition of carbon-based
pronucleophiles to isomerizable alkynoates. We began this work with an open mind and with
optimism that success in achieving the bond formation in an achiral fashion would smoothly
translate to the development of an asymmetric variant of this new reaction.
B. Results and Discussion
The initial attempts to achieve y-addition of an acidic carbon-based pronucleophile were
carried out on the alkynoate illustrated in Scheme 1.16. A wide-range of potential
pronucleophiles were examined with a selection of phosphines as catalysts; these reactions were
run in a broad array of solvents, with and without additives and from room temperature to
100 'C. In no instance was any product formation observed. Our observations were that either
the reaction conditions were too mild, and left us with remaining starting material, or when using
elevated temperature, we saw complete conversion to the undesired isomerization product, the
diene.
Scheme 1.16. Preliminary Investigation Toward y-Alkylations of Isomerizable Alkynoates.
0 o10% phosphine - N
EtO H-Nuc ' EtO Nuc
solvent, additive
temperature
Me Me
H-Nuc Result
0 O
Only diene
Me Me observed
Me
0 0
Only diene
MeO OMe observed
Me
O O
MeO0 ,K OMe observed
These results led us, of course, to think about means by which we could avoid diene and
favor formation of the desired product. The currently accepted mechanism of alkynoate
isomerization is illustrated in Scheme 1.17. Addition of the nucleophilic phosphine to the
alkynoate generates an a-vinyl enolate, A, which through a series of proton transfer steps can
lead to the resonance pair B (1 and 2). It is at B that Trost proposes that elimination of the
phosphine can generate an allene. Although, spectroscopic detection of this intermediate has thus
far been inconclusive, Trost and others have demonstrated that allenes are reactive under the
isomerization conditions and do furnish dieneoates, in similar fashion as alkynoates (see
introduction). Subsequent proton-transfer events effect the walking of the anion down the alkyl
side chain until it positioned appropriately, such that it may release the phosphine and generate
the diene. Intermediate B along this pathway is also interesting because it is at this stage that we
would like our pronucleophile to play the role of an acid, in order to generate an ion-pair
between the phosphine-bound substrate, C, and our newly-generated nucleophile. Formation of
this ion-pair should enable the y-addition to take place.
Scheme 1.17. Proposed Mechanism for both the Phosphine-catalyzed Isomerization and
y-Alkylation Reaction.
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Why was it then that under no reaction conditions examined did we see any y-addition
product starting from the alkynoate? One hypothesis was that preference for one pathway over
the other had to do with the entropy associated with bond formation versus another proton
transfer. It was well understood that addition of most nucleophilic phosphines to alkynoates
required elevated temperature, often between 60 'C and 100 'C. This is not typically the case for
the addition of a phosphine to an allenoate. We postulated that perhaps by subjecting an allenoate
to our reaction conditions we could run the reaction at room temperature, or lower, and favor the
y-addition over diene formation. Whether or not there is any validity to this line of thinking is
still up for debate, as experiments to probe this idea were largely inconclusive. In any event,
upon running the first reaction between an alleneoate and an unhindered acidic carbon
pronucleophile in the presence of PPh3 provided the y-addition product in excellent yield (eq
1.6).
SMeO 0
EtO *,4 Me MeO JOMe  10% PPh 3  0 EtO (1.6)toluene, r.t. Me OMe
84% yield
This result was quite gratifying, but really was just a preview of things to come. It was of
immense interest to investigate the ability of chiral phosphines to impart enantioselectivity in this
new transformation. Of the phosphines examined for this transformation it became abundantly
clear that the phosphepine catalysts which had proved successful for Dr. Wurz's and Dr.
Wilson's cycloaddition chemistry were once again going to be the frontrunners in this process.
Application of the phenyl-substituted phosphepine P4 to this reactant pair led to the formation of
product in 87% yield and 76% ee (eq 1.7).52
52 The absolute stereochemistry of this product has not been determined.
SMeO 0O
EtO0 * Me MeOl OMe 10% (S)-P4 EtO (1.7)
~ MeO--'O-e--, Et (1.7)
toluene, r.t. Me OMe
87% yield
76% ee
P-Ph
(S)-P4
Encouraged by this early result, we began looking at the scope of the reaction and were
surprised to find that changing the alkyl chain on the allene from methyl to n-propyl resulted in
the enantioselectivity of this transformation plummeting to 33%. Interestingly, we soon found
that through the use of diisopropylmalonate in place of dimethylmalonate we could recover
selectivities up to 78% ee in the addition to the n-propyl-substituted allene.
Concurrently with this work, we also found that nitromethane appeared to be a very
suitable pronucleophile under similar reaction conditions. Table 1.5 illustrates the selectivity
observed in the y-alkylation of allenoates with nitromethane. Phosphepine P4 (entry 4) catalyzed
the addition of nitromethane with a similar level of selectivity as it imparted for the malonate
nucleophiles. It is notable that, use of phosphepines P2 or P3 (entries 1 and 2), both of which
have been successful in other transformations, 3,53 did not furnish an acceptable result. However,
upon investigation of the related diethylamino-substituted phosphepine P1, we were pleased to
achieve the desired y-alkylation in both good yield and excellent ee (entry 1). Structurally similar
phosphines P6 (entry 6) and MONOPHOS (entry 11) proved to be poor catalysts for this
transformation, as are a variety of other commercially available chiral phosphines (entries 4, 5
and 7-10).
53 For the first report of these phosphepines, see: (a) Gladialli, S.; Dore, A.; Fabbri, D.; De Lucchi, O.; Manassero,
M. Tetrahedron: Asymmetry 1994, 5, 511-514. For the use of these phosphines as chiral ligands for transition metal-
catalyzed processes, see: (b) Junge, K.; Hagermann, B.; Enthaler, S.; Oehme, G.; Michalik, M.; Monsees, A.;
Riermeier, T.; Dingerdissen, U.; Beller, M. Angew. Chem., Int. Ed. 2004, 43, 5066-5069.
Table 1.5. Survey of Chiral Phosphine Catalysts for the y-Alkylation of Allenoates with
Nitromethane.a
MeON n-Pr Me-N 2  10% Ph-OH MeON NO 2
Me dioxane, r.t. Me n-Pr
racemic
entry phosphine yield (%)b ee (%)c
1 P1 83 93
2 P2 0
3 P3 47 -83
4 P4 51 68
5 P5 64 63
6 P6 51 67
7 BINAP 0
8 QUINAP 0
9 Et-BPE 36 22
10 Et-DUPHOS 0 -
11 MONOPHOS 0
a All data are the average of two experiments. b The yield was determined by GC,
calibrated using an internal standard. C A negative value for the ee signifies that
the illustrated enantiomer of the product is the minor product, rather than the major.
EEt 
Eh 
Et
Et
Et Et ;
(R,R)-Et-BPE (S)-P3
(R,R)-Et-
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,P-NMe 2
(S)-MONOPHOS
P-R
R = Ph ((S)-P4)
R = 4-MeO-C 6H4 ((S)-P5)R = t-Bu ((S)-P2)
R = i-Pr ((S)-P6)
R = NEt 2 ((S)-P1)
Due to their high synthetic versatility, we chose to examine the scope of this reaction
using Weinreb amide-substituted allenes (Table 1.6). 54 While the least hindered allenoate
participates with the highest yield and enantioselectivity (entry 1), this phosphepine-catalyzed y-
addition reaction is quite tolerant of branching adjacent to the allene (entries 3 and 4). This
addition occurs smoothly in the presence of functional groups such as protected alcohols, esters
and olefins (entries, 5-9).55 ,56,57
54 For a review of the Weinreb amide, see: Balasubramaniam, S.; Aidhen, I. S. Synthesis 2008, 3707-3738.
55 (a) Increasing the loading of phenol leads to formation of the undesired isomerization product. (b) The structure
of the aryl alcohol does not have an impact on the selectivity observed. (c) Replacing phenol with benzoic acid leads
Table 1.6. Catalytic Asymmetric y-Alkylation of Allenoates with Nitromethane.a
O0
MeON ..N/ R
Me
racemic
entry
1
2
3C
4
5
6
Me-NO 2
Me
n-Pr
10% (S)-P1
10% Ph-OH
dioxane, r.t.
O
MeO-NN UNO
2
Me R
yield (%)b ee (%)
94 97
81 93
i-Pr
k-_YOTBS
3
4 (;"_CO2Me2
7 CO2M e  82 92
4
8 / 83 92
7
9 6 M e  84 93
6
a All data are the average of two experiments. b Yield of purified
product. c 15% (S)-P1 was used.
We were pleased to find that these reaction conditions, without modification, can be
applied to other electron-deficient allenes. Thus, the allene can bear electron-withdrawing groups
(EWG) other than the Weinreb amide (Table 1.7). A variety of esters give good yields and high
levels of enantioselectivity (entries 1-3). Allenyl nitriles are reactive under these reaction
conditions although, unlike for the other allenes, a mixture of olefins isomers is isolated (entry
to inhibition of the y-addition reaction. (d) Under these reaction conditions (with 15% P1) the tert-butyl substituted
allene goes to 80% conversion by 1H NMR with 40% ee. (e) Dialkyl amides are not suitable substrates under these
reaction conditions. (f) Nitrocyclohexane does not add under these reaction conditions. (g) These reaction conditions
are not applicable to trisubstituted allenoates.
56 Phosphepine P1 is reasonably stable. After exposure of the solid to air for 40 days at room temperature, no
Phosphine oxide was detected by 31P NMR.
According to 31P NMR spectroscopy, the resting state of P1 during the reaction is the free catalyst. Also, there is
no observable interaction between P1 and phenol.
4). We also found that phosphonate esters perform well, particularly with respect to yield, though
the level of enantioselectivity is somewhat lower (entry 5).58
Table 1.7. Catalytic Asymmetric y-Alkylation of Allenoates with Nitromethane.a
EWG *" R Me-NO2
10% (S)-P1
10% Ph-OH
dioxane, r.t.
EWG N0 2
R
racemic
entry EWG R yield (%)b ee (%)
1 MeO 2C. n-Pr 73 93
2 EtO 2C,, n-Pr 91 91
3 t-BuO 2Cy n-Pr 94 90
4C NCy CloH21  47 (5:1, E,Z) 92(E),90(Z)
5 cd (EtO)2(O)PN C5 H11l 87 73
a All data are the average of two experiments. b Yield of purified
product. c 3.0 equiv Ph-OH used. d Reaction temperature = 60 0C
In the course of developing this transformation, some limitations were revealed.
Specifically, trisubstituted allenes and alkyl-substituted amides were not suitable substrates for
this reaction (Scheme 1.18). Also, phenyl and alkyl ketones appear to be too reactive, as only
diene was observed with these substrates.
Scheme 1.18. Unsucessful Allenes in the y-Alkylation Reaction.
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58 Application of these reaction conditions to aryl or alkyl ketones results in the formation of diene.
Concurrent with the development of the nitromethane addition reaction, the reactivity of
other acidic carbon pronucleophiles was examined. It appears that the efficiency of this reaction
is not only highly dependent on the pKa of the pronucleophile, it is also very sensitive to steric
hindrance about the nucleophilic carbon. Pronucleophiles that did not readily participate in a
y-addition process under the optimized nitromethane reaction conditions are illustrated in
Scheme 1.19. Mention of these shortcomings is made in no way to discourage further work on
this transformation, rather they are made to encourage the future investigation of this
transformation. The ability to construct compounds via this strategy would be valuable, and
perhaps future reaction conditions will display a broader scope with respect to the
pronucleophile.
Scheme 1.19. Ineffective Pronucleophiles Under the Finalized Allenoate Alkylation Conditions.
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C. Conclusion
In conclusion, we have, for the first time, found reaction conditions that enable the y-
addition of an acidic pronucleophile to isomerizable allenoates. Success in this endeavor required
utilizing allenoates in place of alkynoates as starting materials. Initially we found conditions that
allowed for the racemic reaction to occur; we subsequently developed a highly enantioselective
variant in which nitromethane served as the pronucleophile. This reaction takes place at room
temperature, uses an easily prepared catalyst and has a broad scope with respect to the allenoate.
Additional studies in this area are ongoing within the group, with Dr. Nicolas Marion and Dr.
Jianwei Sun investigating the intermolecular y-addition of other pronucleophiles.
D. Experimental
I. General
All reactions were carried out in oven-dried glassware under an atmosphere of argon. Et-
BPE, Et-DUPHOS, MONOPHOS and QUINAP were purchased from Strem Chemicals.
Phosphines P1, P2, P4, and P5 were provided by Evonik Industries (formerly Degussa) (we also
prepared phosphines P1, P3, and P6 according to previously reported procedures 59' 60 ). All other
materials were purchased from commercial suppliers.
Low-resolution mass spectrometric measurements were perfomed on an Agilent
LC/MSD-SL (ES+) LCMS system
II. Preparation of Substrates
These procedures have not been optimized.
Synthesis of Allenoates (representative procedure): A 300 mL flask was charged with
a phosphorane (14.5 g, 40.0 mmol), evacuated, and back-filled with argon. CH2C12 (200 mL)
and Et3N (6.1 mL, 40.0 mmol) was added via syringe, and then the solution was cooled to -78
'C in a dry ice/acetone bath. The acyl chloride (40.0 mmol) was then added dropwise via
syringe, over five min. The solution was allowed to warm to room temperature, and then the
reaction was quenched by the addition of silica gel. Upon removal of the solvent with the aid of a
rotary evaporator, this silica was loaded directly onto a pre-packed column and was purified via
flash chromatography (hexanes/ethyl acetate), which furnished the alleneoate as an oil.
59 For phosphines P1, P2, P4, P5 and P6, see: (a) Junge, K.; Hagemann, B.; Enthaler, S.; Oehme, G.; Michalik, M.;
Monsees, A.; Riermeier, T.; Dingerdissen, U.; Beller, M. Angew. Chem., Int. Ed. 2004, 43, 5066-5069.(b) Junge, K.;
Oehme, G.; Monsees, A.; Riermeier, T.; Dingerdissen, U.; Beller, M. J. Organomet. Chem. 2003, 675, 91-96. (c)
Junge, K.; Oehme, G.; Monsees, A.; Riermeier, T.; Dingerdissen, U.; Beller, M. Tetrahedron Lett. 2002, 43, 4977-
4980. (d) Gladiali, S.; Dore, A.; Fabbri, D.; De Lucchi, O.; Manassero, M. Tetrahedron: Asymmetry 1994, 5, 511-
514.
60 For phosphine P3, see: (a) Zhu, S.-F.; Yang, Y.; Wang, L.-X.; Liu, B.; Zhou, Q.-L. Org. Lett. 2005, 7, 2333-2335.
(b) Xie, J.-H.; Zhou, Q.-L. Acc. Chem. Res. 2008, 41, 581-593.
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MeO.N
Me
(±)-N-Methoxy-N-methylpenta-2,3-dienamide. Prepared from N-methoxy-N-methyl-2-
(triphenylphosphoranylidene)acetamide and propionyl chloride via the representative procedure.
'H NMR (CDC13, 500 MHz) 6 6.20-6.10 (m, 1H), 5.61 (quintet, J = 7.3 Hz, 1H), 3.71 (s,
3H), 3.23 (s, 3H), 1.80-1.76 (m, 3H).
1 3C NMR (CDC13, 125 MHz) 5 212.9, 166.1, 90.3, 85.9, 61.8, 32.7, 13.1.
IR (film) 3567, 2974, 2936, 2361, 2339, 1960, 1653, 1457, 1421, 1358 cm - .
LRMS (ES+) calcd for C7H12NO2 (M+H +) 142, found 142.
O
MeO N
Me
Me
(±)-N-Methoxy-N-methylhepta-2,3-dienamide. Prepared from N-methoxy-N-methyl-2-
(triphenylphosphoranylidene)acetamide and pentanoyl chloride via the representative procedure.
'H NMR (CDCl3 , 500 MHz) 6 6.15 (quintet, J= 2.9 Hz, 1H), 5.64 (q, 6.8 Hz, 1H), 3.71
(s, 3H), 3.23 (s, 3H), 2.14-2.09 (m, 2H), 1.49 (sextet, J= 7.4 Hz, 2H), 0.95 (t, J= 7.3 Hz, 3H).
13C NMR (CDCl3 , 125 MHz) 8 212.2, 166.1, 95.2, 86.3, 61.5, 32.6, 29.7, 22.2, 13.6.
IR (film) 3567, 3291, 3042, 2961, 2935, 2873, 2361, 2339, 1958, 1653, 1463, 1424, 1364
-1
cm .
LRMS (ES+) calcd for C9HI6NO2 (M+H +) 170, found 170.
0
MeO.N'
Me.
Me
Me
(+)-N-Methoxy-N,5-dimethylhexa-2,3-dienamide. Prepared from N-methoxy-N-
methyl-2-(triphenylphosphoranylidene)acetamide and isovaleroyl chloride via the representative
procedure.
1H NMR (CDC13, 500 MHz) 6 6.20 (q, J= 3.1 Hz, 1H), 5.66 (t, J= 6.1 Hz, 1H), 3.71 (s,
3H), 3.23 (s, 3H), 2.52-2.42 (m, 1H), 1.08 (d, J= 6.7 Hz, 6H).
13C NMR (CDC13, 125 MHz) 6 211.1, 166.1, 102.6, 87.4, 61.8, 32.6, 27.7, 22.5, 22.3.
IR (film) 3291, 2963, 2937, 2871, 2361, 2339, 1957, 1653, 1465, 1384 cm-1.
LRMS (ES+) calcd for C9H 16NO2 (M+H ) 170, found 170.
0
MeO' N
Me J
(+)-5-Cyclopentyl-N-methoxy-N-methylpenta-2,3-dienamide. Prepared from N-
methoxy-N-methyl-2-(triphenylphosphoranylidene)acetamide and 3-cyclopentyl-propanoyl
chloride via the representative procedure.
'H NMR (CDCl3, 500 MHz) 6 6.16-6.12 (m, 1H), 5.63 (q, J= 7.3 Hz, 1H), 3.71 (s, 3H),
3.26 (s, 3H), 2.14 (dt, J = 7.2, 2.8 Hz, 2H), 1.95 (septet, J = 7.6 Hz, 1H), 1.83-1.75 (m, 2H),
1.64-1.47 (m, 4H), 1.22-1.14 (2H).
13C NMR (CDC13, 125 MHz) 6 212.6, 166.2, 94.8, 85.9, 61.8, 39.7, 34.2, 32.7, 32.4, 25.4.
IR (film) 3290, 2948, 2867, 2361, 2339, 1654, 1424, 1363 cm 1.
LRMS (ES+) calcd for C12H20NO2 (M+H+) 210, found 210.
0
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(+)-8-(tert-Butyldimethylsilyloxy)-N-methoxy-N-methylocta-2,3-dienamide. Prepared
from N-methoxy-N-methyl-2-(triphenylphosphoranylidene)acetamide and 6-(tert-
butyldimethylsilyloxy)hexanoyl chloride via the representative procedure.
'H NMR (CDC13, 300 MHz) 6 6.09-6.06 (m, 1H), 5.57 (t, J= 6.7 Hz, 1H), 3.63 (s, 3H),
3.56-3.52 (m, 2H), 3.16 (s, 3H), 2.15-2.05 (m, 2H), 1.60-1.38 (m, 4H), 0.81 (s, 9H), -0.04 (s,
6H).
13C NMR (CDC13, 125 MHz) 6 212.2, 166.1, 95.5, 86.5, 63.0, 61.8, 32.7, 32.3, 27.4, 26.1,
25.3, 18.5, -5.1.
IR (film) 3308, 2935, 2857, 2361, 2340, 1959, 1658, 1472 cm1.
LRMS (ES+) calcd for C16H32NO3Si (M+H+) 314, found 314.
O
MeO N'
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(±)-Methyl-8-(methoxy(methyl)amino)-8-oxoocta-5,6-dienoate. Prepared from N-
methoxy-N-methyl-2-(triphenylphosphoranylidene)acetamide and methyl adipoyl chloride via
the representative procedure.
1H NMR (CDC13, 500 MHz) 8 6.18 (quintet, J= 2.9 Hz, 1H), 5.63 (q, J= 6.7 Hz, 1H),
3.71 (s, 3H), 3.66 (s, 3H), 3.23 (s, 3H), 2.39 (t, J= 7.4 Hz, 2H), 2.18 (qd, J= 7.1, 3.0 Hz, 2H),
1.80 (quintet, J= 7.4 Hz, 2H).
13C NMR (CDC13, 125 MHz) 6 212.3, 173.9, 165.9, 94.7, 86.9, 61.9, 51.7, 33.3, 32.8,
27.1, 24.1.
IR (film) 3282, 2951, 2361, 2339, 1959, 1734, 1653, 1639, 1457 cm-1.
LRMS (ES+) calcd for C11H18NO4 (M+H+) 228, found 228.
0
MeO, N,
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0
(+)-Methyl-10-(methoxy(methyl)amino)-10-oxodeca-7,8-dienoate. Prepared from N-
methoxy-N-methyl-2-(triphenylphosphoranylidene)acetamide and methyl 8-chloro-8-
oxooctanoate chloride 61 via the representative procedure.
'H NMR (CDCl 3, 500 MHz) 6 6.06 (m, 1H), 5.52 (q, J= 2.3 Hz, 1H), 3.61 (s, 3H), 3.55
(s, 3H), 3.13 (s, 3H), 2.20 (t, J= 7.4 Hz, 2H), 2.06-2.01 (m, 2H), 1.56-1.49 (m, 2H), 1.42-1.35
(m, 2H), 1.31-1.24 (m, 2H).
13C NMR (CDCl 3, 125 MHz) 6 212.2, 174.2, 166.0, 95.3, 86.5, 61.8, 51.5, 34.0, 32.7,
28.6, 28.5, 27.4, 24.8.
IR (film) 3288, 2937, 2859, 2361, 2338, 1958, 1734, 1653 cm - .
LRMS (ES+) calcd for C13H22NO4 (M+H) 256, found 256.
O
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(+)-N-Methoxy-N-methyltrideca-2,3,12-trienamide. Prepared from N-methoxy-N-
methyl-2-(triphenylphosphoranylidene)acetamide and 10-undecenoyl chloride via the
representative procedure.
'H NMR (CDC13, 500 MHz) 6 6.15 (quintet, J= 2.9 Hz, 1H), 5.80 (qt, J= 10.3, 6.7 Hz,
1H), 5.64 (q, J= 6.9 Hz, 1H), 4.98 (dq, J= 17.1, 1.6 Hz, 1H), 4.92 (dquintet, J= 10.2, 1.2 Hz,
1H), 3.71 (s, 3H), 3.24 (s, 3H), 2.13 (qd, J= 7.0, 3.0 Hz, 2H), 2.05-2.00 (m, 2H), 1.46 (quintet, J
= 6.4 Hz, 2H), 1.40-1.27 (m, 8H).
13C NMR (CDC13, 125 MHz) 5 212.3, 166.1, 139.4, 114.3, 95.7, 86.5, 61.9, 34.0, 29.4,
29.3, 29.23, 29.21, 29.12, 29.10, 27.8.
61 Schinzer, D.; Limberg, A.; BShm, O. M. Chem.-Eur. J. 1996, 2, 1477-1482.
IR (film) 3075, 2927, 2855, 2361, 2338, 1959, 1653, 1464, 1423, 1362 cm.
LRMS (ES+) calcd for C15H2 6NO2 (M+H +) 252, found 252.
O
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(+)-(Z)-N-Methoxy-N-methylnonadeca-2,3,10-trienamide. Prepared from N-methoxy-
N-methyl-2-(triphenylphosphoranylidene)acetamide and oleoyl chloride via the representative
procedure.
'H NMR (CDC13, 500 MHz) 6 6.15 (quintet, J= 2.9 Hz, 1H), 5.64 (q, J= 6.9 Hz, 1H),
5.37-5.30 (m, 2H), 3.71 (s, 3H), 3.24 (s, 3H), 2.16-2.11 (m, 2H), 2.02-1.99 (m, 4H), 1.50 (m,
2H), 1.37-1.22 (m, 18H), 0.88 (t, J= 6.9 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 212.3, 166.2, 130.1, 129.9, 95.6, 86.4, 61.8, 32.7, 32.1,
29.9, 29.8, 29.7, 29.53, 29.52, 29.2, 29.1, 29.0, 27.8, 27.4, 27.3, 22.9, 14.3.
IR (film) 3300, 3003, 2923, 2853, 2361, 2338, 1959, 1653, 1457, 1420, 1362 cm-.
LRMS (ES+) calcd for C22 H 4 0NO2 (M+H+) 350, found 350.
O
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(+)-Methyl-hepta-2,3-dienoate [111425-91-5]. Prepared from methyl (triphenyl-
phosphoranylidene)acetate and pentanoyl chloride via the representative procedure.
'H NMR (CDCl 3, 500 MHz) 6 5.59 (m, 2H), 3.68 (s, 3H), 2.10-2.05 (m, 2H), 1.48-1.41
(m, 2H), 0.91 (t, J= 7.4 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 212.6, 166.9, 95.4, 88.0, 52.1, 29.7, 22.1, 13.6.
IR (film) 2960, 2935, 2875, 2361, 2337, 1961, 1723, 1437, 1262 cm - .
LRMS (ES+) calcd for C8H130 2(M+H ) 141, found 141.
0EtO,
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(d-)-Ethyl-hepta-2,3-dienoate [861668-05-5]. Prepared from ethyl (triphenyl-
phosphoranyliden)acetate and pentanoyl chloride via the representative procedure.
'H NMR (CDC13, 500 MHz) 6 5.62-5.56 (m, 2H), 4.22-4.15 (m, 2H), 2.14-2.09 (m, 2H),
1.53-1.45 (m, 2H), 1.27 (t, J= 5.7 Hz, 3H), 0.95 (t, J= 7.4 Hz, 3H).
0
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(±-)-tert-Butyl-hepta-2,3-dienoate [151860-31-0]. Prepared from (tert-butoxycarbonyl-
methylene)triphenylphosphorane and pentanoyl chloride via the representative procedure.
'H NMR (CDC13, 500 MHz) 6 5.55 (q, J= 6.9 Hz, 1H), 5.47 (q, J= 2.6 Hz, 1H), 2.09 (m,
2H), 1.52-1.42 (m, 11H), 0.95 (t, J= 7.3 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 212.1, 165.8, 95.0, 89.9, 80.8, 29.8, 28.3, 22.2, 13.7.
IR (film) 3004, 2967, 2934, 2875, 2361, 2338, 1960, 1717, 1368, 1147 cm-1.
LRMS (ES+) calcd for CllH 190 2 (M+H+) 183, found 183.
NC
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(-)-Tetradeca-2,3-dienenitrile. Prepared from (triphenylphosphoranylidene)-acetonitrile
and dodecanoyl chloride via the representative procedure.
1H NMR (CDCl 3 , 500 MHz) 6 5.72 (q, J= 7.1 Hz, 1H), 5.20 (dt, J = 6.5, 3.1 Hz, 1H),
2.16-2.11 (m, 2H), 1.48-1.43 (m, 2H), 1.37-1.24 (m, 14H), 0.86 (t, J= 6.9 Hz, 3H).
'
3C NMR (CDC13, 125 MHz) 6 215.4, 113.9, 97.1, 67.4, 32.1, 29.8, 29.7, 29.54, 29.51,
29.1, 28.6, 27.4, 22.9, 14.3.
IR (film) 3017, 2955, 2926, 2855, 2361, 2338, 2226, 1961, 1734, 1466 cm l .
LRMS (ES+) calcd for C14H24N (M+) 206, found 206.
O
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(+)-Diethyl-octa-1,2-dienylphosphonate [344554-28-5]. Prepared according to a
literature procedure.62
1H NMR (CDC13, 500 MHz) 6 5.43 (sextet, J= 7.0 Hz, 1H), 5.29 (sextet, J= 3.4 Hz, 1H),
4.14-4.07 (m, 4H), 2.09 (quintet of doublets, J= 7.2, 3.4 Hz, 2H), 1.46-1.41 (m, 2H), 1.35-1.29
(m, 10H), 1.33 (t, J= 7.0 Hz, 3H).
13C NMR (CDCl3 , 125 MHz) 6 211.9, 92.4, 80.8, 79.2, 62.2, 31.2, 28.67, 28.64, 27.4,
22.5, 16.4, 14.1.
IR (film) 3482, 2980, 2958, 2931, 2859, 2872, 2360, 2338, 1955, 1258 cm-1.
LRMS (ES+) calcd for C12H240 3P (M+H+) 247, found 247.
III. Asymmetric, Phosphine-Catalyzed y-Alkylation
General Procedure. In a glove box, the catalyst (S)-P1 (29 mg, 0.075 mmol, 10%) and
phenol (7.0 mg, 0.075 mmol, 10%) were added to an oven-dried 20-mL vial. These solids were
dissolved in anhydrous dioxane (15 mL), and then nitromethane (225 jiL, 3.75 mmol, 5.5 equiv)
and the allene (0.75 mmol) were added via syringe. The vial was capped and removed from the
glove box, and the reaction mixture was stirred at room temperature for 15 h. It was then
concentrated and purified by column chromatography (hexanes:ethyl acetate or hexanes:
CH 2C12). TLCs were visualized with KMnO4 stain.
62 Altenbach, H.-J.; Korff, R. Tetrahedron Lett. 1981, 22, 5175-5178.
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(E)-N-Methoxy-N-4-dimethyl-5-nitropent-2-enamide (Table 1.6, entry 1). The
compound was prepared according to the general procedure with (±)-N-methoxy-N-methylpenta-
2,3-dienamide (106 mg, 0.75 mmol). After purification by flash chromatography (30% EtOAc in
hexanes), the title compound was isolated as a colorless oil (144 mg, 95% yield) with 97% ee.
[a]D22 = -45.4 (c = 1.0, CHCl 3). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 38.7 min (minor), 44.5 min
(major).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(140 mg, 93% yield) with 97% ee.
'H NMR (CDC13, 500 MHz) 6 6.73 (dd, J= 15.4, 7.8 Hz, 1H), 6.45 (d, J= 15.4 Hz, 1H),
4.37 (dd, J= 12.2, 7.7 Hz, 1H), 4.31 (dd, J= 12.2, 7.0 Hz, 1H), 3.63 (s, 3H), 3.18 (s, 1H), 3.24-
3.15 (m, 1H), 1.15 (d, J= 6.8 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 165.9, 145.2, 120.6, 79.9, 62.0, 35.8, 32.4, 17.0.
IR (film) 3287, 2972, 2361, 2339, 1669, 1558 cm.
LRMS (ES+) calcd for C8H1 5N20 4 (M+H) 203, found 203.
MeO, . N0/
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(E)-N-Methoxy-N-methyl-4-(nitromethyl)hept-2-enamide (Table 1.6, entry 2). The
compound was prepared according to the general procedure with (±)-N-methoxy-N-methylhepta-
2,3-dienamide (127 mg, 0.75 mmol). After purification by flash chromatography (30% EtOAc in
hexanes), the title compound was isolated as a colorless oil (137 mg, 80% yield) with 93% ee.
[a]D22 = -29.7 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 24.5 min (major), 28.7 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(141 mg, 82% yield) with 93% ee.
1H NMR (CDC13, 500 MHz) 6 6.63 (dd, J= 15.4, 9.1 Hz, 1H), 6.44 (d, J= 15.4 Hz, 1H),
4.38 (dd, J= 12.3, 5.9 Hz, 1H), 4.30 (dd, J= 12.2, 8.9 Hz, 1H), 3.61 (s, 3H), 3.17 (s, 3H), 3.09-
3.01 (m, 1H), 1.46-1.17 (m, 4H), 0.85 (t, J= 7.2 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 165.7, 144.2, 122.0, 79.1, 62.0, 41.3, 33.6, 32.4, 20.0,
13.9.
IR (film) 2961, 2935, 2874, 2361, 2338, 1668, 1635, 1558, 1379 cm -1.
LRMS (ES+) calcd for C1 0H19N20 4 (M+H+) 231, found 231.
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(E)-N-Methoxy-N,5-dimethyl-4-(nitromethyl)hex-2-enamide (Table 1.6, entry 3).
The compound was prepared according to the general procedure (except 15% catalyst was used)
with (+)-N-methoxy-N,5-dimethylhexa-2,3-dienamide (127 mg, 0.75 mmol). After purification
by flash chromatography (30% EtOAc in hexanes), the title compound was isolated as a
colorless oil (102 mg, 60% yield) with 81% ee.
[]D22 = -29.9 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 19.7 min (major), 24.0 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(108 mg, 63% yield) with 81% ee.
'H NMR (CDC13, 500 MHz) 6 6.72 (dd, J= 15.4, 9.5 Hz, 1H), 6.44 (d, J= 15.4 Hz, 1H),
4.49 (dd, J= 12.2, 5.1 Hz, 1H), 4.35 (dd, J= 12.1, 9.8 Hz, 1H), 3.63 (s, 3H), 3.19 (s, 3H), 2.91
(septet, J= 5.4 Hz, 1H), 1.80 (sextet, J= 6.7 Hz, 1H), 0.92 (dd, J= 13.0, 6.7 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 165.6, 142.5, 122.8, 77.9, 62.0, 47.6, 32.4, 30.0, 20.5,
19.2.
IR (film) 2965, 2876, 2361, 2338, 1668, 1653, 1635, 1558, 1472, 1457 cm - .
LRMS (ES+) calcd for C1 0H19N20 4 (M+H ) 231, found 231.
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(E)-5-Cyclopentyl-N-methoxy-N-methyl-4-(nitromethyl)pent-2-enamide (Table 1.6,
entry 4). The compound was prepared according to the general procedure with (+)-5-
cyclopentyl-N-methoxy-N-methylpenta-2,3-dienamide (157 mg, 0.75 mmol). After purification
by flash chromatography (30% EtOAc in hexanes), the title compound was isolated as a
colorless oil (146 mg, 72% yield) with 87% ee.
[a]D22 = -3.5 (c = 1.0, CHCl3). HPLC analysis of the product: Daicel CHIRALPAK OD-H
column; 3.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 33.7 min (major), 46.2 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(152 mg, 75% yield) with 86% ee.
'H NMR (CDC13, 500 MHz) 6 6.65 (dd, J= 15.4, 9.4 Hz, 1H), 6.47 (d, J= 15.4 Hz, 1H),
4.38 (dd, J= 12.3, 5.8 Hz, 1H), 4.30 (dd, J= 12.2, 9.0 Hz, 1H), 3.63 (s, 3H), 3.18 (s, 3H), 3.13-
3.04 (m, 1H), 1.75-1.70 (m, 3H), 1.58-1.36 (m, 6H), 1.05-1.00 (m, 2H).
13C NMR (CDC13, 125 MHz) 6 165.7, 144.4, 122.0, 79.4, 62.0, 41.0, 38.0, 37.4, 33.3,
33.0, 32.4, 32.1, 25.23, 25.22.
IR (film) 2941, 2867, 2361, 2339, 1669, 1653, 1635, 1558 cm -1.
LRMS (ES+) calcd for C1 3H23N20 4 (M+H ) 271, found 271.
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(E)-8-(tert-Butyldimethylsilyloxy)-N-methoxy-N-methyl-4-(nitromethyl)oct-2-
enamide (Table 1.6, entry 5). The compound was prepared according to the general procedure
with (±)-8-(tert-butyldimethylsilyloxy)-N-methoxy-N-methylocta-2,3-dienamide (235 mg, 0.75
mmol). After purification by flash chromatography (25% EtOAc in hexanes), the title compound
was isolated as a colorless oil (156 mg, 56% yield) with 92% ee.
[a]D22 = -19.2 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 16.6 min (major), 18.4 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(163 mg, 58% yield) with 92% ee.
'H NMR (CDC13, 500 MHz) 6 6.65 (dd, J= 15.4, 9.1 Hz, 1H), 6.5 (d, J= 15.4 Hz, 1H),
4.39 (dd, J= 12.3, 6.0 Hz, 1H), 4.32 (dd, J= 12.3, 9.0 Hz, 1H), 3.63 (s, 3H), 3.57-3.50 (m, 2H),
3.18 (s, 3H), 3.09-3.02 (m, 1H), 1.54-1.24 (m, 6H), 0.83 (s, 9H), -0.01 (s, 6H).
13C NMR (CDCl3 , 125 MHz) 6 165.6, 144.1, 122.1, 79.0, 62.9, 62.0, 41.6, 32.6, 31.4,
26.1, 23.3, 18.5, -5.1.
IR (film) 2933, 2858, 2361, 2339, 1668, 1653, 1635, 1557, 1380 cm l .
LRMS (ES+) calcd for Cl 7H35N205Si (M+H +) 375, found 375.
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(E)-Methyl 8-(methoxy(methyl)amino)-5-(nitromethyl)-8-oxooct-6-enoate (Table 1.6,
entry 6). The compound was prepared according to the general procedure with (+)-methyl 8-
(methoxy(methyl)amino)-8-oxoocta-5,6-dienoate (170 mg, 0.75 mmol). After purification by
flash chromatography (15 -- 50% EtOAc in hexanes), the title compound was isolated as a
colorless oil (165 mg, 76% yield) with 94% ee.
[a]D22 = -29.7 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK AD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 59.9 min (major), 74.3 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(158 mg, 73% yield) with 92% ee.
1H NMR (CDC13, 500 MHz) 6 6.61 (dd, J= 15.4, 9.1 Hz, 1H), 6.47 (d, J= 15.5 Hz, 1H),
4.39 (dd, J= 12.4, 6.0 Hz, 1H), 4.31 (dd, J= 12.3, 8.8 Hz, 1H), 3.61 (s, 3H), 3.58 (s, 3H), 3.16
(s, 3H), 3.08-3.00 (m, 1H), 2.25 (t, J= 6.9 Hz, 2H), 1.64-1.41 (m, 4H).
13C NMR (CDC13, 125 MHz) 6 173.5, 165.6, 143.5, 122.5, 78.8, 62.0, 51.8, 41.3, 33.6,
32.4, 30.8, 22.2.
IR (film) 2952, 2871, 2361, 2338, 1734, 1664, 1635, 1557 cm 1.
LRMS (ES+) calcd for C12H21N 20 6 (M+H +) 289, found 289.
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(E)-Methyl-10-(methoxy(methyl)amino)-7-(nitromethyl)-10-oxodec-8-enoate (Table
1.6, entry 7). The compound was prepared according to the general procedure with (+)-methyl
10-(methoxy(methyl)amino)-10-oxodeca-7,8-dienoate (191 mg, 0.75 mmol). After purification
by flash chromatography (20 -+ 50% EtOAc in hexanes), the title compound was isolated as a
colorless oil (195 mg, 82% yield) with 92% ee.
[a]D22 = -25.7 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 56.7 min (major), 63.5 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(193 mg, 82% yield) with 92% ee.
'H NMR (CDCl 3, 500 MHz) 6 6.58 (dd, J= 15.4, 9.1 Hz, 1H), 6.40 (d, J= 15.4 Hz, 1H),
4.35 (dd, J= 12.3, 5.9 Hz, 1H), 4.28 (dd, J= 12.3, 8.7 Hz, 1H), 3.58 (s, 3H), 3.55 (s, 3H), 3.13
(s, 3H), 3.02-2.94 (m, 1H), 2.19 (t, J= 7.4 Hz, 3H), 1.52-1.16 (m, 7H).
13C NMR (CDCl3, 125 MHz) 6 174.0, 165.7, 144.0, 122.1, 79.0, 61.9, 51.6, 41.4, 33.9,
32.3, 31.3, 28.9, 26.5, 24.7.
IR (film) 2938, 2861, 2361, 2339, 1734, 1558 cm-.
LRMS (ES+) calcd for C14H 2 5N20 6 (M+H +) 317, found 317.
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(E)-N-Methoxy-N-methyl-4-(nitromethyl)trideca-2,12-dienamide (Table 1.6, entry
8). The compound was prepared according to the general procedure with (+d)-N-methoxy-N-
methyltrideca-2,3,12-trienamide (189 mg, 0.75 mmol). After purification by flash
chromatography (5 --+ 40% EtOAc in hexanes), the title compound was isolated as a colorless oil
(199 mg, 85% yield) with 92% ee.
[a]D2 2 = -26.0 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK AD-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 14.7 min (major), 18.0 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(190 mg, 81% yield) with 92% ee.
'H NMR (CDC13, 500 MHz) 6 6.62 (dd, J= 15.4, 9.1 Hz, 1H), 6.43 (d, J= 15.4 Hz, 1H),
5.71 (ddt, J= 17.0, 10.2, 6.7 Hz, 1H), 4.93-4.83 (m, 2H), 4.37 (dd, J= 12.3, 6.0 Hz, 1H), 4.29
(dd, J= 12.1, 8.8 Hz, 1H), 3.60 (s, 3H), 3.16 (s, 3H), 3.06-2.98 (m, 1H), 1.97-1.93 (m, 2H), 1.48-
1.14 (m, 12H).
13C NMR (CDC13, 125 MHz) 6 165.7, 144.3, 139.2, 122.0, 114.4, 79.1, 61.9, 60.5, 41.5,
33.9, 31.6, 29.4, 29.1, 29.0, 26.8, 14.3.
IR (film) 3289, 3075, 2925, 2855, 2361, 2339, 1653 cm 1 .
LRMS (ES+) calcd for C16H29N20 4 (M ) 313, found 313.
"NO 2
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(2E,11Z)-N-Methoxy-N-methyl-4-(nitromethyl)icosa-2,11-dienamide (Table 1.6,
entry 9). The compound was prepared according to the general procedure with (+)-(Z)-N-
methoxy-N-methylnonadeca-2,3,10-trienamide (262 mg, 0.75 mmol). After purification by flash
chromatography (7 --* 14% EtOAc in hexanes), the title compound was isolated as a colorless oil
(257 mg, 83% yield) with 93% ee.
[M]D 22 = -24.0 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 57.4 min (major), 64.0 min
(minor).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(260 mg, 84% yield) with 93% ee.
'H NMR (CDC13, 500 MHz) 6 6.64 (dd, J = 15.4, 9.4 Hz, 1H), 6.47 (dd, J = 15.4 Hz,
1H), 5.31-5.20 (m, 2H), 4.38 (dd, J= 12.3, 6.0 Hz, 1H), 4.30 (dd, J= 12.1, 8.9 Hz, 1H), 3.61 (s,
3H), 3.17 (s, 3H), 3.08-2.98 (m, 1H), 2.00-1.88 (m, 4H), 1.48-1.10 (m, 22H), 0.81 (t, J= 6.5 Hz,
3H).
13C NMR (CDCl 3, 125 MHz) 6 165.8, 144.3, 130.2, 129.7, 122.0, 79.1, 61.9, 41.5, 36.8,
32.4, 32.0, 31.6, 29.9, 29.8, 29.7, 29.5, 29.4, 29.2, 27.4, 27.3, 26.9, 22.9, 14.3.
IR (film) 3003, 2926, 2855, 2361, 2339, 1667, 1635, 1557, 1464 cm-.
LRMS (ES+) calcd for C23H43N20 4 (M+H +) 411, found 411.
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(E)-Methyl-4-(nitromethyl)hept-2-enoate (Table 1.7, entry 1). The compound was
prepared according to the general procedure with (+)-methyl hepta-2,3-dienoate (105 mg, 0.75
mmol). After purification by flash chromatography (30% hexanes in CH 2C12), the title compound
was isolated as a colorless oil (109 mg, 72% yield) with 92% ee.
[a]D22 = -31.8 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 24.8 min (minor), 32.7 min
(major).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(113 mg, 74% yield) with 93% ee.
'H NMR (CDC13, 500 MHz) 6 6.72 (dd, J= 15.6, 9.1 Hz, 1H), 5.90 (d, J= 15.7 Hz, 1H),
4.42 (dd, J= 12.3, 5.9 Hz, 1H), 3.85 (dd, J= 12.3, 8.7 Hz, 1H), 3.73 (s, 3H), 3.10-3.03 (m, 1H),
1.50-1.25 (m, 4H), 0.91 (t, J= 7.3 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 166.3, 146.1, 124.2, 78.9, 52.0, 41.0, 33.5, 20.0, 13.9.
IR (film) 2960, 2935, 2875, 2361, 2339, 1717, 1661, 1558, 1436 cm -1.
LRMS (ES+) calcd for C9H1 6NO4 (M+H +) 202, found 202.
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(E)-Ethyl-4-(nitromethyl)hept-2-enoate (Table 1.7, entry 2). The compound was
prepared according to the general procedure with (1+)-ethyl-hepta-2,3-dienoate (131 mg, 0.75
mmol). After purification by flash chromatography (30% hexanes in CH2C12), the title compound
was isolated as a colorless oil (148 mg, 92% yield) with 91% ee.
[a]D22 = -29.5 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 15.2 min (minor), 18.1 min
(major).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(143 mg, 89% yield) with 92% ee.
1H NMR (CDC13, 500 MHz) 6 6.66 (dd, J= 15.6, 9.0 Hz, 1H), 5.85 (d, J= 15.6 Hz, 1H),
4.39 (dd, J= 12.3, 5.9 Hz, 1H), 4.32 (dd, J= 12.3, 8.6 Hz, 1H), 4.14 (q, J= 7.1 Hz, 2H), 3.06-
2.98 (m, 1H), 1.44-1.22 (m, 7H), 0.87 (t, J= 7.2 Hz, 3H).
13C NMR (CDC13, 125 MHz) 8 165.9, 145.9, 124.4, 78.8, 60.8, 40.9, 33.5, 20.0, 14.3,
13.9.
IR (film) 2962, 2935, 2875, 2361, 2339, 1717, 1653, 1558 cm1.
LRMS (ES+) calcd for C10HI8NO 4 (M) 216, found 216.
O
t-BuO NO 2
Me
(E)-tert-Butyl-4-(nitromethyl)hept-2-enoate (Table 1.7, entry 3). The compound was
prepared according to the general procedure with (+)-tert-butyl-hepta-2,3-dienoate (137 mg, 0.75
mmol). After purification by flash chromatography (10% EtOAc in hexanes), the title compound
was isolated as a colorless oil (173 mg, 95% yield) with 90% ee.
[a]D 22 = -29.4 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 13.6 min (minor), 17.4 min
(major).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(168 mg, 93% yield) with 90% ee.
'H NMR (CDCl3 , 500 MHz) 6 6.56 (dd, J= 15.6, 9.0 Hz, 1H), 5.77 (d, J= 15.6 Hz, 1H),
4.37 (dd, J= 12.3, 6.1Hz, 1H), 4.31 (dd, J= 12.3, 8.5 Hz, 1H), 3.04-2.96 (m, 1H), 1.42-1.20 (m,
13H), 0.86 (t, J= 6.6 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 165.1, 144.6, 126.1, 80.9, 78.9, 40.8, 33.5, 28.2, 20.0,
13.9.
IR (film) 2964, 2934, 2875, 2361, 2339, 1713, 1654, 1554, 1368, 1159 cm-.
LRMS (ES+) calcd for C8H 12NO4 (M-t-Bu +) 186, found 186.
NC 
NO 2
Me
8
(E)-4-(Nitromethyl)tetradec-2-enenitrile (Table 1.7, entry 4). The compound was
prepared according to the general procedure (except 3.0 equiv of phenol was used) with (L)-
tetradeca-2,3-dienenitrile (154 mg, 0.75 mmol). After purification by flash chromatography
(30% hexanes in CH 2C12 ), the title compound was isolated as a colorless oil (96 mg, 48% yield
(5:1 E:Z olefin isomers)) with 92% ee (E isomer) and 90% ee (Z isomer).
[a]D2 2 = -26.1 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: E isomer: 49.9 min (minor),
53.9 min (major); Z isomer: 24.2 min (minor), 32.7 min (major).
The second run was performed with (R)-P1. The product was isolated as a colorless oil
(90 mg, 45% yield (5:1 E:Z olefin isomers)) with 92% ee (E isomer) and 91% ee (Z isomer).
'H NMR (CDC13, 500 MHz) 6 (mixture of inseparable isomers) E isomer: 6.50 (dd, J=
14.4, 9.3 Hz, 1H), 5.45 (d, J= 16.3 Hz, 1H), 4.45-4.31 (m, 2H), 3.08-2.96 (m, 1H), 1.55-1.18 (m,
18H), 0.87 (t, J= 6.9 Hz, 3H); Z isomer: 6.31 (apparent t, J= 10.9 Hz, 1H), 5.50 (d, J= 10.9 Hz,
1H), 4.51-4.38 (m, 2H), 3.50-3.40 (m, 1H), 1.55-1.18 (m, 18H), 0.87 (t, J= 6.9 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 (mixture of inseparable isomers) 152.9, 152.4, 116.6,
103.4, 103.2, 78.5, 78.3, 42.4, 41.0, 39.8, 32.1, 31.5, 31.1, 29.8, 29.7, 29.5, 29.47, 29.42, 26.9,
22.9, 14.3.
IR (film) 3055, 2925, 2855, 2360, 2339, 2226, 1636, 1558, 1465, 1457 cm -1.
LRMS (ES+) calcd for C1 5H26N2 0 2 (M+H +) 267, found 267.
O
II(EtO) 2P" N 2
Me
3
(E)-Diethyl-3-(nitromethyl)oct-l-enylphosphonate (Table 1.7, entry 5). The
compound was prepared according to the general procedure (except 3.0 equiv of phenol was
used and the reaction mixture was heated at 60 OC) with (+)-diethyl octa-1,2-dienylphosphonate
(185 mg, 0.75 mmol). After purification by flash chromatography (30% hexanes in EtOAc), the
title compound was isolated as a colorless oil (203 mg, 89% yield) with 75% ee.
[a]D22 = -18.3 (c = 1.0, CHCl3). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 41.4 min (minor), 46.7 min
(major).
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The second run was performed with (R)-P1. The product was isolated as a colorless oil
(193 mg, 84% yield) with 72% ee.
'H NMR (CDCl 3, 500 MHz) 6 6.45 (ddd, J= 21.6, 17.1, 8.7 Hz, 1H), 5.64 (dd, J= 18.9,
17.1 Hz, 1H), 4.35 (dd, J= 12.2, 5.6 Hz, 1H), 4.26 (dd, J= 12.2, 9.0 Hz, 1H), 4.01-3.87 (m, 4H),
2.96-2.89 (m, 1H), 1.42-1.30 (m, 2H), 1.28-1.11 (m, 12H), 0.77 (t, J= 6.6 Hz, 3H).
13C NMR (CDC13, 125 MHz) 8 150.6, 121.7, 78.8, 62.0, 43.2, 43.0, 31.5, 31.1, 26.4, 22.5,
16.5, 16.4, 14.0.
IR (film) 2958, 2932, 2860, 2361, 2339, 1639, 1553, 1380, 1246 cml .
LRMS (ES+) calcd for C13H26NO 5P (M+H+) 308, found 308.
IV. Determination of Absolute Stereochemistry
The stereochemistry of the y-alkylation products was assigned by correlation with known
compounds.
1) (S)-3-methyl-2-(nitromethyl)butanal 63
MeMeO,N / Me
I MeMe
racemic
10% (R)-P1
10% Ph-OH
Me-NO2  go
dioxane, r.t.
03; DMS
IN
O
H NO 2
Me-Me
2) (R)-tert-butyl 2-(hydroxymethyl)pentylcarbamate 64
0 10% (S)-P1
Me n-Pr Me-NO2 10% Ph-OH
MeO,MN  NOPr -
Me dioxane, r.t.
racemic
1) Ino, HCI
2) Boc 20
3) 03; NaBH 4 HO"', NHBoc
n-Pr
63 Enders, D.; Syrig, R.; Raabe, G.; Fernmndez, R.; Gasch, C.; Lassaletta, J.-M.; Llera, J.-M. Synthesis, 1996, 48-52.6 4 Chi, Y.; Gellman, S. H. J. Am. Chem. Soc. 2006, 128, 6805-6806.
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E. 1H NMR Spectra of Selected Compounds
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file /data/gfu/Tsm dpwr
/Tsm-12-129-AH.fid dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used
bs 8 dfrq2
tpwr 56 dn2
pw 8.6 dpwr2
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 16 dmf2
alock n dseq2
gain not used dres2
FLAGS homo2
ii n
in n dfrq3
dp y dn3
hs nn dpwr3
DISPLAY dof3
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wp 3990.6 dmm3
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date Feb 4 2009 dfrq 125.
solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-12-130-3H.fld dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf 1
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used DEC2
bs 8 dfrq2
tpwr 56 dn2
pw 8.6 dpwr2
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 8 dmf2
alock n dseq2
gain not used dres2
FLAGS homo2
11 n DEC3
in n dfrq3
dp y dn3
hs nn dpwr3
DISPLAY dof3
sp 3.7 dm3
wp 3990.6 dmm3
vs 26 dmf3
sc 0 dseq3
wc 250 dres3
hzmm 15.96 homo3
Is 33.57 PROCESSING
0 rfl 1233.8 wtfile
LA rfp 0 proc
th 7 fn 26
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werr
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SAMPLE
date Feb 4 2009
solvent CDC13
file /data/gfu/Tsm-
/Tsm-12-129-CH.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp 3.7
wp 3990.6
vs 13
sc 0
wc 250
hzmm 15.96
is 33.57
S rfl 1233.8
rfp 0
th 7
ins 1.000
ai ph
DEC. & VT
dfrq 125
dn
dpwr
dof
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dmm
dmf 1
dseq
dres
homo
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf 2
dseq2
dres2
homo2
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dn3
dpwr3
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wtfile
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SAMPLE
date Mar 1 2009
solvent CDC13
file /data/gfu/Tsm-
/Tsm-13-043-H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 0.5
dl 0.050
tof 867.7
nt 64
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp -120.3
wp 2523.2
vs 151
sc 0
we 250
hzmm 10.09
is 297.16
C rfl 661.0
rfp 0
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wtfile
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file /data/gfu/Tsm-
/Tsm-12-130-5H.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
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in n
dp y
hs nn
DISPLAY
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wp 3990.6
vs 44
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is 33.57
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expl s2pul
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date Feb 4 2009 dfrq
solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-12-130-4H.fid dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used
bs 8 dfrq
tpwr 56 dn2
pw 8.6 dpwr
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 8 dmf2
alock n dseq
gain not used dres
FLAGS homo
11 n
in n dfrq
dp y dn3
hs nn dpwr
DISPLAY dof3
sp 3.7 dm3
wp 3990.6 dmm3
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sc 0 dseq
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hzmm 15.96 homo
is 33.57
0 rfl 1233.8 wtfi
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solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-12-130-2H.fld dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf 1
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used DEC2
bs 8 dfrq2
tpwr 56 dn2
pw 8.6 dpwr2
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 8 dmf2
aloc n dseq2
gain not used dres2
FLAGS homo2
11 n DEC3
in n dfrq3
dp y dn3
hs nn dpwr3
DISPLAY dof3
sp 3.7 dm3
wp 3990.6 dmm3
vs 25 dmf3
sc 0 dseq3
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Is 33.57 PROCESSING
rfl 1233.8 wtfile
rfp 0 proc
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file /data/gfu/Tsm-
/Tsm-12-130-1H.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp 3.7
wp 3990.6
vs 33
sc 0
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hzmm 15.96
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date Feb 28 2009
solvent CDC13
file /data/export/~
home/gfu/Tsm/bullw
inkle/Tsm-13-methy~
lesteralleneH.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
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ACQUISITION
sfrq 499.746
tn H1
at 3.001
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sw 10504.2
fb not used
bs 8
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pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
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.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
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in n
dp y
hs nn
DISPLAY
sp 3.1
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vs 8
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hzmm 15.99
- Is 33.57
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SAMPLE DEC. & VT
date Feb 4 2009 dfrq 125
solvent CDC13 dn
file /data/gfu/Tsm~ dpwr
/Tsm-12-060-H.fid dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf 11
at 3.001 dseq
np 63050 dres
SW 10504.2 homo
fb not used DEC2
bs 8 dfrq2
tpwr 56 dn2
pw 8.6 dpwr2
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 8 dmf2
alock n dseq2
gain not used dres2
FLAGS homo2
il n DEC3
in n dfrq3
dp y dn3
hs nn dpwr3
DISPLAY dof3
sp 3.7 dm3
wp 3990.6 dmm3
vs 119 dmf3
sc 0 dseq3
wc 250 dres3
hzmm 15.96 homo3
Is 33.57 PROCESSING
rfl 1233.8 wtfile
rfp 0 proc
th 7 fn 26,
ins 1.000 math
ai ph
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
0
NC M
1
0
n
c
200
1.0
n
ft
2144
f
wft
7 6 5I
0.31
3
3.90 6.68
1.21 35.72
L-4 LJ
3.45
0.45
ppm
__ I
I I I I I , r I I I I i I I I I , I I I 1 I I I I I I I I I I I 1I I
1.17
1.00
STANDARD PROTON PARANETERS
expl s2pul
SANPLE DEC. & VT
date Feb 4 2009 dfrq 125
solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-12-072-H.fid dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf 1
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used DEC2
bs 8 dfrq2
tpwr 56 dn2
pw 8.6 dpwr2
dl 2.000 dof2
tof 1519.5 dm2
nt 16 dmm2
ct 8 dmf2
alock n dseq2
gain not used dres2
FLAGS homo2
il n DEC3
in n dfrq3
dp y dn3
hs nn dpwr3
DISPLAY dof3
sp 3.7 dm3
wp 3990.6 dmm3
vs 57 dmf3
sc 0 dseq3
wc 250 dres3
hzmm 15.96 homo3
is 33.57 PROCESSING
rfl 1233.8 wtfile
S rfp 0 proc
th 7 fn 26,
Ins 1.000 math
al cdc ph
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
0
0II
(EtO)2 P
3 Me
ft
2144
f
wft
_ _ _ _ I
7 6
1.00
0.89
3
3.81
2.40
I I
2 .33
10.19
1
3.28
ppm
L id!
I I I I I I I I I I I I I I i I I I I I I I I I I I F
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Feb 15 2009
solvent CDCl3
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-13-007-H-
.fid
ACQUISITION
sfrq 499.746
tn Hi
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp 0.3
wp 3994.4
vs 72
sc 0
we 250
hzmm 15.98
is 33.57
rfl 1233.8
rfp 0
th 7
ins 1.000
ai cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1'
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26:
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
ft
2144
f
wft
O
MeO
Me Me
Table 1.6, entry 1
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3 2 1 ppm
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IIXJq
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Feb 15 2009
solvent CDC13
file /data/export/~
home/gfu/Tsm/bullw-
inkle/Tsm-13-005-H-
.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
i1 n
In n
dp y
hs nn
DISPLAY
sp 0.3
wp 3994.4
vs 67
sc 0
WC 250
hzmm 15.98
is 33.57
rfl 1233.8
rfp 0
th 7
Ins 1.000
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26:
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
ft
2144
f 0
MeO. NN NO2
Me
Me
Table 1.6, entry 2
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1 ppm
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7
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A
I
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Feb 15 2009 dfrq
solvent CDCl3 dn
file /data/export/- dpwr
home/gfu/Tsm/bullw dof
inkle/Tsm-13-008-H- dm
.fid dmm
ACQUISITION dmf
sfrq 499.746 dseq
tn H1 dres
at 3.001 homo
np 63050
sw 10504.2 wtfi
fb not used proc
bs 8 fn
tpwr 56 math
pw 8.6
dl 2.000 werr
tof 1519.5 wexp
nt 16 wbs
ct 8 Wnt
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp 0.3
wp 3994.4
vs 68
sc 0
wc 250
hzmm 15.98
is 33.57
rfl 1233.8
rfp 0
th 7
ins 1.000
ai ph
DEC. & VT
125.672
C13
30
0
1
PROCESSING
le
26:
w
0000
1.0
n
ft
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f
0
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Table 1.6, entry 4
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Feb 24 2009
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-13-044-1-
RH.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp -197.3
wp 4192.3
vs 37
sc 0
wc 250
,) hzmm 16.77
C is 33.57
rfl 1233.8
rfp 0
th 7
ins 1.000
ai ph
dfrq
dn
dpwr
dof
dm
dmm
dmf
dseq
dres
homc
temp
wtfi
proc
fn
math
werr
wexp
wbs
wnt
DEC. & VT
125.672
C13
30
0
nnn
w
10000
1.0
n
20.0
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE DEC. & VT
date Feb 15 2009 dfrq 125.672
solvent CDC13 dn C13
file /data/export/- dpwr 30
home/gfu/Tsm/bullw- dof 0
inKle/Tsm-13-012-H- dm nnn
.fid dmm w
ACQUISITION dmf 10000
sfrq 499.746 dseq
tn H1 dres 1.0
at 3.001 homo n
np 63050 PROCESSING
sw 10504.2 wtfile
fb not used proc ft
bs 8 fn 262144
tpwr 56 math f
pw 8.6
dl 2.000 werr
tof 1519.5 wexp
nt 16 wbs
ct 0 wnt wft
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -0.8
wp 4000.2
vs 87
sc 0
wc 250
hzmm 16.00
is 33.57
rfl 1233.8
rfp 0
th 7
ins 1.000
O
MeO'N N02
Me OMe
0
Table 1.6, entry 6
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expl s2pul
SAMPLE D
date Feb 23 2009 dfrq
solvent CDC13 dn
file /data/gfu/Tsm dpwr
/Tsm-13-030-1H.fld dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used temp
bs 8
tpwr 56 dfrq2
pw 8.6 dn2
dl 2.000 dpwr2
tof 1519.5 dof2
nt 16 dm2
ct 8 dmm2
alock n dmf2
gain not used dseq2
FLAGS dres2
11 n homo2
In n
dp y dfrq3
hs nn dn3
DISPLAY dpwr3
sp 4.4 dof3
wp 3993.2 dm3
vs 34 dmm3
sc 0 dmf3
wc 250 dseq3
hzmm 15.97 dres3
is 33.57 homo3
t- rfl 1233.8 PI9 rfp 0 wtfll
th 7 proc
ins 1.000 fn
ai cdc ph math
EC. & VT
125.672
C13
30
0
nnn
w
10000
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DEC3
ROCESSING
e
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werr
wexp
wbs
wnt
1.0
n
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0
0
MeO,eO 
N02
Me OMe
0
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STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Feb 15 2009
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-13-010-H-
.fld
ACQUISITION
sfrq 499.746
tn Hi
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 0
alock n
gain not used
FLAGS
11 n
In n
dp y
hs nn
DISPLAY
sp -0.8
wp 4000.2
vs 55
PA sc
wc
W hzmm
is
rfl
rfp
th
ins
ai cdc
0
250
16.00
33.57
1233.8
0
7
1.000
DEC. & VT
dfrq 125.
dn
dpwr
dof
dm
dmm
dmf 1(
dseq
dres
homo
PROCESSING
wtfile
proc
fn 261
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
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1.0
n
ft
2144
f
wft
0
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Table 1.6, entry 8
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expl s2pul
SAMPLE
date Feb 15 2009
solvent CDCl3
file /data/export/~
home/gfu/Tsm/bullw-
inkle/Tsm-13-009-H~
.fid
ACQUISITION
sfrq 499.746
tn H1i
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 0
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -0.8
wp 4000.2
vs 213
sc
wc
S hzmm
- is
rf I
rfp
0
250
16.00
33.57
1233.8
0
7
1.000
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26
math
werr
wexp
wbs
wnt
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C13
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0
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w
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f
wft
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6
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expl s2pul
SAMPLE
date Feb 23 2009
solvent CDC13
file /data/gfu/Tsm-
/Tsm-13-034-H.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
i1 n
In n
dp y
hs nn
DISPLAY
sp 4.4
wp 3993.2
vs 38
sc 0
wc 250
hzmm 15.97
- is 33.57
.) rfl 1233.8
LA rfp 0
th 7
ins 1.000
ai ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1I
dseq
dres
homo
temp
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf 2
dseq2
dres2
homo2
DEC3
dfrq3
dn3
dpwr3
dof 3
dm3
dmm3
dmf3
dseq3
dres3
homo3
PROCESSING
wtfile
proc
fn 26:
math
werr
wexp
wbs
wnt
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w
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SAMPLE
date Feb 23 2009
solvent CDC13
file /data/gfu/Tsm-
/Tsm-13-032.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp 4.4
wp 3993.2
vs 86
sc 0
wc 250
hzmm 15.97
is 33.57
rfl 1233.8
rfp 0
th 7
ins 100.000
ai ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
temp
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf2
dseq2
dres2
homo2
DEC3
dfrq3
dn3
dpwr3
dof 3
dm3
dmm3
dmf 3
dseq3
dres3
homo3
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wtfile
proc
fn 26;
math
werr
wexp
wbs
wnt
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w
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date Feb 23 2009
solvent CDC13
file /data/gfu/Tsm-
/Tsm-13-033.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp 4.4
wp 3993.2
vs 42
sc 0
wc 250
hzmm 15.97
is 33.57
rfl 1233.8
rfp 0
th 7
ins 100.000
ai ph
DEC. & VT
dfrq 125.
dn
dpwr
dof
dm
dmm
dmf 10
dseq
dres
homo
temp 2
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf 2
dseq2
dres2
homo2
DEC3
dfrq3
dn3
dpwr3
dof3
dm3
dmm3
dmf 3
dseq3
dres3
homo3
PROCESSING
wtfile
proc
fn 26
math
werr
wexp
wbs
wnt
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expl s2pul
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date Feb 23 2009 dfrq 125
solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-13-036-H.fld dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf 1
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used temp
bs 8 DEC2
tpwr 56 dfrq2
pw 8.6 dn2
dl 2.000 dpwr2
tof 1519.5 dof2
nt 16 dm2
ct 8 dmm2
alock n dmf2
gain not used dseq2
FLAGS dres2
il n homo2
In n DEC3
dp y dfrq3
hs nn dn3
DISPLAY dpwr3
sp 4.4 dof3
wp 3993.2 dm3
vs 69 dmm3
SC 0 dmf3
wc 250 dseq3
hzmm 15.97 dres3
is 33.57 homo3
k) rfl 1233.8 PROCESSING
00 rfp 0 wtfile
th 7 proc
ins 1.000 fn 26:
al ph math
werr
wexp
wbs
wnt
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C13
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w
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8
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SAMPLE DE
date Feb 23 2009 dfrq
solvent CDC13 dn
file /data/gfu/Tsm- dpwr
/Tsm-13-035-H.fid dof
ACQUISITION dm
sfrq 499.746 dmm
tn H1 dmf
at 3.001 dseq
np 63050 dres
sw 10504.2 homo
fb not used temp
bs 8
tpwr 56 dfrq2
pw 8.6 dn2
dl 2.000 dpwr2
tof 1519.5 dof2
nt 16 dm2
ct 8 dmm2
alock n dmf2
gain not used dseq2
FLAGS dres2
ii n homo2
in n
dp y dfrq3
hs nn dn3
DISPLAY dpwr3
sp 4.4 dof3
wp 3993.2 dm3
vs 71 dmm3
sc 0 dmf3
wc 250 dseq3
hzmm 15.97 dres3
is 33.57 homo3
rfl 1233.8 PF
rfp 0 wtfili
th 7 proc
ins 100.000 fn
math
werr
wexp
wbs
wnt
EC. & VT
125.672
C13
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0
nnn
w
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CHAPTER 2
Nickel-Catalyzed Negishi Cross-Couplings of
Secondary Propargylic Electrophiles
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Introduction and Background
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A. Introduction
In recent years, significant progress has been made in the area of transition metal-
catalyzed cross-coupling. 65 Cross-coupling reactions are generally defined as a set of reactions in
which a new carbon-carbon bond (R1-R 2) is formed through the union of an organometallic
reagent (R'-M l, where R1 = C, N, O, S, P, or B) and a carbon electrophile (R2-X, where X = I,
Br, Cl, OMs, OTf, or N2; Ms = methanesulfonyl, Tf = trifluoromethanesulfonyl) through the use
of a transition metal catalyst. With respect to nomenclature, common names have been assigned
to the various cross-coupling reactions based on the identity of M', often named after the
individuals who contributed either to their discovery or subsequent development (Scheme 2.1).
A generalized mechanism is presented in Scheme 2.1.66 It has been traditionally held that
inner-sphere cross-coupling reactions consist of three fundamental steps. 67 There are instances in
which the order of the first two steps may vary from that which is illustrated in Scheme 2.1. The
process begins with the oxidative addition of a suitable catalyst (LnM) into the C-X bond of the
organic electrophile. Transmetalation generates a diorganometallic intermediate (LnMRR2),
which then can reductively eliminate. This last step regenerates the transition metal catalyst
(LnM) and releases the product (R'-R 2). The overall efficiency of this three-step process is
highly dependent on the nature of the metal and its associated ligands, which remain bound to
the metal throughout this process.
65 (a) Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: New York,
2004. (b) Handbook of Organopalladium Chemistry for Organic Synthesis; Negishi, E.-i., Ed.; Wiley-Interscience:
New York, 2002.
66 For discussion and leading references, see: Principles and Applications of Organotransition Metal Chemistry;
Collman, J. P.; Hegedus, L. S.; Norton, J. R.; Finke, R. G., Eds.; University Science Books: Sausalito, CA 1987.
67 The definitition of "cross-coupling reaction" may be a subject of debate. We have chosen to define a cross-
coupling reaction as a process in which both the nucleophilic atom of the organometallic reagent and the
electrophilic carbon of the carbon electrophile are covalently bonded to a transition metal prior to reductive
elimination. It should be noted that IUPAC has yet to put forth a definition of "cross-coupling reaction".
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Scheme 2.1. Generalized Mechanism for Metal-Catalyzed Cross-Coupling Reactions.
oxidative
Ri-R 2  addition X-R 2
reductive
elimination
LnM R2  LnM R
2
M1= Ri1 X(
B Suzuki-Miyaura
Si Hiyama
Sn Stille
Mg Kumada
Zn Negishi M1-X M1-R 1Zr Negishi
Al Nozaki transmetalation
This mechanism, though simplified, is widely accepted, in particular for palladium
catalysis,68 and is commonly referred to as a Pdo/Pd I cycle, as these are the two oxidation states
palladium holds during different stages of this process.
The mechanism shown in Scheme 2.1 is descriptive for cross-coupling reactions between
organic partners not containing P-hydrogens, specifically sp- and sp 2-hybridized partners (such
as aryl-, alkenyl- and alkynyl-electrophiles). The extension of cross-coupling reactions to 3-
hydrogen-containing alkyl electrophiles 69,70 has long remained elusive. This is, in part, due to the
slower oxidative addition of LM into more the electron-rich Ralky-X bonds and the commonly
observed undesired reaction pathway known as P-hydride elimination. It is believed that agostic
interactions between the transition metal and the 3-hydrogens present on the alkyl electrophile
trigger 3-hydride elimination. Often P-hydride elimination outcompetes transmetallation and
reductive elimination (see Scheme 2.2). Scheme 2.2 illustrates the commonly accepted
68 Kochi, J. K. Organometallic Mechanisms, and Catalysis; Academic Press: New York, 1978; pp 393-398.69 For reviews of cross-coupling reactions of alkyl electrophiles, see: (a) Rupolph, A.; Lautens, M. Angew. Chem.,
Int. Ed. 2009, 48, early view (and references therein). (b) Frisch, A. C.; Beller, M. Angew. Chem., Int. Ed. 2005, 44,
674-688. (c) Netherton, M. R.; Fu, G. C. Adv. Synth. Catal. 2004, 346, 1525-1532.70 For further discussion of the difficulties associated with cross-coupling of alkyl electrophiles, see: (a) Cirdenas,
D. J. Angew. Chem., Int. Ed. 2003, 42, 384-387. (b) Luh, T.-Y.; Leung, M.-k.; Wong, K.-T. Chem. Rev. 2000, 100,
3187-3204.
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mechanism for a palladium-catalyzed cross-coupling of alkyl partners. For nickel-based cross-
coupling reactions of alkyl fragments, the mechanism requires further study.7 1,70a
Scheme 2.2. Generalized Mechanism for Metal-Catalyzed Cross-Coupling Reactions of
13-Hydrogen Containing Alkyl Electrophiles.
Me oxidative Me
RAhM addition Xa eR Me LnM X Me
reductive
elimination slow
Me Me
LnM" LnM _3-hydride
R H X H elimination
LnM H Me
M1-X M1-R
transmetalation
Whereas the focus in cross-coupling chemistry traditionally has been on the formation of
new sp2-sp 2 C-C bonds, 72 our group and others have been working to expand the scope of these
processes to include new sp 3-sp 2 and sp 3-sp 3 C-C bonds. 69 ,73
71 For mechanistic studies of nickel-catalyzed couplings of unactivated alkyl electrophiles, see: (a) Jones, G. D.;
Martin, J. L.; McFarland, C.; Allen, O. R.; Hall, R. E.; Haley, A. D.; Brandon, R. J.; Konovalova, T.; Desrochers, P.
J.; Pulay, P.; Vicic, D. A. . Am. Chem. Soc. 2006, 128, 13175-13183. (b) Lin, X.; Phillips, D. L. J. Org. Chem.
2008, 73, 3680-3688.
72 For work in this area from our group, see: Fu, G. C. Acc. Chem. Res. 2008, 41, 1555-1564, and references therein.
73 Couplings with organoboron compounds: (a) Ishiyama, T.; Abe, S.; Miyaura, N.; Suzuki, A. Chem. Lett. 1992,
691-694. (b) Netherton, M. R.; Dai. C.; Neuschitz, K.; Fu, G. C. J. Am. Chem. Soc. 2001, 123, 10099-10100. (c)
Kirchhoff, J. H.; Netherton, M. R.; Hills, I. D.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 13662-13663, and references
therein. Couplings with organozinc compounds: (d) Devasagayaraj, A.; Stidemann, T.; Knochel, P. Angew. Chem.,
Int. Ed. Engl. 1995, 34, 2723-2725. (e) Jensen, A. E.; Knochel, P. J. Org. Chem. 2002, 67, 79-85, and references
therein. (f) Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 12527-12530. Couplings with organomagnesium
compounds: (g) Terao, J.; Watanabe, H.; Ikumi, A.; Kuniyasu, H.; Kambe, N. J. Am. Chem. Soc. 2002, 124, 4222-
4223. (h) Terao, J.; Ikumi, A.; Kuniyasu, H.; Kambe, N. J. Am. Chem. Soc. 2003, 125, 5646-5647. (i) Frisch, A. C.;
Shaikh, N.; Zapf, A.; Beller, M. Angew. Chem., Int. Ed. 2002, 41, 4056-4059. (j) Frisch, A. C.; Rataboul, F.; Zapf,
A.; Beller, M. J. Organomet. Chem. 2003, 687, 403-409. Couplings with organotin compounds: (k) Menzel, K.; Fu,
G. C. J. Am. Chem. Soc. 2003, 125, 3718-3719. (1) Tang, H.; Menzel, K.; Fu, G. C. Angew. Chem., Int. Ed. 2003, 42,
5079-5082. Couplings with organosilicon compounds: (m) Lee, J.-Y.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 5616-
5617. Couplings with organozirconium compounds: (n) Wiskur, S. L.; Korte, A.; Fu, G. C. J. Am. Chem. Soc. 2004,
126, 82-83.
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By the time I joined the Fu laboratory in 2004, substantial progress had been made on
cross-coupling reactions of alkyl electrophiles; much of this work utilized palladium-based
catalysts and bulky, electron-rich phosphines. 73 The bulk of this work had been focused on the
development of reaction conditions whereby primary nucleophiles could be coupled with
primary electrophiles. The remainder of this section highlights some of the work performed in
the Fu group prior to my joining. Developments which took place during my time in the group
are discussed throughout Chapter 2.
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B. Negishi Coupling Reaction
In 2003, Steve Zhou developed a catalyst that, for the first time, allowed for the cross-
coupling of primary organozinc reagents with secondary electrophiles.74 This significant step
forward required a shift from palladium to nickel. Nickel, which had been used by Kambe75 and
Knochel 76 to achieve primary-primary alkyl-alkyl cross-couplings, is believed to be a better
catalyst for cross-coupling alkyl electrophiles because it is more reactive in the oxidative
addition of alkyl electrophiles than palladium and it is less prone to undergo n-hydride
elimination.77 Dr. Zhou's Ni(cod) 2/(s-Bu)-Pybox catalyst displayed a broad scope (Scheme 2.3).
With respect to the electrophile, both cyclic and acyclic secondary bromides and iodides coupled
efficiently. An array of functional groups were compatible with the room-temperature reaction
conditions, including ethers, acetals, esters, amides and protected amines.
Scheme 2.3. Nickel-Catalyzed Negishi Reactions of Alkyl Bromides and Iodides.
4% Ni(cod)2R 8% s-Bu-Pybox
X YZn-Rk DMA, r.t.
R DMA, r.t.
R
)-Ralkyl
R
N N
Me Me Me Me
s-Bu-Pybox
MeMe
Me
X = Br
91%
V o-O
X = Br
62%
Me
TsN J Me
X = Br
66%
NEt2
X=1
78%
X = Br
68%
Me 0
Me OEt
X=I
62%
74 Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 14726-14727.
75 See ref 72g and 72h, and: (c) Terao, J.; Todo, H.; Ikumi, A.; Kambe, N. Angew. Chem. Int. Ed. 2004, 43, 6180-
6182.
76 (a) Giovannini, R.; Stildemann, T.; Dussin, G.; Knochel, P. Angew. Chem. Int. Ed. 1998, 37, 2387-2390. Also,
see: ref. 72d.
77 Koga, N.; Obara, S.; Kitaura, K.; Morokuma, K. J. Am. Chem. Soc. 1985, 107, 7109-7116.
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Development of the first metal-catalyzed method for cross-coupling f3-hydrogen
containing secondary electrophiles, opened the door for asymmetric cross-coupling reactions, as
a stereocenter may be produced at the carbon that bears the leaving group. The ability to control
the configuration about this new stereocenter would clearly have a dramatic impact on the utility
of this reaction. Dr. Zhou devoted considerable time towards the development of such a process.
Among the many secondary electrophiles he studied in this context, benzylic bromides led to the
most promising and exciting results. Dr. Zhou found that with (i-Pr)-Pybox he could obtain the
product in up to 46% yield and 72% ee (eq 2.1).78 It is worth noting, that this remarkable process
is stereoconvergent. The racemic starting material remains racemic throughout the reaction, and
yet, one enantiomer of product is generated in preference over the other.
4% NiBr2-diglyme n-Bu
Me B5% (S)-(iPr)-Pybox Me O '1eN
DMA, r.t.
racemic Me Me
46% yield
72% ee (S)-(i-Pr)-Pybox
This preliminary work was further optimized by Forrest Arp; he found conditions for
which a subclass of benzylic halides, a-bromoindanes, could participate in a stereoconvergent
cross-coupling reaction with primary organozinc bromides, obtaining very high levels of
enantioselectivity (Scheme 2.4). 7 9 The nucleophilic coupling partner could possess a wide range
of functionality: acetals, nitriles, primary alkyl chlorides, protected amines and ethers were well
tolerated. Similar to the work by Dr. Zhou, a departure from the indane scaffold to an acylic
benzylic bromide led to a dramatic loss of selectivity (95% - 75% ee).
78 For a more thorough description of Zhou's asymmetric cross-coupling studies, please refer to his thesis: Zhou, J.
Ph. D. Thesis, Massachusetts Institute of Technology, Cambridge, MA, September 2005.
79 Arp, F. O.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 10482-10483.
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Scheme 2.4. Catalytic Enantioselective Negishi Reactions of Racemic Secondary Benzylic
Halides.
10% NiBr2-diglyme
13% (S)-(iPr)-Pybox
BrZn-RalkyI
DMA, O °C
Ralkyl
13 examples;
39-89% yield
75-99% ee
0 0
N
Me /Me
Me Me
(S)-(iPr)-Pybox
n-Hex
Me 1W
89% yield
96% ee
47% yield 72% yield
91% ee 98% ee
P
76% yield
98% ee
OBn
1 2
Me
Me
63% yield
75% ee
Concurrent to the work by Dr. Arp, Christian Fischer developed a similar set of reaction
conditions which proved to be suitable for the cross-coupling of primary organozinc bromides
with a-bromo amides in excellent enantioselectivities (Scheme 2.5).8o This method was the first
reported example of an asymmetric cross-coupling of a secondary electrophile. Dr. Fischer was
able to modulate both the reactivity and enantioselectivity of this transformation in part through
variation of the amide nitrogen substituents; the N-phenyl, N-benzyl-amide proved to be the best
combination. Importantly, an assortment of functionalized nucleophiles coupled well under these
reaction conditions.
80 Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594-4595.
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Br
racemic
Scheme 2.5. Asymmetric Nickel-Catalyzed Cross-Couplings of Secondary a-Bromo Amides
with Organozinc Reagents.
10% NiCl2-glyme
13% (R)-iPr-Pybox
YZn-RalkyIF
DMI/THF, 0 °C
BnN JyR
Ph Ralkyl
12 examples;
51-90% yield
77-96% ee
N N
Me- Me
Me Me
(R)-iPr-Pybox
0
Bn'N 
Me
Ph Me
90% yield
91% ee
0
Bn-N Me
Ph n-Hex
90% yield
96% ee
O0
Bn'N Me
Ph
58% yield
92% ee
0
BnN Me
Ph Me Me
78% yield
87% ee
0
Bn'N Me
Ph K Me
Me
78% yield
95% ee
C. Suzuki Coupling Reaction
In 2003, during his next project, Dr. Zhou demonstrated that a nickel-based catalyst was
not exclusively active for Negishi reactions, but also worked very well, once optimized, for
Suzuki cross-coupling reactions between arylboronic acids and secondary electrophiles (Scheme
2.6).81 A Ni(cod) 2/bathophenanthroline-based catalyst system was capable of facilitating the
coupling of an array of functionalized arylboronic acids; this included electron-rich and electron-
poor nucleophiles (and even several heteroaromatic examples) with secondary bromides and
iodides. There were some limitations with respect to the electrophilic partner; namely, cyclic and
acyclic bromides more sterically demanding than cyclohexane or isopropyl bromide were not
efficient. That being said, the development of this reaction set the groundwork for a great wealth
of methodology which was developed over the next several years, particularly for Hiyama and
Stille reactions (see the next two sections).
81 Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2004, 126, 1340-1341.
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Ph Br
racemic
Scheme 2.6. Suzuki Cross-Couplings of Unactivated Secondary Alkyl Bromides and Iodides.
4% Ni(cod) 2  Ph Ph
R1  8% bathophenanthroline R1)X (HO) 2B-Ar 0 )-Ar
R 2  KOt-Bu R
2  N N
s-BuOH
60 oC 11 examples; bathophenanthroline
44-90% yield
Me O Me  Me
X = Br X = Br X = Br
68% 67% 90%
CNO
X=Br X=Br X=l
63% 44% 62%
D. Hiyama Coupling Reaction
Following Dr. Zhou's initial success in his Suzuki cross-coupling reactions between
arylboronic acids and secondary electrophiles, Dave Powell developed reaction conditions that
allowed for the efficient coupling of secondary electrophiles with organosilicon reagents
(Scheme 2.7).82 En route to accomplishing this goal, Dr. Powell found that air-stable nickel-
glyme precatalysts were quite suitable to this new family of coupling reactions. It is worth noting
that these nickel salts have now become a mainstay within the group, and have allowed for many
of the new reactions to be carried out on the bench in the absence of a N2-filled glovebox. Dr.
Powell's reaction conditions made use of bathophenanthroline as the ligand, and cesium fluoride
was used as an activator to generate intermediate silicates which undergo transmetalation more
easily. This reaction displayed a broad scope with respect to the electrophile; several substrates
which proved difficult for Dr. Zhou's Suzuki reaction readily reacted under these conditions.
Although even ortho-substituted nucleophiles performed well in this reaction, a drawback of
using aryl trifluorosilanes is that often distillation is the only means by which these nucleophiles
can be purified.
82 Powell, D. A.; Fu, G. C. J. Am. Chem. Soc. 2004, 126, 7788-7789.
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Scheme 2.7. Nickel-Catalyzed Cross-Couplings of Organosilicon Reagents with Unactivated
Secondary Alkyl Bromides.
6.5% NiBr 2-diglyme
7.5% bathophenanthroline R1
F3Si-Ar /-Ar
3.8 equiv CsF R2
DMSO, 60 C
14 examples;
60-82% yield
Cbz-Na -\
63%
71 OMe
71%
Ph Ph
N N
bathophenanthroline
80%
Ar
72%
Ar = p-C6 H4CI
E. Stille Coupling Reaction
A nickel-based catalyst also proved to be effective for the Stille arylation of secondary
electrophiles (Scheme 2.8).83 The NiCl 2/bipyridine catalyzed reaction, developed by Dr. Powell
and Dr. Toshihide Maki, displayed a scope similar to Dr. Powell's Hiyama reaction (c.f. Scheme
2.7). This reaction had the distinct advantage that it was effective with trichloroaryl tin reagents,
thus generating no triorganotin byproducts. 84 Circumventing generation of triorganotin
compounds not only simplifies purification of the resultant product, but also lowers the health
risk associated with Stille reactions.
83 Powell, D. A.; Maki, T.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 510-511.
84 For the toxicity of triorganotins, see: Bulten, E. J.; Meinema, H. In Metals and Their Compounds in the
Environment; Merian, E., Ed.; VCH: New York, 1991; Chapter 11.30, p. 1243.
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R1
>-Br
R
2
62%
O 70%
Scheme 2.8. Stille Cross-Couplings of Unactivated Secondary Alkyl Bromides Using
Monoorganotin Reagents.
10% NiCI2
R1  15% 2,2'-bipyridine R1
/-Br Cl3Sn-Ar --Ar
R
2  KOt-Bu R 2 N N
t-BuOHli-BuOH
60 oC 9 examples; 2,2-bipyridine
48-83% yield
Me
n-Heptyl 
-Me
72% 47% 83%
Me
Me M H Me,
O _F \ MeOMe i-Bu H OMe)8 i-Bu H
H
70% 71% 55%
(X = I)
F. Conclusion
Thus was the state of the art in 2005 regarding the coupling of secondary electrophiles; it
has been exciting to participate and observe the developments which have taken place in the
years since. When I began my study of nickel-catalyzed couplings of secondary propargylic
halides, I had no way of predicting the path it would take. This chapter discusses work on the
nickel-catalyzed couplings of secondary propargylic halides with a variety of organozinc
nucleophiles. Section 2.2 describes progress toward an asymmetric alkylation reaction. In
Section 2.3, the development of the first alkyl-alkyl secondary-secondary cross-coupling is
described. Section 2.4 describes the application of this coupling reaction to the formal synthesis
of a-cembra-2,7,11-triene-4,6-diol. The last section of this thesis (Section 2.5) discusses the
development of the first asymmetric Negishi reaction of arylzinc reagents with secondary
electrophiles.
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Section 2.2
Nickel-Catalyzed Asymmetric Cross-Couplings of
Racemic Propargylic Halides with Alkylzinc Reagents
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A. Introduction
The first investigation of asymmetric transition metal-catalyzed cross-coupling reactions
were carried out by Hayashi and Kumada in the mid-1970's. 85 In that work, the asymmetric,
nickel-catalyzed cross-couplings with chiral bidentate phosphines allowed for the dynamic
resolution of configurationally unstable benzylic magnesium reagents and the efficient coupling
with sp 2-hybridized electrophiles (in up to 17% ee).86 In short order, Hayashi and Kumada
discovered that more efficient conditions could be developed through use of chiral, bidentate
aminophosphine ligands. Thus, with the amino-alcohol derived ligand Valphos,
enantioselectivities up to 83% could be obtained for the coupling of vinyl bromides with
secondary benzylic magnesium reagents (eq 2.2).87
MgCI NiC12  Me
" Me Br (S)-Valphos Me Me2N  PPh2 (2.2)
racemic 83% ee (S)-Valphos
Additional study discovered that ferrocenyl-based aminophosphines of the type shown in
equation 2.3 could provide even higher levels of enantioselectivity in the coupling of substituted
vinyl bromides and a-(trimethylsilyl)benzylmagnesium bromide. 88
Ph
_ 
H, Me
MgCI 
NMe2
PdC2[(R)Ph PdC 2[(R)-(S)-PPFA] -(S)-PPF(2.3)SiMe 3 Br SiMe3  Fe Pd--\Pd-CIIPCPh CI
racemic 95% ee PdCI2[(R)-(S)-PPFA]
When I joined the Fu group in 2004, Dr. Fischer and Dr. Arp had recently developed the
first examples of asymmetric cross-coupling reactions of electrophiles bearing j3-hydrogens (see
85 For a historical note, see: Hayashi, T. J. Organomet. Chem. 2001, 653, 41-45.
86 Kiso, Y.; Tamao, K.; Miyake, N.; Yamamoto, K.; Kumada, M. Tetrahedron Lett. 1974, 16, 3-6.
87 (a) Hayashi, T.; Fukushima, M.; Konishi, M.; Kumada, M. Tetrahedron Lett. 1980, 21, 79-82. (b) Hayashi, T.;
Konishi, M.; Fukushima, M.; Kanehira, K.; Hioki, T.; Kumada, M. J. Org. Chem 1983, 48, 2195-2205.
88 (a) Hayashi, T.; Hagihara, T.; Katsuro, Y.; Kumada, M. Bull. Chem. Soc. Jpn. 1983, 56, 363-364. (b) Hayashi, T.;
Yamamoto, A.; Hojo, M.; Ito, Y. J. Chem. Soc., Chem. Commun. 1989, 495-496. (c) Hayashi, T.; Yamamoto, A.;
Hojo, M.; Kishi, K.; Ito, Y.; Nishioka, E.; Miura, H.; Yanagi, K. J. Organomet. Chem. 1989, 370, 129-139.
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introduction). As my umpolung project (Chapter 1, Section 1) was drawing to a close, I had a
high level of interest in contributing to this exciting and new area of study. As success in these
reactions had required the use of activated electrophiles, we chose to study the asymmetric
alkylation of secondary propargylic halides. I felt that success in this study would allow for
straightforward access to enantioenriched secondary propargylic compounds and would solve an
unmet challenge. 89
B. Results and Discussion
Naturally our first attempt of an asymmetric alkylation of secondary propargylic halides
was simply to apply the final conditions which proved successful for Dr. Fischer and Dr. Arp.
Thus, application of the NiC12-glyme/(i-Pr)-Pybox reaction conditions to a trimethylsilyl-
protected propargylic bromide was carried out. We were pleased to see that these reaction
conditions furnished the desired product in good yield, albeit with modest selectivity (19% ee, eq
2.4).
TMS 10% NiCI2*glyme TMS
B BrZnHex 13% (i-Pr)-Pybox Hex N
DMA, r.t. N N(2.4)
n-Bu 1.6 equiv n-Bu
Me 7-Me
racemic 79% yield Me Me
19% ee
Examination of the group's library of chiral Pybox ligands,90 a brief selection of which
are illustrated in Table 2.1, presented a possible avenue for further optimization. The free-alcohol
containing Pybox L5 revealed itself as the best of the group's current library; although the yield
was modest, the ee increased to 38%.
89 For some leading references to the chemistry of alkynes, see: (a) Acetylene Chemistry; Diederich, F., Stang, P. J.,
Tykwinski, R. R., Eds.; Wiley-VCH: New York, 2005. (b) The Chemistry of Triple-Bonded Functional Groups;
Patai, S., Ed.; Wiley: New York, 1994.
90 For a review on Pybox ligands, see: Desimoni, G.; Faita, G.; Quadrelli, P. Chem. Rev. 2003, 103, 3119-3154.
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Table 2.1. Initial Foray into an Asymmetric Alkylation Reaction of Propargylic Halides.
TMS
nBr
n-Bu
10% NiCl2-glyme
13% Pybox
BrZn-Hex ,
1.5 equiv DMA, r.t.
racemic
TMS
Hex
n-Bu
ntry Pybox ligand
1 NO
Ph LI Ph
0 2
P L2 WPh Ph
3 0I 0/N N-
OMe L3 MeO
NN
Me L4 -Me
OTBS TBSO
5 0
Me L5 rMe
OH HO
6 H, N O
L6 I
GC yield (%) ee (%)
4
90 17
14 <5
92 23
30 38
21 21
Because of the noticable difference in selectivity observed for L5 versus L4, it was
hypothesized that the presence of a free alcohol, or even the deprotonated alcohol could have a
positive impact on this coupling reaction. Pybox L5 requires a somewhat tedious multi-step
synthesis91 and it was soon realized that ligand L7, which gave similar results under these
reaction conditions, could be made on large scale in a single step.92 In fact, with Pybox L7,
91 Iwasa, S.; Tsushima, S.; Nishiyama, K.; Tsuchiya, Y.; Takezawa, F.; Nishiyama, H. Tetrahedron: Asymmetry
2003, 14, 855-865.
92 Schinnerl, M.; Seitz, M.; Kaiser, A.; Reiser, O. Org. Lett. 2001, 3, 4259-4262.
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e
reactions run at 0 oC, in which the electrophile was added last provided the desired product in
25% yield and 62% ee.
N NPh,N N. u-Ph
OH L7 HO
Over the next several months, a large variety of reaction conditions were surveyed.93 It
was found that a THF:DMA solvent mixture was best; yields also increased upon addition of
ZnBr2 as an additive (eq 2.5). All additional attempts to improve this reaction using L7 were
unsuccessful.
TMS
Br
n-Bu
racemic
10% NiCI2-glyme
13% L7
BrZn-n-Hex 50% ZnBr2
1.5 equiv 1.75:1 THF:DMA
-10 °C
17h
TMS
n-Hex
n-Bu
42% starting material
55% yield
75% ee
Some time was devoted to improving the basic scaffold of L7. As it had been observed
that the 5,5'-diphenyl substitution on the oxazolines was beneficial, a small set of Pybox ligands
were synthesized in which the electronic character of these aryl groups was modified. Some time
was also devoted to variation of the central pyridine ring (Scheme 2.9). 94
93 Other silyl- and acetone-based substituted propargylic
enantioselectivity.
94 (a) L8 was prepared according to: Miller, P.; Bol6a, C.
L11 were prepared according to ref. 92.
halides did not offer any improvements with respect to
Helv. Chim. Acta. 2001, 84, 1093-1111. (b) L9, L10 and
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(2.5)
Scheme 2.9. Analogues of Pybox L7.
L7
L8
L9
L10
Ll1
HO
X=H
X = NO 2
X = SMe
X = OMe
X=H
Y=H
Y=H
Y=H
Y=H
Y = CF 3
Out of this work came only a marginal improvement to the selectivity; Pybox L9 was
found capable of facilitating this coupling with 78% ee at low temperature. As is clear in
equation 2.6, the efficiency of this reaction was quite poor, and in the end, this led us to consider
other families of ligands.
TMS
Br
n-Bu
racemic
10% NiCl2-glyme
13% L9
50% ZnBr 2BrZn-n-Hex
1.5 equiv 1:1 DMA:glyme
-10 oC
17 h
TMS
n-Hex
n-Bu
85% starting material
14% yield
78% ee
In 2005, Beller and co-workers published a series of papers describing the synthesis of
Pybim ligands, 95 which performed reasonably in Ru-catalyzed asymmetric epoxidations. The
similarity of these ligands to the Pybox family that we had been focusing on was clear, and the
possible flexibility of their synthesis was considered attractive. A number of Pybim ligands
(Scheme 2.10), reported by Beller, were prepared and applied to our asymmetric alkylation.
95 Anilkumar, G.; Bhor, S.; Tse, M.-K.; Klawonn, M.; Bitterlich, B.; Beller, M. Tetrahedron: Asymmetry 2005, 16,
3536-3561.
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(2.6)
Scheme 2.10. Pybim Ligands.
R R
V 
N
R
L12 = \.OPh
\ O-1-Naphth
\ Ph
V FMOC
,H
\ Ph
Me
The best results obtained, to date, with this family of ligands is shown in equation 2.7. It
was found that the phenyl carbamate substituted Pybim ligand could impart the same level of
enantioselectivity as L9. Once again, the low temperature necessary for this selectivity was
detrimental to the overall reactivity of the system.
TMS
Br
n-Bu
racemic
10% NiCI2-glyme
13% L12
BrZn-n-Hex
1.5 equiv 0 DMA
17 h
TMS
n-Hex
n-Bu
77% starting material
13% yield
78% ee
Allene formation
It is well established that palladium-catalyzed cross-coupling reactions of propargylic
electrophiles with organometallic reagents typically provide the allene, rather than the alkyne, as
the predominant product. 96 We have observed that nickel-catalyzed alkylations of propargylic
96 (a) Tsuji, J.; Mandai T. in Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F. Diederich), Wiley-
VCH; New York, 2004, chap. 10. (b) Ma, S. Eur. J. Org. Chem. 2004, 1175-1183. The regioselectivity of the
corresponding nickel-catalyzed processes has not been well-studied.
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(2.7)
halides always lead to formation of a propargylic product, when the ligand is tridentate.
Interestingly, we have found that the regioselectivity of this reaction is dictated by choice of the
ligand. Thus, nickel-catalyzed alkylations of propargylic halides lead to formation of allenes
when a bidentate ligand is used (eq 2.8). Due in part to time constraints, a more thorough study
of this reactivity was not pursued.
cat. Ni n-Bu
TMS bidentate ligand
Br BrZn-n-Hex . TMS (2.8)
n-Bu n-Bu
racemic yield and regioselectivity
dependent on ligand
C. Conclusion
It was at this stage of the project that we began to grow somewhat pessimistic about the
success of this effort as a whole. Of the reaction conditions surveyed to date, we were capable of
achieving the coupling in high yield, with low levels of selectivity, or in the instances where
selectivity began to increase, the efficiency plummeted.
Our original reasons for studying this transformation were still of interest: there had been
no reports of nickel-catalyzed cross-coupling reaction of secondary propargylic halides and we
were observing high regioselectivity in these couplings. Thus nickel-based catalysis still seemed
to be the ideal strategy for the synthesis of more complex propargylic compounds. We decided it
would be interesting to investigate other families of organozinc reagents and their coupling
reactions with propargylic halides. This decision proved to be an excellent one and the results of
those efforts are described in the Sections 2.3-2.5.
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D. Further Developments
Negishi Coupling Reaction
Coinciding with the initiation of the asymmetric alkylation of propargylic halides
discussed in the previous section, Dr. Sunghee Son looked into the development of an
asymmetric alkylation of allylic halides. Preliminary studies showed that the reaction could
occur with high levels of enantioselectivity with styrenyl-type secondary bromides under the
conditions Dr. Arp developed for his a-bromo indane coupling reaction. Unfortunately, low
yields and decomposition of the starting material hampered progress on this coupling reaction.
Dr. Son found that use of allylic chlorides was considerably more practical. After extensive
studies, Dr. Son discovered that, moving away from (i-Pr)-Pybox to the unique homobenzylic
substituted Pybox in addition to including 4.0 equivalents of anhydrous NaCl, she could
accomplish the desired coupling not only in good yield, but with excellent levels of
enantioselectivity (Scheme 2.1 1).97 The synthetic utility of this transformation was highlighted in
Dr. Son's concise formal synthesis of fluvirucinine A. Others have also seen the value of this
reaction, as now the homobenzylic Pybox is commercially available. 98
Scheme 2.11. Nickel-Catalyzed Asymmetric Negishi Cross-Couplings of Secondary Allylic
Chlorides with Alkylzincs.
Cl 5.0% NiCl2.glyme Ralkyl O
R1  R3 BrZn-Rlk 5.5% (S)-(BnCH 2)-Pybox R R3  N N N
R2 4.0 equiv NaCI R2 N
racemic DMA/DMF, -10 C 13 examples; Bn Bn
81-98% yield (S)-(BnCH 2)-Pybox79-98% ee
OMe Me
n-Hex ( Me
Me Me Me Me EtO Me
Me Me O
95% yield 54% yield 84% yield 86% yield
87% ee 98% ee 95% ee 96% ee
97 Son, S.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 2756-2757.98 Available from Aldrich, catalog number: 704059.
151
Suzuki Coupling Reaction
The first example of the coupling of an alkylboron reagent and a secondary alkyl
electrophile was published in 2007. Dr. Bunnai Saito found that primary alkyl 9-BBN reagents
could be coupled with a broad selection of secondary bromides using a NiCl 2-glyme/diamine-
based catalyst (Scheme 2.12). 99 Although some functionalized nucleophiles proved problematic
under these reaction conditions (such as unhindered esters), the ease of nucleophile preparation
certainly adds strength to this methodology.
Scheme 2.12. Alkyl-Alkyl Suzuki Cross-Couplings of Unactivated Secondary Alkyl Halides.
R
>-X 9-BBN-Ralkyl
R
(j - --XPh
75%
6% NiCI2 .glyme
8% trans-N,N'-dimethyl- R1,2-cyclohexanediamine g RalkyI
KOt-Bu R
i-BuOH/dioxane
r.t. 14 examples;
64-93% yield
Ph 
-- Ph
Me
82%
(87% OTBS
87%
MeHN NHMe
trans-N,N'-dimethyl-
1,2-cyclohexanediamine
OMe
92%
It was of immediate interest to investigate an asymmetric variant of this new alkylation
reaction. Upon examining the outcome of the reaction when (R,R)-N,N'-dimethyl-1,2-
cyclohexanediamine was used in the coupling reaction described above, Dr. Saito was quite
pleased to observe formation of the product in 58% ee. Following substantial optimization, an
efficient, highly selective variant of this coupling was described in 2008 (Scheme 2.13).100 It was
imperative that the electrophile be homobenzylic in order to obtain high enantioselectivity.
99 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2007, 129, 9602-9603.
100 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 6694-6695.
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Scheme 2.13. Enantioselective Alkyl-Alkyl
Homobenzylic Halides.
Suzuki Cross-Couplings of Unactivated
10% Ni(cod) 2
12% (R,R)-N,N'-dimethyl-
1,2-di-(m-C 6H4CF 3)diamine
KOt-Bu
i-BuOH
i-Pr20, 5 C
ph "
R
Ralkyl
14 examples;
62-86% yield
40-94% ee
F3C CF 3
MeHN NHMe
(R,R)-N,N'-dimethyl-
1,2-di-(m-C 6H4CF3)diamine
Ph Me
Ph
84% yield
94% ee
Ph Ph
Ph
68% yield
90% ee
68% yield 74% yield
78% ee 85% ee
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ph RPh
Br
racemic
9-BBN-Ralkyl
E. Experimental
I. General
All reactions were carried out in oven-dried glassware under an atmosphere of argon.
N,N-Dimethylacetamide was purchased from Fluka (anhydrous). All other chemicals were
purchased and used without further purification.
Low-resolution mass spectrometric measurements were performed on an Agilent (EI)
GCMS system.
For preparation of starting materials, see Chapter 2, Section 3.
II. Starting Material
TMS
Br
n-Bu
'H NMR (CDC13, 300 MHz) 6 4.48 (t, J= 6.6 Hz, 1H), 1.98 (q, 6.6 Hz, 2H), 1.54-1.44
(m, 2H), 1.33 (sextet, J= 7.2 Hz, 2H), 0.92 (t, 7.2 Hz, 3H), 0.18-0.16 (m, 9H).
13C NMR (CDC13, 75 MHz) 8 104.2, 92.0, 39.6, 37.6, 29.7, 22.1, 14.1, -0.02.
IR (film) 2959, 2863, 2361, 2338, 2174, 1457, 1250 cm1.
HRMS (EI) calcd for C9H 16BrSi (M-Me) 231, found 231.
III. Product Characterization
TMS
T n-Hex
n-Bu
'H NMR (CDCl 3, 300 MHz) 6 2.38-2.24 (m, 1H), 1.45-1.20 (m, 16H), 0.94-0.82 (m, 6H),
0.12 (s, 9H).
LRMS (EI) calcd for C16H32Si (M+) 252, found 252.
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n-Hex
TMS-
n-Bu
1H NMR (CDC13, 300 MHz) 6 4.81-4.77 (m, 1H), 2.00-1.87 (m, 4H), 1.45-1.20 (m, 12H),
0.96-0.81 (m, 6H), 0.10 (s, 9H).
LRMS (EI) calcd for C1 6H32Si (M+) 252, found 252.
IV. Determination of Absolute Stereochemistry
0
BnN , n-Bu
Ph h-Hex
1. LiAIH 4
2. PCC
3. CBr 4, PPh34. TMSCI TMS
-ZZ. n-Bu
n-Hex
For preparation of the chiral amide, see: Ref. 79
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F. 1H NMR Spectra of Selected Compounds
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Section 2.3
Nickel-Catalyzed Negishi Cross-Couplings of Secondary
Nucleophiles with Secondary Propargylic Electrophiles
160
A. Introduction
In previous sections we have described some recent progress toward extending the scope
of transition metal-catalyzed cross-coupling reaction from the construction of sp2-sp 2 carbon-
carbon bonds to that of sp3-sp 3 carbon-carbon bonds. Furthermore, a significant amount of work
has been focused on the coupling of more sterically demanding coupling partners, including
secondary alkyl electrophiles. We have seen that this area of progress was initiated in work by
Zhou and Fu, in which it was reported that a Ni(cod)2/(s-Bu)-Pybox system catalyzes Negishi
reactions of secondary alkyl bromides and iodides with primary alkyl zinc reagents (eq 2 .9 ).73,72d
4% Ni(cod) 2
X YZn-Raky 8% (s-Bu)-Pybox
R DMA, r.t.
R
)-Ralkyl
R
O 0
N NJ
Me Me Me Me
(s-Bu)-Pybox
In 2002, Knochel reported nickel-based reaction conditions for the cross-coupling of
primary alkyl electrophiles with primary alkylzinc reagents. Additionally, it was reported that
several cross-couplings of primary alkyl electrophiles and secondary organozinc reagents could
be effected as well (Scheme 2.14).'
101 Jensen, A. E.; Knochel, P. J. Org. Chem. 2002, 67, 79-85.
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(2.9)
Scheme 2.14. Knochel's Couplings of Secondary Organozinc Reagents with Primary Alkyl
Electrophiles.
Ralkyl-X Zn-(Ralkyl)2
10% Ni(acac)220%
F Ralkyl-Ralkyl
3.0 equiv Bu 4 NI
THF/NMP, 0 oC
0
ON 'kMe
62%
o
73%
O0
EtO Me
2
48%
EtO 
61%0
61%
0
PhA '/ OPiv
57%
Ph"AV Me
Me
63%
In our continued study of alkyl cross-couplings it was of course of interest to study
reactions of even more sterically demanding coupling partners; namely, the coupling of a
secondary alkyl halide with a secondary organometallic reagent. Based on the ease of synthesis
and high functional group compatibility of secondary organozinc halide reagents we chose to
develop a Negishi cross-coupling reaction.10 2
B. Results and Discussion
At the outset of this project, it was speculated that propargylic electrophiles might be an
interesting entry into this new coupling reaction, as they can be thought of as one of the least
sterically demanding secondary electrophiles one might imagine, and thus would be an ideal
choice for an initial investigation. This hypothesis was quickly validated with an early hit. Thus,
using 10% NiCl2-glyme and 13% terpyridine in DMA led to formation of 28% of the desired
coupling product (see eq 2.10).
102 For the preparation of organozinc halides, see the experimental section.
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,N. 10% NiC 2 glyme TMS. _TMS Br 13% terpyridine (2.10)
Br IZn."O 0.16M, DMA r.t. W
n-Bu 1.5 equiv n-Bu
28% yield
Upon further optimization, we soon found that we could further increase the yield to 44%
simply by reducing the concentration of the reaction to 0.05 M. For some time, this proved to be
the best result we could obtain, as we were unable to find reaction conditions which could evade
the formation of a considerable amount of electrophile homocoupling. Our current theory to
explain this homocoupling is as follows: we believe that transmetalation of the secondary
organozinc halide reagent onto nickel is slow, allowing a [1,3]-isomerization to take place on the
propargylic nickel species formed via oxidative addition (Scheme 2.15). In the cases where R is
small, the equilibrium favors the allenylnickel intermediate and it is this intermediate that
proceeds to participate in undesired side reactions leading to the formation of the homocoupled
products.
Scheme 2.15. Formation of Undesired Homocoupling Products.
Me Me Me MMe
Electrophile
Homocoupling
Our thinking was that simply by increasing the steric demand of R we would be able to
slow, or eliminate, this isomerization process and enable the initial oxidative addition adduct to
undergo transmetallation and proceed to formation of the desired product (Scheme 2.16).
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Scheme 2.16. Suppression of Undesired Homocoupling Products.
[Ni]
. [Ni]
MeMe
Desired
Product
Table 2.2 summarizes the effect R has on the reaction efficiency. We see that, with a very
small group such as methyl, we obtain only 15% of the desired product.10 3 As we increased the
steric demand of the alkyne-capping group we see that conversion to desired product also
increases. We were quite pleased to see that utilizing the sterically-demanding TIPS-protecting
group allowed us to obtain 89% of the desired product.
Table 2.3 has been included to illustrate the impact of various other reaction parameters.
In the absence of NiCl2 glyme or terpyridine, essentially no carbon-carbon bond formation
occurs (entries 2 and 3). Other ligands, both bidentate and tridentate, that have been examined
are less useful than terpyridine (entries 4-6), as are solvents other than DMA (entries 7-9).
103 Terminal alkynes gave no detectable cross-coupling product.
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Table 2.2. Effect of the Alkyne Substituent on the Efficiency of Negishi Reactions of Secondary
Nucleophiles with Secondary Propargylic Electrophiles.
IZn
1.6 equiv
10% NiCl2-glyme
10% terpyridine
DMA
R
n-Bu
entry R = yield (%)a
1 I-Me 15
2 I-TMS 48
3 -Si(Me) 2Ph 45
4 I-SiPh3  56
5 I-TIPS 89
a Yield was determined by GC versus an internal
standard.
Table 2.3. Negishi Reactions of Secondary
Electrophiles: Effect of Reaction Parameters.
TIPS
nBr
n-Bu
Zn.6 eq
1.6 equiv
Nucleophiles
10% NiCI2-glyme
10% terpyridine
DMA, r.t.
with Secondary Propargylic
TIPS
n-Bu
entry variation from "standard" conditions yield (%)a
1 none 89
2 no NiCl2*glyme <5
3 no terpyridine <5
4 bipyridine, instead of terpyridine <5
5 isopropyl pybox, instead of terpyridine 10
6 2,6-bis(N-pyrazolyl)pyridine, instead of terpyridine 62
7 THF, instead of DMA 11
8 DMF, instead of DMA 9
9 DMI, instead of DMA 4
a Yield was determined by GC versus an internal standard.
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R
Br
n-Bu
These optimized conditions (NiC12.glyme/terpyridine/DMA) can be applied to a broad
range of Negishi cross-couplings of propargylic bromides (Table 2.4). Esters, olefins (no E/Z
isomerization), ethers and carbamates are compatible with the reaction conditions. 0 4
Table 2.4. Room-Temperature Negishi Reactions of Secondary Nucleophiles with Secondary
Propargylic Electrophiles.
R
aBr
alkyl IZn-R
1
1.6 equiv.
10% NiCI2.glyme
10% terpyridine
DMA, r.t.
R
R1
alkyl
entry R alkyl IZn-R 1  yield (%)a
1 TIPS ./ Me IZn 88
2 TIPS ~ CO2 Me IZn 72
3 TIPS i IZn 72
Et
4 TIPS A . Me IZn- O 70
5 TIPS 'Me IZn NCbz 74
6 TIPS - -C 2Me IZn 
M e  63
Me
7 tBu / , C0 2Me IZn 72
8 tBu - Ph IZn- 73
a Isolated yield (average of two experiments).
In the interest of exploring the versatility of this catalyst, these reaction conditions can be
applied without modification to Negishi reactions of less-hindered coupling partners. Thus,
104 Notes: (a) In the absence of NiCl 2'glyme or terpyridine, essentially no cross-coupling occurs. (b) Organozinc
iodides, rather than bromides, were employed owing to ease of synthesis. (c) Attempts to cross-couple an acetone-
protected or an aryl-substituted alkyne were not successful. (d) Under our standard conditions, Negishi reactions of
hindered electrophiles (e.g., alkyl = iPr in Table 2.4) proceed in low yield, and unactivated alkyl chlorides are not
suitable cross-coupling partners.
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primary organozinc bromides can be coupled in exceptional yield with secondary propargylic
bromides. Also, the primary-primary coupling occurs without incident. It is worth noting that
ethers, esters and unactivated alkyl chlorides are unaffected by these reaction conditions (see
Table 2.5).105
Table 2.5. Negishi Reactions of Primary Nucleophiles with Secondary and Primary Propargylic
Electrophiles.
TIPS
" Br
R
10% NiCl2.glyme
10% terpyridine
BrZn-R 1
DMA, r.t.
1.6 equiv
TIPS
Ri
R
entry alkyl BrZn-R1  yield (%)a
1 Cl BrZn--' OBn 97
2 BrZn OEt 96
3 H BrZn OEt 90
a Isolated yield (average of two experiments).
When we attempted to apply the NiC12-glyme/terpyridine/DMA conditions to the
coupling of more sterically demanding secondary organozinc reagents, we found that the
efficiency of the reaction decreased dramatically (Equation 2.11). Accompanying the desired
product, a substantial quantity of reduced electrophile was also observed (i.e. dehalogenation).
TIPS 10% NiCl2-glyme
Br IZnKO 10% terpyridine
Me equiDMA1.6 equiv
TIPS M e
20% yield
20% yield
105 A Negishi cross-coupling of a primary propargylic bromide with a secondary alkylzinc reagent proceeded in low
yield.
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(2.11)
Fortunately, replacing terpyridine with the related tridentate ligand 2,6-bis(N-
pyrazolyl)pyridine (L13) and using THF in place of DMA as the solvent solved this difficulty. 10 6
We postulate that the slightly larger bite-angle of L13 is responsible for the recovery of
reactivity. Once again, a very brief table describing the impact of various other reaction
parameters has been included for illustrative purposes (Table 2.6). As before, in the absence of
NiCl2 "glyme or terpyridine, essentially no carbon-carbon bond formation occurs (entries 2 and
3). Other solvents, for example DMA, are inferior to THF but solvent mixtures can have a
positive impact (entries 5 and 6).
Table 2.6. Negishi Reactions of Secondary Nucleophiles with Secondary Propargylic
Electrophiles: Effect of Reaction Parameters.
Br IZn_ 5% L13
n-Bu THF, r.t. n-Bu
1.6 equiv.
L1 = n
entry variation from "standard" conditions yield (%)a
1 none 85
2 no NiCI2-glyme <5
3 no 2,6-bis(N-pyrazolyl)pyridine <5
4 terpyridine, instead of 2,6-bis(N-pyrazolyl)pyridine 20
5 DMA, instead of THF 66
6 2:1 THF:DMA, instead of THF 72
a Yield was determined by GC versus an internal standard.
Thus, with a second set of reaction conditions (NiC12'glyme/Ll3/THF) many additional
coupling reactions between secondary propargylic electrophiles and more hindered secondary
organozinc reagents may now be accomplished. As illustrated in Table 2.7, a variety of
functional groups are tolerated, such as alkynes, unactivated chlorides and ethers.
106 Vicic et al., have reported that [Ni(cod)2]/2,6-bis(N-pyrazolyl)-pyridine in THF catalyzes the Negishi coupling of
a primary alkylzinc reagent with a primary alkyl bromide (45% yield) and with a primary alkyl iodide (67% yield):
Ref 68a.
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Table 2.7. Room-Temperature Negishi Reactions of Secondary Nucleophiles with Secondary
Propargylic Electrophiles.
R
Br IZn-R 1
alkyl
1.6 equiv
5% NiCI2 glyme5% L13
THF, r.t.
L13 =
CN N
entry R alkyl IZn-R 1  yield (%)a
1 TIPS / ~ Me Zn-O 86
2 TIPS / Et IZn 78
5
3 TIPS CI IZnO 82
Me
4 TIPS IZn 81
5 TIPS Me IZn Ph 76b
6 TIPS \ h IZn--Et 50b
3 IEt
a Isolated yield (average of two experiments). b 3.0 equiv RZnl used.
We have determined that these reaction conditions do not work exclusively for
propargylic bromides, but also for propargylic chlorides, still at room temperature (eqs. 2.12 and
2.13).
TIPS
Me
ZnOIZn
10% NiCI2 'glyme
10% terpyridine
DMA, r.t.
1.6 equiv
TIPS O
Me
76% yield
Me
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R R'
alkyl
(2.12)
TIPS
CEt
Et
5% NiCl2-glyme
IZn 5% L13
THF, r.t.
1.6 equiv
L13-
N N
TIPS
Et
75% yield
C. Conclusions
We have developed the first alkyl-alkyl secondary-secondary cross-coupling, specifically
the nickel-catalyzed coupling of secondary propargylic bromides with secondary alkylzinc halide
reagents. The catalyst systems presented are also capable of coupling primary alkylzinc bromides
with primary and secondary propargylic bromides. This new methodology has also been shown
to be capable of coupling propargylic chlorides. For a discussion of the application of this cross-
coupling reaction to the formal synthesis of 2,7,11-cembratriene-4,6-diol, see Chapter 2,
Section 3.
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D. Experimental
I. General
All reactions were carried out in oven-dried glassware under an atmosphere of argon.
N,N-Dimethylacetamide was purchased from Fluka (anhydrous), and THF was dried by passage
over activated alumina. All other chemicals were purchased and used without further
purification.
High-resolution mass spectrometric measurements were performed on a Bruker Daltonics
APEXII 3 Tesla Fourier Transform Mass Spectrometer system.
Low-resolution mass spectrometric measurements were performed on an Agilent GCMS
system.
II. Preparation of Substrates
These procedures have not been optimized.
Synthesis of Propargylic Alcohols (representative procedure): A 100 mL flask was
charged with (triisopropylsilyl)acetylene (2.2 mL, 10.0 mmol), evacuated, and back-filled with
argon. THF (50 mL) was then added via syringe. The solution was then cooled to -78 'C in a dry
ice/acetone bath. After 15 min of cooling, n-BuLi (6.6 mL of a 1.6 M solution in hexanes, 10.5
mmol) was added dropwise, via syringe. After an additional 20 min of stirring, the aldehyde
(11.0 mmol) was added via syringe. The solution was allowed to warm to room temperature, at
which point the reaction was quenched with an aqueous saturated ammonium chloride solution
(25 mL). The layers were separated, and the aqueous layer was extracted twice with CH2C12 (50
mL). The combined organic layers were washed with brine (50 mL) and dried over MgSO 4,
filtered and concentrated under reduced pressure. The resultant oil was purified via flash
chromatography (hexanes/EtOAc or pentane/Et20) to give the propargylic alcohols as oils.
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TMS
OH
n-Bu
1-(Trimethylsilyl)hept-1-yn-3-ol [CAS # 75045-85-1]. Prepared from (trimethylsilyl)-
acetylene and valeraldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 5 4.32 (t, J= 6.6 Hz, 1H), 2.20 (broad s, 1H), 1.71-1.62 (m,
2H), 1.46-1.23 (m, 4H), 0.89 (t, J= 6.9 Hz, 3H), 0.14 (s, 9H).
Ph(Me)2Si
OH
n-Bu
1-(Dimethyl(phenyl)silyl)hept-1-yn-3-ol. Prepared from (dimethylphenylsilyl)acetylene
and valeraldehyde by the representative procedure.
'H NMR (CDC13, 300 MHz) 8 7.65-7.61 (m, 2H), 7.43-7.38 (m, 3H), 4.41 (t, J= 6.9 Hz,
1H), 1.78-1.64 (m, 2H), 1.49-1.32 (m, 4H), 0.93 (t, J= 6.9 Hz, 3H), 0.43 (s, 6H).
13C NMR (CDC13, 75 MHz) 6 133.9, 130.3, 129.7, 128.2, 108.9, 87.5, 63.1, 45.3, 37.6,
27.6, 26.2, 22.6, 22.3, 14.3, 14.1.
IR (film) 3384, 2959, 2872, 2361, 2171, 1675, 1428 cm -1.
HRMS (ESI) calcd for C15H22OSi (M+Na) 269.1332, found 269.1332.
Ph3Si
OH
n-Bu
1-(Triphenylsilyl)hept-l-yn-3-ol. Prepared from (triphenylsilyl)acetylene and valer-
aldehyde by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 7.67-7.63 (m, 6H), 7.44-7.35 (m, 9H), 4.52 (t, J= 6.3 Hz,
1H), 1.86-1.78 (m, 2H), 1.55-1.32 (m, 4H), 0.92 (t, J= 7.5 Hz, 3H).
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13C NMR (CDC13, 75 MHz) 8 135.7, 133.5, 130.3, 128.2, 111.9, 84.7, 63.3, 37.6, 27.6,
22.6, 14.3.
IR (film) 3373, 3070, 2957, 2931, 2861, 1429, 1113 cm 1 .
HRMS (ESI) calcd for C25H26OSi (M+CH3COO-) 429.1880, found 429.1874.
TIPS
OH
n-Bu
1-(Triisopropylsilyl)hept-1-yn-3-ol. Prepared from (triisopropylsilyl)acetylene and
valeraldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 5 4.38 (t, J= 6.6 Hz, 1H), 1.75-1.65 (m, 2H), 1.48-1.31 (m,
4H), 1.06-1.04 (m, 21H), 0.90 (t, J= 7.4 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 109.0, 85.6, 63.2, 45.6, 37.8, 27.5, 22.6, 18.7, 14.1.
IR (film) 3377, 2943, 2866, 2360, 1676, 1464, 1018 cm-.
HRMS (ESI) calcd for C16H31OSi (M-H+) 267.2139, found 267.2142.
TIPS
OH
MeO 2C' )
Methyl-6-hydroxy-8-(triisopropylsilyl)oct-7-ynoate. Prepared from (triisopropylsilyl)-
acetylene and methyl-6-oxohexanoate by the representative procedure.
1H NMR (CDC13, 300 MHz) 8 4.37 (dt, J= 6.3, 4.8 Hz, 1H), 3.64 (s, 3H), 2.30 (t, J= 7.5,
2H), 2.07 (d, J= 4.8, 1H), 1.75-1.61 (m, 4H), 1.54-1.46 (m, 2H), 1.05-1.04 (m, 21H).
13C NMR (CDC13, 75 MHz) 5 174.3, 108.8, 85.7, 62.8, 51.8, 37.7, 34.2, 24.9, 24.8, 18.8,
11.3.
IR (film) 3436, 2944, 2865, 2167, 1742, 1463, 1200, 1176, 1017 cm-1.
HRMS (ESI) calcd for C18H370 3 Si (M+CH3COO-) 385.2405, found 385.2408.
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t-Bu
OH
MeO 2C H
Methyl-6-hydroxy-9,9-dimethyldec-7-ynoate. Prepared from 3,3-dimethylbut- 1-yne
and methyl-6-oxohexanoate by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.32 (t, J= 6.3 Hz, 1H), 3.64 (s, 3H), 2.30 (t, J= 7.5 Hz,
2H), 2.01 (bs, 1H), 1.68-1.59 (m, 4H), 1.49-1.41 (m, 2H), 1.18 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 174.4, 94.0, 79.7, 62.5, 51.7, 37.9, 34.2, 31.2, 27.5, 25.0,
24.8.
IR (film) 3437, 2969, 2866, 1740, 1437, 1263, 1205, 1021 cm-.
HRMS (ESI) calcd for Cl3H220 3 (M+Na+) 249.1461, found 249.1465.
t-Bu
OH
Ph )2
6,6-Dimethyl-l-phenylhept-4-yn-3-ol. Prepared from 3,3-dimethylbut- 1-yne and
3-phenylpropanal by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 7.32-7.19 (m, 5H), 4.36 (t, J= 6.6 Hz, 1H), 2.78 (t, J= 7.8
Hz, 2H), 2.03-2.94 (m, 2H), 1.23 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 141.8, 128.7, 128.6, 126.1, 94.5, 79.6, 62.2, 47.3, 39.9,
31.8, 31.2.
IR (film) 3430, 2971, 2252, 1665, 1454 cml.
LRMS (El) calcd for C15H 200 (M+) 216, found 216.
174
TIPS
OH
)5
Et
(Z)-l-(triisopropylsilyl)dodec-9-en-1-yn-3-ol. Prepared from (triisopropylsilyl)-
acetylene and (Z)-dec-7-enal by the representative procedure.
'H NMR (CDCl 3, 300 MHz) 6 5.40 (m, 2H), 4.38 (q, J= 5.7, 1H), 2.07-1.98 (m, 4H),
1.83-1.81 (m, 1H), 1.75-1.64 (m, 2H), 1.50-1.45 (m, 2H), 1.37-1.32 (m, 4H), 1.06-1.04 (m, 21H),
0.94 (t, J= 7.5 Hz, 3H).
13C NMR (CDC13, 75 MHz) 5 131.9, 129.3, 109.0, 85.6, 63.2, 38.1, 29.9, 29.2, 27.2, 25.3,
20.7, 18.8, 14.6, 11.3.
IR (film) 3388, 2942, 2865, 1463, 1265, 1018, 883 cm -1.
HRMS (EI) calcd for C23H43OSi (M+CH 3COO) 395.2976, found 395.2976.
H Me
Dodec-9-ynal [CAS # 131944-50-8]. A 300 mL flask was charged with pyridinium
chlorochromate (5.2 g, 24.0 mmol), evacuated, and back-filled with argon. To the orange solid
was added CH2C12 (100 mL) and dodec-9-yn-l-ol (3.6 g, 20 mmol). The resulting dark-brown
reaction mixture was stirred for 3 h at r.t., and then Et20 (100 mL) was added, leading to the
precipitation of a brown solid. The mixture was allowed to stand at r.t. for 2 h, and then it was
filtered through a plug of silica gel (washed with Et20). The solvent was removed, and the
residue was purified by column chromatography (pentane:Et20 95:5) to give 2.3 g of the
aldehyde as a clear colorless oil (63%).
'H NMR (CDC13, 300 MHz) 6 9.76-9.75 (m, 1H), 2.42 (td, J = 7.5, 1.8 Hz, 2H), 2.17-
2.11 (m, 4H), 1.65-1.60 (m, 2H), 1.47-1.44 (m, 2H), 1.36-1.30 (m, 6H), 1.11 (t, J= 6.6 Hz, 3H).
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TIPS
OH
Et -
7
1-(Triisopropylsilyl)tetradeca-1,11-diyn-3-ol. Prepared from (triisopropylsilyl)-
acetylene and dodec-9-ynal by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.37 (q, J= 12.0 Hz, 1H), 2.18-2.08 (m, 4H), 1.86 (d, J=
5.4 Hz), 1.71-1.64 (m, 2H), 1.49-1.43 (m, 4H), 1.38-1.30 (m, 6H), 1.10 (t, J= 7.2 Hz, 3H), 1.06-
1.04 (m, 21H).
13C NMR (CDC13, 75 MHz) 8 109.1, 85.6, 81.8, 79.7, 63.2, 38.1, 29.4, 29.34, 29.31, 29.0,
25.3, 18.9, 18.8, 14.6, 12.6, 11.3.
IR (film) 3330, 2939, 2864, 2168, 1463, 1320, 1017, 883 cm-.
HRMS (EI) calcd for C25H4 50 3 (M+CH3COO-) 421.3132, found 421.3130.
TIPS
OH
Me
4-(Triisopropylsilyl)but-3-yn-2-ol [CAS # 726202-65-9]. Prepared from (triisopropyl-
silyl)acetylene and acetaldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.53 (dq, J= 6.6, 1.2 Hz, 1H), 1.75 (d, J= 5.1 Hz, 1H),
1.47 (d, J= 6.6 Hz, 3H), 1.06-1.04 (m, 21H).
TIPS
OH
6-Chloro-l-(triisopropylsilyl)hex-1-yn-3-ol. A 300 mL flask was charged with
pyridinium chlorochromate (5.2 g, 24.0 mmol), evacuated, and back-filled with argon. To the
orange solid was added CH 2C12 (100 mL) and 4-chlorobutanol (2.0 mL, 20 mmol). The resulting
dark-brown reaction mixture was stirred for 3 h at r.t., and then Et20O (100 mL) was added,
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leading to the precipitation of a brown solid. The mixture was allowed to stand at r.t. for 2 h, and
then it was filtered through a plug of silica gel (washed with Et20). The solvent was removed,
and the residue was used as in the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.44 (t, J= 6.3 Hz, 1H), 3.58 (t, J= 6.3 Hz, 2H), 2.17
(broad s, 1H), 2.00-1.92 (m, 2H), 1.88-1.80 (m, 2H), 1.05-1.04 (m, 21H).
13C NMR (CDC13 , 75 MHz) 6 108.3, 86.3, 62.4, 44.9, 35.2, 28.5, 18.8, 11.3.
IR (film) 3361, 2944, 2866, 2169, 1463, 1070 cm - .
HRMS (ESI) calcd for C17H32C1OSi (M+CH 3COO) 347.1804, found 347.1802.
TIPS
OH
BnO Y
4
7-(Benzyloxy)-l-(triisopropylsilyl)hept-1-yn-3-ol. A 300 mL flask was charged with
pyridinium chlorochromate (6.6 g, 31.0 mmol), evacuated, and back-filled with argon. To the
orange solid was added CH 2C12 (125 mL) and 5-benzyloxy-l-pentanol (5.0 g, 25.7 mmol). The
resulting dark-brown reaction mixture was stirred for 3 h at r.t., and then Et20 (100 mL) was
added, leading to the precipitation of a brown solid. The mixture was allowed to stand at r.t. for 2
h, and then it was filtered through a plug of silica gel (washed with Et20). The solvent was
removed, and the residue was used as in the representative procedure.
'H NMR (CDCl 3, 300 MHz) 6 7.38-7.26 (m, 5H), 4.50 (s, 2H), 4.39 (t, J= 6.3 Hz, 1H),
3.48 (t, J= 6.6 Hz, 2H), 1.84-1.53 (m, 7H), 1.06 (s, 21H).
13C NMR (CDCl3 , 75 MHz) 6 138.7, 128.6, 127.9, 127.8, 108.9, 85.7, 73.1, 70.4, 63.1,
37.9, 29.5, 22.1, 18.8, 11.3.
IR (film) 3380, 2945, 2890, 2866, 2253, 1666, 1462 cm -1.
HRMS (ESI) calcd for C25H4 104Si (M+CH3COO-) 433.2769, found 433.2756.
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TIPS
OH
i-Pr
5-Methyl-l-(triisopropylsilyl)hex-1-yn-3-ol [CAS # 913618-91-4]. Prepared from
(triisopropylsilyl)acetylene and isobuytraldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.44-4.37 (m, 1H), 1.99-1.96 (m, 1H), 1.86 (septet, J= 6.6
Hz, 1H), 1.68-1.50 (m, 2H), 1.07-1.05 (m, 21H), 0.93 (t, J= 6.0 Hz, 6H).
TIPS
OH
Ph )
2
5-Phenyl-l-(triisopropylsilyl)pent-1-yn-3-ol. Prepared from (triisopropylsilyl)acetylene
and 3-phenylpropanal by the representative procedure.
1H NMR (CDC13, 300 MHz) 8 7.32-7.18 (m, 5H), 4.40 (t, J= 6.6 Hz, 1H), 2.83 (t, J= 8.1
Hz, 2H), 2.08-1.96 (m, 2H), 1.09 (s, 21H).
13C NMR (CDC13, 75 MHz) 6 141.6, 128.8, 128.7, 126.2, 108.6, 86.3, 62.6, 39.8, 31.7,
18.8, 11.3.
IR (film) 3428, 2945, 2866, 2253, 1727, 1462 cm-1.
LRMS (EI) calcd for C2 0H32 OSi (M+) 316, found 316.
TIPS
OH
Et
1-(Triisopropylsilyl)pent-1-yn-3-ol [CAS # 263720-71-4]. Prepared from (triisopropyl-
silyl)acetylene and propionaldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.39-4.30 (m, 1H), 1.87-1.63 (m, 3H), 1.06-0.99 (m, 24H).
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Synthesis of Propargylic Bromides (representative procedure). A 500 mL flask was
charged with imidazole (1.3 g, 19.5 mmol), evacuated, and back-filled with argon. CH 2C12 (100
mL) was added via syringe, followed by the addition of the propargylic alcohol (16.3 mmol).
This solution was allowed to stir for 15 min, Next, dibromotriphenyl-phosphorane (8.24 g, 19.5
mmol) was added as a solid. The reaction was run under argon and monitored by TLC. Upon
completion (usually 3-4 h), the reaction was quenched by the addition of silica gel, and was
concentrated and dried under reduced pressure. Once dry, this plug of silica was subjected to
flash chromatography (hexanes/ethyl acetate or pentane/diethyl ether) to give the propargylic
bromides as oils.
TMS
Br
n-Bu
(3-Bromohept-1-ynyl)trimethylsilane.
11H NMR (CDC13, 300 MHz) 6 4.48 (t, J= 6.6 Hz, 1H), 1.98 (q, J= 6.6 Hz, 2H), 1.54-
1.44 (m, 2H), 1.33 (sextet, J= 7.2 Hz, 2H), 0.92 (t, J= 7.2 Hz, 3H), 0.18-0.16 (m, 9H).
13C NMR (CDCl 3, 75 MHz) 6 104.2, 92.0, 39.6, 37.6, 29.7, 22.1, 14.1, 0.0.
IR (film) 2959, 2863, 2361, 2338, 2174, 1457, 1250 cm-1.
HRMS (EI) calcd for C9H16BrSi (M-Me) 231, found 231.
Ph(Me)2Si
Br
n-Bu
(3-Bromohept-1-ynyl)dimethyl(phenyl)silane.
IH NMR (CDCl 3 , 300 MHz) 6 7.70-7.60 (m, 2H), 7.45-7.38 (m, 3H), 4.57 (t, J= 6.9 Hz,
1H), 2.10-2.02 (m, 2H), 1.65-1.50 (m, 2H), 1.39 (sextet, J = 7.2 Hz, 2H), 0.96 (t, J = 9.6 Hz,
3H), 0.47-0.44 (m, 6H).
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13C NMR (CDC13, 75 MHz) 8 136.8, 133.4, 129.8, 128.2, 105.9, 90.1, 39.5, 37.4, 29.8,
22.1, 14.2, -0.7.
IR (film) 2959, 2862, 2361, 2339, 1428, 1250, 1116 cml.
LRMS (El) calcd for C9H16BrSi (M-C 6H5+) 231, found 231.
Ph 3Si
Br
n-Bu
(3-Bromohept-1-ynyl)triphenylsilane.
'H NMR (CDC13, 300 MHz) 6 7.67-7.63 (m, 6H), 7.47-7.36 (m, 9H), 4.64 (t, J= 6.6 Hz,
1H), 2.13-2.06 (m, 2H), 1.64-1.53 (m, 2H), 1.38 (sextet, J = 7.5 Hz, 2H), 0.94 (t, J = 9.6 Hz,
3H).
13C NMR (CDC13, 75 MHz) 6 135.7, 133.3, 130.3, 128.2, 108.0, 87.0, 39.4, 37.1, 29.8,
22.1, 14.2.
IR (film) 3069, 2957, 2930, 2361, 2339, 2174, 1429, 1114 cm-1.
LRMS (EI) calcd for C19H20BrSi (M-C6H5+) 355, found 355.
TIPS
Br
n-Bu
(3-Bromohept-1-ynyl)triisopropylsilane.
1 H NMR (CDC13, 300 MHz) 6 4.54 (t, J= 6.9 Hz, 1H), 2.04-1.97 (m, 2H), 1.59-1.49 (m,
2H), 1.09-1.07 (m, 21H), 0.92 (t, J= 7.2 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 106.2, 88.8, 39.8, 37.8, 29.7, 22.1, 18.8, 14.2, 11.4.
IR (film) 3054, 2944, 2866, 2305, 1463, 1265 cm-1.
HRMS (EI) calcd for C16H31BrSi (M ) 330.1373, found 330.1388.
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TIPS
Br
Me02C )4
Methyl-6-bromo-8-(triisopropylsilyl)oct-7-ynoate.
'H NMR (CDCl 3, 300 MHz) 6 4.54 (t, J= 6.6 Hz, 1H), 3.67 (s, 3H), 2.33 (t, J= 7.5 Hz,
2H), 2.02 (q, J= 8.4 Hz, 2H), 1.72-1.52 (m, 4H), 1.07 (s, 21H).
13C NMR (CDC13, 75 MHz) 6 174.0, 105.8, 89.1, 51.8, 39.6, 37.2, 34.0, 27.0, 24.3, 18.7,
11.3.
IR (film) 2945, 2890, 2866, 2253, 1733, 1464 cm -1.
HRMS (ESI) calcd for C18H 33BrNaO2Si (M+Na+) 411.1325, found 411.0534.
t-Bu
Br
MeO 2C )4
Methyl-6-bromo-9,9-dimethyldec-7-ynoate.
'H NMR (CDC13, 300 MHz) 6 4.54 (t, J= 6.6 Hz, 1H), 2.34 (t, J= 7.5 Hz, 2H), 2.02-1.95
(m, 2H), 1.72-1.50 (m, 4H), 1.20 (s, 9H).
'
3C NMR (CDC13, 75 MHz) 6 4.54 (t, J =6.3 Hz, 1H), 3.64 (s, 3H), 2.33 (t, J = 7.5 Hz,
2H), 2.02-1.94 (m, 2H), 1.74-1.48 (m, 4H), 1.20 (s, 9H).
IR (film) 2969, 2867, 1740, 1436, 1363, 1265, 1203, 1170 cm'.
HRMS (ESI) calcd for C13H21BrNaO2 (M+Na ) 311.0617, found 311.0617.
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t-Bu
Br
Ph
2
(3-Bromo-6,6-dimethylhept-4-ynyl)benzene.
'H NMR (CDC13, 300 MHz) 8 7.33-7.17 (m, 5H), 4.49 (t, J= 6.6 Hz, 1H), 2.84 (t, J= 7.2
Hz, 2H), 2.32-2.24 (m, 2H), 1.23 (s, 9H).
'
3 C NMR (CDC13, 75 MHz) 8 140.6, 128.8, 128.7, 126.4, 96.9, 77.9, 42.0, 38.0, 33.8,
31.0, 27.9.
IR (film) 3028, 2970, 2929, 2865, 2245 cm-1.
HRMS (EI) calcd for C15H19Br (M+) 278.0665, found 278.0625.
TIPS
Br
)5
Et
(Z)-(3-Bromododec-9-en-1-ynyl)triisopropylsilane.
'H NMR (CDC13, 300 MHz) 6 5.49-5.28 (m, 2H), 4.53 (t, J= 6.9 Hz, 1H), 2.06-1.94 (m,
6H), 1.62-1.49 (m, 2H), 1.42-1.30 (m, 4H), 1.06 (s, 21H), 0.98-0.92 (m, 3H).
13C NMR (CDC13, 75 MHz) 6 132.0, 129.1, 106.1, 88.9, 40.0, 37.7, 29.7, 28.5, 27.4, 27.1,
20.7, 18.8, 14.6, 11.4.
IR (film) 3005, 2942, 2865, 2360, 2170, 1463 cm -1.
LRMS (EI) calcd for C18H 32BrSi (M-i-Pr +) 355, found 355.
182
TIPS
Br
Et -
(3-Bromotetradeca-1,1 1-diynyl)triisopropylsilane.
'H NMR (CDC13, 300 MHz) 5 4.53 (t, J= 6.6 Hz, 1H), 2.19-2.09 (m, 4H), 2.03-1.95 (m,
2H), 1.60-1.26 (m, 10H), 1.13-1.04 (m, 24H).
13C NMR (CDCl 3, 75 MHz) 6 106.1, 88.9, 81.8, 79.6, 40.0, 37.7, 29.3, 29.1, 28.9, 28.8,
27.5, 18.9, 18.8, 14.6, 12.6, 11.4.
IR (film) 2942, 2865, 2253, 1463 cm-1.
HRMS (EI) calcd for C2oH34BrSi (M-i-Pr ) 381.1607, found 381.1113.
TIPS
Br
Me
(3-Bromobut-1-ynyl)triisopropylsilane.
IH NMR (CDC13, 300 MHz) 6 4.63 (q, J= 6.6 Hz, 1H), 1.91 (d, J= 6.9 Hz, 3H), 1.07 (s,
21 H).
13C NMR (CDC13, 75 MHz) 5 107.3, 88.0, 31.8, 27.8, 18.8, 11.3.
IR (film) 2945, 2866, 2253, 1463, 1383 cm'1.
HRMS (EI) calcd for C13H25BrSi (M+) 288.0903, found 288.0900.
TIPS
Br
3
(3 -Bromo-6-chlorohex-1-ynyl)triisopropylsilane.
1H NMR (CDCl 3, 300 MHz) 6 4.60 (t, J= 6.5 Hz, 1H), 3.64-3.56 (m, 2H), 2.21-2.15 (m,
2H), 2.09-2.03 (m, 2H), 1.07 (s, 21H).
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13C NMR (CDCl 3 , 75 MHz) 8 105.3, 89.7, 44.2, 37.0, 36.5, 30.3, 18.8, 11.3.
IR (film) 2944, 2891, 2361, 2338, 1464 cm 1.
HRMS (EI) calcd for C12H27BrClSi (M-i-Pr ) 307.0281, found 307.0469.
TIPS
Br
Bn O )
4
(7-(Benzyloxy)-3-bromohept-1-ynyl)triisopropylsilane.
1H NMR (CDC13, 300 MHz) 8 7.39-7.26 (m, 5H), 4.55 (t, J= 6.6 Hz, 1H), 4.50 (s, 2H),
3.50-3.46 (m, 2H), 2.18-1.99 (m, 2H), 1.68-1.63 (m, 2H), 1.07 (s, 21H).
13C NMR (CDC13, 75 MHz) 8 138.7, 128.6, 127.8, 127.7, 105.9, 89.1, 73.1, 70.2, 39.8,
37.6, 29.1, 24.4, 18.8, 11.4.
IR (film) 3030, 2942, 2865, 2170, 1462, 1363, 1104, 883 cm-1.
HRMS (ESI) calcd for C23H37BrNaOSi (M+Na+) 459.1689, found 459.1678
TIPS
Br
i-Pr
(3-Bromo-5-methylhex-1-ynyl)triisopropylsilane.
1H NMR (CDC13, 300 MHz) 8 4.54 (t, J= 7.5 Hz, 1H), 1.95-1.86 (m, 3H), 1.06 (s, 21H),
0.94-0.92 (m, 6H).
13C NMR (CDC13, 75 MHz) 8 106.3, 88.7, 48.9, 36.3, 27.2, 22.2, 21.9, 18.7, 11.4.
IR (film) 2959, 2866, 2170, 1465 cm - .
HRMS (EI) calcd for C16H31BrSi (M+) 330.1373, found 330.1379.
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TIPS
Br
Ph )
2
(3-Bromo-5-phenylpent-1-ynyl)triisopropylsilane.
1H NMR (CDC13, 300 MHz) 6 7.35-7.20 (m, 5H), 4.50 (t, J= 6.6 Hz, 1H), 2.90 (t, J= 8.1
Hz, 2H), 2.37-2.29 (m, 2H), 1.11 (s, 21H).
13C NMR (CDC13, 75 MHz) 6 140.4, 130.3, 128.8, 126.5, 105.8, 89.4, 41.7, 36.8, 33.7,
18.8, 11.4.
IR (film) 3065, 3028, 2944, 2865, 2249, 2168, 1463 cm-1.
LRMS (EI) calcd for C2oH31BrSi (M+) 378, found 378.
TIPS
CI
Et
(3-Chloropent-1-ynyl)triisopropylsilane. Prepared by the representative procedure,
substituting dichlorotriphenylphosphorane for dibromotriphenylphosphorane.
1H NMR (CDCl3, 300 MHz) 6 4.53 (t, J= 6.3 Hz, 1H), 1.97 (dt, J= 13.5, 7.5 Hz, 2H),
1.10 (t, J= 7.5 Hz, 3H), 1.08-1.06 (m, 21H).
13C NMR (CDCl3, 75 MHz) 6 105.3, 87.9, 50.6, 32.8, 18.8, 11.3, 10.7.
IR (film) 2944, 2892, 2866, 2361, 2175, 1463 cm1.
LRMS (EI) calcd for C14H27CISi (M+) 258, found 258.
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TIPS
CI
i-Pr
(3-Chloro-5-methylhex-1-ynyl)triisopropylsilane. Prepared by the representative
procedure, substituting dichlorotriphenylphosphorane for dibromotriphenylphosphorane.
1H NMR (CDC13, 300 MHz) 6 4.58 (t, J = 7.6 Hz, 1H), 1.92 (sextet, J = 7.3 Hz, 1H),
1.86-1.81 (m, 2H), 1.08-1.07 (m, 21H), 0.94 (dd, J= 6.5, 1.1 Hz, 6H).
13C NMR (CDCl 3 , 75 MHz) 6 105.8, 87.6, 48.5, 47.7, 26.0, 22.2, 18.8, 11.3.
IR (film) 2959, 2944, 2893, 2867, 2361, 2339, 2173, 1464, 1386, 1368 cm-1.
LRMS (EI) calcd for C16H31C1Si (M+) 286, found 286.
TIPS
Br
(3-Bromoprop-1-ynyl)triisopropylsilane [CAS # 104465-98-7]. Prepared from 3-
(triisopropylsilyl)-2-propyn-1-yl' 07 by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 3.94 (s, 2H), 1.06 (s, 21H).
Preparation of Alkyl Iodides (representative procedure): A 100 mL flask, wrapped in
aluminium foil, was charged with imidazole (1.0 g, 14.7 mmol) and triphenylphosphine (3.9 g,
14.7 mmol), evacuated, and back-filled with argon. CH2C12 (40 mL) was added via syringe,
followed by the addition of the alcohol (9.8 mmol). This solution was allowed to stir for 15 min.
Next, iodine (3.75 g, 14.7 mmol) was added portionwise as a solid. The reaction was run under
argon and monitored by TLC. Upon completion (usually 3-4 hours), the solvent was removed
under reduced pressure and the resultant solid was triturated with 3:1 hexanes:Et20 (60 mL) for
1 h, the solid was then removed via filtration and the solution was concentrated under reduced
pressure to give the desired iodide as a crude oil. The iodide was then purified via distillation
under reduced pressure.
107 Prepared according to Ogoshi, S.; Nishigushi, S.; Tsutsumi, K.; Kurosawa, H. J. Org. Chem. 1995, 60, 4650-
4652.
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04-Iodotetrahydro-2H-pyran [CAS # 25637-18-7]. Prepared from tetrahydro-pyran-4-ol
by the representative procedure.
'H NMR (CDCI3, 300 MHz) 6 4.45 (quintet, J= 6.2 Hz, 1H), 3.85-3.78 (m, 2H), 3.56-
3.49 (m, 2H), 2.19-2.12 (m, 4H).
Boc
N
tert-Butyl-4-iodopiperidine-l-carboxylate [CAS # 885275-003]. Prepared from benzyl
4-hydroxy-1 -piperindinecarboxylate by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 7.38-7.33 (m, 5H), 5.13 (s, 2H), 4.46 (quintet, J= 6.0 Hz,
1H), 3.69-3.61 (m, 2H), 3.44-3.36 (m, 2H), 2.90-2.60 (m, 4H).
Me Me
I
3-lodopentane [CAS # 1809-05-8]. Prepared from 3-pentanol by the representative
procedure.
'H NMR (CDC13, 300 MHz) 6 4.09-4.01 (m, 1H), 1.93-1.68 (m, 4H), 1.02 (t, J= 6.9 Hz,
6H).
Iodocycloheptane [CAS # 2404-36-6]. Prepared from cycloheptanol
representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.48 (septet, J= 4.5 Hz, 1H), 2.33-2.11 (m, 4H), 1.60-1.55
(m, 6H), 1.48-1.39 (m, 2H).
187
the
O
Iodocyclooctane [CAS # 1556-10-1]. Prepared from cyclooctanol by the representative
procedure.
IH NMR (CDC13, 300 MHz) 6 4.60 (quintet, J= 6.3 Hz, 1H), 2.27-2.20 (m, 4H), 1.70-
1.42 (m, 10OH).
Me
(3-Iodobutyl)benzene [CAS # 59456-20-1]. Prepared from 4-phenylbutan-2-ol by the
representative procedure.
'H NMR (CDC13, 300 MHz) 6 7.32-7.19 (m, 5H), 4.17-4.05 (m, 1H), 2.90-2.80 (m, 1H),
2.75-2.64 (m, 1H), 2.22-2.09 (m, 1H), 1.95 (d, J= 6.9 Hz, 3H), 1.95-1.82 (m, 1H).
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Preparation of Organozine Reagents: Conditions A (solvent: DMA). A 25 mL
Schlenk flask was charged with zinc powder (0.98 g, 15 mmol) and heated to 80 oC under high
vacuum for 30 min. After back-filling with argon, DMA (to give a total volume of 10 mL) and
iodine (0.13 g, 0.50 mmol) were added. After the red color of iodine had faded, the alkyl halide
(10 mmol) was added. The colorless reaction mixture was stirred for 6 h at 80 oC (the
disappearance of the starting material and the formation of the organozinc reagent can readily be
monitored by no-D NMR). The gray solution (-1.0 M) was transferred into a dry vessel via
cannula. These organozinc solutions can be stored at room temperature for several weeks in a dry
atmosphere without deterioration.
Preparation of Organozinc Reagents: Conditions B (solvent: THF). A 25 mL Schlenk
flask was charged with zinc powder (0.98 g, 15 mmol) and heated to 80 oC under high vacuum
for 30 min. After back-filling with argon, THF (to give a total volume of 10 mL) and iodine
(0.13 g, 0.50 mmol) were added. After the red color of iodine had faded, the alkyl halide (10
mmol) was added. The colorless reaction mixture was stirred for 12 h at room temperature (the
disappearance of the starting material and the formation of the organozinc reagent can readily be
monitored by no-D NMR). The gray solution (-1.0 M) was transferred into a dry vessel via
cannula. These organozinc solutions can be stored at room temperature for several weeks in a dry
atmosphere without deterioration.
III. Preparation of Ligand
L13,[CAS # 123640-38-0] Prepared by a literature procedure.'0 8
'H NMR (CDC13, 500 MHz) 6 8.61 (dd, J = 2.9, 0.5 Hz, 2H), 7.96 (dd, J= 8.5, 6.9 Hz,
1H), 7.85 (d, J = 8.0 Hz, 2H), 7.75 (d, J= 1 Hz, 2H), 6.52 (dd, J = 2.5, 2.0 Hz, 2H).
108 Jameson, D.L.; Goldsby, K.A. J. Org. Chem. 1990, 55, 4992-4994.
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IV. Negishi Cross-Coupling Reactions
General Procedures
Negishi Cross-Coupling Reactions: General Procedure A (Table 2.3, 2.4 and eq
2.12). In the air (no special precautions are necessary), a 20 mL vial was charged with
NiC12-glyme (10.9 mg, 0.050 mmol) and terpyridine (11.6 mg, 0.050 mmol). The vial was
purged with argon for 5 min, and then DMA (10.0 mL) was added via syringe. The resulting
opaque, green solution was stirred at room temperature for 20 min, then the organozinc reagent
(1.0 M in DMA; 0.80 mL, 0.80 mmol) was added. The resulting dark-brown reaction mixture
was stirred for 10 min at room temperature. Next, the propargylic bromide (0.50 mmol) was
added via syringe; the reaction mixture became light, but darkened over several hours. The
reaction was allowed to run for 16 h at room temperature. Then, the excess organozinc reagent
was quenched by the addition of EtOH (1.0 mL), and the brown mixture was diluted with 100
mL t-BuOMe, this solution was washed 3 times with 50 mL of water, once with brine, and then
dried over MgSO 4. After filtration, the solution was concentrated under reduced pressure and the
resultant oil was purified by flash chromatography (hexanes/EtOAc or pentane/Et2O).
Negishi Cross-Coupling Reactions: General Procedure B (Table 2.6, 2.7 and eq
2.13). In the air (no special precautions are necessary), an oven-dried 4 mL vial, with teflon
stirbar, was charged with NiC12-glyme (5.5 mg, 0.025 mmol) and L13 (5.3 mg, 0.025 mmol).
The vial was capped with a rubber septa and purged with argon for 5 min, and then THF (0.87
mL) was added via syringe. The resulting opaque, light green solution was stirred at room
temperature for 20 min, then the organozinc reagent (-1.0 M in THF; 0.80 mL, 0.8 mmol) was
added. The resulting dark-brown reaction mixture was stirred for 10 min at room temperature.
Next, the propargylic bromide (0.50 mmol) was added via syringe. The reaction was allowed to
run for 7 h at room temperature, under a positive atmosphere of argon. Then, the excess
organozinc reagent was quenched by the addition of EtOH (0.5 mL), and the brown mixture was
filtered through a short plug of silica gel, eluting with -60 mL Et20, which was subsequently
concentrated. The resultant oil was purified by flash chromatography (hexanes/EtOAc or
pentane/Et 2O).
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TIPS
n-Bu
(3-Cyclohexylhept-1-ynyl)triisopropylsilane (Table 2.4, entry 1). The compound was
prepared according to General Procedure A. After chromatography on silica gel (pentane), the
desired compound was isolated as a colorless oil: run 1: 147 mg (88%); run 2: 149 mg (89%).
'H NMR (CDCl 3, 500 MHz) 6 2.24 (quintet, J= 4.7 Hz, 1H), 1.82-1.63 (m, 5H), 1.53-
1.19 (m, 12H), 1.08-1.05 (m, 21H), 0.90 (t, J= 7.1 Hz, 3H).
13C NMR (CDCl3, 125 MHz) 6 111.8, 81.7, 41.6, 39.3, 32.4, 31.9, 30.2, 29.0, 26.9, 26.8,
26.6, 22.8, 18.9, 14.3, 11.6.
IR (film) 2928, 2864, 2723, 2361, 2338, 2163, 1463, 1381 cm-1.
LRMS (EI) calcd for C22H42Si (M+) 334, found 334.
TIPS
MeO 2
Methyl-6-cyclohexyl-8-(triisopropylsilyl)oct-7-ynoate (Table 2.4, entry 2). The
compound was prepared according to the General Procedure A. After chromatography on silica
gel (pentane:Et20O 100:1), the desired compound was isolated as a colorless oil: run 1: 140.5 mg
(72%); run 2: 139.0 mg (71%).
'H NMR (CDC13, 300 MHz) 6 3.66 (s, 3H), 2.31 (t, J = 7.5, 2H), 2.24 (quintet, J= 4.5
Hz, 1H), 1.79-1.17 (m, 17H), 1.07-1.05 (m, 21H).
13C NMR (CDC13, 75 MHz) 6 174.4, 111.3, 82.0, 51.7, 41.6, 39.1, 34.3, 32.3, 31.8, 29.0,
27.6, 26.8, 26.7, 26.6, 25.0, 18.9, 11.5.
IR (film) 2928, 2864, 2255, 2163, 1736, 1462 cm-1.
HRMS (EI) calcd for C24H4402NaSi (M+Na+) 415.3003, found 415.2998.
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TIPS
(Z)-(3-Cyclohexyldodec-9-en-1-ynyl)triisopropylsilane (Table 2.4, entry 3). The
compound was prepared according to the General Procedure A. After chromatography on silica
gel (pentane), the desired compound was isolated as a colorless oil: run 1: 143.3 mg (71%); run
2: 144.8 mg (72%).
H NMR (CDC13, 300 MHz) 6 5.36-5.31 (m, 2H), 2.25-2.21 (m, 1H), 2.05-1.97 (m, 4H),
1.80-1.07 (m, 19H), 1.07-1.05 (m, 21H), 0.97 (t, J= 7.2 Hz, 3H).
13C NMR (CDCl 3, 75 MHz) 6 131.8, 129.6, 41.6, 39.4, 32.7, 31.9, 30.0, 29.3, 29.1, 27.9,
27.3, 26.9, 26.8, 26.6, 20.7, 18.9, 14.6, 11.6.
IR (film) 2928, 2863, 2362, 2163, 1463, 995, 883 cm-1.
HRMS (EI) calcd for C24H43Si (M-i-Pr+) 359.3128, found 359.3319.
TIPS
n-Bu
Triisopropyl(3-(tetrahydro-2H-pyran-4-yl)hept-1-ynyl)silane (Table 2.4, entry 4).
The compound was prepared according to the General Procedure A. After chromatography on
silica gel (hexanes:Et20 10:1), the desired compound was isolated as a colorless oil: run 1: 113.9
mg (68%); run 2: 120.2 mg (72%).
1H NMR (CDCl3, 300 MHz) 5 4.01-3.94 (m, 2H), 3.39-3.34 (m, 2H), 2.27-2.25 (m, 1H),
1.72 (d, J= 9 Hz, 1H), 1.57-1.51 (m, 5H), 1.46-1.29 (m, 5H), 1.07-1.04 (m, 21H), 0.89 (t, J= 6.9
Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 110.5, 82.6, 68.4, 68.3, 39.1, 38.8, 31.8, 31.5, 29.9, 29.8,
22.7, 18.9, 14.3, 11.5.
IR (film) 2940, 2864, 2164, 1464, 1386, 1097, 883, 734 cm-1.
HRMS (ESI) calcd for C21H40NaOSi (M+Na+) 359.2741, found 359.2727.
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TIPS
NCbz
Me
tert-Butyl-4-(4-(triisopropylsilyl)but-3-yn-2-yl)piperidine-1-carboxylate (Table 2.4,
entry 5). The compound was prepared according to the General Procedure A. After
chromatography on silica gel (hexanes:CH 2C 2:Et2O 70:25:5), the desired compound was
isolated as a colorless oil: run 1: 159.8 mg (75%); run 2: 162.5 mg (76%).
'H NMR (CDC13, 300 MHz) 6 7.38-7.29 (m, 5H), 5.11 (d, J= 5.5 Hz, 2H), 4.23 (d, J=
30.4 Hz, 2H), 2.80-2.65 (m, 2H), 2.45-2.35 (m, 1H), 1.84 (d, J = 12.5 Hz, 1H), 1.68 (broad s,
1H), 1.46-1.30 (m, 3H), 1.17 (d, J= 7.0 Hz, 3H), 1.06-1.04 (m, 21H).
13 C NMR (CDCl3, 75 MHz) 6 155.4, 137.1, 128.7, 128.1, 11.6, 81.7, 67.1, 44.5, 44.4,
41.3, 32.4, 30.1, 18.8, 18.7, 11.4.
IR (film) 2944, 2865, 2253, 2163, 1688, 1449 cm-1.
HRMS (ESI) calcd for C26H41NNaO2Si (M+Na +) 450.2799, found 450.2797.
TIPS
Me
Me0 2C ) Me
Methyl-6-isopropyl-8-(triisopropylsilyl)oct-7-ynoate (Table 2.4, entry 6). The
compound was prepared according to the General Procedure A. After chromatography on silica
gel (pentane:Et20O 100:1), the desired compound was isolated as a colorless oil: run 1: 114.0 mg
(65%); run 2: 104.0 mg (60%).
'H NMR (CDCl3, 300 MHz) 6 3.66 (s, 3H), 2.21 (t, J= 7.5 Hz, 2H), 2.27-2.23 (m, 1H),
1.70-1.55 (m, 4H), 1.46-1.37 (m, 3H), 1.06-1.04 (m, 21H), 0.96 (dd, J= 15.7, 6.5 Hz, 6H).
13C NMR (CDC13, 75 MHz) 6 174.4, 110.8, 82.2, 51.7, 39.9, 34.2, 32.8, 31.8, 27.7, 25.0,
21.5, 18.9, 18.8, 11.5.
IR (film) 2942, 2865, 2164, 1744, 1463, 1173, 996, 883 cm.
HRMS (ESI) calcd for C21H4002Si (M+Na+) 375.2690, found 375.2676.
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t-Bu
MeO 2C 4
Methyl-6-cyclohexyl-9,9-dimethyldec-7-ynoate (Table 2.4, entry 7). The compound
was prepared according to the General Procedure A. After chromatography on silica gel
(pentane:Et 20 100:1), the desired compound was isolated as a colorless oil: run 1: 108.0 mg
(74%); run 2: 102.0 mg (70%).
'H NMR (CDC13, 300 MHz) 6 3.65 (s, 3H), 2.30 (t, J= 7.5 Hz, 2H), 2.11-2.08 (m, 1H),
1.76-1.68 (m, 3H), 1.66-1.58 (m, 4H), 1.52-1.48 (m, 1H), 1.39-1.34 (m, 3H), 1.24-1.05 (m, 15H).
13C NMR (CDC13, 75 MHz) 6 174,5, 91.2, 80.5, 51.7, 41.7, 37.8, 34.4, 32.4, 31.7, 29.2,
27.6, 27.5, 26.8, 26.7, 26.6, 25.1.
IR (film) 2968, 2928, 2855, 2254, 1731, 1450 cm -1.
HRMS (ESI) calcd for C19H 32NaO2 (M+Na+) 315.2295, found 315.2287.
t-Bu
Ph
2
(3-Cyclopentyl-6,6-dimethylhept-4-ynyl)benzene (Table 2.4, entry 8). The compound
was prepared according to the General Procedure A. After chromatography on silica gel
(pentane), the desired compound was isolated as a colorless oil: run 1: 96.5 mg (72%); run 2:
98.5 mg (73%).
'H NMR (CDC13, 300 MHz) 6 7.34-7.20 (m, 5H), 2.93-2.87 (m, 1H), 2.74-2.68 (m, 1H),
2.32-2.27 (m, 1H), 1.89-1.85 (m, 1H), 1.79-1.29 (m, 10H), 1.28 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 142.7, 128.5, 128.2. 125.6, 91.0, 80.3, 44.1, 36.6, 36.2,
33.9, 31.5, 30.9, 29.4, 27.4, 25.7, 25.6.
IR (film) 3063, 2963, 2868, 1704, 1453, 1264, 1202, 699 cm-1.
HRMS (EI) calcd for C20H28 (M') 268.2185, found 268.2185.
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TIPS
OBn
CI
(6 -(Benzyloxy)-3-(3-chloropropyl)hex-1-ynyl)triisopropylsilane (Table 2.5, entry 1).
The compound was prepared according to the General Procedure A, the organozinc reagent was
made from ((3-bromopropoxy)methyl)benzene via the General Procedure A. After
chromatography on silica gel (hexanes:Et2O 95:5), the desired compound was isolated as a
colorless oil: run 1: 171.7 mg (97%); run 2: 175.1 mg (98%).
1H NMR (CDCl3 , 300 MHz) 6 7.38-7.26 (m, 5H), 4.50 (s, 2H), 3.57 (t, J = 6.3 Hz, 2H),
3.55 (dt, J= 6.0, 2.1 Hz, 2H), 2.42 (septet, J= 4.8 Hz, 1H), 2.10-1.42 (m, 10H), 1.07-1.02 (m,
21 H).
13C NMR (CDC13, 75 MHz) 6 138.8, 128.6, 127.8, 127.4, 111.5, 82.1, 72.9, 70.2, 45.2,
32.6, 32.2, 32.1, 30.6, 27.7, 18.9, 11.5.
IR (film) 2942, 2864, 2163, 1462, 1364, 1102, 883, 676 cm -1.
LRMS (EI) calcd for C22H34C1IOSi (M-i-Pr +) 377, found 377.
TIPS
CO02 Et
Ph ) )42
Ethyl-7-phenethyl-9-(triisopropylsilyl)non-8-ynoate (Table 2.5, entry 2). The
compound was prepared according to the General Procedure A, the organozinc reagent was made
from ethyl 6-bromohexanoate via the General Procedure A. After chromatography on silica gel
(hexanes:EtOAc 30:1), the desired compound was isolated as a colorless oil: run 1: 177.1 mg
(95%); run 2: 180.6 mg (97%).
1H NMR (CDC13, 300 MHz) 6 7.35-7.15 (m, 5H), 4.12 (q, J= 7.2 Hz, 2H), 2.88 (quintet,
J= 6.6 Hz, 1H), 2.77-2.67 (m, 1H), 2.42-2.34 (m, 1H), 2.28 (t, J= 7.2 Hz, 2H), 1.76-1.25 (m,
10H), 1.25 (t, J= 7.2 Hz, 3H), 1.09-1.06 (m, 21H).
'
3C NMR (CDC13, 75 MHz) 6 174.0, 142.5, 128.8, 128.6, 125.9, 112.3, 81.8, 60.4, 37.6,
35.3, 34.5, 33.9, 32.5, 29.2, 27.2, 25.1, 18.9, 14.5, 11.5.
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IR (film) 2941, 2864, 2163, 1738, 1463, 1179, 883, 676 cm1 .
LRMS (El) calcd for C2 5H39 0 2 Si (M-i-Pr ) 399, found 399.
TIPS
CO2Et
H
Ethyl-9-(triisopropylsilyl)non-8-ynoate (Table 2.5, entry 3). The compound was
prepared according to the General Procedure A. After chromatography on silica gel
(hexanes:Et 20 20:1), the desired compound was isolated as a colorless oil: run 1: 152.9 mg
(89%); run 2: 150.5 mg (90%).
1H NMR (CDC13, 300 MHz) 6 4.10 (q, J= 7.2 Hz, 2H), 2.30-2.20 (m, 4H), 1.66-1.30 (m,
8H), 1.24 (t, J= 7.2 Hz, 3H), 1.04-1.02 (m, 21H).
13C NMR (CDC13, 75 MHz) 6 174.0, 109.2, 80.3, 60.4, 34.5, 28.8, 28.7, 28.5, 25.0, 19.9,
18.8, 14.4, 11.5.
IR (film) 2942, 2865, 2361, 2338, 2254, 2169, 1727, 1464, 1194 cm - .
LRMS (EI) calcd for C20H380 2Si (M+) 338, found 338.
TIPS
n-Bu
(3-Cycloheptylhept-1-ynyl)triisopropylsilane (Table 2.7, entry 1). The compound was
prepared according to General Procedure B. After chromatography on silica gel (hexanes), the
desired compound was isolated as a colorless oil: run 1: 146 mg (84%); run 2: 156 mg (89%).
'H NMR (CDC13, 500 MHz) 6 2.30 (quintet, J= 4.5 Hz, 1H), 1.76-1.65 (m, 5H), 1.59-
1.24 (m, 14H), 1.08-1.04 (m, 21H), 0.90 (t, J = 7.1 Hz, 3H).
13C NMR (CDC13, 125 MHz) 6 112.1, 81.2, 43.4, 40.3, 33.6, 32.6, 30.4, 30.3, 28.5, 28.4,
27.4, 27.1, 22.8, 18.9, 14.3, 11.5.
IR (film) 2929, 2863, 2723, 2361, 2338, 2163, 1463, 1380, 1365 cm-.
LRMS (EI) calcd for C23H44Si (M+) 348, found 348.
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TIPS
(3-Cycloheptyltetradeca-1,11-diynyl)triisopropylsilane (Table 2.7, entry 2). The
compound was prepared according to the General Procedure B. After chromatography on silica
gel (hexanes), the desired compound was isolated as a colorless oil: run 1: 174.0 mg (79%); run
2: 170.8 mg (77%).
1H NMR (CDC13, 300 MHz) 5 2.32-2.27 (m, 1H), 2.20-2.09 (m, 4H), 1.73-1.67 (m, 4H),
1.60-1.20 (m, 21H), 1.11 (t, J= 7.2 Hz, 3H), 1.08-1.04 (m, 21H).
13C NMR (CDC13, 75 MHz) 8 112.2, 81.8, 81.3, 79.8, 43.4, 40.3, 33.6, 32.9, 30.4, 29.6,
29.4, 29.3, 29.1, 28.5, 28.4, 28.0, 27.4, 27.1, 19.0, 18.9, 14.6, 12.6, 11.6.
IR (film) 2928, 2862, 2163, 1462, 1320, 995 cm1.
HRMS (EI) calcd for C27H 47Si (M-i-Pr+) 399.3441, found 399.3024.
TIPS
CIHD
3
(6-Chloro-3-cyclooctylhex-1-ynyl)triisopropylsilane (Table 2.7, entry 3). The
compound was prepared according to the General Procedure B. After chromatography on silica
gel (hexanes), the desired compound was isolated as a colorless oil: run 1: 156.0 mg (82%); run
2: 155.7 mg (82%).
SH NMR (CDCl 3, 300 MHz) 6 3.59 (t, J= 6.5 Hz, 2H), 2.31 (dt, J= 4.5, 6.0 Hz, 1H),
2.18-2.00 (m, 1H), 1.92-1.82 (m, 1H), 1.78-1.40 (m, 17H), 1.07-1.04 (m, 21H).
13C NMR (CDC13, 75 MHz) 6 111.1, 82.2, 45.3, 41.3, 40.1, 32.6, 31.1, 30.0, 29.6, 27.2,
26.8, 26.7, 25.9, 18.9, 11.5
IR (film) 2923, 2864, 2164, 1463, 995, 883, 676 cm- .
LRMS (EI) calcd for C23H43CISi (M+) 382, found 382.
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(3-Cyclooctyl-5-methylhex-1-ynyl)triisopropylsilane (Table 2.7, entry 4). The
compound was prepared according to the General Procedure B. After chromatography on silica
gel (hexanes), the desired compound was isolated as a colorless oil: run 1: 147.5 mg (81%); run
2: 147.2 mg (81%).
1H NMR (CDC13, 500 MHz) 6 2.35 (dt, J= 10.5, 4.5 Hz, 1H), 1.90-1.83 (m, 1H), 1.76-
1.38 (m, 16H), 1.16-1.08 (m, 1H), 1.06-1.03 (m, 21H), 0.93-0.87 (m, 6H).
13C NMR (CDC13, 75 MHz) 6 112.0, 81.2, 42.0, 41.4, 38.8, 32.9, 29.5, 27.1, 26.9, 26.8,
26.7, 26.4, 26.0, 23.9, 21.8, 18.9, 11.6.
IR (film) 2924, 2865, 2164, 1465, 1383, 1071 cm 1.
HRMS (EI) calcd for C24H46Si (M+) 362.3363, found 362.3372.
TIPS
Me
Ph
n-Bu
Triisopropyl(3-(4-phenylbutan-2-yl)hept-1-ynyl)silane (Table 2.7, entry 5). The
compound was prepared according to the General Procedure B (3.0 equiv RZnI was used). After
chromatography on silica gel (hexanes), the desired compound was isolated as a colorless oil:
run 1: 147.9 mg (77%); run 2: 141.7 mg (74%).
'H NMR (CDC13, 300 MHz) 1:1 mixture of diastereomers, 6 7.31-7.18 (m, 10H), 2.81-
2.71 (m, 1H), 2.67-2.60 (m, 2H), 2.57-2.44 (m, 2H), 2.37-2.30 (m, 1H), 1.90-1.83 (m, 2H), 1.66-
1.24 (m, 14H), 1.09-0.99 (m, 50H), 0.95-0.87 (m, 6H).
13C NMR (CDC13, 75 MHz) 1:1 mixture of diastereomers, 6 143.1, 143.0, 128.62,
128.60, 128.5, 128.4, 125.8, 111.7, 110.6, 81.9, 81.8, 39.2, 37.8, 37.7, 36.4, 36.1, 35.1, 33.9,
33.8, 33.1, 31.9, 30.4, 30.2, 22.8, 18.9, 17.8, 15.7, 14.3, 11.6.
IR (film) 3027, 2941, 2864, 2164, 1496, 1462, 1380, 996, 908 cm-.
HRMS (EI) calcd for C23H37Si (M-i-Pr+) 341.2659, found 341.2977.
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TIPS
Et
BnO )4 Et
(7-(Benzyloxy)-3-(pentan-3-yl)hept-1-ynyl)triisopropylsilane (Table 2.7, entry 6).
The compound was prepared according to the General Procedure B (3.0 equiv RZnI was used).
After chromatography on silica gel (preparative TLC; hexanes:Et 20 100:1), the desired
compound was isolated as a colorless oil: run 1: 109.0 mg (51%); run 2: 102.4 mg (48%).
1H NMR (CDCl 3, 300 MHz) 6 7.35-7.27 (m, 5H), 4.50 (s, 2H), 3.47 (t, J= 6.6 Hz, 2H),
2.52-2.45 (m, 1H), 1.70-1.59 (m, 3H), 1.56-1.14 (m, 8H), 1.06-1.04 (m, 21H), 0.88 (t, J= 6.6
Hz, 6H).
13C NMR (CDC13, 75 MHz) 6 138.9, 128.6, 127.8, 127.7, 111.5, 81.6, 73.1, 70.7, 45.2,
35.5, 32.6, 29.9, 24.9, 24.2, 23.2, 18.9, 12.2, 11.9, 11.6.
IR (film) 2940, 2864, 2163, 1462, 1380, 1103, 883 cm-1.
HRMS (ESI) calcd for C28H48NaOSi (M+Na+) 451.3367, found 451.3348.
TIPS
0
i-Pr
Triisopropyl(5-methyl-3-(tetrahydro-2H-pyran-4-yl)hex-1-ynyl)silane (Eq 2.12). The
compound was prepared according to General Procedure A. After chromatography on silica gel
(0% -- 8% Et20O in hexanes), the desired compound was isolated as a colorless oil: run 1: 126
mg (75%); run 2:128 mg (76%).
'H NMR (CDCl3, 300 MHz) 6 4.02-3.95 (m, 2H), 3.40-3.31 (m, 2H), 2.38-2.31 (m, 1H),
1.97-1.82 (m, 1H), 1.72- 1.38 (m, 7H), 1.20-1.02 (m, 21H), 0.90 (dd, J= 13.2, 6.6 Hz, 6H).
'3C NMR (CDC13, 75 MHz) 6 110.2, 82.7, 68.4, 68.3, 41.5, 39.5, 36.8, 31.6, 29.7, 26.3,
23.9, 21.6, 18.9, 11.5.
IR (film) 2956, 2941, 2865, 2361, 2339, 2163, 1465, 1385, 1368 cm 1.
LRMS (EI) calcd for C 18H 33OSi (M-i-Pr ) 293, found 293.
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(3-Cyclooctylpent-1-ynyl)triisopropylsilane (Eq 2.13). The compound was prepared
according to the General Procedure B. After chromatography on silica gel (hexanes), the desired
compound was isolated as a colorless oil: run 1: 123.8 mg (74%); run 2: 127.1 mg (76%).
1H NMR (CDC13, 300 MHz) 6 2.22-2.16 (m, 1H), 1.75-1.40 (m, 17H), 1.10-0.98 (m,
24H).
13C NMR (CDC13, 75 MHz) 8 112.0, 81.3, 42.8, 40.9, 32.7, 29.4, 27.2, 26.9, 26.8, 26.8,
26.0, 18.9, 12.6, 11.5.
IR (film) 2924, 2864, 2722, 2163, 1463, 1381 cm l .
LRMS (EI) calcd for C22H42Si (M ) 334, found 334.
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bs 8 werr
tpwr 54 wexp
pw 8.0 wbs
dl 0.050 wnt
tof 867.7
nt 16
ct 8
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp -3.4
wp 2400.9
vs 76
U I
0
250
9.60
155.98
2778.9
2178.7
1 201.000
sc
wc
t' hzmm
is
rfl
rfp
th.
ins
nm
.100
H1
30
0
nnn
c
200
ft
L072
Ph3Si
Br
n-Bu
6j 5 3 2 1 ppm
L " L L-r
2.11
1.00
2.19
2.49 3.20
7
6.22 0.41
9.45
I-1
".1.
-- I I I I I I ] 1
Jl
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Apr 4 2007
solvent CODC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-07-101H.fid
ACQUISITION
sfrq 300.101
tn HI
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 0.5
dl 0.050
tof 867.7
nt 16
ct 8
alock
gain
11
in
dp
sp
wp
vs
sc
wec
hzmm
is
rfl
rfp
th
ins
nm
n
not used
FLAGS
DISPLAY
ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Br
n-BU
y
0.4
2403.5
151
0
250
9.61
128.88
2779.2
2178.7
20
1.000
I~~~~~~~~~~ ~ ~'' ' ' 1 ' ' ' ' 1 ' ' ' '
4
1.00
1.95
ppm
1.95 20.56
2.13 3.07
7
I I" "
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Nov 13 2006
solvent CDC13
file /data/export/~-
home/gfu/Tsm/mrhat~
/Tsm-06-029.fid
ACQUISITION
sfrq 300.101
tn H1i
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
Ct
alock
gain
11
in
dp
sp
wp
vs
Sc
wc
hzmm
is
rf 1
rfp
th
ins
nm
16
n
not used
FLAGS
n
n
y
DISPLAY
-1.8
2402.0
213
0
250
9.61
500.00
2779.6
2178.7
20
1.000
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dm
daf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Br
MeO 2C 4
i I .
6
1.00
3.05
2 1
2.12 4.62
2.08 21.37
ppm
1--F f
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Nov 13 2006
solvent CDC13
file /data/export/~-
home/gfu/Tsm/mrhat~
/Tsm-06-030.fid
ACQUISITION .
sfrq 300.101
tn HI
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp 2.6
wp 2400.9
vs 151
sc 0
wc 250
hzmm 9.60
is 500.00
rfl 2779.5
rfp 2178.7
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
t-Bu
Br
MeO2C
_________________.____"_______________i . d. I _________
ppm
9.60
1.00
1.97
2.10 3.97
7
0 .43 3.02
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Jun 12 2007 dfrq 300
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tsm/mrhat- dof
/Tsm-02-137H.fid dm
ACQUISITION dmm
sfrq 300.101 dmf
tn H1 PROCESSING
at 4.003 wtfile
np 48052 proc
sw 6002.4 fn 13
fb not used
bs 8 werr
tpwr 54 wexp
pw 8.0 wbs
dl 0.050 wnt
tof 867.7
nt 16
ct 16
alock
gain
11
in
dp
DISI
sp
wp
vs
sc
wc
1h) .hzmm
0 is
rfl
rfp
th
ins
nm ph
n
not used
FLAGS
PLAY
y
2.3
2398.4
151
0
250
9.59
500.00
600.4
0
20
1.000
.100
H1
30
0
nnn
c
200
ft
1072
t-Bu
Ph
2
I ' I I I I I '
7 6 5 4 3
5.57 2.13
1.00
1 ppm
_ I
i ( | I I * •
T
2.03
-- J
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 25 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-08-059H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -0.2
wp 2400.9
vs 605
sc 0
wc 250
hzmm 9.60
is 500.00
rfl 600.4
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Br
Et
f f
1 1 1 i l I I lll ll'' I l I I - -- -- --.
7
1.98
1.00
6.25 4.34 3.15
2.25 21.48
5 ppm
I
I I'
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 25 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-08-060H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct
alock
gain
il
in
dp
sp
wp
vs
sc
wc
hzmm
is
rfl
rfp
th
ins
nm
16
n
not used
FLAGS
n
n
y
DISPLAY
-0.2
2400.9
349
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Et )7
7
0
250
9.60
31.25
600.4
0
20
1.000
1 I r i I
7 6
I I
ppm
1.00 2.32
4.82
, l L.--T--.2
28.51
12.92
-- --
I I I I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Mar 30 2007 dfrq 300.100
solvent CDC13 dn H1
file /data/export/- dpwr 30
home/gfu/Tsm/mrhat- dof 0
/Tsm-07-093.fid Adm nnn
ACQUISITION dmm c
sfrq 300.101 dmf 200
tn H1 PROCESSING
at 4.003 wtfile
np 48052 proc ft
sw 6002.4 fn 131072
fb not used
bs 8 werr
tpwr 54 wexp
pw 8.0 wbs
dl 0.050 wnt
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -1.1
wp 2402.0
vs 151
sc 0
we 250
hzmm 9.61
is 500.00
rfl 2778.9
rfp 2178.7
th 20
ins 1.000
nm ph
~~II
r I I I I I I I I I I I I I I I I I I I
7 6
TIPS
eBrMe
....1.00
3.29
ppm
__
!
I S I "
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Oct 30 2006
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-05-139.f-
id
ACQUISITION
sfrq 499.749
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.9
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp 2.6
wp 3990.8
vs 680
SC 0
wc 250
hzmm 15.96
is 33.57
rfl 4869.8
rfp 3628.1
th 7
Ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
I7
.673
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f
wft
1.801.00
1.98
TIPs
Br
CI
3
6i
9(_L
17.74
ppm
1 1 - --
--
.... I
1.85
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Dec 6 2006 dfrq 300
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tsm/mrhat~ dof
/Tsm-06-062H.fid dm
ACQUISITION dmm
sfrq 300.101 dmf
tn H1 PROCESSING
at 4.003 wtfile
np 48052 proc
sw 6002.4 fn 13
fb not used
bs 8 werr
tpwr 54 wexp
pw 8.0 wbs
dl 0.050 wnt
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp 0.1
wp 2400.9
vs 198
sc 0
250
9.60
420.75
2778.8
2178.7
20
1.000
we
NQ hzmm
is
h) rfl
rfp
th
ins
nm ph
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Br
BnO)
4
SI I I I I I
7 6 5 4 3 2
2.15
1.00 2.22
2.00 0.79
4.20
1 ppm
23.28
If
3.9355
0.82
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 12 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-05-102H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in
dp
sp
wp
vs
sc
wc
hzmm
is
rfl
rfp
th
Ins
nm
n
y
DISPLAY
2.3
2398.4
208
0
250
9.59
500.00
600.4
0
20
1.000
ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
I 1
7 6
1.00
2.67
1
19.69
5.35
TIPS
i 
-  Br
i-Pr
K
I
)
ppm
I -' ' -
--
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 12 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat~
/Tsm-05-121-2H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in
dp
sp
wp
vs
sc
wc
hzmm
Is
rfl
rfp
th
ins
nm
DEO. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13:
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Br
Ph
2
DISPLAY
-1.5
2402.2
567
0
250
9.61
500.00
600.4
0
15
1.000
6 5
5.16
4 3 2 1 ppm
2.18
1.00 2.14
-ji
I ' ' ' ' I ' ' ' r ( , t I I I I I I I 1 I I I I I
L~
22.79
,---I .--- ---,j
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 19 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-08-propargyli-
cchlorideH.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -0.7
wp 2398.5
vs 151
sc 0
we 250
hzmm 9.59
is 500.00
rfl 2778.9
rfp 2178.7
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300.
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 131
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
TIPS
Et
I I
7 6
1.00
2.23
5 ppm
" I
25.52
25.52
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Jun 30 2007 dfrq 300.100
solvent CDCIS dn H1
file /data/gfu/Tsm dpwr 30
/Tsm-08-065.fld dof 0
ACQUISITION dm nnn
sfrq 300.101 dmm c
tn H1 dmf 200
at 4.003 PROCESSING
np 48052 wtfile
sw 6002.4 proc ft
fb not used fn 131072
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs
tof 867.7 wnt
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp 1.9
wp 2395.5
vs 151
sc 0
wc 250
hzmm 9.58
h is 500.00
rfl 600.4
0\ rfp 0
th 20
Ins 2.000
nm ph
I~~ 
_ _ __ 
_ _
I I I
7 6 5 4 SI I I3 2 1 ppm
2.00
21.25
TIPS
Br
I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Jun 2 2007
solvent CDC13
file /data/gfu/Tsm-
/Tsm-07-078H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb nct used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain nct used
FLAGS
ii n
in n
dp y
DISPLA'
sp -1.4
wp 2402.2
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 600.4
rfp 0
th 20
ins 1.000
nm ph
7
DEC. & VT
dfrq 300.
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtf il e
proc
fn 13:
werr
wexp
wbs
wnt
I6
.100
H1
30
0
nnn
c
200
ft
1072
0Y
ppm
2.25
2.29
1.00
C r _n_,'
4.34
Lw
STANDARD 1H OBSERVE
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13:
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
Boc
I - -- -- I I I I II'II I I I I I I I I..
4 3
2.00
0.00-0.00
0.99
2.10
expl stdlh ,
SAMPLE
date Mar 2
solvent
file /data/e
home/gfu/Tsm
/Tsm-07-0
ACQUISITI
.sfrq 3
tn
at
np
sw
fb no
bs
tpwr
pw
dl
tof
nt
ct
alock
gain no
FLAGS
ii
in
dp
DISPLAY
sp
wp
vs
sc
wc
hzmm
is
rfl
rfp
th
ins
nm ph
9 2007
CDC13
xport/-
/mrhat-
90 .fid
DN
00.101
H1
4.003
48052
6002.4
t used
8
54
8.0
0.050
867.7
16
0
n
t used
n
n
y
300.2
103.6
151
0
250
8.41
L14.97
600.4
0
20
2.000
7
5.43 2.01
ppm
--
I
4.25
L]__
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Apr 4 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-07-098H.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -2.0
wp 2399.6
vs 151
sc 0
wc 250
hzmm 9.60
is 500.00
rfl 2779.0
rfp 2178.7
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
6
7 6 5 4 3 2 1 ppm
4.33
1.00
2.16
6.63
0.28
.r --
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Dec 6 2006 dfrq
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tsm/mrhat- dof
/Tsm-06-066H.fid dm
ACQUISITION dmm
sfrq 300.101 dmf
tn H1
at 4.003 wtfi
np 48052 proc
sw 6002.4 fn
fb not used
bs 8 werr
tpwr 54 wexp
pw 8.0 wbs
dl 0.050 wnt
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in
dp
DISPLAY
sp
wp
vs
sc
wec
hzmm
is
rfl
rfp
th
ins
nm ph
DEC. & VT
300.100
PROCESSING
le
133
nnn
c
200
ft
1072
y
-0.2
2400.9
151
0
250
9.60
500.00
600.4
0
20
1.000
4
3
3
4.44
1.00
0.20
1 ppm
J~C~
~----~----~-----~--' I I I 1 I 1 I I I I I I -I 1 I I I I 1 I I r I: i
11.31
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Mar 15 2007
solvent CDC13
file /data/export/~-
home/gfu/Tsm/mrhat~-
/Tsm-07-060-distil~-
l.fid
ACQUISITION
sfrq 300.101
tn H1i
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
i1 n
in n
dp y
DISPLAY
sp -0.2
wp 2400.9
vs 151
sc 0
wc 250
hzmm 9.60
is 161.54
rfl 600.4
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.100
H1
30
0
nnn
c
200
ft
1072
MeI Ph
Mel Ph
1.002.31
2.93
1.09 3.27
1.08 1.02 1.00
6
JF7--
0.30
ppm
L I
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Jan 22 2007
solvent CD2C12
file /data/export/-
home/gfu/Tsm/bullw-
inkle/Tsm-06-111.f-
id
ACQUISITION
sfrq 499.747
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.9
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
iil n
in n
dp y
hs nn
DISPLAY
sp 995.4
wp 4003.2
vs 134
sc 0
wc 250
hzmm 16.01
is 33.57
rfl 3903.5
rfp 2663.6
th 7
ins 1.000
ai cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13:
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f
wft
5 4 3 ppm
1.65
1.00 1.48 1.47
N gI '
N N/A
: 1 I 1 r I I
,,
--1.671.6 1.72
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE DEC. & VT
date Apr 13 2008 dfrq 125.
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tsm/bullw- dof
inkle/Tsm-10-107-1- dm
H.fid dmm
ACQUISITION dmf 10
sfrq 499.746 dseq
tn H1 dres
at 3.001 homo
np 63050 PROCESSING
sw 10504.2 wtfile
fb not used proc
bs 8 fn 261
tpwr 56 math
pw 8.6
dl 2.000 werr
tof 1519.5 wexp
nt 32 wbs
ct .16 wnt
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -11.4
wp 4009.0
vs 34
sc
h.) wc
k) hzmm
is
rfl
rfp
th
Ins
ai
.672
C13
30
0
nnn
w
1000
1.0
ft
2144
f
wft
TIPS
nTable 2.4, entry u
Table 2.4, entry I
250
16.04
33.57
1233.8
0
7
1.000
__.. _ _ __ _ ______ -_______________ ___
7 6 5
I I
4 3 2
1 ppm
1 PPM
1.07 13.87 3.60
6.15 24.31
- - 3- _ I ~- ---
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Oct 31 2006
solvent CDC13
file /data/export/-
home/gfu/Tsm/bull -
inkle/Tsm-06-005.f~
id
ACQUISITION
sfrq 499.749
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.9
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp -2.2
wp 3994.2
vs 377
sc 0
WC 250
hzmm 15.98
is 33.57
rfl 4870.3
rfp 3628.1
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13J
math
werr
wexp
wbs
wnt
.673
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f TIPS
/5
Et
Table 2.4, entry 3
7 6
y0.07o.o
'5 4 3 1 ppm
1.00 3.33 1.15 23.98
4.33 2.41 14.16 3.051.87
pI em. -w •
I I I I I I I 
. . ..-- 
- - 1 11 1 1 I
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Apr 3 2007
solvent CDC13
file /data/export/-
home/gfu/Tsm/bullw~
inkle/Tsm-7-075-07H.
fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -4.7
wp 4002.1
vs 22
sc 0
wc 250
hzmm 16.01
is 33.57
rfl 4865.9
rfp 3628.1
th 7
ins 1.000
ai cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26;
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
ft
2144
f
TIPS
n-Bu
Table 2.4, entry 4
I I
7 6
2.14
2.12
1.04 4.73 2.78
1.00 5.47 20.51
0.41
5
A
ppm
i.
I I
STANDARD PROTON PARAMETERS
expl s2pul.
SAMF
date Apr
solvent
file /date
home/gfu/1
inkle/Tsm-
ACQUISI
sfrq
tn
at
np
sw
fb
bs
tpwr
pw
dl
tof
nt
ct
alock
gain
FLAG
tl
in
dp
hs
DISPL
sp
wp
vs
SC
we
hzmm
is
rfl
rfp
th
ins
al cdc
DEC. & VT
125.672
C13
30
0
nnn
LE
3 2007 dfrq
CDC13 dn
/export/~ dpwr
sm/bullw- dof
07-097H.- dm
fid dmm
TION dmf
499.746 dseq
H1 dres
3.001 homo
63050
10504.2 wtfi
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Section 2.4
Formal Synthesis of a-Cembra-2,7,11-triene-4,6-diol
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A. Introduction
The cembrenoids are a large family of diterpenes which have received a considerable
amount of synthetic attention.10 9 In 1962, the a- and P-cembra-2,7,11-triene-4,6-diols (Scheme
2.17) were isolated by Roberts and Rowland from aged burley tobacco (Nicotiana
tabacum)."110 1 Not only have these cembrenoids been found to act as growth regulators in the
tobacco plant, when present in high concentrations they have been shown to increase the plant's
resistance to pests and fungal infections.112 Furthermore, these compounds have been shown to
inhibit tumor promotion in mice. 113
Scheme 2.17. Structure of the a- and P-Cembra-2,7,1 1-triene-4,6-diols.
HO HO, Me Me HO Me OH Me
Me Me Me MeMe 1 Me
Me Me
a-2,7,11-Cembratriene-4,6-diol 13-2,7,11-Cembratriene-4,6-diol
Despite the great attention devoted toward the synthesis of cembrenoids, to date, only
two groups have focused on the construction of the a- and P-cembra-2,7,11-triene-4,6-diols (see
Scheme 2.18). A series of communications from Marshall described the application of their work
on diastereoselective Wittig rearrangements to first the racemic and, later, the enantioselective
syntheses of these diterpenes. 114 Thomas et al. have also reported their efforts in the synthesis of
109 (a) Tius, M. A. Chem. Rev. 1988, 88, 719-732. (b) Weinheimer, A. J.; Chang C. W. J.; Matson, J. A. Fortschr.
Chem. Org. Naturst. 1979, 36, 285-387 (c) Hanson, J. R. Nat. Prod. Rep. 1994, 11, 265-277. (d) Wahlberg P.;
Enzell, C. R. Nat. Prod. Rep. 1987, 4, 237-276.
11o Isolation and structure: (a) Roberts, D. L.; Rowland, R. L. J. Org. Chem. 1962, 27, 3989-3995. (b) Roberts, D. L.;
Rowland, R. L. J. Org. Chem. 1963, 28, 1165-1169.
111 Stereochemistry: (a) Walberg, I.; Wallin, I.; Narbonne, C.; Nishida, T.; Enzell, C. R.; Berg, J.-E. Acta Chem.
Scand., Ser. B 1982, 36, 147-153. (b) Springer, J. P.; Clardy, J.; Cox, R. H.; Cutler, H. G.; Cole, R. J. Tetrahedron
Lett. 1975, 16, 2737-2740. (c) Aasen, A. J.; Junker, N.; Enzell, C. R.; Berg, J.-E.; Pilotti, A.-M. Tetrahedron Lett.
1975, 16, 2607-2610.
112 Fuchs, A.; Slobbe, W.; Mol, P. C.; Posthumus, M. A. Phytochemistry 1983, 22, 1197-1199.
113 Saito, Y.; Takayawa, H.; Konishi, S.; Yoshida, D.; Mizusaki, S. Carcinogenesis 1985, 6, 1189-1194.
114 (a) Marshall, J. A.; Robinson, E. D.; Adams, R. D. Tetrahedron Lett. 1988, 29, 4913-4916. (b) Marshall, J. A.;
Robinson, E. D. Tetrahedron Lett. 1989, 30, 1055-1058. (c) Marshall, J. A.; Robinson, E. D.; Lebreton, J. J. Org.
Chem. 1990, 55, 227-239.
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these compounds."1 5 The synthesis performed by Thomas centers on the application of a
macrocyclic olefination reaction to construct the medium-sized ring found in a- and f3-cembra-
2,7,11-triene-4,6-diol.
Scheme 2.18. Previous Syntheses of a-Cembra-2,7,11-triene-4,6-diol.
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B. Results and Discussion
Following our development of the nickel-catalyzed Negishi cross-couplings of secondary
nucleophiles with secondary propargylic electrophiles, described in the previous section, we
were interested in utilizing this methodology in the synthesis of a natural product. We saw a
racemic formal synthesis of a-cembra-2,7,11-triene-4,6-diol (an intermediate in the Thomas
"5 (a) Astles, P. C.; Thomas, E. J. Synlett 1989, 42-45. (b) Astles, P. C.; Thomas, E. J. J. Chem. Soc., Perkin Trans.
1 1997, 845-856.
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synthesis, 1, Scheme 2.18) as an excellent opportunity to highlight our new cross-coupling
reaction.
With this objective in mind, we envisioned the 14-membered macrocycle could be
constructed via an intramolecular aldol reaction (Scheme 2.19). The aldol precursor, 11, was to
be accessed via elaboration of the terminal alkyne present in the deprotected product of our
secondary-secondary Negishi cross-coupling, thus making use of the synthetic utility of alkynes
as two carbon linkers. We envisioned that the isopropyl substituent could be installed by our
Negishi reaction of a propargylic bromide, which we saw originating from farnesyl acetate. This
strategy allowed us to purchase two of the tri-substituted olefins (in the desired configuration)
which are present in the backbone of this diterpene.
Scheme 2.19. Retrosynthetic Analysis of Thomas Intermediate 1.
Me
Me Thomas
-zz
0
O MeMe Me e
Me
Me
farnesyl
acetate
O
(t-Bu)Ph 2SiO Me
So Me
Me
Me1
TIPS
olefin cleavage RO
and
alkynylation
Me
macrocyclic
aldol
Me
Me
Me
20-20 propargylic cross-coupling
and
alkynylation
Me
IZn--
Me
The Formal Synthesis of a-Cembra-2,7,11-triene-4,6-diol
As outlined in our retrosynthetic analysis, the formal synthesis of a-cembra-2,7,11-triene-
4,6-diol commenced with farnesyl acetate. We utilized a modification of the three-step olefin
cleavage protocol developed by Corey for his synthesis of Dolabellane, 116 to access aldehyde 5
(Scheme 2.20). Treatment of farnesyl acetate with NBS in a mixture of THF/H 20 led to selective
116 Corey, E. J.; Kania, R. S. J. Am. Chem. Soc. 1996, 118, 1229-1230.
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formation of bromohydrin 2 (62%), which under mild basic conditions readily closed to give the
trisubstituted epoxide 3 in nearly quantitative yield. These basic reaction conditions also led to
the cleavage of the allylic acetate. This was not considered a problem, as it allowed us to install a
somewhat more stable protecting group, a pivaloate (see 4), which could be easily removed in
concert with another transformation later in the synthesis. Aqueous sodium periodate and
periodic acid effected in situ epoxide opening and diol cleavage to produce aldehyde 5 in
excellent yield (90%).
Scheme 2.20. Synthesis of Aldehyde 5.
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Completion of our cross-coupling substrate, propargyl bromide 6, was accomplished via
addition of lithiated TIPS-protected acetylene to aldehyde 5, and subsequent bromination using a
phosphorus(V) brominating reagent, with imidazole as the base (Scheme 2.21, 86% over two
steps).
Scheme 2.21. Synthesis of Propargylic Bromide 6.
Li
TIPS
5
-78 "C
95%
O o
1 TIPS, l TIPS
t-Bu 0 PPh 3Br 2, t-BuOH Imidazole Br
Me 90% Me
Me 6 Me
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With the cross-coupling precursor in hand, we were very interested in how well our
newly developed coupling reaction would perform. We were pleased to see that 6 cross-coupled
smoothly with isopropylzinc iodide under our standard conditions; due to the high value of the
bromide we opted to use 3.0 equivalents of the nucleophilic partner for a slight improvement in
yield. Although the reaction proceeded without incident on 1.6 gram scale (7, 61%), somewhat
lower yields were obtained when the scale was increased to 5.0 grams (52%). Deprotection of
the alkynyl silyl-protecting group proceeded in nearly quantitative yields with 1.0 equivalent of
TBAF in refluxing THF to give the terminal alkyne 8.
Scheme 2.22. Large-Scale Negishi Reaction of Propargylic Bromide 6.
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Construction of diol 10 commenced with a simple alkynylation of acetaldehyde with 8,
which proceeded in acceptable yield (61%) to give propargylic alcohol 9. At this stage we were
set to generate the third E-olefin present in the macrocycle and remove the pivaloate protecting
group. This reduction was accomplished through the use of LiAlH4, in refluxing THF, to provide
diol 10 in excellent yield (95%, -1:1 dr).
Scheme 2.23. Synthesis of Diol 10.
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The mixture of diastereoisomers at this stage was of no concern, as we next needed to
oxidize both the primary and secondary allylic alcohols in order to access our desired aldol
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reaction precursor 11. We felt it would be ideal to accomplish both oxidation reactions in a
single experimental step. We initially attempted a PCC oxidation and were pleased to obtain the
desired dicarbonyl in 57% yield. Unfortunately, even after column chromatography, precursor 11
obtained via this oxidation had a tendency to decompose upon sitting, even under inert gas and at
low temperature. At the time, the presence of trace chromium was deemed the culprit for this
instability. Thus, another oxidation method was required. The mild oxidation reagent MnO 2 was
tested next, as it is known to be very effective for allylic alcohol oxidations. It was soon
determined that the MnO2 required activation by heat for any reactivity to be observed.
Disappointingly, the activated MnO2 rapidly oxidized the primary alcohol, but yielded only trace
amounts of the bis-oxidation product, even under high reagent loading or extended reaction
times. Exceptional reactivity was observed once we applied Ley's TPAP 117 oxidation conditions
to this substrate. To our delight 10% TPAP, with 3.0 equivalents NMO as the reoxidant,
generated 11 within 30 minutes in 97% yield (Table 2.8).
Table 2.8. Oxidation of Diol 10.
OH
HO Me Me
MeMe
Me
Me
10
Reaction
Conditions
entry reaction conditions result
1 PCC (2.4 equiv), CH 2C 2, 3 h
2 MnO 2 (20.0 equiv), CH 2C12, 24 h
3 activated MnO 2 (20.0 equiv),
CH 2C12, 24 h
4 10% TPAP, NMO (3.0 equiv),
4A MS, MeCN/CH 2C12 , 12 h
5 10% TPAP, NMO (3.0 equiv),
4A MS, MeCN/CH 2C12 , 30 min
57% 11
no reaction
15% 10 recovered
60% mono-oxidation
trace 11
96% 11
97% 11
117 For a review of TPAP oxidations, see: Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Synthesis 1994,
639-666.
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We were now poised to evaluate the second key step in our formal synthesis, the
macrocyclic, intramolecular aldol reaction of 11 to produce aldol 12. It was understood that this
reaction was going to be difficult for a number of reasons; not only are macrocyclic,
intramolecular aldol reactions relatively uncommon, 118 our starting material contains an
enolizable vinylogous aldehyde and a vinylogous methyl ketone, a combination likely to
participate in a variety of undesirable reactions. Also, it was our goal to isolate the desired
diastereoisomer, and we had no concrete reasons to believe this isomer would be generated,
much less favored. With these potential difficulties in the back of our mind, we proceeded to
investigate this interesting transformation.
O
HO 0 Me
Me
Me
12 Me
We initiated our study with conditions originally reported by Evans 119 (TiCl4, Et3N,
CH2CL2, -78 oC), and for which a modification had been reported by Danishefsky in his synthesis
of the macrocycle rapamycin.11 i The rapamycin synthesis relies on closure of a 31-membered
ring via an aldol reaction of an a-methoxy ketone with a vinylogous aldehyde (11% yield; with
TiC130i-Pr, Et3N, CH 2C 2, -78 °C). Application of these reaction conditions to our system only
resulted in the formation of presumed polymerization products. After attempting to generate the
desired ketone enolate with a variety of bases including n-BuLi and LDA, we began to see
promising reactivity with HMDS bases such as KHMDS. 120 Ultimately we found that through
118 For selected references relating to macrocyclic, intramolecular aldol reactions, see: (a) Rassu, G.; Auzzas, L.;
Pinna, L.; Zambrano, V.; Zanardi, F.; Battistini, L.; Gaetani, E.; Curti, C.; Casiraghi, G. J. Org. Chem. 2003, 68,
5881-5885. (b) Wei, C.-Q.; Zhao, G.; Jiang, X.-R.; Ding, Y. J. Chem. Soc., Perkin Trans. 1 1999, 3531-3536. (c)
Caddick, S.; Delisser, V. M.; Doyle, V. E.; Khan, S.; Avent, A. G.; Vile, S. Tetrahedron 1999, 55, 2737-2754. (d)
Katoh, T.; Nagata, Y.; Yoshino, T.; Nakatani, S.; Terashima, S. Tetrahedron 1997, 53, 10253-10270. (e) Meng, D.;
Bertinato, P.; Balog, A.; Su, D.-S.; Kamenecka, T.; Sorensen, E. J.; Danishefsky, S. J. J. Am. Chem. Soc. 1997, 119,
10073-10092. (f) Magnus, P.; Carter, R.; Davies, M.; Elliott, J.; Pitterna, T. Tetrahedron 1996, 52, 6283-6306. (g)
Toshima, K.; Ohta, K.; Yanagawa, K.; Kano, T.; Nakata, M.; Kinoshita, M.; Matsumura, S. J. Am. Chem. Soc. 1995,
117, 10825-10831. (h) Takao, K.; Ochiai, H.; Yoshida, K.; Hashizuka, T.; Koshimura, H.; Tadano, K.; Ogawa, S. J.
Org. Chem. 1995, 60, 8179-8193. (i) Hayward, C. M; Yohannes, D.; Danishefsky, S. J. J Am. Chem. Soc. 1993,
115, 9345-9346.
119 Evans, D. A.; Rieger, D. L.; Bilodeau, M. T.; Urpi, F. J. Am. Chem. Soc. 1991, 113, 1047-1049.
120 For a similar approach, see Danishefsky's synthesis of the Epothilones A and B; ref. 118e.
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the use of low temperature (-78 'C) and KHMDS, we were able to achieve this difficult bond
formation. The best results were obtained when we carried out the alcohol-protection on the
crude material from this aldol reaction; this strategy greatly eased the purification and we
isolated the desired product, 1, as a single diastereoisomer, in 19% yield over two steps (Scheme
2.24). To date, we have not found a satisfactory rationale to explain the apparent high
stereoselectivity of this reaction. Nevertheless, this unique intramolecular, macrocyclic aldol
reaction served as an ideal solution for the completion of our formal synthesis of a-cembra-
2,7,11 -triene-4,6-diol.
Scheme 2.24. Intramolecular, Macrocyclic Aldol Reaction: Completion of the Formal Synthesis.
O
Me Me t-BuPh2SiO Me
H 1. KHMDS, -78 C
2. t-BuPh 2SiCI Me
imidazole
Me 19% (two steps) 1 Me
C. Conclusion
In conclusion we completed a formal synthesis of a-cembra-2,7,11-triene-4,6-diol,
compound 1; the antepenultimate intermediate in Thomas' synthesis was constructed in 12 steps.
The construction of this diterpene in 14 steps is a significant improvement over the 21-step
process developed by Marshall and the 23 steps required by Thomas. This synthesis, starting
with famesyl acetate, made use of our nickel-catalyzed secondary-secondary cross-coupling
reaction, the powerful linking ability of alkynes, and an intramolecular macrocyclic aldol
reaction to construct the final 14-membered ring.
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D. Experimental
I. General
All reactions were carried out in oven-dried glassware under an atmosphere of argon.
N,N-Dimethylacetamide was purchased from Fluka (anhydrous), and THF, Et20, toluene and
CH2C12 were dried by passage over activated alumina. All other chemicals were purchased and
used without further purification.
High-resolution mass spectrometric measurements were performed on a Bruker Daltonics
APEXII 3 Tesla Fourier Transform Mass Spectrometer system.
Low-resolution mass spectrometric measurements were performed on an Agilent
LC/MSD-SL (ES+) LCMS system.
II. Formal Synthesis of 2,7,11-Cembratriene-4,6-diol
0
\\ Me OH0 MeMe Br
Me
Me
2
[CAS # 54795-59-4]. Prepared by a literature procedure. 116 Farnesyl acetate (20.0 g, 75.6
mmol) was taken up in THF (1700 mL) and cooled to 0 OC. To this solution was added water
(1500 mL) until the solution became cloudy. N-bromosuccinimide (14.8 g, 83.2 mmol) was
added portionwise over 1 h. The reaction was allowed to stir an additional hour at 0 oC, the THF
was then removed in vacuo at 5 'C and the resultant suspension was extracted with 20% Et20 in
hexanes (4 x 350 mL). The combined organic layers were washed with brine, dried over MgSO 4,
filtered and concentrated in vacuo to give a yellow oil. Purification via chromatography (10% --
20% Et20 in hexanes) gave 16.9 g (62%) of the desired bromohydrin 2 as a colorless oil.
'H NMR (CDC13, 300 MHz) 6 5.33 (tq, J= 6.9, 1.2 Hz, 1H), 5.17 (tq, J= 7.0, 1.1 Hz,
1H), 4.58 (d, J= 6.9 Hz, 2H), 3.95 (dd, J= 11.4, 1.8 Hz, 1H), 2.38-2.20 (m, 2H), 2.18-1.90 (m,
9H), 1.83-1.65 (m, 1H), 1.69 (s, 3H), 1.58 (s, 3H), 1.33 (s, 3H), 1.32 (s, 3H).
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[CAS # 5233-99-8]. Prepared by a literature procedure. 116 Bromohydrin 2 (16.9 g, 46.7
mmol) was taken up in anhydrous MeOH (360 mL) and was treated with K2C0 3 (16.1 g, 116.7
mmol). The suspension was stirred at room temperature for 2 h. The solvent was removed in
vacuo and the residue was taken up in Et20O (200 mL) and filtered through a plug of celite which
was washed with Et20O (500 mL). The combined Et20 fractions were then washed with brine,
dried over Na2SO 4, filtered and dried in vacuo to give 10.8 g (97%) of the desired epoxide 3 as a
colorless oil.
'H NMR (CDC13, 300 MHz) 6 5.39 (tq, J= 5.7, 1.2 Hz, 1H), 5.14 (tq, J= 6.3, 1.2 Hz,
1H), 4.12 (d, J= 6.3 Hz, 2H), 2.69 (t, J= 6.0 Hz, 1H), 2.16-1.98 (m, 6H), 1.66-1.54 (m, 9H),
1.28 (s, 3H), 1.24 (s, 3H).
O
Me
t-Bu O Me O
Me
Me
4
Epoxide 3 (10.8 g, 45.3 mmol) and dry CH2C12 (113 mL) were added to an oven-dried
round-bottomed flask under argon. After addition of NEt3 (25.3 mL, 181.2 mmol), the stirred
solution was cooled to 0 oC. Once chilled, pivaloyl chloride (11.2 mL, 90.6 mmol) was added
dropwise over 10 min via syringe. The ice bath was then removed and the reaction was allowed
to stir at room temperature for 3 h. The reaction was quenched by the addition of saturated
aqueous NH4Cl (120 mL), this solution was allowed to stir for 1 h. The layers were then
separated and the aqueous layer was washed with CH 2C 2 (3 x 75 mL). The combined organic
fractions were dried over Na2SO 4, filtered, and concentrated. Column chromatography (11%
Et20 in hexanes) gave 13.9 g (95%) of the desired pivaloate ester 4 as a colorless oil.
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'H NMR (CDC13 , 300 MHz) 6 5.31 (tq, J= 6.0, 1.0 Hz, 1H), 5.14 (tq, J= 7.0, 1.0 Hz,
1H), 4.56 (d, J = 7.0 Hz, 2H), 2.70, (t, J = 6.0 Hz, 1H), 2.19-2.03 (m, 6H), 1.69 (s, 3H), 1.69-
1.58 (m, 2H), 1.61 (s, 3H), 1.30 (s, 3H), 1.26 (s, 3H), 1.19 (s, 9H).
13C NMR (CDC13, 75 MHz) 8 178.8, 141.7, 134.7, 124.5, 118.9, 64.4, 61.5, 58.5, 39.6,
38.9, 36.5, 27.6, 27.5, 26.4, 25.1, 18.9, 16.7, 16.2.
IR (film) 2963, 2931, 2361, 2339, 2251, 1726, 1283, 1155, 916 cm-1.
LRMS (EI) calcd for C20H340 3 (M+) 322, found 322.
O
t-Bu ) 0
H
Me
Me
5
Pivaloate ester 4 (6.48 g, 20.0 mmol) was taken up in THF (120 mL) and H20 (25 mL),
and cooled to 0 oC. NalO4 (2.5 g, 11.5 mmol) and HIO4-2H 20 (5.0 g, 22.1 mmol) were then
added in one portion. The reaction was allowed to warm to room temperature and was stirred
another 30 min. The reaction was then quenched with 60 mL saturated aqueous NaHCO 3. The
solution was extracted with 1:1 EtOAc:hexanes (2 x 200 mL), washed with brine, dried over
Na2SO 4, filtered, and concentrated. Column chromatography (9% Et20 in hexanes) gave 5.06 g
(90%) of the desired aldehyde 5 as a colorless oil.
11H NMR (CDC13, 500 MHz) 6 9.72 (t, J= 2.0 Hz, 1H), 5.28 (tq, J= 7.0, 1.0 Hz, 1H),
5.10 (tq, J= 5.5, 1.0 Hz, 1H), 4.54 (dd, J= 7.0, 0.5 Hz, 2H), 2.51-2.47 (m, 2H), 2.29 (t, J= 7.5
Hz, 2H), 2.17-2.00 (m, 4H), 1.67 (s, 3H), 1.59 (s, 3H), 1.17 (s, 9H).
'
3C NMR (CDCl 3, 75 MHz) 8 202.8, 178.8, 141.5, 133.6, 124.9, 119.1, 61.5, 42.5, 39.4,
38.9, 32.0, 27.4, 26.3, 16.7, 16.3.
IR (film) 2973, 2934, 2718, 2361, 2339, 1726, 1480, 1282, 1154 cm -1.
LRMS (EI) calcd for C17H2 8 0 3 (M+) 280, found 280.
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Triisopropylacetylene (3.25 g, 17.8 mmol) was added to an oven-dried round-bottomed
flask under argon. To the flask was added 75 mL of dry THF via syringe. The solution was
cooled to -78 'C, with a dry ice/acetone bath, and treated with n-BuLi (11.1 mL, 17.8 mmol, 1.6
M in hexanes), and allowed to stir for 30 min. At this point aldehyde 5 (5.0 g, 17.8 mmol) in 25
mL THF at -78 'C was added via cannula. The reaction was allowed to stir at -78 'C for an
additional 30 min, at which point the dry ice/acetone bath was removed and the reaction was left
to warm to 0 oC and quenched with saturated aqueous NH4Cl (50 mL). The suspension was
extracted with EtOAc (3 x 75 mL). The combined organic fractions were washed with brine,
dried over MgSO 4, filtered, and concentrated. Column chromatography (9% Et20 in hexanes)
gave 7.88 g (95%) of the desired propargylic alcohol 12 as a colorless oil.
'H NMR (CDC13 , 300 MHz) 6 5.30 (tq, J= 6.6, 1.2 Hz, 1H), 5.16 (tq, J= 6.9, 1.2 Hz,
1H), 4.56 (d, J= 6.9 Hz, 2H), 4.36 (q, J= 6.0 Hz, 1H), 2.20-2.00 (m, 6H), 1.96 (d, J= 5.7 Hz,
1H), 1.86-1.74 (m, 2H), 1.68 (s, 3H), 1.61 (s, 3H), 1.18 (s, 9H), 1.07 (s, 21H).
13C NMR (CDC13, 75 MHz) 6 178.9, 141.6, 134.9, 124.9, 119.1, 108.9, 85.8, 62.9, 61.6,
39.6, 38.9, 36.3, 35.4, 27.4, 26.4, 18.8, 16.7, 16.1, 11.3.
IR (film) 3447, 2943, 2865, 2361, 2339, 2168, 1729, 1458, 1283, 1154 cm -1.
LRMS (ESI) calcd for C28H5oNaO3Si (M+Na+) 485, found 485
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Prepared from propargylic alcohol 12 (7.7 g, 16.6 mmol) and the representative
bromination procedure from Chapter 2, section 2. Column chromatography (3% Et20O in
hexanes) gave 7.85 g (9%) of the desired propargylic bromide 6 as a colorless oil.
'H NMR (CDCl 3, 300 MHz) 6 5.32 (tq, J= 6.9, 1.2 Hz, 1H), 5.16 (tq, J= 6.9, 1.2 Hz,
1H), 4.56 (d, J= 6.9 Hz, 2H), 4.55 (t, J = 6.6 Hz, 1H), 2.25-2.17 (m, 2H), 2.16-2.00 (m 6H), 1.70
(s, 3H), 1.60 (s, 3H), 1.19 (s, 9H), 1.07 (s, 21H).
13C NMR (CDC13, 75 MHz) 5 178.8, 141.7, 133.4, 125.7, 119.0, 106.0, 89.0, 61.5, 39.6,
38.9, 38.5, 37.4, 37.2, 27.4, 26.4, 18.8, 16.7, 16.2, 11.4.
IR (film) 3054, 2944, 2866, 2361, 2339, 1771, 1265, 1158, 740 cm -1.
LRMS (EI) calcd for C28H49BrO2 Si (M+) 524, found 524.
O SII TIPS
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In the air, a 100 mL round-bottomed flask was charged with NiClz2glyme (65.7 mg, 0.30
mmol) and terpyridine (69.9 mg, 0.30 mmol). The vial was purged with argon for 5 min, and
then DMA (60.0 mL) was added via syringe. The resulting opaque, green solution was stirred at
room temperature for 20 min, then isopropylzinc iodide (1.0 M in DMA; 9.0 mL, 9.0 mmol) was
added. The resulting dark-brown reaction mixture was stirred for 10 min at room temperature.
Next, the propargylic bromide 6 (1.57 g, 3.0 mmol) was added via syringe; the reaction mixture
became light, but darkened over several hours. The reaction was allowed to run for 16 h at room
temperature. Then, the excess organozinc reagent was quenched by the addition of EtOH (2.0
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mL), and the brown mixture was diluted with 100 mL t-BuOMe, this solution was washed 3
times with 50 mL of H2 0, once with brine, and then dried over MgSO 4. After filtration, the
solution was concentrated under reduced pressure and the resultant oil was purified by flash
chromatography (3% Et20O in hexanes) to provide 900 mg (61%) of the desired ester 7 as a
colorless oil.
'H NMR (CDC13, 500 MHz) 6 5.32 (tq, J= 6.9, 1.2 Hz, 1H), 5.13 (tq, J= 6.9, 1.2 Hz,
1H), 4.56 (d, J= 7.0 Hz, 2H), 2.27-2.17 (m, 2H), 2.14-2.03 (m, 5H), 1.69 (s, 3H), 1.69-1.62 (m,
1H), 1.59 (s, 3H), 1.51-1.47 (m, 2H), 1.19 (s, 9H), 1.04 (s, 21H), 0.98 (d, J= 6.5 Hz, 3H), 0.96
(d, J= 7.0 Hz, 3H).
13C NMR (CDCl 3, 75 MHz) 6 178.8, 141.9, 135.4, 124.3, 118.8, 110.9, 82.2, 61.6, 39.7,
39.6, 38.9, 38.7, 38.0, 31.8, 27.4, 26.5, 21.5, 18.9, 16.7, 16.7, 16.1, 11.6.
IR (film) 2942, 2865, 2361, 2339, 2168, 1732, 1463, 1283, 1153 cm-.
LRMS (ESI) calcd for C31H56NaO2Si (M+Na+) 511, found 511.
O
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Ester 7 (44.8 mg, 0.092 mmol) was added to an oven-dried round-bottomed flask under
argon. To the flask was added THF (1.5 mL) via syringe, followed by the addition of tetrabutyl
ammonium fluoride (92 pL, 0.092 mmol, 1.0 M solution in THF). The solution was heated at
reflux for 15 min, once cooled to room temperature, the reaction was quenched with saturated
aqueous NH4Cl (1.0 mL). The suspension was extracted with Et20 (3 x 5 mL). The combined
organic fractions were washed with brine, dried over MgSO 4, filtered, and concentrated. Column
chromatography (2% Et20 in hexanes) gave 30.0 mg (99%) of the desired alkyne 8 as a colorless
oil.
'H NMR (CDCl 3, 500 MHz) 6 5.32 (tq, J= 6.9, 1.2 Hz, 1H), 5.14 (tq, J= 6.9, 1.2 Hz,
1H), 4.56 (d, J= 7.0 Hz, 2H), 2.29-2.16 (m, 2H), 2.15-2.00 (m, 6H), 1.74-1.64 (m, 4H), 1.60 (s,
3H), 1.55-1.50 (m, 2H), 1.20 (s, 9H), 0.98 (d, J= 7.0 Hz, 3H), 0.96 (d, J= 6.5 Hz, 3H).
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13 C NMR (CDCI 3, 75 MHz) 6 178.9, 141.8, 135.1, 124.3, 118.9, 86.4, 70.4, 61.6, 39.7,
38.9, 38.2, 37.7, 31.4, 31.1, 27.4, 26.4, 21.2, 18.5, 16.7, 16.2.
IR (film) 3309, 2961, 2928, 2872, 2361, 2339, 1723, 1457, 1282, 1152 cm-1.
LRMS (EI) calcd for C22H360 2 (M+) 332, found 332.
0 OH
t-Bu Me Me
\Me Me
Me
Alkyne 8 (1.35 g, 4.07 mmol) was added to an oven-dried round-bottomed flask under
argon. To the flask was added THF (30 mL) via syringe. The solution was cooled to -78 'C, with
a dry ice/acetone bath, and treated with n-BuLi (2.54 mL, 4.07 mmol, 1.6 M in hexanes), and
allowed to stir for 30 min. At this point, acetaldehyde (1.2 mL, 20.3 mmol) was added via
syringe. The reaction was allowed to stir at -78 OC for an additional 30 min, at which point the
dry ice/acetone bath was removed and the reaction was left to warm to 0 oC and quenched with
saturated aqueous NH4Cl (30 mL). The suspension was extracted with EtOAc (3 x 75 mL). The
combined organic fractions were washed with brine, dried over MgSO 4, filtered, and
concentrated. Column chromatography (12% Et20O in hexanes) gave 930 mg (61%) of the desired
propargylic alcohol 9 as a clear colorless oil.
'H NMR (CDC13, 300 MHz) 1:1 mixture of diastereomers, 6 5.32 (tq, J= 6.9, 1.2 Hz,
2H), 5.14 (tq, J= 6.9, 1.2 Hz, 2H), 4.56 (d, J= 7.0 Hz, 4H), 4.57-4.49 (m, 2H), 2.12-1.95 (m,
14H), 1.78 (dd, J= 5.1, 2.1 Hz, 2H), 1.69 (s, 6H), 1.70-1.65 (m, 2H), 1.59 (s, 6H), 1.48 (q, J=
7.5 Hz, 4H), 1.44 (d, J= 6.6 Hz, 6H), 1.19 (s, 18H), 0.95 (d, J= 6.9 Hz, 6H), 0.92 (d, J= 6.6 Hz,
6H).
13C NMR (CDC13, 75 MHz) 1:1 mixture of diastereomers, 6 179.0, 178.9, 141.8, 141.8,
135.2, 134.6, 124.9, 124.3, 119.5, 119.0, 118.9, 96.6, 86.3, 84.8, 83.8, 61.6, 61.5, 58.8, 39.7,
39.6, 38.9, 38.8, 38.7, 38.3, 37.9, 37.7, 37.2, 36.8, 36.3, 33.3, 31.7, 31.5, 31.4, 31.1, 30.3, 27.4,
27.3, 26.5, 26.4, 25.2, 21.4, 21.3, 18.8, 18.6, 16.7, 16.7, 16.2, 16.1.
IR (film) 3429, 2963, 2928, 2873, 2361, 2339, 2206, 1727, 1675, 1427, 1284, 1157 cm-.
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LRMS (EI) calcd for C24H400 3 (M+) 376, found 376.
OH
HO OH Me
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THF (1 mL) was added to an oven-dried round-bottomed flask under argon. To the flask
was added LiA1H 4 (800 tL, 1.59 mmol, 2.0 M solution in THF). To this stirring solution was
added a solution of propargylic alcohol 9 (200 mg, 0.53 mmol) in THF (5.0 mL) dropwise via
syringe. This mixture was heated at reflux for 3 h. After cooling to room temperature the reaction
was further cooled to 0 oC, and quenched by dropwise addition of saturated aqueous Rochell's
salt (1.5 mL). The resultant mixture was filtered and the precipitate was washed with Et20 (15
mL), the filtrate was concentrated. Column chromatography (50% EtOAc in hexanes) gave 148.0
mg (95%) of the desired allylic alcohol 10 as a clear colorless oil.
IH NMR (CDC13, 500 MHz) 1:1 mixture of diastereomers 6 5.45-5.29 (m, 6H), 5.08-
5.03 (m, 2H), 4.25 (quintet, J= 6.5 Hz, 2H), 4.12 (d, J= 7.0 Hz, 4H), 2.13-2.05 (m, 4H), 2.04-
1.99 (m, 4H), 1.98-1.77 (m, 8H), 1.73-1.66 (m, 2H), 1.64 (s, 6H), 1.58-1.45 (m, 4H), 1.55 (s,
6H), 1.24 (dd, J= 6.5, 2.5 Hz, 6H), 0.85-0.77 (m, 12H).
13C NMR (CDC13, 75 MHz) 1:1 mixture of diastereomers 6 139.6, 135.9, 135.8, 135.6,
132.7, 132.7, 132.7, 124.0, 123.9, 123.8, 69.3, 59.6, 59.5, 48.3, 48.2, 39.7, 39.7, 37.7, 37.6, 31.9,
31.8, 30.5, 30.3, 26.3, 26.2, 23.9, 23.8, 20.9, 20.8, 19.2, 19.1, 16.4, 16.2, 16.1.
IR (film) 3333, 2960, 2928, 2871, 2240, 1742, 1667, 1450, 1384, 1367, 974 cm -1.
LRMS (EI) calcd for C1 9H340 2 (M+) 294, found 294.
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Allylic alcohol 10 (260 mg, 0.89 mmol) was added to an oven-dried round-bottomed
flask under argon. To the flask was added CH2C12 (6 mL) and MeCN (600 jtL) via syringe,
followed by N-methyl morpholine oxide (310 mg, 2.64 mmol) and oven-dried 4 A molecular
sieves (430 mg). To this stirring solution was next added tetrapropylammonium perruthenate
(31.0 mg, 0.088 mmol). After 30 min the reaction was diluted with CH 2C12 (25 mL) and filtered
through a plug of silica gel, eluting with EtOAc (200 mL). Upon concentration, the resultant oil
was purified via column chromatography (20% EtOAc in hexanes) to give 250.7 mg (97%) of
the desired aldehyde 11 as a clear colorless oil.
'H NMR (CDCl3, 300 MHz) 8 9.99 (d, J= 8.1 Hz, 1H), 6.58 (dd, J= 15.9, 9.6 Hz, 1H),
6.01 (dd, J= 15.9, 0.6 Hz, 1H), 5.87 (dq, J= 7.8, 1.2 Hz, 1H), 5.08-5.05 (m, 1H), 2.26 (s, 3H),
2.25-2.19 (m, 4H), 2.17 (d, J=1.5 Hz, 3H), 1.99-1.60 (m, 10H), 1.58 (s, 3H), 1.44-1.32 (m, 1H),
0.89 (d, J= 6.6 Hz, 3H), 0.85 (d, J= 6.9 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 198.7, 191.5, 163.9, 150.9, 136.4, 132.6, 127.6, 123.1,
49.1, 40.7, 37.7, 31.9, 29.9, 27.3, 25.8, 20.9, 19.4, 17.4, 16.3.
IR (film) 3055, 2862, 2360, 2336, 1697, 1671, 1422, 1368, 1265, 738 cm -1.
LRMS (EI) calcd for C1 9H300 2 (M+ ) 290, found 290.
258
(t-Bu)Ph2SiO Me
Me
Me
1
Aldehyde 11 (40.0 mg, 0.137 mmol) was added to an oven-dried round-bottomed flask
and placed under argon. To the flask was added anhydrous THF (137 mL), this solution was
cooled to -78 'C and treated with KHMDS (1.65 mL of 0.5 M solution in toluene, 0.413 mmol).
The reaction was allowed to stir for 6 h at -78 OC. The reaction was then quenched via filtration
though a short plug of silica gel, which was washed with Et20 (500 mL). The filtrate was
concentrated and filtered through another short plug of silica, eluting with 2:1 hexanes:EtOAc
(200 mL), this solution was then concentrated. The crude aldol (11.2 mg) was then taken up in
dry CH2C12 (1.5 mL), under argon. To this solution was added imidazole (7.9 mg, 0.116 mmol)
and t-BuPh 2SiCl (31.8 mg, 0.116 mmol) at room temperature. The reaction was allowed to stir
for 12 h at which point it was quenched with saturated aqueous NH 4C1 solution and extracted
with CH2C12 (3 x 5 mL), the combined organic layers were dried over dried over MgSO 4,
filtered, and concentrated. Column chromatography (3% EtOAc in hexanes) gave 14.8 mg (19%
over two steps) of racemic 7,11 -Dimethyl-4-isopropyl- 13-(tert-butyl-
diphenylsilyloxy)cyclotetradeca-2,7,11 
-triene- -one 1 as a clear oil.
Synthetic:
'H NMR (CDCl 3, 500 MHz) 6 7.69-7.64 (m, 4H), 7.42-7.32 (m, 6H), 6.47 (dd, J= 15.5,
10.0 Hz, 1H), 5.74 (d, J= 15.9 Hz, 1H), 5.06 (d, J= 9.5 Hz, 1H), 4.82 (dt, J= 8.5, 4.5 Hz, 1H),
4.67 (m, 1H), 3.00 (dd, J= 15.5, 10.5 Hz, 1H), 2.60 (dd, J= 15.5, 4.5 Hz, 1H), 2.02-1.84 (m,
4H), 1.74-1.66 (m, 2H), 1.59-1.52 (m, 4H), 1.50 (s, 3H), 1.45-1.33 (m, 2H), 1.03-1.02 (m, 10H),
0.85 (d, J= 6.5 Hz, 3H), 0.81 (d, J= 6.5 Hz, 3H).
'
3C NMR (CDC13, 75 MHz) 6 198.4, 151.1, 137.5, 136.1, 136.0, 134.5, 134.3, 133.7,
131.9, 129.8, 129.7, 127.8, 127.5, 127.3, 125.7, 67.6, 50.3, 48.2, 38.6, 37.6, 33.1, 27.7, 27.1,
24.0, 20.6, 19.9, 19.4, 16.3, 15.6.
IR (film) 3054, 2960, 2929, 2857, 2360, 2306, 1680, 1658, 1620, 1428, 1265, 1111,
1058, 823, 740, 705 cm1.
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MS (EI) calcd for C35H480 2 Si (M+Na+) 551.3, found 551.3.
Literature:1 15a
'H NMR (CDCl 3, 300 MHz) 6 7.70 (m, 4H), 7.38 (m, 6H), 6.50 (dd, J= 15, 9 Hz, 1H),
5.75 (d, J= 15, 1H), 5.08 (d, J= 8, 1H), 4.80 (m, 1H), 4.68 (m, 1H), 3.12 (dd, J= 15, 10 Hz,
1H), 2.60 (dd, J= 15, 4 Hz, 1H), 2.1-1.4 (m, 10H), 1.6 (s, 3H), 1.5 (s, 3H), 1.00 (s, 9H), 0.86 (d,
J= 6 Hz, 3H), 0.82 (d, J= 6 Hz, 3H).
13 C NMR Not Reported.
IR (film) 1687, 1662, 1621, 1428, 1111, 1057, 823, 740, 703 cm-1.
HRMS (EI) calcd for C35H480 2Si (M+) 528.3423, found 528.3414.
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E. IH NMR Spectra of Selected Compounds
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Section 2.5
Nickel-Catalyzed Asymmetric Cross-Couplings of Racemic
Propargylic Halides with Arylzinc Reagents
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A. Introduction
In Chapter 2, Section 2.2 we discussed the development of the first secondary-secondary
cross-coupling reaction, namely, the nickel-catalyzed cross-coupling of secondary propargylic
halides with secondary alkylzinc iodide reagents. Despite achieving only modest success in our
attempts to develop an asymmetric alkylation of propargylic halides (Chapter 2, Section 2.1), we
were still interested in exploring the possibilities of this class of electrophiles. Furthermore, as
we had now seen that the apparent rate of transmetalation was dependent on the nature of the
organometallic reagent, we were quite curious about not only the transmetalation rate with aryl
nucleophiles, but also whether this would have an exploitable impact on the possibility to
develop an asymmetric arylation. At the outset of this work there had been no reports of
asymmetric Negishi arylation reactions of alkyl electrophiles.
B. Results and Discussion
Encouraged by the modest levels of success obtained in the alkylation chemistry and by
the work of others in the group with Pybox ligands, we undertook an exploration of reaction
conditions towards the development of the arylation reaction illustrated in eq 2.14, where the
electrophile was a TMS-protected secondary propargylic bromide and the initial nucleophile was
ZnPh2-
TMS nickel TMS.0
T RBr ZnPh2  p yo RS Ph (2.14)
R R
R R
racemic goal: high yield,
high ee
The first attempt at this cross-coupling was performed on a propargylic bromide with
diphenylzinc (1.5 equiv) using 10% NiC12-glyme and 13% (i-Pr)-Pybox in DMA at room
temperature, as illustrated in eq 2.15. We were quite pleased to obtain 31% of the desired
product, in a quite promising level of enantioselectivity (60% ee).
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TMS 10% NiCl2.glyme
S ZnPh 13% (i-Pr)-PyboxBuBr ZnPh 2equiv
n-Bu 1.5 equiv 0.1 M, DMA, r.t.
TMS
Ph
n-Bu
31% yield
60% ee
In our initial studies we found that a solvent mixture (3:1 toluene:THF) appeared to give
the best results; the THF was thought to be required, in part, to solublize the ZnPh2, which at this
stage of the project was purchased from Aldrich (92% purity). A broad ligand survey revealed
that a number of Pybox ligands imparted a good level of enantioselectivity to this transformation.
Table 2.9. Initial Pybox Screening for the Asymmetric Negishi Arylation of Propargylic
Bromides.
TMS
-Br
n-Bu
10% NiCl 2 .glyme TMS
13% (R)-Pybox PhZnPh 2
1.5 equiv 0.1 M, 3:1 DMA:THF Bu
r.t.
entry Pybox, R = yield (%)a ee (%)b entry Pybox, oxazoline = yield (%)a ee (%)b
1 l-Me 40 71 O Ph
2 -i-Pr 64 75 1N "'Me
Me
3 -s-Bu 63 79
H
4 2-i-Bu 60 77
12 42 75
5 -t-Bu 62 79 N
6 -Bn 58 75
7 N-OMe 19 50 13 \ 52 15
N-OMe
Me
8 5 0
OMe
Me
9 66 80
OTBS
Me
10 4--Me 16 56
OH
a Yield was determined by GC versus an internal standard. b Determined by Chiral GC.
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(2.15)
7-Me
Me
Due in part to its commercial availability, a considerable amount of effort was devoted
towards further optimization of this reaction with (i-Pr)-Pybox as the ligand. We observed that
the efficiency of this reaction was highly dependent on the quality of the Ph2Zn, and that
different batches of material from Aldrich had dramatically different reactivity. At times, the
material from Aldrich failed to produce any cross-coupling product. This problem was rectified
by changing the source of the Ph2Zn to Strem (99% purity).
Despite finding a solution to our reproducibility problems, the project was still plagued
by low yields and ee's in the 70's. We thought, due to the positive effect which was observed in
our earlier alkylation work, that a survey of additives may be worth examining. To our delight a
number of additives did have a positive impact on this coupling reaction. The addition of 1.0
equiv of InBr 3 or La(OTf)3 reduced the quantity of nucleophile homocoupling and appeared to
have a positive impact on the enantioselectivity (Table 2.10).121 In further studies we found that
by using only 50% La(OTf) 3 we could not only see improved selectivity (74% -- 83% ee), but
that the efficiency of the reaction improved dramatically (34% --+ 94% ee). Extensive screening
of other lanthanide-based additives furnished no improvement over this result.
Table 2.10. Effect of Additives on the Asymmetric Negishi Arylation of Propargylic Bromides.
5% NiCl2.glyme
TMS 6.5% (S)-(s-Bu)-Pybox TMS
Br ZnPh2  X equiv additive Ph
n-Bu 1.5 equiv 0.1 M, glyme n-Bur.t.
entry additive X equiv yield (%)a ee (%)b
1 none N/A 27 74
2 La(OTf)3  0.2 86 84
3 La(OTf)3  0.5 94 83
4 La(OTf) 3  0.7 88 83
5 La(OTf)3  1.0 45 82
6 InBr3  0.5 71 76
7 InBr3  1.0 56 81
8 InBr3  1.5 1 n.d.
a Yield was determined by GC versus an internal standard.
b Determined by chiral GC.
121 It is worth noting that independent synthesis of InPh3 showed that this reagent does not cross-couple efficiently
under these reaction conditions.
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After thorough screening of lanthanide additives, the best result obtained while using (s-
Bu)-Pybox was at -20 'C in glyme; we could obtain 90% ee with 14% yield. At this stage, we
thought that our reaction conditions may have changed enough that it would make sense to
reexamine the ligands from Table 2.9, as we may have unwisely been optimizing a local
maximum and our new reaction conditions may work better with an alternative ligand. To our
delight, this turned out to be true, and we soon found that the use of indanyl pybox, L6, at 0 OC
gave the desired product in 71% yield and 90% ee (eq 2.16). Furthermore, it soon became
apparent that the La(OTf) 3 additive was no longer required.
TMS 5% NiCI2-glyme TMS H - 0 H6.5% (-)-L6 h1
Br ZnPh 2  . P- N N (2.16)
n-Bu 1.5 equiv 0.1 M, glyme, C n-Bu H H
racemic
71% yield (-)-L6
90% ee
Shortly after making this discovery, the reaction conditions were further optimized,
leading to an improvement in the chemical yield and selectivity (eq 2.17).
TMS 7.5% NiCI2 .glyme TMS
Br ZnPh2  9.8% (-)-L6 Ph (2.17)
n-Bu 1.4 equiv 0.2 M, glyme, -20 C n-Bu
racemic
80% yield
91% ee
Unfortunately, diarylzinc reagents are not widely available and as we were interested in
the development of a reaction with a broad scope, we realized we needed reliable access to
functionalized diarylzinc reagents. Control experiments suggested our reaction was not tolerant
of stoichiometric magnesium or lithium halide salts. Indeed, attempts to generate diarylzinc
reagents via transmetallation of aryl-Grignard or aryllithium reagents failed to produce desirable
results in the coupling reaction. Careful trituration and removal of magnesium halide salts after
transmetallation did produce reactive diarylzinc reagents (see Scheme 2.25).122 However, this
122 For a representitive procedure for the preparation of diaryl zinc reagents, with the removal of magnesium halide
salts, see: Lee, K.; Brown, K. M.; Hird, A. W.; Hoveyda, A. H. J. Am. Chem. Soc. 2006, 128, 7182-7184.
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process was not attractive experimentally and we desired a more straightforward and
operationally simple route to our arylzinc reagents.
Scheme 2.25. Transmetalation Reactions to Synthesize ZnAr2.
In situ preparation from aryl lithium reagents
1) 0.75 equiv ZnCl2 TMS
PhLi 'T
2) 3.0% NiCI2-glyme1.5 equiv 3.9% (-)-L6 Me
TMS <10% yield
Br 65% ee
racemic
(1.0 equiv) Me
glyme, -20 oC
Preparation followed by isolation
0.50 equiv. ZnCl2
THFIEt 20O
PhMgBr ,then, dioxane
1.0 equiv followed by filtration
of magnesium salts
In situ preparation from aryl magnesium reagents
1) 0.75 equiv ZnCI 2 TMS
PhMgBr THF
2) 3.0% NiCI2 glyme1.5 equiv 3.9% (-)-L6 Me
TMS <10% yield
Br 70% ee
racemic
(1.0 equiv) Me
glyme, -20 oC
Isolated solid performs
Ph 2Zn identically to commercial
reagent
In 2002, Bolm and coworkers reported a transmetallation from boron to zinc, generating
arylzinc reagents from boronic acids and diethylzinc; our initial attempts with this protocol were
ineffective in our coupling (eq 2.18).123,124 The major product under these reaction conditions
was that derived from ethyl-transfer from the excess ZnEt2. Gratifyingly, modification of this
procedure (eq 2.19) allowed us to successfully generate arylzinc reagents in situ that performed
quite well in this cross-coupling reaction.
123 (a) Bolm, C.; Rudolph, J. J. Am. Chem. Soc. 2002, 124, 14850-14851. (b) Schmidt, F.; Stemmler, R. T.; Rudolph,
J.; Bolm, C. Chem. Soc. Rev. 2006, 35, 454-470.
124 For a discussion of boron-to-zinc transmetalation, see: (ca) Jimeno, C.; Sayalero, S.; Fjermestad, T.; Colet, G.;
Maseras, F.; Pericas, M. A. Angew. Chem., Int. Ed. 2008, 47, 1098-1101.
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1) 6.0 equiv. Et 2Zn TMS
toluene
PhB(OH) 2  toluene
2) 3.0% NiCI2 .glyme (2.18)
2.0 equiv 3.9% (-)-L6 Me
TMS <5% yield
Br 73% ee
racemic
(1.0 equiv) Me
glyme, -20 0C
1) 2.8 equiv. Et 2Zn TMS
glyme
PhB(OH) 2  glyme
2) 3.0% NiCI2 glyme (2.19)2.0 equiv 3.9% (-)-L6 Me
TMS 90% yield
Br 92% ee
racemic
(1.0 equiv) Me
glyme, -20 0C
With optimized conditions (eq 2.19) in hand, we set out to establish the scope of this
cross-coupling reaction. Beginning with trimethylsilyl-protected propargylic bromides, with
which the optimization had been carried out, we were pleased to discover that these propargylic
bromides undergo couplings with a range of arylzinc reagents in high ee (Table 2.11).
Unfunctionalized arylzinc reagents couple efficiently (entries 1 and 2). A protected aryl diol
couples in good yield, regardless of the size of the alkyl group on the electrophile (entries 3 and
4). Coupling of ortho-substituted nucleophiles is possible in very good ee, but with only modest
efficiency (entry 5).125 Functionalization of the electrophile is also well tolerated, as are alkyl
ethers and meta-substitution on the nucleophile (entries 6 and 7).
125 We were unsuccessful in our attempts to transmetalate o-tolylboronic acid.
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Table 2.11. Asymmetric Cross-Couplings of TMS-Protected Propargylic Bromides with
Arylzinc Reagents.
TMS. 3.0% NiCl2 glyme TMSTMS3.9% (-)-L6 TMS
Br ArZnEt 3.9% ()6 Ar
glyme, -20 T
alkyl 2.0 equiv alkyl
racemic
entry alkyl arylzinc reagent yield (%)a ee (%)b
1 n-Bu - Me 92 93
2 n-Bu 70C 93
3 Me - 75 94
4 i-Bu -0 71 93
5 n-Bu 39 92
MeO
6 OEt 
Ot-Bu
7 79 94
Et OMe
a Isolated yield, average of two reactions. b Determined by HPLC or GC.
c 3.0 equiv ArZnEt used.
Trimethylsilyl-protected alkynes are not unique in their ability to participate in this
coupling reaction. Other common silyl-based protecting group may also be used; for example,
(dimethyl)phenylsilyl- and TIPS-protected propargylic bromides react quite effectively in this
coupling under the standard conditions (eqs 2.20 and 2.21).
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Ph(Me) 2Si EtZn F
racemic 2.0 equiv
3.0% NiCI2 .glyme F
3.9% (-)-L6 Ph(Me)2 Si e~
glyme, -20 °C
88% yield
88% ee
TIPS
Bracem
racemic Me
EtZn' 
t-B u
2.0 equiv
3.0% NiCI2 glyme
3.9% (-)-L6
glyme, -20 °C
TIPS t-Bu
81% yield Me
93% ee
Not only propargylic bromides, but also chlorides, undergo cross-coupling under our
standard conditions (eq 2.22). Although the yield is somewhat lower, the ee, not surprisingly, is
essentially identical to that observed for the reaction of the corresponding bromide.
3.0% NiCI2 .glymeTMS 3.9% (-)-L6
CI Ph-ZnEt ,
n-Bu 2.0 equiv glyme, -20 *C
racemic
TMS
N Ph
n-Bu
61% yield
91% ee
Gratifyingly, these reaction conditions can also be applied to a broad spectrum of
differentially alkyl substituted propargylic bromides, still resulting in exclusive formation of
enantioenriched alkynes (Table 2.12). A full range of alkyl substituted propargylic bromides
readily participate in this asymmetric coupling reaction; the alkyl substituent can range in size
from methyl to tert-butyl (entries 1-5).126 Phenyl-substituted propargylic bromides also couple
in high yield and ee (entry 6).
126 Note: Under our standard conditions, (a) a cross-coupling between the propargylic bromide in Entry 3, Table 2.11
and the zinc reagent derived from p-trifluoromethylphenyl boronic proceeded in 31% isolated yield and 86% ee.
Personal correspondence with Prof. C. Bolm and Dr. J. Rudolph leads us to believe that the transmetalation is the
problematic step. (b) All attempts at vinylations have been unsuccessful thus far.
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(2.20)
(2.21)
(2.22)
Table 2.12. Asymmetric Cross-Couplings of Propargylic Bromides with Arylzinc Reagents.
R
> Br
alkyl
racemic
ArZnEt
2.0 equiv
3.0% NiCl2-glyme
3.9% (-)-L6
glyme, -20 0C
R
Ar
alkyl
entry propargylic bromide arylzinc reagent yield (%)a ee (%)b
1 Me Br - 81 88
Me
2 Me Br - N' M e  78c 84
Me
3 Me - Br -OMe 76 91
Me
4Br +OMe 63 89
Me Me
5 Me r - Me  81 92
CI
Me
a Isolated yield, average of two reactions. b Determined by HPLC or GC.
c 3.0 equiv ArZnEt used.
In 2007, Wright and Anderson reported a number of new, highly efficient ligands for
dihydrofolate reductase (DHFR) from Cryptosporidium hominis and Toxoplasma gondii, two
apicomplexan parasitic protozoa responsible for wasting disease, neonatal death and cerebral
inflammation. 127 The most biologically active of these new compounds was 13 (Scheme 2.26).
127 Pelphrey, P. M.; Popov, V. M.; Joska, T. M.; Beierlein, J. M.; Bolstad, E. S. D.; Fillingham, Y. A.; Wright, D. L.;
Anderson, A. C. J. Med. Chem. 2007, 50, 940-950.
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Scheme 2.26. Novel Antibiotics Developed by Wright and Anderson.
NH2
NOMe
H2N NOMe
OMe
Trimethoprim
used as an antibacterial
agent since the 1960's
effective for only small
subset of species of DHFR
Me
NH2  OMe
N'N OMe
H2 N N Me OMe
Inhibitory Potency
IC50 = 14 pIM Cryptosporidium hominis
IC50 = 8 IpM Toxoplasma gondii
Modeling and SAR development
Inhibitory Potency
IC50 = 0.038 pM Cryptosporidium hominis
IC50 = 0.0014 jM Toxoplasma gondii
propargyl-based linker has a dramatic impact on potency
Compound 14 was an intermediate en route to 13 and is clearly accessible in short order
via the method just described. Originally, 14 was prepared in 5 steps (22% yield), in which the
stereochemistry was installed through use of Evans stoichiometric chiral-auxiliary chemistry. It
is now possible to generate 14 in two steps 128 (63% yield) in a catalytic, enantioselective fashion
(Scheme 2.27). It is also worth noting that this cross-coupling scales up well and can be easily
run on a gram scale.
128 This synthesis begins with commercially available 4-(trimethylsilyl)but-3-yn-2-ol.
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Scheme 2.27. Improved Synthesis of a Dihydrofolate Reductase Inhibition Ligand.
Me3.0% NiCI2 -glyme 1. LHMDS, Mel Me
3.9% (-)-L6 Me 2. DIBAL-H Me
Me EtZnAr; 3. CBr 4 , PPh 3
Br then K2 C0 3  OMe 4. Mg/ O,,N OMe
TMS 68% 14 OMe 25%, O 0 OM e
racemic 93%ee OMe 90% OMe
5.0 mmol scale NH2(1.03 g)
Pd(PPh3)2C12, CulI
H2N'N Me
Me
NH2  OMe
OMe
H2N N Me 13 OMe
Allene formation
As was discussed in Chapter 2, Section 2, transition metal-catalyzed cross-coupling
reactions of propargylic electrophiles with organometallic reagents typically provide the allene,
rather than the alkyne, as the predominant product.94 In our studies of this asymmetric arylation,
we once again found conditions that favor formation of allenic products over propargylic ones.
When applying our standard conditions to propargylic halides, in which the alkyne is substituted
with an electron-withdrawing substituent, such as an ester, we isolated only an allene (eq 2.23).
Interestingly, this allene was formed in 47% ee. 129 To date, attempts to improve the observed
selectivity have not been fruitful. 130 Also, the arylation regioselectivity has the same ligand
dependence as was observed for our asymmetric alkylation: nickel-catalyzed arylations of
propargylic halides lead to formation of allenes when a bidentate ligand is used. Due in part to
time constraints, a more thorough study of this reactivity was not performed.
129 Absolute configuration of the product has not been determined.
130 Koyel Bhattacharyya, an undergraduate researcher in our lab, carried out the studies based on this initial result.
Improving the enantioselectivity of this transformation has proven difficult.
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EtO2C 7.5% NiCl2-glyme Ph
Br Ph2Zn 9.8% L6 E EtO2C *B n-Bu (2.23)
n-Bu 1.5 equiv glyme, r.t.
racemic 90% yield47% ee
C. Conclusion
In this section, we have described the development of the first catalytic asymmetric cross-
couplings of secondary propargylic bromides. Furthermore this method represents the first
example of an asymmetric Negishi-type arylation of an alkyl electrophile. Importantly,
transmetalation from readily available, and stable, arylboronic acids allows easy and
straightforward preparation of the mixed arylzinc reagents used in this coupling. This method,
allows access to a wide range of differently substituted, enantioenriched alkynes from easily
prepared racemic propargylic halides.
286
D. Further Developments
This section highlights some of the recent progress made within the Fu group on a variety
of arylation reactions. Specifically it includes a description of nickel-catalyzed Negishi, Suzuki,
Hiyama and Kumada arylation reactions.
Negishi Coupling Reaction
In 2009, Pam Lundin and Jorge Esquivias published the first catalytic, asymmetric
method for the cross-coupling of arylzinc reagents with a-bromoketones (Scheme 2.28).131 They
found that through use of the Pybox ligand L14, high yields and enantioselectivities could be
obtained in the coupling of arylzinc iodides and a-bromoaryl ketones. Across the spectrum, the
level of enantioselectivity observed for this process was exceptionally high and only ortho-
substitution on the electrophile caused a slight decrease.
Scheme 2.28. The First Catalytic Asymmetric Cross-Coupling of Arylzinc Reagents with a-
Bromoketones.
5% NiCl2 .glyme
lZn-Ar
2  13% (+)-L14
glyme/THF, -30 °C
Arl"KR
Ar2
18 examples;
71-93% yield
72-96% ee
o N_ 0Phitie N N _ Ph
OMe MeO
(+)-L14
O Et O O O
Me Me oMe MeO Me
"0 MeO 0
NMe 2
88% yield 85% yield 79% yield 90% yield 76% yield96% ee 93% ee 75% ee 96% ee 95% ee
131 Lundin, P. M.; Esquivias, J.; Fu, G. C. Angew. Chem., Int. Ed. 2009, 48, 154-156.
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0
Arl R
Br
racemic
Suzuki Coupling Reaction
An important development in the cross-coupling of secondary alkyl electrophiles came in
2006, when Dr. Francisco Gonzilez-Bobes developed a set of reaction conditions' 32 which
overcame some of the limitations of Dr. Zhou's initial report.79 In a move away from more
traditional sp 2-hybridized nitrogen-based ligands, Dr. Gonzilez-Bobes found that amino alcohols
could serve as excellent ligands in a nickel-catalyzed Suzuki reaction of unactivated alkyl halides
and boronic acids. Orthogonal sets of reaction conditions were developed for the coupling of
bromide and iodides (Scheme 2.29) and that of chlorides (Scheme 2.30). These reaction
conditions were much more tolerant with respect to the steric hindrance about the alkyl halide
and thus were able to not only efficiently couple larger cyclic electrophiles, but also a variety of
acyclic electrophiles.
Scheme 2.29. Nil2/trans-2-Aminocyclohexanol-Catalyzed Suzuki Cross-Couplings of Secondary
Alkyl Bromides and Iodides.
60
Ralkyl-X (HO)2B-Ar
X = Br, I
Me
68%
77%
6% Nil2
% trans-2-aminocyclohexanol
NaHMDS
i-PrOH, 60 C
Ralkyl-Ar
15 examples;
66-92% yield
Ts-N / t-Bu
66%
Me -
Ph 7
73%
HO NH 2
trans-2-aminocyclohexanol
\/ Me
92%
Me
Ph-\ OMe
85%
132 Gonzilez-Bobes, F.; Fu, G. C. J. Am. Chem. Soc. 2006, 128, 5360-5361.
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Scheme 2.30. NiC12"glyme/Prolinol-Catalyzed Suzuki Cross-Couplings of Secondary Alkyl
Chlorides.
6% NiCI2 .glyme
12% prolinol
Ralkyl-X (HO)2B-Ar 1 Ralkyl-Ar N OKHMDS H H
X = C i-PrOH, 60 5 examples; prolinol
46-84% yield
O-Q lO MeMe I& Me
84% 80% 74%
Hiyama Coupling Reaction
Just as Dr. Powell's Hiyama81 and Stille82 cross-coupling reactions built off the success of
Dr. Zhou's Suzuki reaction, the development of second generation arylation reactions had their
roots in Dr. Gonzilez-Bobes' Ni/amino alcohol Suzuki arylation reaction. The discovery that
amino alcohols could serve as ligands in cross-coupling reactions was exciting for two main
reasons. The first was that a large number of these compounds are commercially available and/or
easily prepared. The second, and more important reason, is that although sp2-hybridized
nitrogen-based ligands had proved their utility in a number of coupling reactions, these same
reactions were inefficient when the steric demand immediately adjacent to the nitrogen was
increased. This clearly posed a significant impediment to the development of asymmetric
arylation reactions.
As the group's primary successes in developing asymmetric cross-coupling reactions had
required the use of activated electrophiles; en route to developing an asymmetric Hiyama
arylation reaction, Neil Strotman and Stefan Sommer developed conditions under which
activated electrophiles coupled efficiently with trifluorosilicon reagents mediated by an amino
alcohol, norephedrine (Scheme 2.3 1).133 This arylation reaction displayed an impressively broad
electrophile scope, allowing for the coupling of not only unactivated, cyclic and acyclic
electrophiles, but also for an array of activated ones. a-Bromoketones, esters, amides,
133 Strotman, N. A.; Sommer, S.; Fu, G. C. Angew. Chem., Int. Ed. 2007, 46, 3556-3558.
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phosphonates, nitriles and allylic chlorides all funished good yields of the desired arylated
products.
Scheme 2.31. Hiyama Reactions of Activated and Unactivated Secondary Halides Catalyzed by
a Nickel/Norephedrine Complex.
10% NiCI2-glyme
15% norephedrine Ph Me
Ralkyl-X F3Si-Ar Ralkyl-Ar
12% LiHMDS, 8% H20 HO NH2
X = Br, I, Cl DMA, 60 0C 20 examples; norephedrine
59-89% yield
F MeO Me \ OMe Cbz-N 9-
OMe
59% 86% 76% 82%
SMe NC Me 0 n-Pr n-Pr
t-BuO __ Me Me (EtO)2 PY M e  0
82% 76% 60% 76%
Dr. Strotman continued his work in the area of Hiyama chemistry with the development
of an asymmetric arylation of ca-bromoesters (Scheme 2.32). Low levels of enantioselectivity
were observed in coupling reactions using trifluorosilanes and amino alcohol ligands, but this
was resolved by moving to trimethoxysilanes and diamine ligands. Early into this work it
became clear that there was a requirement of a very sterically demanding ester in order to obtain
good levels of enantioselectivity. After exploration of various bulky esters, it was found that a
BHT-ester proved best. Upon Dr. Stroman's departure, Xing Dai worked to finalize the reaction
conditions and explored the scope of this transformation. 134 For a series of a-bromo BHT-esters,
the yield and selectivity for phenylation was good to excellent. Unfortunately, a large number of
functionalized trimethoxyaryl silanes either did not couple efficiently, or the newly generated
chiral center was racemized under the basic reaction conditions. Dr. Dai did accomplish
asymmetric vinylations under these reaction conditions, representing another first for the group.
134 Dai, X.; Strotman, N. A.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 3302-3303.
290
Scheme 2.32. Catalytic Asymmetric Hiyama Cross-Couplings of Racemic a-Bromoesters.
O0
BHTO_ R (MeO)3Si-Rsp2
Br
racemic
10% NiCI2 .glyme
12% (S,S)-N,N'-dimethyl-
1,2-diphenyldiamine
2.0 equiv TBAT
dioxane, r.t.
BHT = 2,6-di-t-butyl-4-methylphenol
TBAT = [F2 SiPh3 ]E [NBu4]
0
BHTO IyR
Rsp2
17 examples;
64-84% yield
75-99% ee
Ph Ph
MeHN NHMe
(S,S)-N,N'-dimethyl-
1,2-diphenyldiamine
O0
BHTO Me
80% yield
99% ee
78% yield
80% ee
O0
BHTO Me
74% yield
89% ee
0
BHTO ' Me
66% yield
93% ee
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72% yield
92% ee
E. Experimental
I. General
All reactions were carried out in oven-dried glassware under an atmosphere of argon. All
chemicals, including NiC12 -glyme (Strem), ligand L6 (Aldrich; Strem), ZnEt2 (Strem), and
glyme (Fluka), were purchased and used without further purification.
II. Preparation of Substrates
These procedures have not been optimized.
Synthesis of Propargylic Alcohols (representative procedure): A 100 mL flask was
charged with a terminal alkyne (10.0 mmol), evacuated, and back-filled with argon. THF (50
mL) was then added via syringe. The solution was then cooled to -78 OC in a dry ice/acetone
bath. After 15 min of cooling, n-BuLi (6.6 mL of a 1.6 M solution in hexanes, 10.5 mmol) was
added dropwise, via syringe. After an additional 20 min of stirring, the aldehyde (11.0 mmol)
was added via syringe. The solution was allowed to warm to room temperature, at which point
the reaction was quenched with an aqueous saturated ammonium chloride solution (25 mL). The
layers were separated, and the aqueous layer was extracted twice with CH 2C12 (50 mL). The
combined organic layers were washed with brine (50 mL) and dried over MgSO 4, filtered and
concentrated under reduced pressure. The resultant oil was purified via flash chromatography
(hexanes/EtOAc or pentane/Et 20) to give the propargylic alcohols as oils.
TMS
OH
n-Bu
(+)-l-(Trimethylsilyl)hept-1-yn-3-ol [CAS # 75045-85-1]. Prepared from
(trimethylsilyl)acetylene and valeraldehyde by the representative procedure.
1H NMR (CDCl3, 300 MHz) 6 4.32 (t, J= 6.6 Hz, 1H), 2.20 (broad s, 1H), 1.71-1.62 (m,
2H), 1.46-1.23 (m, 4H), 0.89 (t, J= 6.9 Hz, 3H), 0.14 (s, 9H).
292
TMS
OH
i-Pr
(+)-5-Methyl-l-(trimethylsilyl)hex-1-yn-3-ol [CAS # 80352-60-9]. Prepared from
(trimethylsilyl)acetylene and isobuytraldehyde by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.38 (t, J= 6.8 Hz, 1H), 1.82 (septet, J= 6.7 Hz, 1H),
1.67-1.47 (m, 2H), 0.92 (dd, J = 6.0, J= 3.0 Hz, 6H), 0.16-0.15 (m, 9H).
TIPS
OH
Et
(+)-l-(Triisopropylsilyl)pent-1-yn-3-ol [CAS # 263720-71-4] Prepared from
(triisopropylsilyl)acetylene and propionaldehyde by the representative procedure.
'H NMR (CDC13, 300 MHz) 8 4.39-4.30 (m, 1H), 1.87-1.63 (m, 3H), 1.06-0.99 (m, 24H).
Ph(Me) 2Si
OH
n-Bu
1-(Dimethyl(phenyl)silyl)hept-1-yn-3-ol. Prepared from (dimethylphenylsilyl)-
acetylene and valeraldehyde by the representative procedure.
'H NMR (CDC13, 300 MHz) 8 7.65-7.61 (m, 2H), 7.43-7.38 (m, 3H), 4.41 (t, J= 6.9 Hz,
1H), 1.78-1.64 (m, 2H), 1.49-1.32 (m, 4H), 0.93 (t, J= 6.9 Hz, 3H), 0.43 (s, 6H).
13C NMR (CDC13, 75 MHz) 8 133.9, 130.3, 129.7, 128.2, 108.9, 87.5, 63.1, 45.3, 37.6,
27.6, 26.2, 22.6, 22.3, 14.3, 14.1.
IR (film) 3384, 2959, 2872, 2361, 2171, 1675, 1428 cm-1.
HRMS (ESI) calcd for C15H 22OSi (M+Na+) 269.1332, found 269.1332.
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TIPS
OH
i-Pr
(±)-5-Methyl-l-(triisopropylsilyl)hex-1-yn-3-ol [CAS # 913618-91-4] Prepared from
isobuytraldehyde by the representative procedure.
'H NMR (CDCl 3, 300 MHz) 6 4.44-4.37 (m, 1H), 1.99-1.96 (m, 1H), 1.86 (septet, J= 6.6
Hz, 1H), 1.68-1.50 (m, 2H), 1.07-1.05 (m, 21H), 0.93 (t, J= 6.0 Hz, 6H).
Synthesis of Propargylic Bromides (representative procedure). A 500 mL flask was
charged with imidazole (1.3 g, 19.5 mmol), evacuated, and back-filled with argon. CH2C12 (100
mL) was added via syringe, followed by the addition of the propargylic alcohol (16.3 mmol).
This solution was allowed to stir for 15 min. Next, dibromotriphenylphosphorane (8.24 g, 19.5
mmol) was added as a solid. The reaction was run under argon and monitored by TLC. Upon
completion (usually 3-4 h), the reaction was quenched by the addition of silica gel, and was
concentrated and dried under reduced pressure. Once dry, this plug of silica was subjected to
flash chromatography (hexanes/EtOAc or pentane/Et20) to give the propargylic bromides as oils.
Et
Br
Me
(±)-2-Bromohex-3-yne [CAS # 109-48-8]. Prepared from (±)-hex-3-yn-2-ol by the
representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.62 (qt, J= 6.8, 2.1 Hz, 1H), 2.22 (qd, J= 7.5, 2.1 Hz,
2H), 2.79 (d, J= 6.8 Hz, 3H), 1.11 (t, J= 7.5 Hz, 3H).
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(+)-(3-Bromopent-1-ynyl)cyclohexane. Prepared from (+)-1-cyclohexylpent-1-yn-3-ol
by the representative procedure. (±)-1-Cyclohexylpent-1-yn-3-ol [CAS # 185322-10-5] was
prepared from ethynylcyclohexane and propionaldehyde by the representative propargylic
alcohol procedure and used without intermediate purification.
1H NMR (CDCl 3, 300 MHz) 6 4.58-4.51 (m, 1H), 2.49-2.38 (m, 1H), 1.98 (quintet, J=
6.1 Hz, 2H), 1.82-1.62 (m, 4H), 1.50-1.24 (m, 6H), 1.06 (t, J= 7.2 Hz, 3H).
13C NMR (CDCl3, 75 MHz) 6 92.6, 79.4, 40.6, 33.8, 32.6, 29.3, 26.1, 24.9, 12.0.
IR (film) 2972, 2932, 2854, 2360, 2340, 2234, 1448, 1173 cml.
LRMS (EI) calcd for CllH 1 7 (M-Br +) 149, found 149.
t-Bu
Br
CI-
(±)-5-Bromo-8-chloro-2,2-dimethyloct-3-yne. A 300 mL flask was charged with
pyridinium chlorochromate (5.2 g, 24.0 mmol), evacuated, and back-filled with argon. To the
orange solid was added CH2C12 (100 mL) and 4-chlorobutanol (2.0 mL, 20 mmol). The resulting
dark-brown reaction mixture was stirred for 3 h at r.t., and then Et20 (100 mL) was added,
leading to the precipitation of a brown solid. The mixture was allowed to stand at r.t. for 2 h, and
then it was filtered through a plug of silica gel (washed with Et20). The solvent was removed,
and the residue was used as in the representative propargylic alcohol procedure. The crude (+)-1-
chloro-7,7-dimethyloct-5-yn-4-ol was then brominated via the representative procedure
IH NMR (CDC13, 300 MHz) 6 4.59 (t, J= 6.0 Hz, 1H), 3.58 (t, J= 6.7 Hz, 2H), 2.17-2.08
(m, 2H), 2.05-1.96 (m, 2H), 1.20 (s, 9H).
13C NMR (CDCl3, 75 MHz) 6 97.0, 77.6, 44.2, 37.6, 37.4, 30.9, 30.4, 27.8.
IR (film) 2969, 2867, 2360, 2340, 2236, 1475, 1456, 1363, 1264 cm-.
LRMS (EI) calcd for C1oH16BrCl (M-Br +) 171, found 171.
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TMS
Br
n-Bu
(-)-(3-Bromohept-1-ynyl)trimethylsilane. Prepared from (+)-1-(trimethylsilyl)hept-1-
yn-3-ol by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.48 (t, J= 6.6 Hz, 1H), 1.98 (q, J= 6.6 Hz, 2H), 1.54-
1.44 (m, 2H), 1.33 (sextet, J= 7.2 Hz, 2H), 0.92 (t, 7.2 Hz, 3H), 0.18-0.16 (m, 9H).
13C NMR (CDC13, 75 MHz) 6 104.2, 92.0, 39.6, 37.6, 29.7, 22.1, 14.1, 0.0.
IR (film) 2959, 2863, 2361, 2338, 2174, 1457, 1250 cm1.
LRMS (EI) calcd for C9H 16BrSi (M-i-Pr ) 231, found 231.
TMS
Br
i-Pr
(-)-(3-Bromo-5-methylhex-1-ynyl)trimethylsilane. Prepared from (±)-5-methyl-1-
(trimethylsilyl)hex-1-yn-3-ol by the representative procedure.
IH NMR (CDC13, 300 MHz) 6 4.50 (t, J= 7.3 Hz, 1H), 1.94-1.86 (m, 3H), 0.92 (dd, J=
6.5, 2.6 Hz, 6H), 0.16 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 104.3, 91.9, 48.7, 36.1, 27.0, 22.1, 22.0, 0.0.
IR (film) 2960, 2871, 2360, 2340, 2173, 1469, 1250, 1170 cm-.
LRMS (EI) calcd for CloH 19Si (M-Br +) 167, found 167.
TMS
Br
Me
(A)-(3-Bromobut-1-ynyl)trimethylsilane [CAS # 2004440-80-8] Prepared from (+)-4-
(trimethylsilyl)but-3-yn-2-ol by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.59 (q, J= 7.0 Hz, 1H), 1.88 (d, J= 6.1 Hz, 3H), 0.16 (s,
9H).
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Me
Br
Et
(+)-4-Bromohex-2-yne [CAS # 99979-72-3] Prepared from (±)-hex-4-yn-3-ol by the
representative procedure.
'H NMR (CDC13, 300 MHz) 6 4.51-4.45 (m, 1H), 1.97 (quintet, J= 7.4 Hz, 2H), 1.87-
1.86 (m, 3H), 1.05 (t, J= 7.2 Hz, 3H).
TIPS
Br
Et
(+)-(3-Bromopent-1-ynyl)triisopropylsilane [CAS # 234110-29-3] Prepared from (±)-
1 -(Triisopropylsilyl)pent- 1-yn-3-ol by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.53 (t, J = 6.2 Hz, 1H), 2.02 (quintet,
1.11 (t, J= 7.2 Hz, 3H), 1.07 (s, 21H).
(+)-3-Bromopent-1-ynyl)benzene [CAS # 27975-78-61
J= 7.2 Hz, 2H),
Prepared from (+)- 1-phenyl- 1-
penyn-3-ol by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 7.47-7.43 (m, 2H), 7.34-7.31 (m, 3H), 4.77 (t, J= 6.3 Hz,
1H), 2.13 (quintet, J= 7.2 Hz, 2H), 1.17 (t, J= 7.2 Hz, 3H).
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Ph(Me)2Si
Br
n-Bu
(±)-(3-Bromohept-1-ynyl)dimethyl(phenyl)silane. Prepared from (±)-1-
(dimethyl(phenyl)silyl)hept- 1-yn-3-ol by the representative procedure.
'H NMR (CDC13, 300 MHz) 6 7.70-7.60 (m, 2H), 7.45-7.38 (m, 3H), 4.57 (t, J= 6.9 Hz,
1H), 2.10-2.02 (m, 2H), 1.65-1.50 (m, 2H), 1.39 (sextet, J = 7.2 Hz, 2H), 0.96 (t, J = 9.6 Hz,
3H), 0.47-0.44 (m, 6H).
13C NMR (CDC13, 75 MHz) 6 136.8, 133.4, 129.8, 128.2, 105.9, 90.1, 39.5, 37.4, 29.8,
22.1, 14.2, -0.7.
IR (film) 2959, 2862, 2361, 2339, 1428, 1250, 1116 cm'.
LRMS (EI) calcd for C9H16BrSi (M-C6H5+) 231, found 231.
TIPS
Br
i-Pr
(±)-(3-Bromo-5-methylhex-1-ynyl)triisopropylsilane. Prepared from (±)-5-methyl-1-
(triisopropylsilyl)hex-1-yn-3-ol by the representative procedure.
1H NMR (CDC13, 300 MHz) 6 4.54 (t, J= 7.5 Hz, 1H), 1.95-1.86 (m, 3H), 1.06 (s, 21H1),
0.94-0.92 (m, 6H).
13C NMR (CDC13, 75 MHz) 6 106.3, 88.7, 48.9, 36.3, 27.2, 22.2, 21.9, 18.7, 11.4.
IR (film) 2959, 2866, 2170, 1465 cm - .
HRMS (EI) calcd for C16H 31BrSi (M) 330.1373, found 330.1379.
TMS
Br
EtO2C )4
(±)-Ethyl 6-bromo-8-(trimethylsilyl)oct-7-ynoate. Prepared from (±)-ethyl 6-hydroxy-
8-(trimethylsilyl)oct-7-ynoate by the representative procedure. (±)-Ethyl 6-hydroxy-8-
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(trimethylsilyl)oct-7-ynoate was prepared from (trimethylsilyl)acetylene and ethyl 6-
oxohexanoate 13 5 by the representative propargylic alcohol procedure, and used without
intermediate purification.
'H NMR (CDC13, 300 MHz) 6 4.47 (t, J= 6.7 H, 1H), 4.09 (q, J= 7.1 Hz, 2H), 2.29 (t, J
= 7.1 Hz, 2H), 1.97 (q, J= 6.8 Hz, 2H), 1.63 (sextet, J= 7.1 Hz, 2H), 1.57-1.48 (m, 2H), 1.22 (t,
J= 7.1 Hz, 3H), 0.14 (s, 9H).
13C NMR (CDCl 3 , 75 MHz) 6 173.5, 103.8, 92.2, 60.5, 39.4, 37.1, 34.3, 27.0, 24.2, 14.5,
-0.1.
IR (film) 2958, 2867, 2360, 2340, 2170, 1735, 1457, 1373, 1250, 1181 cm1.
LRMS (EI) calcd for C12H20BrO2Si (M-CH 3+) 303, found 303.
TMS
-t/ Br
4
(+)-(Z)-(3-Bromododec-9-en-1-ynyl)trimethylsilane. Prepared from (±)-(Z)- 1-
(trimethylsilyl)dodec-9-en- 1-yn-3-ol by the representative procedure. (±)-(Z)- 1-
(Trimethylsilyl)dodec-9-en-1-yn-3-ol was prepared from (trimethylsilyl)acetylene and (Z)-dec-7-
enal by the representative propargylic alcohol procedure and used without intermediate
purification.
1H NMR (CDC13, 300 MHz) 6 5.41-5.26 (m, 2H), 4.49 (t, J= 6.8 Hz, 1H), 2.08-1.94 (m,
6H), 1.57-1.47 (m, 2H), 1.40-1.30 (m, 4H), 0.95 (t, J= 7.5 Hz, 3H), 0.17 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 132.0, 129.1, 104.2, 92.0, 39.8, 37.6, 29.7, 28.4, 27.4, 27.1,
20.8, 14.6, -0.2.
IR (film) 3005, 2961, 2932, 2857, 2360, 2340, 2172, 1457, 1250 cm-1.
LRMS (EI) calcd for C15H 27Si (M-Br +) 235, found 235.
135 Tanaka, F.; Kinoshita, K.; Tanimura, R.; Fujii, I. J. Am. Chem. Soc. 1996, 118, 2332-2339.
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III. Cross-Coupling Reactions
Standard Conditions:
Preparation of the arylzinc reagents: Set up in a nitrogen glovebox. In 20 mL vial,
Et2Zn (neat, 366 pL, 3.5 mmol) was added dropwise to a solution of boronic acid (2.5 mmol) in
glyme (5.0 mL). The vial capped and heated at 60 oC for 12 h.
3.0% NiCI2 -glyme
R 3.9% (-)-L6
Br ArZnEt (+L6 Ar
glyme, -20 °C
alkyl 2.0 equiv alkyl
racemic
H H
N N
H H
(-)-L6
Indanyl-Pybox
General Procedure. In a N2-filled glovebox, a 4 mL vial was charged with NiC12-glyme
(3.3 mg, 0.0150 mmol), (-)-L6 (7.7 mg, 0.0195 mmol), then glyme (1.3 mL). This solution was
stirred for 10 min. Then the arylzinc reagent was added (0.5 M in glyme, 2.0 mL, 1.0 mmol) and
the vial was capped with a septum. This solution was stirred for 10 min at room temperature and
then the vial was placed into a -20 oC bath. The reaction mixture was stirred for 10 min, and then
the propargylic bromide was added via syringe (0.5 mmol). The reaction was stirred for 14 h at
-20 'C. Then, the excess arylzinc reagent was quenched with EtOH (0.3 mL). The mixture was
passed through a short plug of silica (eluting with 1:1 Hexanes: Et 20) to remove inorganic salts
and most of the glyme. The filtrate was concentrated, and the resultant oil was purified by flash
chromatography.
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Conditions under which Ph2Zn may be coupled efficiently.
TMS 7.5% NiCl2glyme TMS
Br 9.75% (-)-L6
Ph2Zn oc0PZMe n glyme, -20 C Me
1.4 equiv
racemic 80% yield
1 91% ee
(-)-L6
Indanyl-Pybox
In a N2-filled glovebox, a 4 mL vial was charged with NiC12-glyme (8.2 mg, 0.0150
mmol), (-)-L6 (19.1 mg, 0.0195 mmol), then glyme (1.25 mL). This solution was stirred for 10
min. Then a solution of Ph2Zn (Strem, 99%) was added (153 mg in 1.25 mL glyme, 1.4 equiv,
0.7 mmol) and the vial was capped with a septum. This solution was stirred for 10 min at room
temperature and then the vial was placed into a -20 OC bath. The reaction mixture was stirred for
10 min, and then (+)-(3-bromohept-1-ynyl)trimethylsilane (124 mg, 0.5 mmol) was added via
syringe. The reaction was stirred for 1 h at -20 oC. Then, the excess arylzinc reagent was
quenched with EtOH (0.3 mL). The mixture was passed through a short plug of silica (eluting
with 1:1 Hexanes: Et20) to remove inorganic salts and most of the glyme. The filtrate was
concentrated, and the resultant oil was purified by flash chromatography (0 - 5% Et20 in
hexanes), (S)-trimethyl(3-phenylhept-1-ynyl)silane was isolated as a colorless oil (98.0 mg, 80%
yield) with 91% ee (see eq 2.19 for assay information).
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IV. Eqs 2.18 and 2.19, Conditions/Products
Eq 2.18:
1) 6.0 equiv. Et2Zn TMStoluene
PhB(OH) 2  toluene -
2) 3.0% NiCl2.glyme2.0 equiv 3.9% (-)-L6
Me
TMS <5% yield
Br 73% ee
racemic
(1.0 equiv) Meglyme, -20 °C
Preparation of the arylzinc reagent (Eq 2.18): Set up in a nitrogen glovebox. In 20 mL
vial, Et2Zn (neat, 628 iL, 6.0 mmol) was added dropwise to a solution of phenylboronic acid
(243 mg, 2.0 mmol) in toluene (13.3 mL). The vial capped and heated at 60 'C for 12 h.
Trimethyl(3-phenylhept-1-ynyl)silane (Eq 2.18). In a nitrogen glovebox, a 20 mL vial
was charged with NiCl2 -glyme (3.3 mg, 0.0150 mmol), (-)-L6 (7.7 mg, 0.0195 mmol), then
glyme (1.3 mL). This solution was stirred for 10 min. Then the arylzinc reagent (from above)
was added (0.15 M in toluene, 6.7 mL, 1.0 mmol) and the vial was capped with a septum. This
solution was stirred for 10 min at room temperature and then the vial was placed into a -20 OC
bath. The reaction mixture was stirred for 10 min, and then the (±)-(3-bromohept-1-
ynyl)trimethylsilane (124 mg, 0.5 mmol) was added via syringe. The reaction was stirred for 14
h at -20 'C. Then, the excess arylzinc reagent was quenched with EtOH (0.3 mL). The mixture
was passed through a short plug of silica (eluting with 1:1 Hexanes: Et20O) to remove inorganic
salts and most of the glyme. The filtrate was concentrated, and analyzed by GC. The product was
not isolated, as it was clear that the reaction had given <5% yield (73% ee, see eq 2.19 for assay
information).
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Eq 2.19:
1) 2.8 equiv. Et 2Zn TMS
glyme
PhB(OH) 2
2) 3.0% NiCI2 .glyme2.0 equiv 3.9% (-)-L6 Me
TMS 90% yield
Br 92% ee
racemic
(1.0 equiv) Meglyme, -20 C
(R)-Trimethyl(3-phenylhept-1-ynyl)silane (Eq 2.19). The compound was prepared
according to the General Procedure with (±)-(3-bromohept-1-ynyl)trimethylsilane (124 mg, 0.5
mmol) and the arylzinc reagent (~0.5 M in glyme; 2.0 mL, 1.0 mmol). After purification by
column chromatography (0 - 5% Et20O in hexanes), the title compound was isolated as a
colorless oil (110.0 mg, 90% yield) with 92% ee.
[a]D 22 = +11.6 (c = 1.0, CHCl 3). Chiral GC analysis of the product: Chirasil Dex CB
column; method: 100 'C -- 130 'C @ 10 oC/min, hold 10 min, then - 170 'C @ 9 oC/min, hold
5 min, flow rate 1.0 mL/min; retention times: 15.5 min (major), 15.3 min (minor).
1H NMR (CDC13, 500 MHz) 6 7.37-7.23 (m, 5H), 3.65 (t, J= 7.2 Hz, 1H), 1.77-1.72 (m,
2H), 1.48-1.29 (m, 4H), 0.91 (t, J= 7.1 Hz), 0.26 (s, 9H).
13C NMR (CDC13, 125 MHz) 6 142.3, 128.6, 127.7, 126.8, 108.8, 87.2, 39.0, 38.7, 29.7,
22.6, 14.2, 0.4.
IR (film) 3086, 3063, 3029, 2958, 2934, 2873, 2860, 2361, 2339, 2172, 1494, 1453, 1249
cm-.
LRMS (EI) calcd for Cl6H 24Si (M+) 244, found 244.
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V. Asymmetric Negishi Cross-Coupling Reactions
TIPS
n-Bu Me
Trimethyl(3-p-tolylhept-1-ynyl)silane (Table 2.11, entry 1). The compound was
prepared according to the General Procedure with (±)-(3-bromohept-1-ynyl)trimethylsilane (124
mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0 mmol). After purification
by column chromatography (0 -- 5% Et20O in hexanes), the title compound was isolated as a
colorless oil (121.0 mg, 94% yield) with 94% ee.
[a]D2 2 = +7.7 (c = 1.0, CHC13). Chiral GC analysis of the product: Chirasil Dex CB
column; method: 100 'C - 130 'C @ 10 °C/min, hold 10 min, then -+ 170 "C @ 9 °C/min, hold
5 min, flow rate 1.0 mL/min; retention times: 18.0 min (major), 17.9 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(116.2 mg, 90% yield) with 92% ee.
'H NMR (CDCl3, 300 MHz) 6 7.23 (d, J= 8.1 Hz, 2H), 7.12 (d, J= 8.2 Hz, 2H), 3.59 (t,
J= 7.2 Hz, 1H), 2.33 (s, 3H), 1.74-1.66 (m, 2H), 1.44-1.25 (m, 4H), 0.88 (t, J= 7.0 Hz, 3H),
0.17 (s, 9H).
13C NMR (CDCl3, 75 MHz) 6 139.3, 136.3, 129.3, 127.6, 109.1, 86.9, 38.7, 38.6, 29.7,
22.6, 21.3, 14.2, 0.5.
IR (film) 2958, 2933, 2860, 2360, 2340, 1271, 1513, 1457, 1249 cm-1.
LRMS (EI) calcd for C17H 26Si (M+) 258, found 258.
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TIPS
n-Bu
Trimethyl(3-(naphthalen-2-yl)hept-1-ynyl)silane (Table 2.11, entry 2). The
compound was prepared according to the General Procedure, except that 6% catalyst and 3.0
equivalents of arylzinc reagent were used, with (±)-(3-bromohept-1-ynyl)trimethylsilane (124
mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 3.0 mL, 1.5 mmol). After purification
by column chromatography (0 -+ 4% Et20O in hexanes), the title compound was isolated as a
colorless oil (106.7 mg, 72% yield) with 93% ee.
[a]D 22 = +2.6 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 8.3 min (major), 11.2
min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(100.4 mg, 68% yield) with 92% ee.
1H NMR (CDC13, 300 MHz) 6 7.83-7.78 (m, 4H), 7.50-7.43 (m, 3H), 3.79 (t, J= 7.1 Hz,
1H), 1.85-1.77 (m, 2H), 1.46-1.29 (m, 4H), 0.88 (t, J= 7.0 Hz, 3H), 0.21-0.20 (m, 9H)
'
3C NMR (CDC13, 75 MHz) 6 139.7, 133.7, 132.6, 128.3, 128.0, 127.9, 126.2, 126.1,
125.7, 108.8, 87.5, 39.1, 38.4, 29.7, 22.7, 14.3, 0.5.
IR (film) 3055, 2958, 2859, 2361, 2340, 2169, 1943, 1507, 1457, 1249 cm 1.
LRMS (El) calcd for C2oH26Si (M ) 294, found 294.
TIPS
Me
(3-(Benzo[d][1,3]dioxol-5-yl)but-1-ynyl)trimethylsilane (Table 2.11, entry 3). The
compound was prepared according to the General Procedure with (+)-(3-bromobut-1-
ynyl)trimethylsilane (103 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0
mmol). After purification by column chromatography (0 - 5% Et20O in hexanes), the title
compound was isolated as a colorless oil (100.0 mg, 69% yield) with 95% ee.
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[a]D 22 = +9.5 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OJ-H
column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 6.5 min (major), 6.9 min
(minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(103.4 mg, 72% yield) with 91% ee.
'H NMR (CDC13, 300 MHz) 6 6.89 (d, J= 1.7 Hz, 1H), 6.81 (dd, J= 8.0, 1.7 Hz, 1H),
6.75 (d, J= 8.0 Hz, 1H), 5.94 (s, 2H), 3.70 (q, J= 14.3 Hz, 1H), 1.43 (d, J = 7.1 Hz, 3H), 0.17
(s, 9H).
13C NMR (CDC13, 75 MHz) 6 147.9, 146.4, 137,3, 120.1, 109.7, 108.4, 107.7, 101.1,
86.4, 32.8, 25.1, 0.4.
IR (film) 2961, 2930, 2897, 2777, 2361, 2339, 2169, 1505, 1487, 1438, 1297, 1249 cm-.
LRMS (EI) calcd for C14H 180 2Si (M+) 246, found 246.
TIPS
i-Pr)
(3-(Benzo[dj [1,3]dioxol-5-yl)-5-methylhex-1-ynyl)trimethylsilane (Table 2.11, entry
4). The compound was prepared according to the General Procedure with (+)-(3-bromo-5-
methylhex-1-ynyl)trimethylsilane (124 mg, 0.5 mmol) and the arylzinc reagent (~0.5 M in
glyme; 2.0 mL, 1.0 mmol). After purification by column chromatography (0 --+ 5% Et20O in
hexanes), the title compound was isolated as a colorless oil (100.0 mg, 69% yield) with 95% ee.
[a]D 22 = +10.5 (c = 1.0, CHCl3). HPLC analysis of the product: Daicel CHIRALPAK OJ-
H column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 5.0 min (major), 5.5 min
(minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(103.4 mg, 72% yield) with 91% ee.
'H NMR (CDCl3, 300 MHz) 6 6.86 (d, J= 1.6 Hz, 1H), 6.75 (d, J= 1.5 Hz, 1H), 6.74 (d,
J = 0.6 Hz, 1H), 5.94 (s, 2H), 3.59 (dd, J = 9.2, 6.6 Hz, 1H), 1.82-1.59 (m, 2H), 1.49-1.39 (m,
1H), 0.92 (d, J= 6.5 Hz, 6H), 0.16 (s, 9H).
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13C NMR (CDC13, 75 MHz) 6 147.9, 146.4, 136.5, 120.6, 108.9, 108.3, 108.1, 101.1,
87.0, 48.4, 36.8, 26.1, 23.1, 22.2, 0.4.
IR (film) 2957, 2870, 2776, 2361, 2339, 2168, 1504, 1487, 1249 cm-.
LRMS (EI) calcd for C17H240 2Si (M+) 288, found 288.
TIPS
n-Bu
MeO
(3-(2-Methoxyphenyl)hept-1-ynyl)trimethylsilane (Table 2.11, entry 5). The
compound was prepared according to the General Procedure (except the reaction was run at
room temperature for 6 h, and the arylzinc reagent was prepared in toluene), with (+)-(3-
bromohept-1-ynyl)trimethylsilane (124 mg, 0.5 mmol) and the arylzinc reagent (~0.3 M in
toluene; 3.3 mL, 2.0 mmol). After purification by column chromatography (0 -- 5% Et20 in
hexanes), the title compound was isolated as a colorless oil (51.0 mg, 37% yield) with 91% ee.
[a]D22 = +15.8 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD
column; solvent system: 100% hexanes; 0.2 mL/min; retention times: 23.7 min (major), 24.8 min
(minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(56.0 mg, 41% yield, 92% ee)
1H NMR (CDC13, 300 MHz) 6 7.53 (dd, J= 7.5, 1.7 Hz, 1H), 7.21 (td, J= 8.1, 5.7 Hz,
1H), 6.98-6.95 (m, 1H), 6.85-6.83 (m, 1H), 4.12 (dd, J= 8.6, 5.2 Hz, 1H), 3.82 (s, 3H), 1.74-1.67
(m, 1H), 1.63-1.55 (m, 1H), 1.47-1.26 (m, 4H), 0.89 (t, J= 7.2 Hz, 3H), 0.18 (s, 9H).
13C NMR (CDCl3, 75 MHz) 6 156.3, 130.7, 128.7, 127.8, 120.8, 110.5, 109.5, 86.3, 55.6,
36.7, 32.0, 29.7, 22.5, 14.2, 0.5.
IR (film) 2958, 2860, 2836, 2360, 2340, 2169, 1600, 1588, 1492, 1464, 1438, 1246 cm-1.
LRMS (EI) calcd for C17H26 OSi (M+) 274, found 274.
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TMS
Ot-Bu
EtO 2C )4
Ethyl 6-(4-(tert-butoxymethyl)phenyl)-8-(trimethylsilyl)oct-7-ynoate (Table 2.11,
entry 6). The compound was prepared according to the General Procedure with (±)-ethyl 6-
bromo-8-(trimethylsilyl)oct-7-ynoate (153 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in
glyme; 2.0 mL, 1.0 mmol). After purification by column chromatography (0 - 12% Et20O in
hexanes), the title compound was isolated as a colorless oil (152.6 mg, 76% yield) with 94% ee.
[a]D22 = +7.0 (c = 1.0, CHCl3). HPLC analysis of the product: Daicel CHIRALPAK OD
column; solvent system: 0.2% IPA in hexanes; 0.1 mL/min; retention times: 57.5 min (major),
62.9 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(151.4 mg, 75% yield) with 94% ee.
'H NMR (CDCl3 , 300 MHz) 6 7.28 (broad s, 4H), 4.42 (s, 2H), 4.10 (q, J= 7.1 Hz, 2H),
3.61 (t, J= 7.3 Hz, 1H),
13C NMR (CDCl3, 75 MHz) 8 173.9, 140.8, 138.4, 127.9, 127.6, 108.6, 87.3, 73.6, 64.1,
60.4, 38.5, 38.3, 34.5, 27.9, 27.0, 24.9, 14.5, 0.4.
IR (film) 2973, 2864, 2360, 2340, 2171, 1734, 1388, 1363 cm - .
LRMS (EI) calcd for C23H350 3Si (M-Me) 387, found 387.
TMS
Et ) OMe
(Z)-(3-(3-Methoxyphenyl)dodec-9-en-1-ynyl)trimethylsilane (Table 2.11, entry 7).
The compound was prepared according to the General Procedure with (±)-(Z)-(3-bromododec-9-
en-1-ynyl)trimethylsilane (158 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0
mL, 1.0 mmol). After purification by column chromatography (0 - 4% Et20 in hexanes), the
title compound was isolated as a colorless oil (135.4 mg, 79% yield) with 94% ee.
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[C]D22 = +15.9 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK
OD-H column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 11.4 min (major),
8.7 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(133.0 mg, 78% yield) with 94% ee.
'H NMR (CDC13, 300 MHz) 6 7.26-7.21 (m, 1H), 6.95-6.90 (m, 2H), 6.80-6.76 (m, 1H),
5.43-5.27 (m, 2H), 3.82 (s, 3H), 3.62 (t, J= 7.2 Hz, 1H), 2.08-1.96 (m, 4H), 1.78-1.68 (m, 2H),
1.48-1.25 (m, 6H), 0.96 (t, J= 7.4 Hz, 3H), 0.19 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 159.9, 143.9, 131.9, 129.6, 129.4, 120.1, 113.3, 112.2,
108.7, 87.4, 55.4, 39.0, 38.7, 29.8, 29.0, 27.3, 27.2, 20.7, 16.6, 0.4.
IR (film) 3003, 2933, 2856, 2360, 2340, 2171, 1601, 1586, 1488, 1456, 1436 cm-1.
LRMS (EI) calcd for C22H34OSi (M+) 342, found 342.
Eq 2.20:
3.0% NiCI2*glyme F
EtZn glyme, -20 0CPh(Me)2Si Met F 3.9% (-)-L6C Ph(Me)2Si e
racemic 2.0 equiv 88% yield
88% ee
(3-(4-Fluorophenyl)hept-1-ynyl)dimethyl(phenyl)silane (eq 2.20). The compound was
prepared according to the General Procedure with (±)-(3-bromohept-1-
ynyl)dimethyl(phenyl)silane (155 mg, 0.5 mmol) and the arylzinc reagent (~0.5 M in glyme; 2.0
mL, 1.0 mmol). After purification by column chromatography (0 -+ 5% Et20O in hexanes), the
title compound was isolated as a colorless oil (139.7 mg, 86% yield) with 90% ee.
[a]D22 = -7.3 (c = 1.0, CHC13). Chiral GC analysis of the desilylated product: Chirasil Dex
CB column; method: 100 'C -+ 130 'C @ 10 "C/min, hold 10 min, then - 170 "C @ 9 "C/min,
hold 5 min, flow rate 1.0 mL/min; retention times: 8.2 min (major), 8.4 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(144.6 mg, 89% yield) with 85% ee.
'H NMR (CDCl3, 300 MHz) 6 7.67-7.63 (m, 2H), 7.40-7.29 (m, 5H), 7.00 (t, J= 8.8 Hz,
2H), 3.67 (t, J = 7.2 Hz, 1H), 1.78-1.68 (m, 2H), 1.45-1.26 (m, 4H), 0.89 (t, J = 7.1 Hz, 3H),
0.43-0.41 (m, 6H).
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13C NMR (CDC13, 75 MHz) 6 137.8, 133.9, 129.6, 129.2, 129.1, 128.1, 115.6, 115.3,
110.5, 85.5, 38.7, 38.4, 29.7, 22.6, 14.3, -0.3.
19F NMR (CDC13, 282 MHz) 8 -117.0.
IR (film) 3069, 2958, 2932, 2860, 2360, 2340, 2172, 1604, 1508, 1428, 1249 cm -1.
LRMS (EI) calcd for C21H25FSi (M+) 324, found 324.
Eq 2.21:
3.0% NiC2-glyme TIPS t-Bu
B TIPSt-Bu 3.9% (-)-L6 T I
Br EtZn glyme, -20 °C
racemic 2.0 equiv 81% yield
93% ee
(3-(4-tert-Butylphenyl)pent-1-ynyl)triisopropylsilane (eq 2.21). The compound was
prepared according to the General Procedure with (±)-(3-Bromopent-1-ynyl)triisopropylsilane
(152 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0 mmol). After
purification by column chromatography (0 - 4% Et20 in hexanes), the title compound was
isolated as a colorless oil (136.5 mg, 77% yield) with 92% ee.
[a]D22 = +14.4 (c = 1.0, CHCl 3). Chiral GC analysis of the desilylated product: Chirasil
Dex CB column; method: 100 'C --+ 130 'C @ 10 'C/min, hold 10 min, then - 170 'C @ 9
'C/min, hold 5 min, flow rate 1.0 mL/min; retention times: 15.2 min (major), 15.8 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(150.3 mg, 84% yield) with 93% ee.
1H NMR (CDC13, 300 MHz) 8 7.35-7.28 (m, 4H), 3.63 (dd, J = 8.4, 5.3 Hz, 1H), 1.88-
1.62 (m, 2H), 1.32 (s, 9H), 1.10-1.08 (m, 21H), 1.02 (t, J= 7.3 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 149.4, 139.0, 127.4, 125.4, 110.2, 83.4, 40.1, 34.7, 32.4,
31.7, 19.0, 12.0, 11.6.
IR (film) 2961, 2865, 2361, 2340, 2169, 1507, 1463 cm-1.
LRMS (El) calcd for C24H40Si (M+) 356, found 356.
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TIPS
n-Bu
Trimethyl(3-phenylhept-1-ynyl)silane (eq 2.22). The compound was prepared
according to the General Procedure with (±)-(3-chlorohept-1-ynyl)trimethylsilane (101 mg, 0.50
mmol) (Note: the reaction was run for 48 h). After purification by flash chromatography (0 -+
5% Et20O in hexanes), the title compound was isolated as a colorless oil (76 mg, 62% yield) with
91% ee.
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(73 mg, 60% yield) with 91% ee. For characterization data, see the description of eq 2.19.
Me
Et 
0
6-(Hex-4-yn-3-yl)-2,3-dihydrobenzo[b][1,4]dioxine (Table 2.12, entry 1). The
compound was prepared according to the General Procedure with (±)-(4-bromohex-2-yne (80.5
mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0 mmol). After purification
by column chromatography (0 -+ 4% Et20 in hexanes), the title compound was isolated as a
colorless oil (87.0 mg, 81% yield) with 90% ee.
[a]D22 = +4.8 (c = 1.0, CHCl3). Chiral GC analysis of the product: Chirasil Dex CB
column; method: 100 'C -- 190 "C @ 5 "C/min, hold 30 min, flow rate 1.0 mL/min; retention
times: 12.0 min (major), 11.9 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(87.6 mg, 81% yield) with 86% ee.
1H NMR (CDC13, 300 MHz) 6 6.90-6.86 (m, 1H), 6.97 (d, J= 1.2 Hz, 2H), 4.24 (s, 4H),
3.43-3.35 (m, 1H), 1.85 (d, J= 2.5 Hz, 3H), 1.73-1.63 (m, 2H), 0.95 (t, J= 7.3 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 143.4, 142.3, 136.4, 120.6, 117.2, 116.4, 81.1, 78.5, 64.6,
64.5, 38.9, 31.9, 12.0, 3.9.
IR (film) 2967, 2931, 2874, 2361, 2339, 1952, 1734, 1683, 1590, 1506 cm - .
LRMS (EI) calcd for C14H160 2 (M+) 216, found 216.
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Me
S Me
\/ NEt
5-(Hex-4-yn-3-yl)-1-methyl-lH-indole (Table 2.12, entry 2). The compound was
prepared according to the General Procedure, except that 6% catalyst and 3.0 equivalents of
arylzinc reagent were used, with (±)-(4-bromohex-2-yne (80.5 mg, 0.5 mmol) and the arylzinc
reagent (-0.5 M in glyme; 3.0 mL, 1.5 mmol). After purification by column chromatography (0
-+ 25% CH2C12 in hexanes), the title compound was isolated as a colorless oil (84.0 mg, 80%
yield) with 86% ee.
[U]D 22 = +3.6 (c = 0.5, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; solvent system: 2.0% IPA in hexanes; 1.0 mL/min; retention times: 7.9 min (major),
8.5 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(80.5 mg, 76% yield) with 82% ee.
'H NMR (CDC13, 300 MHz) 6 7.66-7.65 (m, 1H), 7.33-7.25 (m, 2H), 7.07 (d, J= 3.0 Hz,
1H), 6.50 (dd, J = 3.1, 0.7 Hz, 1H), 3.79 (s, 3H), 3.70-3.63 (m, 1H), 1.94 (d, J = 2.4 Hz, 3H),
1.86 (quintet, J= 7.2 Hz, 2H), 1.05 (t, J= 7.3 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 135.9, 133.9, 129.3, 128.7, 121.6, 119.6, 109.3, 101.0,
82.2, 78.1, 39.8, 33.1, 32.4, 12.3, 4.0.
IR (film) 2962, 2927, 2871, 2819, 2360, 2340, 1513, 1490 cm-1.
LRMS (EI) calcd for C15H1 7N (M+) 211, found 211.
Et
Me OMe
1-(Hex-3-yn-2-yl)-4-methoxybenzene (Table 2.12, entry 3). The compound was
prepared according to the General Procedure with (+)-2-bromohex-3-yne (80.5 mg, 0.5 mmol)
and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0 mmol). After purification by column
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chromatography (0 -* 4% Et20O in hexanes), the title compound was isolated as a colorless oil
(70.5 mg, 75% yield) with 93% ee.
[a]D22 = -2.7 (c = 0.5, CHC13). Chiral GC analysis of the product: Chirasil Dex CB
column; method: 100 'C - 130 'C @ 10 "C/min, hold 10 min, then -+ 170 "C @ 9 "C/min, hold
5 min, flow rate 1.0 mL/min; retention times: 15.8 min (major), 15.6 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(72.6 mg, 77% yield) with 89% ee.
1H NMR (CDC13, 300 MHz) 6 7.29 (d, J= 8.8 Hz, 2H), 6.86 (d, J= 8.8 Hz, 2H), 3.79 (s,
3H), 3.69 (qt, J= 7.1, 2.3 Hz, 1H), 2.22 (qd, J= 7.5, 2.2 Hz, 2H), 1.43 (d, J= 7.1, 3H), 1.15 (t, J
= 7.5 Hz, 3H).
13 C NMR (CDCl 3, 75 MHz) 6 158.4, 136.5, 128.0, 114.0, 83.7, 82.7, 55.5, 31.2, 25.2,
14.6, 12.8.
IR (film) 2973, 2935, 2839, 2361, 2339, 2057, 1734, 1676, 1601, 1511 cm .
LRMS (El) calcd for C13H160 (M+) 188, found 188.
OMe
1-(1-Cyclohexylpent-1-yn-3-yl)-4-methoxybenzene (Table 2.12, entry 4). The
compound was prepared according to the General Procedure with (+)-(3-Bromopent-1-
ynyl)cyclohexane (115 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0
mmol). After purification by column chromatography (0 -+ 5% Et20O in hexanes), the title
compound was isolated as a colorless oil (81.9 mg, 64% yield) with 89% ee.
[a]D 22 = +6.3 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OJ-H
column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 8.8 min (major), 12.8 min
(minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(77.6 mg, 61% yield) with 89% ee.
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IH NMR (CDC13, 300 MHz) 6 2.27 (d, J= 8.8 Hz, 2H), 6.84 (d, J= 8.8 Hz, 2H), 3.79 (s,
3H), 3.51 (ddd, J= 13.8, 5.9, 2.0 Hz, 1H), 2.47- 2.37 (m, 1H), 1.86-1.62 (m, 6H), 1.52-1.38 (m,
3H), 1.38-1.24 (m, 3H), 0.96 (t, J= 7.2 Hz, 3H).
13C NMR (CDC13, 75 MHz) 6 158.3, 135.3, 128.6, 113.8, 87.7, 81.9, 55.4, 38.7, 33.3,
32.4, 29.4, 26.2, 25.1, 11.9.
IR (film) 2927, 2853, 2361, 2339, 1884, 1611, 1508, 1448 cm-1.
LRMS (EI) calcd for C18H240 (M+) 256, found 256.
t-Bu
C )-- /Me3
1-(1-Chloro-7,7-dimethyloct-5-yn-4-yl)-4-methylbenzene (Table 2.12, entry 5). The
compound was prepared according to the General Procedure with (±)-5-bromo-8-chloro-2,2-
dimethyloct-3-yne (126 mg, 0.5 mmol) and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0
mmol). After purification by column chromatography (0 -- 5% Et20O in hexanes), the title
compound was isolated as a colorless oil (109.0 mg, 83% yield) with 92% ee.
[a]D2 2 = -2.6 (c = 1.0, CHC13). Chiral GC analysis of the product: Chirasil Dex CB
column; method: 100 'C --+ 170 'C @ 10 oC/min, hold 20 min, then - 190 'C @ 10 °C/min,
hold 5 min, flow rate 1.0 mL/min; retention times: 14.0 min (major), 13.8 min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(103.8 mg, 79% yield) with 91% ee.
1H NMR (CDC13, 300 MHz) 6 7.25 (d, J= 8.1 Hz, 2H), 7.12 (d, J = 7.8 Hz, 2H), 3.63-
3.55 (m, 2H), 3.54 (t, J= 6.3 Hz, 1H), 2.33 (s, 3H), 1.95-1.67 (m, 4H), 1.24 (s, 9H).
13C NMR (CDC13, 75 MHz) 6 139.7, 136.3, 129.3, 127.4, 92.7, 79.6, 45.2, 36.8, 36.4,
31.6, 30.5, 27.7, 21.3.
IR (film) 2967, 2361, 2340, 1684, 1607, 1456 cm-.
LRMS (EI) calcd for C 17H23C1 (M+) 262, found 262.
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Pent-1-yne-1,3-diyldibenzene (Table 2.12, entry 6). The compound was prepared
according to the General Procedure with (±)-(3-bromopent-1-ynyl)benzene (112 mg, 0.5 mmol)
and the arylzinc reagent (-0.5 M in glyme; 2.0 mL, 1.0 mmol). After purification by column
chromatography (0 -, 4% Et20 in hexanes), the title compound was isolated as a colorless oil
(92.1 mg, 84% yield) with 89% ee.
[a]D2 2 = -4.5 (c = 1.65, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OJ-
H column; solvent system: 100% hexanes; 1.0 mL/min; retention times: 21.7 min (major), 20.2
min (minor).
The second run was performed with (+)-L6. The product was isolated as a colorless oil
(89.0 mg, 81% yield) with 88% ee.
'H NMR (CDC13, 300 MHz) 6 7.47-7.25 (m, 10H), 3.79 (t, J= 7.5 Hz, 1H), 1.92-1.81 (m,
2H), 1.01 (t, J= 7.3 Hz, 3H).
'
3C NMR (CDC13, 75 MHz) 6 142.2, 131.9, 128.7, 128.0, 127.8, 126.9, 124.1, 91.7, 83.6,
40.2, 32.0, 12.2.
IR (film) 2968, 2361, 2339, 2200, 1684, 1598, 1559, 1490 cm-1.
LRMS (EI) calcd for C1 7H1 6 (M+) 220, found 220.
VI. Application: Formal synthesis of a dihydrofolate reductase inhibition ligand
TMS
Br
Me
(±)-(3-Bromobut-1-ynyl)trimethylsilane [CAS # 2004440-80-8] A 500 mL flask was
charged with imidazole (5.8 g, 85.0 mmol), evacuated, and back-filled with argon. CH 2C12 (350
mL) was added via syringe, followed by the addition of (±)-4-(trimethylsilyl)but-3-yn-2-ol (11.8
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ml, 70.4 mmol). This solution was allowed to stir for 15 minutes, then cooled to 0 oC (due to
scale). Next, dibromotriphenylphosphorane (36.0 g, 85.0 mmol) was added as a solid, the
reaction was then removed from the ice bath and allowed to stir at room temperature. The
reaction was run under argon and monitored by TLC. Upon completion (4 hours), the solvent
was removed under reduced pressure, and to the resultant solid was added 300 mL 1:1
Et2zO:hexanes. This was allowed to stir for 30 minutes, then the solid was filtered off and the
solution was concentrated to an oil. The product was then distilled at 40 oC (3.5 torr), 13.1 g
(92%) was collected as a colorless oil.
'H NMR (CDC13, 300 MHz) 8 4.59 (q, J= 7.0 Hz, 1H), 1.88 (d, J= 6.1 Hz, 3H), 0.16 (s,
9H).
H
OMe
OMe
5-(But-3-yn-2-yl)-1,2,3-trimethoxybenzene [CAS # 931103-15-01 (Scheme 2.27). In a
nitrogen glovebox, a 100 mL flask, equipped with a stirbar, was charged with NiCl2"glyme (33
mg, 0.150 mmol), (-)-L6 (77 mg, 0.195 mmol), then glyme (8.3 mL). This solution was stirred
for 10 minutes. Then the arylzinc reagent was added (0.5 M in glyme, 20.0 mL, 10.0 mmol) and
the flask was capped with a septum, and removed from the glovebox. This solution was stirred
for 10 minutes at room temperature then (+)-(3-bromobut-1-ynyl)trimethylsilane (1.03 g, 5.0
mmol) was added via syringe. The reaction was stirred for 6 h at room temperature. Then, the
excess arylzinc reagent was quenched with ethanol (2.0 mL). The mixture was passed through a
short plug of silica (eluting with 1:1 hexanes: Et20) to remove inorganic salts and most of the
glyme. The filtrate was concentrated, and to the resultant oil was added methanol (25.0 mL) and
K2CO 3 (2.0 g, 15.0 mmol), this heterogenous mixture was stirred at room temperature for one
hour. The solution was then diluted with EtOAc (-25 mL) and was washed with 1M HC1. The
aqueous layer was then extracted twice more with EtOAc and the combined organic fractions
were washed with brine and dried over MgSO 4 . The solid was filtered off and the solution was
concentrated to an oil, this oil was purified via column chromatography (20% Et20 in Hexanes).
Residual 1,2,3-trimethoxybenzene (protonated arylzinc reagent) was then removed under
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reduced pressure and gentle heating (200 mtorr, 50 oC). The product was obtained as a light
yellow oil: 0.725 g (66%, 92% ee).
[a]D2 2 = +12.6 (c = 1.0, CHC13). HPLC analysis of the product: Daicel CHIRALPAK OJ-
H column; solvent system: 1.0% IPA in hexanes; 1.0 mL/min; retention times: 25.0 min (major),
21.2 min (minor).
1H NMR (CDC13, 300 MHz) 6 6.61 (s, 2H), 3.87 (s, 6H), 3.83 (s, 3H), 3.71 (qd, J= 7.1,
2.5 Hz, 1H), 2.29 (d, J= 2.6 Hz, 1H), 1.51 (d, J= 7.2 Hz, 3H).
The second run was performed with (+)-L6. The product was isolated as a colorless oil:
0.757 mg (69% yield, 93% ee).
[a]D22 = -10.6 (c = 1.0, CHC13).
VII. Determination of Absolute Stereochemistry
Br
Me, -- Me 2.0 equivtZn
2.0 equiv
3.0% NiCI2-glyme
3.9% (-)-L6
glyme, -20 *C
H2 , Pd/C
Me Me
Result: [a]D22 = +15.8 (c = 1.0, heptane)
Literature: [a]D22 = +20.6 (c = 1.0, heptane)
(S)-Hexan-2-ylbenzene [CAS # 99439-78-8].
'H NMR (CDC13, 500 MHz) 6 7.31-7.17 (m, 5H), 2.68 (sextet, J= 6.9 Hz, 1H), 1.64-
1.50 (m, 2H), 1.33-1.11 (m, 7H), 0.86 (t, J= 7.0 Hz, 3H).
Reference for optical rotation: Pyne, S. G. J. Org. Chem. 1986, 51, 81-87.
Me B 2) PCC TMS
3) CBr 4, PPh 3
O Me 4) n-BuLi, TMSCI Me
t-Bu
(S)-Trimethyl(3-phenylhept-1-ynyl)silane.
See Section IV (eq 2.19) for characterization.
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For the synthesis of the starting material, refer to entry 3, table 2 in Dai, X; Strotman, N.A.; Fu,
G.C. J. Am. Chem. Soc. 2008, 130, 3302-3303.
Stereochemistry was assigned by comparison of the chiral GC elusion order of (S)-trimethyl(3-
phenylhept-1 -ynyl)silane with that observed in eq 2.19.
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F. H NMR Spectra for Selected Compounds
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wtfile
proc
fn 13
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
TIPS
Et
II
I ppm
4.12
19.51
7
1.00
I Ijiti
33
2.30
,'
STANDARD 1H OBSERVE
expi stdlh
SAMPLE
date Feb 17 2008
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat~
/Tsm-10-042-8-H.fl-
d
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPL W
sp 1.2
wp 2399.7
vs 151
sc 0
wc 250
hzmm 9.60
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
/i
DEC. & VT
dfrq 300.
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 131
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
BrEt
Et
.1.. 1
I I
7 6
1.00 3.66
2.32
2.50
3.38
ppm
L 1 1-
--- , I I I I I I I I I I I I
__,A j
I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 17 2008
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-10-042-9-H.fi~
d
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp 1.2
wp 2399.7
vs 151
sc 0
we 250
hzmm 9.60
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dam
dmf
temp
PROCESSING
wtfile
proc
fn 131
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
-J
5
2.07 4.16
2.07 2.95
TMS
Et0 2C )4
1.00
1.99
ppm
8.55
----- vl~vK
I I I I I 1 I I 1 i I I I I , , ,
f j
• ' ' I
STANDARD 1H OBSERVE
expl std1h
SAMPLE
date Feb 17 2008
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-~
/Tsm-10-042-10-H.f-
id
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
i1 n
in n
dp y
DISPLAY
sp 1.2
wp 2399.7
vs 151
sc 0
we 250
hzmm 9.60
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300.107
dn H1
dpwr 30
dof 0
dm nnn
dmm c
dmf 200
temp 20.0
PROCESSING
wtfile
proc ft
fn 131072
werr
wexp
wbs
wnt
TMS
E -- Br
Et
I '
5 4
2.01
1.00
2
6.24 4.17
2.09
[I~~~ - I- ' -1 I
7 5 ppm
2.84
8.35
I ' ' I .
I
I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Aug 27 2007
solvent CDC13
file /data/export/
home/gfu/Tsm/mrhat-
/Tsm-08-098.fid
ACQUISITION
sfrq 300.101
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp 2.2
wp 2398.5
vs 367
sc 0
wc 250
hzmm 9.59
is 204.10
rfl 600.4
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
PROCESSING
wtfile
proc
fn 131
werr
wexp
wbs
wnt
.100
Hi
30
0
nnn
c
200
ft
1072
TIPS
n-Bu
Eq 2.17
3 2 1 ppm
2.06 3.12
4.43 8.28
7
5.45
5
1.00
I I I I -I I I I 1 I I 1 I I I I I I I I r 1 I r
-j- 
STANDARD PROTON PARAMETERS
expl s2pul
SAMPLE
date Apr 9 2008
solvent CDC13
file /data/export/~-
home/gfu/Tsm/bullw~-
inkle/Tsm-10-100-H ~-
.fid
ACQUISITION
sfrq 499.746
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 32
ct 32
alock n
gain not used
FLAGS
11 n
In n
dp y
hs nn
DISPLAY
sp 2.5
wo 3990.5
sc
Uj wc
I hzmm
S is
rfl
rfp
th
ins
at ph
41
0
250
15.96
33.57
1233.8
0
7
1.000
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26
math
werr
wexp
wbs
wnt
.672
C13
30
0
nnn
w
0000
1.0
n
ft
2144
f
wft
TIPS
n-Bu
Eq 2.18
_~~}IL. __ L~I1J
7 6 5 4 3 2 1 ppm
4.73 2.34 3.43
5.00 8.541.00
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Feb 3 2008 dfrq 300.107
solvent COC13 dn H1
file /data/export/~- dpwr 30
home/gfu/Tsm/mrhat~ dof 0
/Tsm-10-007-H.fid dm nnn
ACQUISITION dmm c
sfrq 300.108 dmf 200
tn HI temp 20.0
at 4.003 PROCESSING
np 48052 wtfile
sw 6002.4 proc ft
fb not used fn 131072
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs
tof 867.7 wnt
nt 16
ct 16
alock n
gain not used
FLAGS
1i n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
TIPS
~h M e
n-Bu
Table 2.11, entry 1
5 4 3 2 1ppm
•p
1.00 2.16 3.33
'. i 
47
8.94
1 
.
7
2.01
1.97
6
--- --
-. 11 4.79
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb
solvent
file /data/E
home/gfu/Tsn
/TSm-10-017
ACQUISIT]
sfrq
tn
at
np
sw
fb nc
bs
tpwr
pw
dl
tof
nt
ct
alock
gain nc
FLAGS
11
in
dp DISPLA)
sp
wp
vs
sc
we
hzmm
Is
rfl
rfp
th
ins
nm ph
.107
H1
30
0
nnn
c
200
20.0
ft
1072
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
1.00
2.10
4.56 8.88
3.18
3 2008
CDC13
xport/-
/mrhat-
-H.fid
ON
00.108
H1
4.003
48052
6002.4
t used
8
54
8.0
0.050
867.7
16
16
n
t used
n
n
Y
-2.1
2402.1
1230
0
250
9.61
259.83
661.0
0
20
1.000
TIPS
n-Ble 2.11, entry 2
Table 2.11, entry 2
7 6
4.05
3.06
5
L
ppm
pp~m
. .. . L ......
I ' I I
L------J -. -.-.- J - --_ _ J
STANDARD 1H OBSERVE
expl std1h
SAMPLE DEC. & VT
date Feb 3 2008 dfrq 300.107
solvent CDC13 dn H1
file /data/export/- dpwr 30
home/gfu/Tsm/mrhat- dof 0
/Tsm-10-010-H.fid dm nnn
ACQUISITION dmm c
sfrq 300.108 dmf 200
tn H1 temp 20.0
at 4.003 PROCESSING
np 48052 wtfile
sw 6002.4 proc ft
fb not used fn 131072
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs
tof' 867.7 wnt
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
ill
TIPS
Me
Table 2.11, entry 3
6
2.11
1.00
2 1 ppm
-- r
' '
3.41
9.12
7
0.97
2.04
- _j_ 'ylr ~ U~-~
i I -i 1 I i -I I- I --I I I I ------I I
" " I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 3 2008
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-10-009-H.flid
ACQUISITION
sfrq 300.108
tn HI
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
tL is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13:
werr
wexp
wbs
wnt
fi
.107
H1
30
0
nnn
c
200
20.0
ft
1072
TIP
i-Pr
Table 2.11, entry 4
- ' I - - I I I
7 6 5 4 3 2
0.99
1.91
2.02
1 ppm
2.05 6.04
1.07 8.15
_ I__ I_
-r 7
1
1.00
-
I
STANDARD PROTON PARAMETERS
exp3 s2pul
SAMPLE DEC. & VT
date Mar 20 2008 dfrq 125.672
solvent CDCIS dn C13
file /data/gfu/Tsm- dpwr 30
/Tsm-10-066-2H.fid dof 0
ACQUISITION dm nnn
sfrq 499.746 dmm w
tn H1 dmf 10000
at 3.001 dseq
np 63050 dres 1.0
sw 10504.2 homo n
fb not used DEC2
bs 8 dfrq2 0
tpwr 59 dn2
pw 8.6 dpwr2 1
dl 2.000 dof2 0
tof 1519.5 dm2 n
nt 16 dmm2 C
Ct 16 dmf2 200
alock n dseq2
gain not used dres2 1.0
FLAGS homo2 n
il n DEC3
in n dfrq3 0
dp y dn3
hs nn dpwr3 1
DISPLAY dof3 0
sp 0.0 dm3 n
wp 4001.5 dmm3 c
vs 42 dmf3 200
sc 0 dseq3
wc 250 dresS 1.0
hzmm 16.01 homo3 n
is 33.57 PROCESSING
rfl 1233.8 wtfile
rfp 0 proc ft
th 7 fn 262144
ins 1.000 math f
ai cdc ph
werr
wexp
wbs
wnt wft
TIPS
n-BU
MeO
Table 2.11, entry 5
ii II d A -. I
7 6
LTJ LYrJ HT
0.98 1.06
1.02 1.01
5 3
L,4 Lyj
1.00
3.04
1.20 5.25
1.36 3.50
ppm
8.44
"Ii J I II|'
I
1 6"
STANDARD 1H OBSERVE
expl std1h
SAMPLE
date Feb 19 2008
solvent CDC13
file /data/export/~
home/gfu/Tsm/mrhat-
/Tsm-10-046-2-H.fi~
d
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct
alock
gain
11
in
dp
sp
wp
vs
sc
L WC
L hzmm
is
rfl
rfp
th
ins
nm
DEC. & VT
dfrq 300.107
dn H1
dpwr 30
dof 0
dm nnn
dmm c
dmf 200
temp 20.0
PROCESSING
wtfile
proc ft
fn 131072
werr
wexp
wbs
wnt
n
not used
FLAGS
n
n
y
DISPLAY
-2.6
2400.9
151
0
250
9.60
500.00
661.0
0
20
1.000
TMS
EtO2 C -)4 
/
Table 2.11, entry 6
Lj&
7 6 5
2.11
2.02 1.00
2.28
ppm
8.79
2.45 3.53
4.49 9.06
Lr4.16
4.16
-- - "-T-- I I I I ~I -r I I I I 1 I I 1 1 I ~I I I -I I I I I I I I I I
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 26 2008 dfrq
solvent CDCl3 dn
file /data/export/- dpwr
home/gfu/Tsm/mrhat- dof
/Tsm-10-047-2H.fid dm
ACQUISITION dmm
sfrq 300.108 dmf
tn H1I temp
at 4.003
np 48052 wtfil
sw 6002.4 proc
fb not used fn
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs
tof 867.7 wnt
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp 1.4
wp 2397.4
vs 151
sc 0
wc 250
hzmm 9.59
is 359.11
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
300
PROCESSING
le
13
.107
H1
30
0
nnn
c
200
20.0
ft
1072
TMS
Et
OMe
Table 2.11, entry 7
s "i Ji j"/
S' ' I I I I
7 6 5 4 3
1.16 1.00
2.14 2.16
3.24
1.00
ppm
9.474.59 7.31
2.03 3.33
------------ T- --
STANDARD 1H OBSERVE
expl std1h
SAMPLE
date Feb 3 2008 dfrq
solvent CDC13 dn
file /data/export/- dpwr
home/gfu/Tsm/mrhat- dof
/Tsm-10-015-H.fid dm
ACQUISITION dmm
sfrq 300.108 dmf
tn HI temp
at 4.003
np 48052 wtfi
sw 6002.4 proc
fb not used fn
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs
tof 867.7 wnt
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
ill
DEC. & VT
300.107
PROCESSING
le
13:
H1
30
0
nnn
c
200
20.0
ft
1072
Ph(Me)2 Si
n-BU
Eq 2.20
1 TT^7--~-~-~-~7-- 1I I - I I 1 -I
7 6 3 2 1 ppm
7.50
1.93
1.00 5.48
2.36 3.86
2.39 2.41
3.18
.....rrrl - - -
f
"1"~ T ' I I
.... -t
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 3 2008
solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-10-012-H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
TIPS
Bu 2 t-Bu
Eq 2.21
7 6 5 4 3
1.00
2 1 ppm
1.97 18.58
8.96 4.49
L37
3.77
__ __ _ __T__ ______
_ r_1 I
STANDARD 1H OBSERVE
expl stdlh
SANPLE
date Jul 3 2008
solvent CDCIS
file /data/export/-
home/gfu/Tsm/mrhat~
/Tsm-11-055-3H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp -1.4
wp 2404.5
vs 151
sc 0
wc 250
hzmm 9.62
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13.
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
TIPS
n-Bu
lid I
I I
7 6 5 4
1.00
I
3 2 1
4.53 8.40
3.07
Eq 2.22
ppm
L __
I
5.25
2.01
2. 01
~ki~
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 3 2008 d
solvent CDC13 d
file /data/export/~ d
home/gfu/Tsm/mrhat~ d
/Tsm-10-011-H.fid d
ACQUISITION d
sfrq 300.108 d
tn H1 t
at 4.003
np 48052 w
sw 6002.4 p
fb not used f
bs 8
tpwr 54 w
pw 8.0 w
dl 0.050 w
tof 867.7 w
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp 
-2.1
wp 2402.1
vs 151
SC 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
7
DEC. & VT
frq 300.107
n H1
pwr 30
of 0
m nnn
mm c
mf 200
emp 20.0
PROCESSING
tfile
roc ft
n 131072
err
exp
bs
nt
5
Me
TOIEt
Table 2.12, entfy I
4 3 2 1 ppm
4.28 2.97
2.12
1.02
1.92 1.00 3.07
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 10 2008
solvent CDC13
file /data/export/~
home/gfu/Tsm/mrhat-
/Tsm-10-025-H.fid
ACQUISITION
sfrq 300.108
tn HI
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 128
ct 64
alock n
gain not used
FLAGS
11 n
in n
dp y
DISPLAY
sp -2.4
wp 2405.5
vs 151
sc 0
wc 250
W hzmm 9.62
- is 500.00
S rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13.
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
Me
,Me
Et N
Table 2.12, entry 2
f f
. ........... -- - T 1 ---7
0.87 0.88
1.94 0.86
I I I I I I , I I I I - I I
5 4 3 2 1 ppm
LHL-- I
2.92
1.00
2.75
2.10
3.10
IrL -j
STANDARD 1H OBSERVE
expl stdlh
SAMPLE DEC. & VT
date Feb 3 2008 dfrq 300.107
solvent CDC13 dn H1
file /data/export/- dpwr 30
home/gfu/Tsm/mrhat- dof 0
/Tsm-10-004-H.fid dm nnn
ACQUISITION dmm c
sfrq 300.108 dmf 200
tn H1 temp 20.0
at 4.003 PROCESSING
np 48052 wtfile
sw 6002.4 proc ft
fb not used fn 131072
bs 8
tpwr 54 werr
pw 8.0 wexp
dl 0.050 wbs Et
tof 867.7 wnt
nt 16
ct 16
alock n OMe
gain not used Me
FLAGS
11 n
in n
dp y Table 2.12, entry 3
DISPLAY
sp 
-2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
V T -I -- - i T! I "- i - -.... I ' -" I , -
7 6 5 4 3 2 1 ppm
2.07 3.25 1.98 3.24
2.03 1.00 3.203.20
7
STANDARD 1H OBSERVE
expl std1h
SAMPLE
date Feb 3 2008
solvent CDC13
file /data/export/~
home/gfu/Tsm/mrhat-
/Tsm-10-005-H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
di 0.050
tof 867.7
nt 16
ct 16
alock
gain
"l
in
dp
sp
wp
vs
sc
wc
hzmm
Is
rfl
rfp
th
ins
nm
n
not used
FLAGS
n
n
y
DISPLAY
-2.1
2402.1
151
0
250
9.61
500.00
661.0
0
20
1.000
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
Et/--- OMe
Table 2.12, entry 4
I!f
6 5 4 3 2 1 ppm
1.053.14
1.00
3.62
6.71 3.78
L --~s-
-2.722.7 3.08
1.99
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 3 2008
Solvent CDC13
file /data/export/-
home/gfu/Tsm/mrhat~
/Tsm-10-006-H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
ii n
in n
dp y
DISPLAY
sp -2.1
wp 2402.1
vs 151
sc 0
wc 250
hzmm 9.61
is 500.00
rfl 661.0
rfp 0
th 20
ins 3.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13:
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
t-Bu
Tabl e 2.12, ent
Table 2.12, entry 5
6-~--1-~--- 3 I I 1 I I I T ~----~----^-_
3
3.29
ppm
4.46
3.00
7
2.67
1.91
I 1)W~-J V ---------- _~_ ~~~-~---~ I\ ~1*
663
10.51
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Feb 3 2008
solvent CDC13
file /data/export/
home/gfu/Tsm/mrhat-
/Tsm-10-016-H.fid
ACQUISITION
sfrq 300.108
tn Hi
at 4.003
np 48052
sw 6002.4
fb nct used
bs 8
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain nct used
FLAGS
ii n
in n
dp y
DISPLAN
sp -2.1
wp 2402.1
vs 151
sc 0
we 250
hzmm 9.61
is 102.09
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph I
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfilie
proc
fn 13
werr
wexp
wbs
wnt
I .11 I' I
3.41
2.27
.107
H1
30
0
nnn
c
200
20.0
ft
1072
Et
Table 2.12, entry 6
7
4.00
7.27
5
1.00
ppm
__I _ _ _ _~I___ ______~
I ' ' ' ' 1
STANDARD 1H OBSERVE
expl stdlh
SAMPLE
date Mar 28 2008
solvent CDCIS
file /data/export/-
home/gfu/Tsm/mrhat-
/Tsm-10-088-H.fid
ACQUISITION
sfrq 300.108
tn H1
at 4.003
np 48052
sw 6002.4
fb not used
bs 16
tpwr 54
pw 8.0
dl 0.050
tof 867.7
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
DISPLAY
sp 1.8
wp 2398.5
vs 151
sc 0
wc 250
hzmm 9.59
is 500.00
rfl 661.0
rfp 0
th 20
ins 1.000
nm ph
DEC. & VT
dfrq 300
dn
dpwr
dof
dm
dmm
dmf
temp
PROCESSING
wtfile
proc
fn 13
werr
wexp
wbs
wnt
.107
H1
30
0
nnn
c
200
20.0
ft
1072
H
OMe
OMe
Me
OMe
14
7 6
1.94
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Conclusion
The primary objective of the work presented in this thesis was to discover and develop
new processes for the construction of carbon-carbon bonds. Specifically, we were most
interested in catalytic methods. The ability to construct a bond between two molecules, which in
the absence of a catalyst, would be unreactive toward one another is truly a powerful means by
which to generate, and control, the complexity of many organic compounds. This work centered
on the application of two families of catalysts: organocatalysts and transition metal catalysts. The
first family used, organocatalysts, falls into a smaller classification which is nucleophilic
catalysts; meaning, the reactivity that these catalysts enable is accessed through the facility of a
nucleophile to generate reactive intermediates. The second type of catalysis developed was
transition metal catalysis; specifically, we made use of nickel-based catalysts to generate bonds
between organic electrophiles and organometallic nucleophiles.
Nucleophilic Catalysis
This thesis described the development of two organocatalytic processes. The first
methodology presented was a P-alkylation reaction of Michael acceptors, catalyzed by a
nucleophilic N-heterocyclic carbene (NHC). The role of the NHC was to facilitate an umpolung
process in which the normally electrophilic P position of a Michael acceptor becomes
nucleophilic and can displace an alkyl electrophile to generate a carbon-carbon bond. This
methodology, in a similar vein to the groundbreaking work on homoenolates by Bode and
Glorius, opens the door for continued exploration of the reactivity this P-nuclophilic intermediate
possesses.
The second organocatalytic process described also represents an umpolung process,
although in this case the catalyst was a nucleophilic phosphine. This method for the
intermolecular y-alkylation of isomerizable allenoates represents a solution to a challenge
presented over 17 years ago when Trost first reported a phosphine-catalyzed isomerization of
alkynoates to dienoates. Not only have a set of reaction conditions been developed for the
construction of carbon-carbon bonds in this fashion, it has been done in a highly asymmetric
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fashion. Thus, a variety of racemic allenoates may be alkylated with nitromethane in
enantiomeric excesses greater than 90%, in good to excellent yields.
Transition Metal Catalysis
In the sections on nickel-catalyzed cross-coupling reactions we described a number of
"firsts" in the field. We began with the development of an asymmetric alkylation of secondary
propargylic halides, and although the results never matched our expectations a number of highly
interesting observations were made regarding the regioselectivity of these nickel-catalyzed
processes. We have described the ability to control the production of proparglic or allenic
products through selection of the appropriate ligand, an option not amenable to palladium
catalysis for this family of electrophiles.
As can be seen, our building frustration during the development of the asymmetric
alkylation reaction encouraged us to explore a greater diversity of cross-coupling reactions of
propargylic halides and resulted in a number of satisfying discoveries. The first of these resulted
in the description of the first alkyl-alkyl secondary-secondary cross-coupling reaction.
Specifically, secondary propargylic electrophiles were coupled with secondary organozinc
reagents, through the application of a nickel-based catalyst system, allowing for the construction
of two contiguous tertiary carbon centers. Furthermore, this new reaction allowed us to complete
a concise synthesis of a biologically active diterpene in significantly fewer steps than were
required in previous studies.
The synthetic value of alkyl-alkyl cross-coupling reactions will undoubtably grow as two
things happen; the first is the ability to couple evermore sterically demanding reaction partners.
Secondly, once more sterically demanding reaction partners can be coupled, the ability to control
the absolute stereochemistry of the newly formed stereogenic centers is of immense importance.
The final section of this thesis describes our development of the first asymmetric Negishi
arylation of a secondary alkyl electrophile. It was found that a nickel-Pybox complex was
capable of coupling secondary propargylic halides with mixed zinc reagents, generated though
the transmetalation of arylboronic acids, with excellent levels of enantioselectivity. Of further
interest was that this process was amenable to a wide range of differentially substituted
propargylic halides, including: silyl-, alkyl- and aryl-substituted propargylic halides. This
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arylation reaction allows facile access to a new family of antibiotics developed by Wright and
Anderson, and has found applications in their ongoing studies.
Final Comment
The purpose of developing new reaction methodology is not only to gain understanding
of, and control over, the reactivity of the elements, but also to decrease the difficulty of
constructing compounds of human interest. It is our sincere hope that the work contained in this
thesis has met this ideal.
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